Psyllid ID: psy5102

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------
Protein Sequence
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENERNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKSAL
Secondary Structure (PSIPRED)
cccHHHHHcHHHHHHHHHHHHHHHHHHHHcccccccEEEccHHHHHHHHHHHccccHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccEEEEEEEcccccccccccccccccccccEEcccccEEEEEcccccEEEEEEEcccccHHHHHHHccHHHHHHHHHccccEEEEEEEEcEEEEcccccHHHHHcccccccccccccccccccccccEEEEEEEEEEEEEEcccHHHHHHHHHHHHccccccEEEccccEEEEEEEcccccEEEEEEEcccccccccccccccHHHHHHHccEEEEEEcccccccHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEcHHHHHHHHHHHHHcccHHHHHHHHHHHcHcHHccHHHccccccccHHHHHHHHHHHHHHHHHHHHccccccccccEcccEEEEEEcccccccccccHHHHcccccccEEcccEEEEEEccccccEEEEEEEcccccHHHHHHHccHHHHHHHHHHccccEEEEEcccEEEEccccHHHHHHHccccccccccccccHHHHccccEEEEEEEEEEEEEEcccEEEEEEEEEEEEEcccccEEEccccEEEEEEEccccEEEEEEEEcccccccccccccccccHHHHcccccEEEccccHcHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKnqnvvfapLSIVGALALVLlgsdgqtkdELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKnqnvvfapLSIVGALALVLlgsdgqtkdELTHFMGvatgrslsnnpEAYASFLEKMRNEVYMYFilpknpdlseftkdldydKFSRIIEstnkvdviytipkmkvtssTELRTVLNTMNVtsmfdvsksdlsnmlddrgvavdQVFHKVDIEVTEQGTVAAASTGIIitriskptvkinrpfiffiyhkptdsivfwgsiykpepqrpyhenernneaeELYQSEifrldfgnpasarFVNNYILSATKSAL
Flexible Loop (DISEMBL)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVatgrslsnkltahslrrGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMgvatgrslsnnPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIiestnkvdviytipkmkvtsstelrtVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEvteqgtvaaastgiiitriskptvkiNRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENERNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKSAL
Low Complexity Region (SEG)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENERNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKSAL
Disordered region (IsUnstruct)
**HFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYK*******************YQSEIFRLDFGNPASARFVNNYIL*******
Disordered Region (DISOPRED)
**H****SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYK*****************ELYQSEIFRLDFGNPASARFVNNYILSATKS**
Disordered Region (DISEMBL)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENERNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKSAL
Disordered Region (DISPRO)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQ*******RNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKS**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYHFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENERNNEAEELYQSEIFRLDFGNPASARFVNNYILSATKSAL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	357	2.2.26 [Sep-21-2011]
B3RFC3	397	Serpin B10 OS=Sorex arane	N/A	N/A	0.436	0.392	0.373	1e-20
B4USX2	397	Serpin B10 OS=Otolemur ga	N/A	N/A	0.442	0.397	0.341	4e-20
A9RA96	397	Serpin B10 OS=Papio anubi	N/A	N/A	0.442	0.397	0.341	7e-19
A5PJK0	397	Serpin B10 OS=Bos taurus	yes	N/A	0.445	0.400	0.321	1e-18
B1MTC3	397	Serpin B10 OS=Callicebus	N/A	N/A	0.442	0.397	0.329	1e-18
B2KI30	397	Serpin B10 OS=Rhinolophus	N/A	N/A	0.445	0.400	0.333	2e-18
Q8K1K6	397	Serpin B10 OS=Mus musculu	yes	N/A	0.369	0.332	0.364	2e-18
B0CMB0	397	Serpin B10 OS=Callithrix	no	N/A	0.439	0.395	0.321	2e-17
Q5BIR5	374	Serpin B8 OS=Bos taurus G	no	N/A	0.403	0.385	0.348	2e-17
P48595	397	Serpin B10 OS=Homo sapien	no	N/A	0.442	0.397	0.323	6e-17

>sp|B3RFC3|SPB10_SORAR Serpin B10 OS=Sorex araneus GN=SERPINB10 PE=3 SV=1

 Score =  100 bits (249), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 95/166 (57%), Gaps = 10/166 (6%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI---- 205
           P+A    L+    ++ +  ILP++   L +  K + YD+ S    ++  +  +YT+    
Sbjct: 234 PQATGLRLDYKNRDLSLLLILPEDVCGLDQLEKAITYDQLSEW--TSEDMMEMYTVELHL 291

Query: 206 PKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVA 265
           PK K+  S +L+T L +M ++  F+ SK+D S M D+R + +  VFHK  +E+ EQGT A
Sbjct: 292 PKFKLEQSYDLKTTLASMGMSDAFNQSKADFSGMSDERNLYLSNVFHKSFVEINEQGTEA 351

Query: 266 AA-STGIIITRISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
           AA S   I  RI  PT++IN   PFIFFI H  T+SI+F+G    P
Sbjct: 352 AAGSASEISVRIKLPTIEINADHPFIFFIRHNKTNSILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.
Sorex araneus (taxid: 42254)

>sp|B4USX2|SPB10_OTOGA Serpin B10 OS=Otolemur garnettii GN=SERPINB10 PE=3 SV=1

 Score = 99.4 bits (246), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 95/164 (57%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPK 207
           P+A    L   R +V ++ +LP++   L +  K + Y+K +    +      DV  ++PK
Sbjct: 234 PQATGLQLYYERRDVSLFILLPEDLGGLEQLEKAITYEKLNEWTSADMMELYDVQLSLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F+ SK+D S M  +R + +  +FHKV +E+ E+GT AAA
Sbjct: 294 FKLEESYDLKSTLSSMGMSDAFNPSKADFSGMSLERNLYLSNIFHKVFVEINEEGTEAAA 353

Query: 268 STGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
            TG  +  RI  P+++ N   PF+FFI H  T+SI+F+G    P
Sbjct: 354 GTGSEVGFRIKYPSIEFNVDHPFLFFIRHNKTNSILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Otolemur garnettii (taxid: 30611)

>sp|A9RA96|SPB10_PAPAN Serpin B10 OS=Papio anubis GN=SERPINB10 PE=3 SV=1

 Score = 95.1 bits (235), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 93/164 (56%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIES--TNKVDVIYTIPK 207
           P+A    L     ++ +  +LP++ + L +  KD+ Y+K +    +      +V   +PK
Sbjct: 234 PQAVGLQLYYKSRDLSLLILLPEDINGLVQLEKDITYEKLNEWTSADMMELYEVQLHLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F  SK+D S M   R + +  VFHK  +E+ EQGT AAA
Sbjct: 294 FKLEDSYDLKSTLSSMGMSDAFSQSKADFSGMSSARNLFLSNVFHKAFVEINEQGTEAAA 353

Query: 268 STGI-IITRISKPTVKI--NRPFIFFIYHKPTDSIVFWGSIYKP 308
            TG  I +RI  P+++   N PF+FFI H  T+SI+F+G +  P
Sbjct: 354 GTGSEIESRIRVPSIEFNANHPFLFFIRHNKTNSILFYGRLCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Papio anubis (taxid: 9555)

>sp|A5PJK0|SPB10_BOVIN Serpin B10 OS=Bos taurus GN=SERPINB10 PE=2 SV=1

 Score = 94.7 bits (234), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 93/165 (56%), Gaps = 6/165 (3%)

Query: 150 NPEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIES--TNKVDVIYTIP 206
           +P+A    L     ++ +  +LP++ D L +  K + Y+K S    +      +V   +P
Sbjct: 233 SPQAMGLQLYYESRDLSLLILLPEDVDGLDQLEKTITYEKLSEWTSADMMELCNVQLNLP 292

Query: 207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA 266
           K K+  + +L++ L++M ++  F+ SK+D S M  +R + +  VFHK  +E+ EQGT AA
Sbjct: 293 KFKLEETYDLKSTLSSMGMSDAFNQSKADFSGMSSERNLFLSNVFHKCFVEINEQGTEAA 352

Query: 267 ASTGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
           A TG  ++ R+  P+++ N   PF+FFI H  T+ I+F+G    P
Sbjct: 353 AGTGSEVSVRMKLPSIEFNADHPFLFFIRHNKTNGILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Bos taurus (taxid: 9913)

>sp|B1MTC3|SPB10_CALMO Serpin B10 OS=Callicebus moloch GN=SERPINB10 PE=3 SV=1

 Score = 94.4 bits (233), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 93/164 (56%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIEST--NKVDVIYTIPK 207
           P+A    L     ++ ++ +LP++ + L +  K + Y+K S+   +      DV   +PK
Sbjct: 234 PQALGLQLYYKSCDLSLFILLPEDINGLEQLEKAITYEKLSKWTSADMMEVYDVQLHLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F  S++D S M   R + +  VFHK  +E+ EQGT AAA
Sbjct: 294 FKLEESYDLKSTLSSMGMSDAFSESEADFSGMSSARNLFLSNVFHKAFVEIDEQGTEAAA 353

Query: 268 STGIIIT-RISKPTVKI--NRPFIFFIYHKPTDSIVFWGSIYKP 308
            +G  I+ RI  P+++   N PF+FFI H  T++I+F+G    P
Sbjct: 354 GSGSEISFRIKVPSIEFNANHPFLFFIRHNKTNNILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Callicebus moloch (taxid: 9523)

>sp|B2KI30|SPB10_RHIFE Serpin B10 OS=Rhinolophus ferrumequinum GN=SERPINB10 PE=3 SV=1

 Score = 94.0 bits (232), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 93/165 (56%), Gaps = 6/165 (3%)

Query: 150 NPEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIEST--NKVDVIYTIP 206
           NP+A    L     ++ ++ +LP++   L +  K + Y+K S    +      DV   +P
Sbjct: 233 NPQAIGLQLYYESRDLSLFLLLPEDVSGLDQLEKAVTYEKLSEWTSADMMELYDVQLHLP 292

Query: 207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA 266
           K K+  S +L++ L++M ++  F+ SK+D S M  +  + +  VFHK  +E+ EQGT A+
Sbjct: 293 KFKLEESYDLKSALSSMGMSDAFNQSKADFSGMSVEGNLFLSNVFHKSFVEINEQGTEAS 352

Query: 267 ASTGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
           A TG  ++ RI  P+++ N   PF+FFI H  T+SI+F+G    P
Sbjct: 353 AGTGSEVSLRIRLPSIEFNADHPFLFFIRHNKTNSILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Rhinolophus ferrumequinum (taxid: 59479)

>sp|Q8K1K6|SPB10_MOUSE Serpin B10 OS=Mus musculus GN=Serpinb10 PE=2 SV=1

 Score = 94.0 bits (232), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 50/137 (36%), Positives = 79/137 (57%), Gaps = 5/137 (3%)

Query: 177 LSEFTKDLDYDKFSRIIEST--NKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKS 234
           L +  + + Y+K  +   +   +  +V   +PK K+  S +L++ L  M +T +F  SK+
Sbjct: 261 LEQLERAITYEKLDKWTSADMMDTYEVQLYLPKFKMEESYDLKSALRGMGMTDVFSQSKA 320

Query: 235 DLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKIN--RPFIFFI 291
           D SNM  +R + +  VFHK  +E+ E+GT AAA TG  I+ RI  P++++N   PF+FFI
Sbjct: 321 DFSNMTSERNLFLSNVFHKTFLEINEEGTEAAAGTGSEISVRIKAPSIELNVDHPFLFFI 380

Query: 292 YHKPTDSIVFWGSIYKP 308
            H  T SI+F G    P
Sbjct: 381 RHNKTKSILFCGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Mus musculus (taxid: 10090)

>sp|B0CMB0|SPB10_CALJA Serpin B10 OS=Callithrix jacchus GN=SERPINB10 PE=3 SV=1

 Score = 90.5 bits (223), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 94/165 (56%), Gaps = 8/165 (4%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYT---IP 206
           P+A    L     ++ ++ +LP++ + L +  K + Y+K +    S + ++V +    +P
Sbjct: 234 PQALGLQLYYKSRDLSLFILLPEDINGLEQLEKAITYEKLNEWT-SADMMEVYHVQLHLP 292

Query: 207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA 266
           K K+  S +L++ L++M +   F  SK+D S M   R + +  VFHK  +E+ EQGT AA
Sbjct: 293 KFKLEESYDLKSTLSSMGMRDAFSESKADFSGMSSARNLFLSNVFHKAFVEIDEQGTEAA 352

Query: 267 ASTGIIIT-RISKPTVKI--NRPFIFFIYHKPTDSIVFWGSIYKP 308
           A +G  I+ R+  P+++   N PF+FFI H  T++I+F+G    P
Sbjct: 353 AGSGSEISFRMKVPSIEFNANHPFLFFIRHNKTNNILFYGRFCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Callithrix jacchus (taxid: 9483)

>sp|Q5BIR5|SPB8_BOVIN Serpin B8 OS=Bos taurus GN=SERPINB8 PE=2 SV=1

 Score = 90.5 bits (223), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 86/152 (56%), Gaps = 8/152 (5%)

Query: 164 EVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKV---DVIYTIPKMKVTSSTELRTV 219
           E+ M  +LP +N DL+   K L Y+KF R   S  K+    V   +P++K+ +S +L   
Sbjct: 224 ELSMLILLPDENTDLAVVEKALTYEKF-RTWTSPEKLTEEKVQVFLPRLKLEASYDLEAF 282

Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII-TRISK 278
           L ++ +T  F+ +K+D S M   + V + +V HK  +EV E+GT AA +T ++  +R  +
Sbjct: 283 LRSLGMTDAFEEAKADFSGMSAKKNVPMSKVAHKCFVEVNEEGTEAAGATAVVRNSRCCR 342

Query: 279 --PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             P    + PF+FFI H+ T+SI+F G    P
Sbjct: 343 MEPKFCADHPFLFFIRHRETNSILFCGRFSSP 374

Bos taurus (taxid: 9913)

>sp|P48595|SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1

 Score = 88.6 bits (218), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 91/164 (55%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIEST--NKVDVIYTIPK 207
           P+A    L     ++ +  +LP++ + L +  K + Y+K +    +      +V   +PK
Sbjct: 234 PKAVGLQLYYKSRDLSLLILLPEDINGLEQLEKAITYEKLNEWTSADMMELYEVQLHLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F  SK+D S M   R + +  VFHK  +E+ EQGT AAA
Sbjct: 294 FKLEDSYDLKSTLSSMGMSDAFSQSKADFSGMSSARNLFLSNVFHKAFVEINEQGTEAAA 353

Query: 268 STGIII-TRISKPTVKI--NRPFIFFIYHKPTDSIVFWGSIYKP 308
            +G  I  RI  P+++   N PF+FFI H  T++I+F+G +  P
Sbjct: 354 GSGSEIDIRIRVPSIEFNANHPFLFFIRHNKTNTILFYGRLCSP 397

Protease inhibitor that may play a role in the regulation of protease activities during hematopoiesis and apoptosis induced by TNF. May regulate protease activities in the cytoplasm and in the nucleus.

Homo sapiens (taxid: 9606)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	357
193688350	532	PREDICTED: plasminogen activator inhibit	0.515	0.345	0.388	1e-27
357615598	444	serine protease inhibitor 6 [Danaus plex	0.501	0.403	0.357	5e-20
389608417	413	serine protease inhibitor 5 [Papilio xut	0.840	0.726	0.251	7e-19
218551711	397	RecName: Full=Serpin B10 gi|190576556|gb	0.436	0.392	0.373	9e-19
218551708	397	RecName: Full=Serpin B10 gi|196050404|gb	0.442	0.397	0.341	2e-18
229368692	374	serine proteinase inhibitor, clade B, me	0.406	0.387	0.370	3e-18
395830701	397	PREDICTED: serpin B10 [Otolemur garnetti	0.442	0.397	0.341	4e-18
344242554	302	Serpin B13 [Cricetulus griseus]	0.795	0.940	0.264	5e-18
301613964	392	PREDICTED: serpin B4-like [Xenopus (Silu	0.450	0.410	0.374	6e-18
344243138	339	Serpin B9 [Cricetulus griseus]	0.725	0.764	0.264	7e-18

>gi|193688350|ref|XP_001946416.1| PREDICTED: plasminogen activator inhibitor 1-like [Acyrthosiphon pisum]

 Score =  130 bits (326), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/188 (38%), Positives = 104/188 (55%), Gaps = 4/188 (2%)

Query: 127 SDGQTKDELTHFMGVATGRSLSNNPEAY---ASFLEKMRNEVYMYFILPK-NPDLSEFTK 182
           S  Q KD +   M V +   L +  E     A  L    N+   YF+LP  N  LS  T 
Sbjct: 331 SSKQNKDCIYVQMMVGSSEVLFHKNEGLEFKAIGLPYKGNQFITYFVLPDTNISLSSLTA 390

Query: 183 DLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD 242
            ++      I  +    ++ Y +PKM + S T LR VL  + +  MFD SK+DLSNM  D
Sbjct: 391 KMNGKTIKNITRTAKITELTYFVPKMTLKSLTNLRPVLQNLGINKMFDPSKADLSNMASD 450

Query: 243 RGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFW 302
            G  +  + H+V+I+V E GTVA+A+T + ITR  +    IN+PFIFFI+H  +D++VFW
Sbjct: 451 PGSYISDILHQVEIDVNEIGTVASAATVVTITRGGQTIFNINKPFIFFIHHVESDTVVFW 510

Query: 303 GSIYKPEP 310
            ++YKP P
Sbjct: 511 STVYKPMP 518

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357615598|gb|EHJ69744.1| serine protease inhibitor 6 [Danaus plexippus]

 Score =  105 bits (261), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/190 (35%), Positives = 103/190 (54%), Gaps = 11/190 (5%)

Query: 130 QTKDELTHFMGVATGRSLSNNPEAYASFLE--KMRNEVYMYFILPK---NPDLSEFTKDL 184
           +T+  LTHFM          N E  A  LE     N++ MY +LP       ++    +L
Sbjct: 255 ETRQTLTHFMRQKGQFHFMVNDELGAQILELPYKGNDISMYILLPPYSMKEGVNNIIANL 314

Query: 185 DYDKFSRIIESTN-KVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR 243
             ++ + ++E      +V+  IPK  +  S +LR +L  + V  +F+ S SD S M++DR
Sbjct: 315 TPERLAAVVEEGYLGREVVVEIPKFTIERSLQLRPILERLGVGDLFNAS-SDFSTMMEDR 373

Query: 244 GVAVDQVFHKVDIEVTEQGTVAAASTGII---ITRISKPTVKI-NRPFIFFIYHKPTDSI 299
           GV  D   HK  I+V E+GTVAAA+T I     +R ++PTV I N PF++ IY KPT+S+
Sbjct: 374 GVIFDDAVHKAKIQVDEEGTVAAAATAIFGFRSSRPAEPTVFIANFPFVYIIYEKPTNSV 433

Query: 300 VFWGSIYKPE 309
           +F G    P+
Sbjct: 434 LFMGVFRDPK 443

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|389608417|dbj|BAM17818.1| serine protease inhibitor 5 [Papilio xuthus]

 Score =  100 bits (250), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 96/381 (25%), Positives = 160/381 (41%), Gaps = 81/381 (21%)

Query: 8   SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFM 67
           S + L RG  + TL +   I   M  + N+ F+P S+  AL L   G+ GQT+  L   +
Sbjct: 34  SRMSLYRGQLEFTLHLFNEINK-MVPDDNIFFSPFSVYHALLLGYFGAGGQTEQSLKRSL 92

Query: 68  GVATGRSLSNKLTAHSLRR---------------GITQMTLDMERAIRSVM--------- 103
            +A      N +TA+ + +                + +M +D    +R  M         
Sbjct: 93  KIAEKMDKINLMTAYKVDKTSRAMNNNSDSYEFTSVNKMFVDRSITVRQCMLDALSAEIE 152

Query: 104 ----------------------TKNQNVVFAPLSIVGALALVLLGSDG------------ 129
                                 TKN    F P   +  +  ++L +              
Sbjct: 153 ALNFQGQPGESREYINDWVSRVTKNNIKDFLPPYAISQVTRMVLANAAYFKGLWASKFLP 212

Query: 130 -QTKDE----------LTHFMGVATGRSLSNNPEAYASFLE--KMRNEVYMYFILPK--- 173
            +TK E          LT+FM          N +  A  LE     N++ MY  LP    
Sbjct: 213 ERTKKEPFFVSESRQTLTYFMKQKGTFHYMVNDDLGAQILELPYKGNDISMYIFLPPYSM 272

Query: 174 NPDLSEFTKDLDYDKFSRIIE-STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
              ++    +L  ++ + ++E S    +V+  IPK  +  S  ++ VL  + V  +F+ S
Sbjct: 273 KEGVTNIIANLTPERLAAVVEESFMGREVVVEIPKFTMERSLPIKGVLQALGVGDLFN-S 331

Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII---ITRISKPTVKI-NRPFI 288
            +D + + DDRG+  D   HK  I++ E+GTVAAA+T I     +R ++P+V I N PF+
Sbjct: 332 SADFTTLTDDRGILFDDAIHKAKIQIDEEGTVAAAATAIFGFRSSRPAEPSVFIANFPFV 391

Query: 289 FFIYHKPTDSIVFWGSIYKPE 309
           + IY +PT+S++F G    P+
Sbjct: 392 YVIYERPTNSVLFMGVYRDPK 412

Source: Papilio xuthus

Species: Papilio xuthus

Genus: Papilio

Family: Papilionidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|218551711|sp|B3RFC3.1|SPB10_SORAR RecName: Full=Serpin B10 gi|190576556|gb|ACE79048.1| MGC159890 protein (predicted) [Sorex araneus]

 Score =  100 bits (249), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 95/166 (57%), Gaps = 10/166 (6%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI---- 205
           P+A    L+    ++ +  ILP++   L +  K + YD+ S    ++  +  +YT+    
Sbjct: 234 PQATGLRLDYKNRDLSLLLILPEDVCGLDQLEKAITYDQLSEW--TSEDMMEMYTVELHL 291

Query: 206 PKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVA 265
           PK K+  S +L+T L +M ++  F+ SK+D S M D+R + +  VFHK  +E+ EQGT A
Sbjct: 292 PKFKLEQSYDLKTTLASMGMSDAFNQSKADFSGMSDERNLYLSNVFHKSFVEINEQGTEA 351

Query: 266 AA-STGIIITRISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
           AA S   I  RI  PT++IN   PFIFFI H  T+SI+F+G    P
Sbjct: 352 AAGSASEISVRIKLPTIEINADHPFIFFIRHNKTNSILFYGRFCSP 397

Source: Sorex araneus

Species: Sorex araneus

Genus: Sorex

Family: Soricidae

Order: Insectivora

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|218551708|sp|B4USX2.1|SPB10_OTOGA RecName: Full=Serpin B10 gi|196050404|gb|ACG64313.1| serine proteinase inhibitor, clade B, member 10 (predicted) [Otolemur garnettii]

 Score = 99.4 bits (246), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 95/164 (57%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPK 207
           P+A    L   R +V ++ +LP++   L +  K + Y+K +    +      DV  ++PK
Sbjct: 234 PQATGLQLYYERRDVSLFILLPEDLGGLEQLEKAITYEKLNEWTSADMMELYDVQLSLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F+ SK+D S M  +R + +  +FHKV +E+ E+GT AAA
Sbjct: 294 FKLEESYDLKSTLSSMGMSDAFNPSKADFSGMSLERNLYLSNIFHKVFVEINEEGTEAAA 353

Query: 268 STGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
            TG  +  RI  P+++ N   PF+FFI H  T+SI+F+G    P
Sbjct: 354 GTGSEVGFRIKYPSIEFNVDHPFLFFIRHNKTNSILFYGRFCSP 397

Source: Otolemur garnettii

Species: Otolemur garnettii

Genus: Otolemur

Family: Galagidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|229368692|gb|ACQ62978.1| serine proteinase inhibitor, clade B, member 8 isoform a (predicted) [Dasypus novemcinctus]

 Score = 99.0 bits (245), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/151 (37%), Positives = 84/151 (55%), Gaps = 6/151 (3%)

Query: 164 EVYMYFILPK-NPDLSEFTKDLDYDKFSRII--ESTNKVDVIYTIPKMKVTSSTELRTVL 220
           E+ M  +LP  N DL+   K+L Y+KF   I  E   K  V   IPK+K+  + +L ++ 
Sbjct: 224 ELSMVILLPDDNTDLTVLEKELTYEKFRAWINPEKMTKSKVQVFIPKLKLEENYDLESIF 283

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS--- 277
            ++ +T  FD +K+D S M   + V V +V HK  +EV E+GT AAA+T ++    S   
Sbjct: 284 QSLGMTDAFDKAKADFSGMSTKKNVPVSKVAHKCFVEVNEEGTEAAAATTVVRNSRSCRV 343

Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            P  + + PF+FFI H  T SI+F G  + P
Sbjct: 344 GPIFRADHPFLFFILHNSTKSILFLGRFFSP 374

Source: Dasypus novemcinctus

Species: Dasypus novemcinctus

Genus: Dasypus

Family: Dasypodidae

Order: Cingulata

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|395830701|ref|XP_003788457.1| PREDICTED: serpin B10 [Otolemur garnettii]

 Score = 98.6 bits (244), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 6/164 (3%)

Query: 151 PEAYASFLEKMRNEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPK 207
           P+A    L   R +V ++ +LP++   L +  K + Y+K +    +      DV  ++PK
Sbjct: 234 PQATGLQLYYERRDVSLFILLPEDLGGLEQLEKAITYEKLNEWTSADMMELYDVQLSLPK 293

Query: 208 MKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA 267
            K+  S +L++ L++M ++  F+ SK+D S M  +R + +  VFHK  +E+ E+GT AAA
Sbjct: 294 FKLEESYDLKSTLSSMGMSDAFNPSKADFSGMSLERNLYLSNVFHKAFVEINEEGTEAAA 353

Query: 268 STGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
            TG  +  RI  P+++ N   PF+FFI H  T+SI+F+G    P
Sbjct: 354 GTGSEVGFRIKYPSIEFNVDHPFLFFIRHNKTNSILFYGRFCSP 397

Source: Otolemur garnettii

Species: Otolemur garnettii

Genus: Otolemur

Family: Galagidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|344242554|gb|EGV98657.1| Serpin B13 [Cricetulus griseus]

 Score = 98.2 bits (243), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 143/314 (45%), Gaps = 30/314 (9%)

Query: 11  ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELT---HFM 67
           +     T+ TL++   +R      +N+  +P SI+ ALA++ LG+ G TK ++     F 
Sbjct: 3   LFAEATTKFTLELYWQLRET---EKNIFCSPTSIMAALAMLELGAKGNTKQQIEKVLQFN 59

Query: 68  GVATGRSLSNKLTAH-----SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALAL 122
           G AT ++       H     S+     Q+   + +   +   K+ N      SI GA   
Sbjct: 60  G-ATKKTTEKSTDCHDEKSESVHHQFQQLMTQVNKPNDAYDLKSAN------SIYGAKDF 112

Query: 123 VLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLE--KMRNEVYMYFILPKNPD-LSE 179
             L    Q   +    M   +  +++   +  A  +E      E+ M+ +LP   D L +
Sbjct: 113 PFL----QNSSKPVQMMKQRSNFNINLLEDVQAKIVEIPYKGKELSMFILLPDEIDGLKK 168

Query: 180 FTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLS 237
               L  DK        N  KV++  ++P+ KV    +L   L  M +   F+  K+D S
Sbjct: 169 LEDKLTADKLIEWASPQNMYKVELYLSLPRFKVEEKYDLTAPLEHMGMVDAFNPQKADFS 228

Query: 238 NMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS---KPTVKINRPFIFFIYHK 294
            M   +G++V +V HK  +EVTE+GT AAA+TG+ ++  S      +  + P++FFI H+
Sbjct: 229 GMSGSQGLSVTKVLHKSFVEVTEEGTEAAAATGVEVSLTSALRNEVITCDHPYLFFIKHR 288

Query: 295 PTDSIVFWGSIYKP 308
             ++I F G +  P
Sbjct: 289 KFNTIFFLGRMVCP 302

Source: Cricetulus griseus

Species: Cricetulus griseus

Genus: Cricetulus

Family: Cricetidae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|301613964|ref|XP_002936465.1| PREDICTED: serpin B4-like [Xenopus (Silurana) tropicalis]

 Score = 97.8 bits (242), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/171 (37%), Positives = 95/171 (55%), Gaps = 10/171 (5%)

Query: 147 LSNNPEAYASFLEKMRNEVY-MYFILPKNPD-LSEFTKDLDYDKFSRI--IESTNKVDVI 202
           L +NPE     L+    E + M  ILP + D L+E    L Y+ F+++  ++ T +V V+
Sbjct: 223 LGSNPELKCRILKLPYEEGFSMKIILPDDIDGLAELETHLTYETFTKLMDLQRTREVQVV 282

Query: 203 YTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG 262
             +P+ K   +  L  VL +M +TS F    ++LS + D  G+A+  V HK  IEV E+G
Sbjct: 283 VKLPQFKFGETYSLTEVLQSMGMTSAFH--GANLSGISDKAGLAISTVVHKSYIEVNEEG 340

Query: 263 TVAAASTGIIITRISKPTVK----INRPFIFFIYHKPTDSIVFWGSIYKPE 309
           T AAA+TGI IT  S P       ++RPF+F I H  T S++F+G    PE
Sbjct: 341 TEAAAATGIGITVTSAPLPPQEFIVDRPFLFCIEHISTKSLLFYGRFTFPE 391

Source: Xenopus (Silurana) tropicalis

Species: Xenopus (Silurana) tropicalis

Genus: Xenopus

Family: Pipidae

Order: Anura

Class: Amphibia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|344243138|gb|EGV99241.1| Serpin B9 [Cricetulus griseus]

 Score = 97.8 bits (242), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 143/299 (47%), Gaps = 40/299 (13%)

Query: 25  RAIRSVMTKN--QNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAH 82
           R ++++   N  +NV ++P+SI  ALA+VLLG+ G T  ++T  +G+ T           
Sbjct: 66  RLLKTLCQNNPSENVCYSPVSISSALAMVLLGAKGDTAVQITQALGLNT---------EE 116

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQ-----TKDELTH 137
            + +G   +  ++ +  R    +  N +FA  +        L+  + +      +++  H
Sbjct: 117 DIHQGFQGLLSNLNKPNRKYSLRVANRLFAENTCE------LIPKEKRPVQMMCREDTFH 170

Query: 138 FMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNP-DLSEFTKDLDYDKFSR----- 191
              V       N  +A    +     E+ M  +LP +  DLS+    L ++K +      
Sbjct: 171 LAYV-------NEVQAQVLVMPYEGMELSMVVLLPDDGVDLSKLENSLTFEKLTAWTRPD 223

Query: 192 IIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVF 251
            ++STN V+V   +PK K+    ++ +V   + +  +F   K+DLS M  +R + V +  
Sbjct: 224 FMKSTN-VEVF--LPKFKLQEDYDMESVFQQLGMVDVFHRDKADLSGMSPERDLCVSKFV 280

Query: 252 HKVDIEVTEQGTVAAASTGIIITRISK--PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           HK  +EV E+GT AAA++ +I    +   PT   + PF+FFI H  T+S++F G    P
Sbjct: 281 HKSVVEVNEEGTEAAAASAVIEFCCASVVPTFCADHPFLFFIRHNKTNSLLFCGRFSSP 339

Source: Cricetulus griseus

Species: Cricetulus griseus

Genus: Cricetulus

Family: Cricetidae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	357
MGI|MGI:2138648	397	Serpinb10 "serine (or cysteine	0.422	0.380	0.343	5.1e-24
RGD|1309833	375	Serpinb8 "serpin peptidase inh	0.403	0.384	0.370	6.1e-23
UNIPROTKB|A5PJK0	397	SERPINB10 "Serpin B10" [Bos ta	0.445	0.400	0.321	6.8e-23
UNIPROTKB|F1P1L7	401	F1P1L7 "Uncharacterized protei	0.417	0.371	0.320	7.9e-23
UNIPROTKB|F5GY69	190	SERPINB11 "Serpin B11" [Homo s	0.369	0.694	0.350	1.8e-22
UNIPROTKB|E1BTF2	408	SERPINB12 "Uncharacterized pro	0.296	0.259	0.390	3.3e-22
RGD|1562868	387	Serpinb3a "serine (or cysteine	0.403	0.372	0.355	3.9e-22
MGI|MGI:894657	374	Serpinb8 "serine (or cysteine)	0.406	0.387	0.350	1.1e-21
UNIPROTKB|F1MG91	416	SERPINB2 "Uncharacterized prot	0.406	0.348	0.335	1.2e-21
UNIPROTKB|F1PH86	421	SERPINA3 "Uncharacterized prot	0.305	0.258	0.405	1.9e-21

MGI|MGI:2138648 Serpinb10 "serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 10" [Mus musculus (taxid:10090)]

 Score = 242 (90.2 bits), Expect = 5.1e-24, Sum P(2) = 5.1e-24
 Identities = 54/157 (34%), Positives = 88/157 (56%)

Query:   158 LEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSR--IIESTNKVDVIYTIPKMKVTSST 214
             L     ++ +  +LP+  D L +  + + Y+K  +    +  +  +V   +PK K+  S 
Sbjct:   241 LHYQNRDLSLLLLLPEAIDGLEQLERAITYEKLDKWTSADMMDTYEVQLYLPKFKMEESY 300

Query:   215 ELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             +L++ L  M +T +F  SK+D SNM  +R + +  VFHK  +E+ E+GT AAA TG  I+
Sbjct:   301 DLKSALRGMGMTDVFSQSKADFSNMTSERNLFLSNVFHKTFLEINEEGTEAAAGTGSEIS 360

Query:   275 -RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
              RI  P++++N   PF+FFI H  T SI+F G    P
Sbjct:   361 VRIKAPSIELNVDHPFLFFIRHNKTKSILFCGRFCSP 397

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IBA

GO:0005575 "cellular_component" evidence=ND

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0010466 "negative regulation of peptidase activity" evidence=IEA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

GO:0030414 "peptidase inhibitor activity" evidence=ISO

GO:0045861 "negative regulation of proteolysis" evidence=ISO

RGD|1309833 Serpinb8 "serpin peptidase inhibitor, clade B (ovalbumin), member 8" [Rattus norvegicus (taxid:10116)]

 Score = 232 (86.7 bits), Expect = 6.1e-23, Sum P(2) = 6.1e-23
 Identities = 57/154 (37%), Positives = 89/154 (57%)

Query:   163 NEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIE----STNKVDVIYTIPKMKVTSSTELR 217
             +E+ M  +LP ++ DL+   K L Y+K          + +KV V +  P++K+  S +L 
Sbjct:   224 DELSMVVLLPDESSDLTVVEKALTYEKLRAWTNPETLTESKVQVFF--PRLKLEESYDLE 281

Query:   218 TVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII-TRI 276
             TVL ++ +T  F+ +K+D S M   + V V +V HK  +EV E+GT AAA+T +I  TR 
Sbjct:   282 TVLQSLGMTDAFEETKADFSGMTSKKNVPVSKVAHKCFVEVNEEGTEAAATTAVIRNTRS 341

Query:   277 SK--PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              +  P    +RPF+FFI+H+ T SI+F G    P
Sbjct:   342 CRIEPRFCADRPFLFFIWHQKTSSILFCGRFSSP 375

GO:0003674 "molecular_function" evidence=ND

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISO;IBA

GO:0005575 "cellular_component" evidence=ND

GO:0005737 "cytoplasm" evidence=IBA

GO:0005829 "cytosol" evidence=IEA;ISO

GO:0008150 "biological_process" evidence=ND

GO:0010951 "negative regulation of endopeptidase activity" evidence=ISO;IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

UNIPROTKB|A5PJK0 SERPINB10 "Serpin B10" [Bos taurus (taxid:9913)]

 Score = 241 (89.9 bits), Expect = 6.8e-23, Sum P(2) = 6.8e-23
 Identities = 53/165 (32%), Positives = 93/165 (56%)

Query:   150 NPEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLDYDKFSR--IIESTNKVDVIYTIP 206
             +P+A    L     ++ +  +LP++ D L +  K + Y+K S     +     +V   +P
Sbjct:   233 SPQAMGLQLYYESRDLSLLILLPEDVDGLDQLEKTITYEKLSEWTSADMMELCNVQLNLP 292

Query:   207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA 266
             K K+  + +L++ L++M ++  F+ SK+D S M  +R + +  VFHK  +E+ EQGT AA
Sbjct:   293 KFKLEETYDLKSTLSSMGMSDAFNQSKADFSGMSSERNLFLSNVFHKCFVEINEQGTEAA 352

Query:   267 ASTGIIIT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
             A TG  ++ R+  P+++ N   PF+FFI H  T+ I+F+G    P
Sbjct:   353 AGTGSEVSVRMKLPSIEFNADHPFLFFIRHNKTNGILFYGRFCSP 397

GO:0030162 "regulation of proteolysis" evidence=ISS

GO:0010951 "negative regulation of endopeptidase activity" evidence=ISS

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

UNIPROTKB|F1P1L7 F1P1L7 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 226 (84.6 bits), Expect = 7.9e-23, Sum P(2) = 7.9e-23
 Identities = 52/162 (32%), Positives = 92/162 (56%)

Query:   158 LEKMRNEVYMYFILPKNPDLSEFT-------KDLDYDKFSRIIESTN--KVDVIYTIPKM 208
             L  + NE+ M+ +LP   D+S+ T       ++L ++K +    S    KV+V   +PK+
Sbjct:   242 LPYVENELSMFVLLPD--DISDNTTGLELVERELTHEKLAEWSNSARMMKVEVELYLPKL 299

Query:   209 KVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
             K+  + +L + L+ M + + FD  ++D + M   +   + +V HK  +EV E+GT AAA+
Sbjct:   300 KIEENYDLTSTLSNMGIQNAFDPVQADFTRMSAKKDFFLSKVIHKAFVEVNEEGTEAAAA 359

Query:   269 TGIIITRISKP--TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             TG+++ R   P  T K + PF+FFI H  + +I+F+G +  P
Sbjct:   360 TGVLVLRSRTPRVTFKADHPFLFFIRHNKSKTILFFGRLCSP 401

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

UNIPROTKB|F5GY69 SERPINB11 "Serpin B11" [Homo sapiens (taxid:9606)]

 Score = 205 (77.2 bits), Expect = 1.8e-22, Sum P(2) = 1.8e-22
 Identities = 48/137 (35%), Positives = 78/137 (56%)

Query:   177 LSEFTKDLDYDKFSRIIESTNKVD--VIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKS 234
             L +  K L+   F     S+N ++  V   +P+ K+ +  EL ++L ++ VT +F+  K+
Sbjct:    54 LEKIEKQLNSGTFHEWTSSSNMMEREVEVHLPRFKLETKYELNSLLKSLGVTDLFNQVKA 113

Query:   235 DLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT---VKINRPFIFFI 291
             DLS M   +G+ + +  HK  ++V+E+GT AAA+TG  I   S P     K N PF+FFI
Sbjct:   114 DLSGMSPTKGLYLSKAIHKSYLDVSEEGTEAAAATGDSIAVKSLPMRAQFKANHPFLFFI 173

Query:   292 YHKPTDSIVFWGSIYKP 308
              H  T++I+F G +  P
Sbjct:   174 RHTHTNTILFCGKLASP 190

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

UNIPROTKB|E1BTF2 SERPINB12 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 222 (83.2 bits), Expect = 3.3e-22, Sum P(2) = 3.3e-22
 Identities = 43/110 (39%), Positives = 68/110 (61%)

Query:   202 IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQ 261
             +Y +P+ K+  +  L  VL  M +T +F  SK+DLS +  ++ + +  + HK  +EV E+
Sbjct:   300 VY-LPRFKLEGTFNLNEVLKAMGMTDIFSESKADLSALSSEKSLVLSNIVHKAYVEVNEE 358

Query:   262 GTVAAASTGIIITRISKPTVKI---NRPFIFFIYHKPTDSIVFWGSIYKP 308
             GT AAA+TG  I R S P +++   +RPF+FFI H PT +I+F+G    P
Sbjct:   359 GTTAAAATGATIVRRSLPLIEVFIADRPFLFFIRHNPTSTILFFGKFCSP 408

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

RGD|1562868 Serpinb3a "serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A" [Rattus norvegicus (taxid:10116)]

 Score = 220 (82.5 bits), Expect = 3.9e-22, Sum P(2) = 3.9e-22
 Identities = 54/152 (35%), Positives = 84/152 (55%)

Query:   164 EVYMYFILPKNPD-LSEFTKDLDYDK---FSRIIESTNKVDVIYTIPKMKVTSSTELRTV 219
             E+ M+ +LP   D L +  + L  DK   ++R  E+ N +D+  ++P+ KV    +L   
Sbjct:   237 ELSMFILLPMEIDGLKKLEEQLTADKLLEWTRA-ENMNMIDLYLSLPRFKVEEKYDLPGP 295

Query:   220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
             L  M +   FD  K+D S M   +G+ V +V HK  +EV E+GT AAA+TG+ ++  S  
Sbjct:   296 LQHMGMVDAFDSKKADFSGMSSTQGLMVSKVLHKSFVEVNEEGTEAAAATGVEVSLTSAQ 355

Query:   280 -TVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
              T   N   PF+F I H  T+SI+F+G +  P
Sbjct:   356 ITEDFNCDHPFLFLIKHNATNSILFFGRMSSP 387

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IBA

GO:0005576 "extracellular region" evidence=IBA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

MGI|MGI:894657 Serpinb8 "serine (or cysteine) peptidase inhibitor, clade B, member 8" [Mus musculus (taxid:10090)]

 Score = 219 (82.2 bits), Expect = 1.1e-21, Sum P(2) = 1.1e-21
 Identities = 53/151 (35%), Positives = 84/151 (55%)

Query:   164 EVYMYFILP-KNPDLSEFTKDLDYDKFSRII--ESTNKVDVIYTIPKMKVTSSTELRTVL 220
             E+ M  +LP ++ DL+   K L Y+K       E+  +  V   +P++K+  S +L TVL
Sbjct:   224 ELSMVILLPDESTDLAVVEKALTYEKLRAWTNPETLTESQVQVFLPRLKLEESYDLETVL 283

Query:   221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RI--S 277
               + +T  F+ +++D S M   + V V +V HK  +EV E+GT AAA+T +I   R   +
Sbjct:   284 QNLGMTDAFEETRADFSGMTTKKNVPVSKVAHKCFVEVNEEGTEAAAATAVIRNARCCRT 343

Query:   278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +P    + PF+FFI+H  T SI+F G    P
Sbjct:   344 EPRFCADHPFLFFIWHHKTSSILFCGRFSSP 374

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISO;IBA

GO:0005737 "cytoplasm" evidence=IBA

GO:0005829 "cytosol" evidence=ISO

GO:0010466 "negative regulation of peptidase activity" evidence=IEA

GO:0010951 "negative regulation of endopeptidase activity" evidence=ISO;IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

GO:0030414 "peptidase inhibitor activity" evidence=IEA

UNIPROTKB|F1MG91 SERPINB2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 228 (85.3 bits), Expect = 1.2e-21, Sum P(2) = 1.2e-21
 Identities = 52/155 (33%), Positives = 81/155 (52%)

Query:   164 EVYMYFILP-----KNPDLSEFTKDLDYDKFSRIIESTNKV--DVIYTIPKMKVTSSTEL 216
             +V M+ +LP      +  L     ++ YDK ++ +        DV+  IP+ K+    EL
Sbjct:   262 DVSMFLLLPDGIAESSTGLEMLESEITYDKLNKWLSKDTMAEDDVVVYIPEFKLEEHYEL 321

Query:   217 RTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-R 275
             +T+L +M +   F   +++ S M     + + +VFH+  +EV E+GT AAA TG I+T R
Sbjct:   322 KTILTSMGMGDAFSQGRANFSGMSGKNDLFLSEVFHQASVEVNEEGTEAAAGTGAIMTGR 381

Query:   276 ISK--PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                  P    + PF+FFI HK T SI+FWG    P
Sbjct:   382 TGHGGPQFVADHPFLFFIMHKITKSILFWGRFASP 416

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

UNIPROTKB|F1PH86 SERPINA3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 217 (81.4 bits), Expect = 1.9e-21, Sum P(2) = 1.9e-21
 Identities = 47/116 (40%), Positives = 73/116 (62%)

Query:   198 KVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIE 257
             ++D +Y +PK  ++SS  L  VL  + V  +F  +++DLS +   + +AV Q+ HK  ++
Sbjct:   305 RIDNLY-LPKFSISSSYNLEDVLPQLGVREVF-TNEADLSRVTGHKNLAVSQIVHKTLLD 362

Query:   258 VTEQGTVAAASTGIIITRISK---P--TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             VTE GT AAA+TG  +   S    P  TV+ NRPF+F I+HK T++I+FWG +  P
Sbjct:   363 VTELGTEAAAATGSKVVFFSGKIGPLVTVRFNRPFLFCIHHKDTENILFWGKVTNP 418

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	357
pfam00079	369	pfam00079, Serpin, Serpin (serine protease inhibit	2e-40
cd00172	364	cd00172, SERPIN, SERine Proteinase INhibitors (ser	3e-38
smart00093	359	smart00093, SERPIN, SERine Proteinase INhibitors	5e-38
cd02059	389	cd02059, ovalbumin_like, The ovalbumin_like group	7e-27
COG4826	410	COG4826, COG4826, Serine protease inhibitor [Postt	3e-25
cd02058	380	cd02058, PAI-2, Plasminogen Activator Inhibitor-2	3e-24
cd02044	370	cd02044, ov-serpin, ovalbumin family of serpins (o	5e-24
cd02051	377	cd02051, PAI-1_nexin-1, Plasminogen activator inhi	7e-23
cd02049	364	cd02049, bacterial_SERPIN, SERine Proteinase INhib	1e-22
cd02056	361	cd02056, alpha-1-antitrypsin_like, alpha-1-antitry	2e-20
cd02048	388	cd02048, neuroserpin, Neuroserpin is a inhibitory	7e-18
cd02057	372	cd02057, maspin_like, Maspin (mammary serine prote	5e-17
cd02045	381	cd02045, antithrombin-III_like, Antithrombin is a	1e-14
cd02055	365	cd02055, PZI, Protein Z-dependent protease inhibit	2e-11
cd02043	381	cd02043, plant_SERPIN, SERine Proteinase INhibitor	4e-11
cd02053	351	cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) i	6e-10
cd02052	374	cd02052, PEDF, Pigment epithelium-derived factor (	9e-10
PHA02948	373	PHA02948, PHA02948, serine protease inhibitor-like	2e-09
cd02047	436	cd02047, HCII, Heparin cofactor II (HCII) inhibits	3e-09
cd02054	372	cd02054, angiotensinogen, Angiotensinogen is part	3e-09
cd02050	352	cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protea	2e-07
cd00172	364	cd00172, SERPIN, SERine Proteinase INhibitors (ser	5e-07
pfam00079	369	pfam00079, Serpin, Serpin (serine protease inhibit	6e-07
pfam00079	369	pfam00079, Serpin, Serpin (serine protease inhibit	2e-06
cd00172	364	cd00172, SERPIN, SERine Proteinase INhibitors (ser	3e-06
cd02046	366	cd02046, hsp47, Heat shock protein 47 (Hsp47), als	7e-06
smart00093	359	smart00093, SERPIN, SERine Proteinase INhibitors	5e-05
smart00093	359	smart00093, SERPIN, SERine Proteinase INhibitors	5e-05
cd02048	388	cd02048, neuroserpin, Neuroserpin is a inhibitory	7e-05
cd02058	380	cd02058, PAI-2, Plasminogen Activator Inhibitor-2	1e-04
cd02058	380	cd02058, PAI-2, Plasminogen Activator Inhibitor-2	1e-04
cd02048	388	cd02048, neuroserpin, Neuroserpin is a inhibitory	1e-04
cd02059	389	cd02059, ovalbumin_like, The ovalbumin_like group	4e-04
cd02059	389	cd02059, ovalbumin_like, The ovalbumin_like group	4e-04
cd02043	381	cd02043, plant_SERPIN, SERine Proteinase INhibitor	4e-04
cd02043	381	cd02043, plant_SERPIN, SERine Proteinase INhibitor	5e-04
PHA02660	364	PHA02660, PHA02660, serpin-like protein; Provision	0.001

>gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor)

 Score =  145 bits (369), Expect = 2e-40
 Identities = 53/153 (34%), Positives = 77/153 (50%), Gaps = 7/153 (4%)

Query: 162 RNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPKMKVTSSTELRT 218
           +  + M  ILP +   L E  K L  +     + S    KV     +PK K+ SS +L+ 
Sbjct: 218 KGNLSMLIILPDEGGGLEELEKSLTAELLEEWLSSLKPRKVREELYLPKFKIESSYDLKE 277

Query: 219 VLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK 278
           VL  + +T  F  SK+D S +     + V +V HK  IEV E+GT AAA+TG++I   + 
Sbjct: 278 VLKKLGITDAFS-SKADFSGISSSEPLYVSKVVHKAFIEVNEEGTEAAAATGVVIVPRAP 336

Query: 279 ---PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              P    +RPF+F I    T SI+F G +  P
Sbjct: 337 PPPPEFVADRPFLFLIRDNSTGSILFMGRVVNP 369

Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369

>gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

 Score =  139 bits (353), Expect = 3e-38
 Identities = 50/143 (34%), Positives = 78/143 (54%), Gaps = 5/143 (3%)

Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M  ILPK    L+E  + L  +K   ++ +  + +V  T+PK K+ SS +L+ VL  + +
Sbjct: 223 MLIILPKEVTGLAELEEKLSAEKLDDLLSNLKEREVEVTLPKFKIESSLDLKEVLQALGI 282

Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK---PTVK 282
           T +F    +DLS++  D  + V +V HK  IEV E+GT AAA+T + I           K
Sbjct: 283 TDLFS-PSADLSSISSDEPLYVSKVIHKAFIEVNEEGTEAAAATAVSIVPRRPSPPVEFK 341

Query: 283 INRPFIFFIYHKPTDSIVFWGSI 305
            +RPF+F I    T +I+F G +
Sbjct: 342 ADRPFLFLIRDDTTGTILFLGRV 364

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364

>gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors

 Score =  139 bits (352), Expect = 5e-38
 Identities = 53/147 (36%), Positives = 80/147 (54%), Gaps = 2/147 (1%)

Query: 163 NEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNT 222
               M  ILP    L +  K L  +   + ++S  K  V   +PK K+  + +L+ VL  
Sbjct: 214 GNASMLIILPDEGGLEKLEKALTPETLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEK 273

Query: 223 MNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-TV 281
           + +T +F  +K+DLS + +D+ + V +V HK  +EV E+GT AAA+TG+I    S P   
Sbjct: 274 LGITDLFS-NKADLSGISEDKDLKVSKVLHKAVLEVNEEGTEAAAATGVIAVPRSLPPEF 332

Query: 282 KINRPFIFFIYHKPTDSIVFWGSIYKP 308
           K NRPF+F I    T SI+F G +  P
Sbjct: 333 KANRPFLFLIRDNKTGSILFMGKVVNP 359

Length = 359

>gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

 Score =  109 bits (274), Expect = 7e-27
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 10/150 (6%)

Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTN----KVDVIYTIPKMKVTSSTELRTVLN 221
           M  +LP     L +    L Y+K      S N    KV+V   +P+ K+     L++VL 
Sbjct: 242 MIVLLPDEISGLEQLESKLTYEKLMEWTSSENMRERKVEV--YLPRFKLEEKYNLKSVLK 299

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT- 280
            M +T +F  SK+DLS +   + + + +  HK  +EV E+GT AAA+TG  I   S P  
Sbjct: 300 AMGMTDIFSESKADLSGISSSKSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSLPVS 359

Query: 281 --VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              + + PF+FFI H  T++I+F+G    P
Sbjct: 360 EEFRADHPFLFFIRHNKTNTILFFGRFSSP 389

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389

>gnl|CDD|227163 COG4826, COG4826, Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones]

 Score =  104 bits (262), Expect = 3e-25
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 8/185 (4%)

Query: 133 DELTHFMGVATGR-SLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSR 191
           ++ +  M    G  +     +A    L    +++ MY +LPK+ +++EF  +   +K++ 
Sbjct: 227 EDKSVDMMSICGDFNYGETSKAKIVELPYKGDDLSMYIVLPKDNNITEFENNFTLEKYTE 286

Query: 192 IIESTNKVDVIYT-IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV 250
           +  +    D +   IPK K  + TEL+  L  M V   F+ + ++ S + D R + +  V
Sbjct: 287 LKSNMEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFE-NTANFSGISDRR-LEISDV 344

Query: 251 FHKVDIEVTEQGTVAAASTGIII----TRISKPTVKINRPFIFFIYHKPTDSIVFWGSIY 306
           FH+  I+V E+GT AAA+T ++      +       ++ PF+F I  + +  I+F G + 
Sbjct: 345 FHQAFIDVDEEGTEAAAATAVVFKAVCAKGGWVEFVVDHPFLFVIEDRRSGCILFIGKVV 404

Query: 307 KPEPQ 311
            PE +
Sbjct: 405 NPEYE 409

Length = 410

>gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2)

 Score =  101 bits (254), Expect = 3e-24
 Identities = 53/159 (33%), Positives = 86/159 (54%), Gaps = 16/159 (10%)

Query: 163 NEVYMYFILP-----KNPDLSEFTKDLDYDKFSRIIESTN-----KVDVIYTIPKMKVTS 212
            E+ M+ +LP         L +  K+L Y+K +   E T+     + +V   +PK K+  
Sbjct: 225 KELSMFILLPDEIEDVTTGLEKLEKELTYEKLN---EWTSPEMMEEYEVEVYLPKFKLEE 281

Query: 213 STELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII 272
           S +L++ L++M +   FD  K+D S M     + + +VFHK  +EV E+GT AAA+T  I
Sbjct: 282 SYDLKSTLSSMGMEDAFDPGKADFSGMSSANDLFLSKVFHKAFVEVNEEGTEAAAATAAI 341

Query: 273 IT-RISKPTVKIN--RPFIFFIYHKPTDSIVFWGSIYKP 308
           +  R   P+ + N   PF+FFI H  T++I+F+G    P
Sbjct: 342 MMLRCLMPSPRFNADHPFLFFIRHNKTNTILFFGRFCSP 380

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380

>gnl|CDD|238999 cd02044, ov-serpin, ovalbumin family of serpins (ov-serpins)

 Score =  101 bits (252), Expect = 5e-24
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 8/148 (5%)

Query: 167 MYFILPKN-PDLSEFTKDLDYDKFSRIIEST----NKVDVIYTIPKMKVTSSTELRTVLN 221
           M+ +LP     L +   +++Y+K ++    +     KV V   +P+ K+    +L++VL 
Sbjct: 225 MFILLPDEVTGLEKLESEINYEKLNKWTSPSTMAEAKVKV--YLPRFKMEKMYDLKSVLE 282

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPT 280
           ++ +   F   +++ S M + +G+A+  V HK  +E+ E GT AA  TG ++  R  K  
Sbjct: 283 SLGMKDAFSEGRANFSGMSETKGLALSNVIHKASLEINEDGTEAAEVTGAVMLQRSVKEE 342

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              + PF+F I H  T+ I+F+G    P
Sbjct: 343 FNADHPFLFIIRHNKTNCILFFGKFSSP 370

Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 370

>gnl|CDD|239006 cd02051, PAI-1_nexin-1, Plasminogen activator inhibitor-1_like

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 3/149 (2%)

Query: 163 NEVYMYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
             + M   LP  K+  LS     +        + +     +   +PK  V + T+L+  L
Sbjct: 229 ESISMLIALPTEKSTPLSAIIPHISTKTIQSWMGTMVPKRMQLVLPKFTVEAETDLKEPL 288

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTG-IIITRISKP 279
             + +T MFD SK++ + +     + V     K  IEV E GT A+A+T  I+I R S P
Sbjct: 289 KALGITDMFDQSKANFTKISRSESLHVSHALQKAKIEVNEDGTKASAATTAILIARSSPP 348

Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              ++RPF+FFI H PT +I+F G I KP
Sbjct: 349 WFIVDRPFLFFIRHNPTGTILFMGQINKP 377

Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 377

>gnl|CDD|239004 cd02049, bacterial_SERPIN, SERine Proteinase INhibitors (serpins), prokaryotic subgroup

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 53/162 (32%), Positives = 80/162 (49%), Gaps = 7/162 (4%)

Query: 150 NPEAYASFLEKMRNEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKM 208
            P   A  L      + MY  LPK N  L EF K L  +K+ + IE     +   ++P+ 
Sbjct: 204 TPGFQAVRLPYGDGRLSMYVFLPKENVSLREFVKTLTAEKWRKWIEQFRMREGSLSLPRF 263

Query: 209 KVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           ++    ELR  L  + +   F    +D S +  +  + + +V HK  IEV E+GT AAA+
Sbjct: 264 QLEYEIELRDALKALGMEEAFTPDAADFSKL-GEGNLYISKVIHKTFIEVNEEGTEAAAA 322

Query: 269 TGIIITRISKP-----TVKINRPFIFFIYHKPTDSIVFWGSI 305
           T + IT  S P     T+  +RPF+F I    T SI+F G++
Sbjct: 323 TSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSILFMGAV 364

Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. Length = 364

>gnl|CDD|239011 cd02056, alpha-1-antitrypsin_like, alpha-1-antitrypsin_like

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 45/143 (31%), Positives = 78/143 (54%), Gaps = 7/143 (4%)

Query: 167 MYFILPKNPDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
            +F+LP    + +    L  D   +  +      VD+   +PK  ++ +  L+ +L  M 
Sbjct: 222 AFFVLPDEGKMKQVEAALSRDTLKKWSKLLSKRSVDLY--LPKFSISGTYNLKDILPKMG 279

Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK--PTVK 282
           +T +F   K+DLS + +   + V +  HK  ++V E+GT AAA+TG+ IT +S   P +K
Sbjct: 280 ITDVFS-DKADLSGITEQPNLKVSKAVHKAVLDVDEKGTEAAAATGVEITPMSALPPILK 338

Query: 283 INRPFIFFIYHKPTDSIVFWGSI 305
            NRPF+  I+ + T+SI+F G +
Sbjct: 339 FNRPFLLLIFDRTTESILFLGKV 361

This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 361

>gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 5/153 (3%)

Query: 163 NEVYMYFILPKNP-DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +E+ +  IL +    L+     +          S  K  V   +P+ KV    +L+ VL 
Sbjct: 227 DEISLMIILSRQEVPLATLEPLVKAPLIEEWANSVKKQKVEVYLPRFKVEQKIDLKDVLK 286

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRI---SK 278
            + +T +F    +DLS + D + + V +VFHKV +EV E+G+ AAAS+G+I         
Sbjct: 287 NLGITEIFSGG-ADLSGISDSKELYVSKVFHKVFLEVNEEGSEAAASSGMIAISRMAVLY 345

Query: 279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQ 311
           P V ++ PF F I ++ T SI+F G +  PE  
Sbjct: 346 PQVIVDHPFFFLIRNRRTGSILFMGRVMHPETM 378

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388

>gnl|CDD|239012 cd02057, maspin_like, Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 12/151 (7%)

Query: 167 MYFILPKNPD-----LSEFTKDLDYDKFSRIIE----STNKVDVIYTIPKMKVTSSTELR 217
           M  +LPK+ +     L +  K L  +  S+       +  KV V  ++PK KV    +L+
Sbjct: 225 MLILLPKDIEDESTGLEKLEKQLTSESLSQWTNPSMMANAKVKV--SLPKFKVEKMIDLK 282

Query: 218 TVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            +L ++ +  +F+   SD S M + +GVA+  V HKV +EV E G  +    G  I +  
Sbjct: 283 AMLESLGLKHIFNEDASDFSGMSETKGVALSNVIHKVCLEVNEDGGESIEVPGARILQ-H 341

Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           K     + PFIF I H  T +I+F+G    P
Sbjct: 342 KDEFNADHPFIFIIRHNKTRNIIFFGRFCSP 372

Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372

>gnl|CDD|239000 cd02045, antithrombin-III_like, Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 7/150 (4%)

Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    LSE  ++L  DK    +++  +  +   IP+ +V  S  ++  L 
Sbjct: 232 DDITMVLILPKEGTTLSEVEQNLTLDKLQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQ 291

Query: 222 TMNVTSMFDVSKSDLSNMLDDRG--VAVDQVFHKVDIEVTEQGTVAAASTGIIIT----R 275
            M +  +F    + L  ++      + V   FHK  +EV E+G+ A+A+T ++IT     
Sbjct: 292 KMGLEDLFSPENAKLPGIVAGGRTDLYVSDAFHKAFLEVNEEGSEASAATAVVITGRSLN 351

Query: 276 ISKPTVKINRPFIFFIYHKPTDSIVFWGSI 305
           I++     NRPF+ FI     ++I+F G +
Sbjct: 352 INRIIFVANRPFLLFIREVAINAIIFMGRV 381

It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. Length = 381

>gnl|CDD|239010 cd02055, PZI, Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10)

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 38/112 (33%), Positives = 62/112 (55%), Gaps = 5/112 (4%)

Query: 196 TNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNML-DDRGVAVDQVFHKV 254
           +  +D+ +  PK K+    E+  +L  + + ++F    +DLS +L D + + V QV  K 
Sbjct: 257 SRNMDIFF--PKFKLDQKYEMHELLRALGIKNIF-APFADLSELLADGKHLQVSQVLQKA 313

Query: 255 DIEVTEQGTVAAASTGIIITRISKPTV-KINRPFIFFIYHKPTDSIVFWGSI 305
            IEV E+GT AAA+ G  I   S P V K++RPF F I+ +    ++F G +
Sbjct: 314 VIEVDEKGTEAAAAIGSEIIAFSMPPVIKVDRPFHFMIFEETFGMLLFIGRV 365

ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Length = 365

>gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 6/110 (5%)

Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD-RGVAVDQVFHKVDIEVTEQGT 263
           IPK K +   E   VL  + +T  FD   + LS    +   + V  V+HK  +EV E+GT
Sbjct: 272 IPKFKFSFGFEASEVLKKLGLTLPFDPGGALLSMSSPEGENLYVSSVYHKACVEVDEEGT 331

Query: 264 VAAASTGIIITRISKPTVKI-----NRPFIFFIYHKPTDSIVFWGSIYKP 308
            AAA+T ++++  S P  +      + PF+F I    T  ++F G +  P
Sbjct: 332 EAAAATAVVMSGTSSPPPRPVDFVADHPFLFLIREDKTGVVLFLGQVMNP 381

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381

>gnl|CDD|239008 cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 4/101 (3%)

Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +PK+K+    EL   L+ + +  +F     DLS + D+  + V  V H+  +E++E+G  
Sbjct: 255 LPKLKLDYQLELNEALSQLGLQELF--QAPDLSGISDEP-LFVSSVQHQSTLELSEKGVE 311

Query: 265 AAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSI 305
           A+A+T +  +R S  +  +NRPF+FFI+       +F GS+
Sbjct: 312 ASAATSVATSR-SLSSFSVNRPFLFFIFEDTMGLPLFMGSV 351

Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. Length = 351

>gnl|CDD|239007 cd02052, PEDF, Pigment epithelium-derived factor (PEDF)_like

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 161 MRNEVYMYFILP----KNPDL------SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKV 210
           +   V + F LP    +N  L      SEF  D+D             V  + T+PK+K+
Sbjct: 228 LTGGVSIMFFLPDKVTQNLTLIEESLTSEFVHDID--------RELKTVKAVLTLPKLKL 279

Query: 211 TSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTG 270
           +  TEL   L  + + S+F     D +  +  + + +  V HK  +E+ E G   A + G
Sbjct: 280 SYETELLPSLQELKLQSLFA--SPDFTK-ITSKPIKLSHVHHKAVLELNEDGAETAPTPG 336

Query: 271 IIITRISKP-TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              T ++ P    ++RPF+F +  + T +++F G +  P
Sbjct: 337 -SATALTFPLEYHVDRPFLFVLRDEDTGALLFIGKVLDP 374

PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. Length = 374

>gnl|CDD|165258 PHA02948, PHA02948, serine protease inhibitor-like protein; Provisional

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 3/105 (2%)

Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +P+  + +  +++++   M   SMF+   +   +M  D  + + ++F    I+V EQGTV
Sbjct: 271 LPRFSIENKRDIKSIAEMM-APSMFNPDNASFKHMTRDP-LYIYKMFQNAKIDVDEQGTV 328

Query: 265 AAASTGIIITRISKPT-VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           A AST ++ T  S P  ++ N PF+F I H  T  I+F G +  P
Sbjct: 329 AEASTIMVATARSSPEELEFNTPFVFIIRHDITGFILFMGKVESP 373

Length = 373

>gnl|CDD|239002 cd02047, HCII, Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 3/105 (2%)

Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +PK K+  +  L   L  M +T +F   K +++ + D++ +A+D   H+  I V E+GT 
Sbjct: 333 LPKFKLEKNYNLIESLKLMGITDLFT-EKGNMAGVSDEK-IAIDLFKHQGTITVNEEGTE 390

Query: 265 AAASTGIIITRISKPT-VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           AAA T +    +S      ++RPF+F IY   T+ ++F G +  P
Sbjct: 391 AAAVTTVGFMPLSTQVRFIVDRPFLFLIYEHRTNCLLFMGRVANP 435

HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. Length = 436

>gnl|CDD|239009 cd02054, angiotensinogen, Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 10/148 (6%)

Query: 165 VYMYFILPKN-PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTM 223
             +  + P    DL +    L     S  +++ +   +  T+PK  +  S +L+ +L  M
Sbjct: 231 ACLLLVQPHEGSDLDKVEGKLPQQNSSNWLKNLSPRTIELTLPKFSLQGSYDLQDLLAQM 290

Query: 224 NVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT--- 280
            + ++   S+++LS + +DR   V +V +KV  E++E GT    ST     +++KP    
Sbjct: 291 ELPALLG-SEANLSKLSNDR-FTVGKVLNKVFFELSEDGTEVQEST----QQLNKPEVLE 344

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           V +NRPF+F +Y   +++I+F G +  P
Sbjct: 345 VTLNRPFLFAVYEANSNAILFLGRVTNP 372

It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372

>gnl|CDD|239005 cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 30/144 (20%), Positives = 68/144 (47%), Gaps = 8/144 (5%)

Query: 167 MYFILPKNP--DLSEFTKDLDYDKFSRIIESTNKVD---VIYTIPKMKVTSSTELRTVLN 221
           +  ++P+ P  DL    + L    F  ++E            T+P++K+  + ++  +++
Sbjct: 212 LVVLVPRGPKEDLEAVERALTPPAFLAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMH 271

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTV 281
            + +  +F    ++L  +  D  +AVD   H+  + +TE+G  AAA+T     R +  + 
Sbjct: 272 KLGLFGLFL--DANLCGLYQDPELAVDAAQHRAVLTLTEKGVEAAAATATSFARTAL-SF 328

Query: 282 KINRPFIFFIYHKPTDSIVFWGSI 305
           +  +PF+F ++       +F G +
Sbjct: 329 EALQPFLFVLWDDQAKVPLFMGRV 352

It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. Length = 352

>gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 23/74 (31%), Positives = 42/74 (56%), Gaps = 2/74 (2%)

Query: 87  GITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRS 146
                 LD+ + + +    ++NVVF+PLSI  ALAL+ LG+ G+T+++L   +G+ +   
Sbjct: 1   ANNDFALDLYKQL-AKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDD 59

Query: 147 LSNNPEAYASFLEK 160
             +  +A+ S L  
Sbjct: 60  -EDVHQAFKSLLSS 72

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364

>gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor)

 Score = 50.3 bits (121), Expect = 6e-07
 Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 2/78 (2%)

Query: 86  RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGR 145
                   D+ + + S  + ++N+ F+PLSI  ALA++ LG+ G+T ++L   +G     
Sbjct: 1   EANNDFAFDLYKQL-SKESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGFPEL- 58

Query: 146 SLSNNPEAYASFLEKMRN 163
                 E + S L  +  
Sbjct: 59  DDEEIHEGFQSLLSSLNK 76

Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369

>gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor)

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 17/56 (30%), Positives = 32/56 (57%), Gaps = 1/56 (1%)

Query: 14 RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 69
                  D+ + + S  + ++N+ F+PLSI  ALA++ LG+ G+T ++L   +G 
Sbjct: 1  EANNDFAFDLYKQL-SKESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGF 55

Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369

>gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 20/54 (37%), Positives = 34/54 (62%), Gaps = 1/54 (1%)

Query: 15 GITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
                LD+ + + +    ++NVVF+PLSI  ALAL+ LG+ G+T+++L   +G
Sbjct: 1  ANNDFALDLYKQL-AKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLG 53

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364

>gnl|CDD|239001 cd02046, hsp47, Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 7/143 (4%)

Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M FI+P + + L    K L  ++    I    K  V  ++PK+ +  S +L+  L  + +
Sbjct: 227 MIFIMPYHVEPLERLEKLLTREQLKTWISKMKKRAVAISLPKVSLEVSHDLQKHLGDLGL 286

Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKI-- 283
           T   D SK+DLS +   + + +  VFH   +E   +G         I  R      K+  
Sbjct: 287 TEAIDKSKADLSKISGKKDLYLSNVFHAAALEWDTEGNPFDPD---IYGREEMRNPKLFY 343

Query: 284 -NRPFIFFIYHKPTDSIVFWGSI 305
            + PFIF +    T+SI+F G +
Sbjct: 344 ADHPFIFLVKDNKTNSILFIGRL 366

It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. Length = 366

>gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 13/41 (31%), Positives = 26/41 (63%)

Query: 29 SVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 69
          +  + ++N+ F+P+SI  ALA++ LG+ G T  ++   +G 
Sbjct: 8  AKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGF 48

Length = 359

>gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 13/41 (31%), Positives = 26/41 (63%)

Query: 101 SVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
           +  + ++N+ F+P+SI  ALA++ LG+ G T  ++   +G 
Sbjct: 8   AKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGF 48

Length = 359

>gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 21/65 (32%), Positives = 35/65 (53%), Gaps = 4/65 (6%)

Query: 88  ITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSL 147
           I ++++D+  A+R+      N++F+PLS   AL +V LG+ G    E+ H +G      L
Sbjct: 4   IAELSVDLYNALRASKEDE-NIIFSPLSTALALGMVELGAKGSALKEIRHSLGY---DGL 59

Query: 148 SNNPE 152
            N  E
Sbjct: 60  KNGEE 64

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388

>gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2)

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 16/52 (30%), Positives = 29/52 (55%), Gaps = 1/52 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
          L    T   L++ + + +  +  +N+ F+P SI  ALA+V LG+ G T  ++
Sbjct: 1  LSAANTSFALNLFKKL-AESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQM 51

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380

>gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2)

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 16/52 (30%), Positives = 29/52 (55%), Gaps = 1/52 (1%)

Query: 84  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 135
           L    T   L++ + + +  +  +N+ F+P SI  ALA+V LG+ G T  ++
Sbjct: 1   LSAANTSFALNLFKKL-AESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQM 51

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380

>gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 18/53 (33%), Positives = 32/53 (60%), Gaps = 1/53 (1%)

Query: 16 ITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          I ++++D+  A+R+      N++F+PLS   AL +V LG+ G    E+ H +G
Sbjct: 4  IAELSVDLYNALRASKEDE-NIIFSPLSTALALGMVELGAKGSALKEIRHSLG 55

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388

>gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 20/58 (34%), Positives = 33/58 (56%), Gaps = 4/58 (6%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTK---DELTHF 66
          L    T+   D+ + ++    KN+N+ F+PLSI  AL +VLLG+   T    +++ HF
Sbjct: 1  LSAANTEFCFDLFKELKK-NHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHF 57

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389

>gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 20/58 (34%), Positives = 33/58 (56%), Gaps = 4/58 (6%)

Query: 84  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTK---DELTHF 138
           L    T+   D+ + ++    KN+N+ F+PLSI  AL +VLLG+   T    +++ HF
Sbjct: 1   LSAANTEFCFDLFKELKK-NHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHF 57

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389

>gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 20/48 (41%), Positives = 28/48 (58%)

Query: 105 KNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPE 152
           K  NV+F+PLSI  AL+LV  G+ G+T D+L  F+G  +   L     
Sbjct: 20  KGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAA 67

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381

>gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 19/36 (52%), Positives = 26/36 (72%)

Query: 33 KNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          K  NV+F+PLSI  AL+LV  G+ G+T D+L  F+G
Sbjct: 20 KGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLG 55

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381

>gnl|CDD|165039 PHA02660, PHA02660, serpin-like protein; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 7/103 (6%)

Query: 6   MRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTH 65
           M+   IL   I +M+LD+   I   + +  N+VF+P S+   L ++ LGS+ +TK+EL+ 
Sbjct: 1   MKKYCILNNNIIKMSLDLGFCILKSLHRF-NIVFSPESLKAFLHVLYLGSERETKNELSK 59

Query: 66  FMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQN 108
           ++G A      N +        IT++ +D    I S    + N
Sbjct: 60  YIGHAYSPIRKNHI------HNITKVYVDSHLPIHSAFVASMN 96

Length = 364

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	357
cd02044	370	ov-serpin ovalbumin family of serpins (ov-serpins)	100.0
cd02057	372	maspin_like Maspin (mammary serine proteinase inhi	100.0
cd02048	388	neuroserpin Neuroserpin is a inhibitory member of	100.0
cd02054	372	angiotensinogen Angiotensinogen is part of the ren	100.0
COG4826	410	Serine protease inhibitor [Posttranslational modif	100.0
cd02051	377	PAI-1_nexin-1 Plasminogen activator inhibitor-1_li	100.0
KOG2392|consensus	380		100.0
cd02059	389	ovalbumin_like The ovalbumin_like group of serpins	100.0
cd02058	380	PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). P	100.0
cd02046	366	hsp47 Heat shock protein 47 (Hsp47), also called c	100.0
cd02047	436	HCII Heparin cofactor II (HCII) inhibits thrombin,	100.0
cd02045	381	antithrombin-III_like Antithrombin is a serine pro	100.0
cd02052	374	PEDF Pigment epithelium-derived factor (PEDF)_like	100.0
PHA02948	373	serine protease inhibitor-like protein; Provisiona	100.0
cd02056	361	alpha-1-antitrypsin_like alpha-1-antitrypsin_like.	100.0
PF00079	371	Serpin: Serpin (serine protease inhibitor); InterP	100.0
cd00172	364	SERPIN SERine Proteinase INhibitors (serpins) exhi	100.0
smart00093	359	SERPIN SERine Proteinase INhibitors.	100.0
cd02049	364	bacterial_SERPIN SERine Proteinase INhibitors (ser	100.0
cd02055	365	PZI Protein Z-dependent protease inhibitor (ZPI) i	100.0
cd02053	351	alpha2AP Alpha2-antiplasmin (alpha2AP) is the prim	100.0
cd02050	352	C1_inh C1 inhibitor (C1-Inh) is a protease inhibit	100.0
cd02043	381	plant_SERPIN SERine Proteinase INhibitors (serpins	100.0
PHA02660	364	serpin-like protein; Provisional	100.0

>cd02044 ov-serpin ovalbumin family of serpins (ov-serpins)

Probab=100.00  E-value=3.2e-59  Score=457.68  Aligned_cols=294  Identities=24%  Similarity=0.454  Sum_probs=261.1

Q ss_pred             HHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc---c-cc
Q psy5102          14 RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL---T-AH   82 (357)
Q Consensus        14 ~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l---~-~~   82 (357)
                      .++++||++||+++... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++..       +++++.+   + +.
T Consensus         3 ~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (370)
T cd02044           3 LANSAFAVDVFKELSKK-SALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVKDVHSSFQTLLSDINKLNSFY   81 (370)
T ss_pred             chhhHHHHHHHHHHhhc-CCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhcCCCCc
Confidence            46789999999999876 67899999999999999999999999999999999999762       3444444   2 44


Q ss_pred             eeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc
Q psy5102          83 SLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS  127 (357)
Q Consensus        83 ~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna  127 (357)
                      .++.+   |+++                     .+||    +.+   ||+||   |+|+ ++++++.+++++++++|+||
T Consensus        82 ~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~lv~~~~l~~~t~lvlvna  161 (370)
T cd02044          82 SLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIENLLPENSVDSQTAMVVVNA  161 (370)
T ss_pred             eEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcCCchhhcCCCCCCCcchhheeeee
Confidence            56655   5554                     5788    233   99999   9999 99999888999999999999


Q ss_pred             -------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHHhh
Q psy5102         128 -------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEFTK  182 (357)
Q Consensus       128 -------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~  182 (357)
                             ++||++..|..++||..              . +|++.+++++++|+  |++++++|+|||| +..+|.++++
T Consensus       162 i~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~l~~l~~  241 (370)
T cd02044         162 AYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEATFNMGNIESLKMKILELPFANKDLSMFILLPDEVTGLEKLES  241 (370)
T ss_pred             eeEcccccCCCChhhCccCcCCcCCCcEEEeeCccccCceeeEEcCCCCeEEEEcccCCCceEEEEEcCCCCCcHHHHHH
Confidence                   89999999999999975              2 56677889999999  9988999999999 8899999999


Q ss_pred             ccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEcc
Q psy5102         183 DLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTE  260 (357)
Q Consensus       183 ~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E  260 (357)
                      .|+.+.+..|..  +++.+.|+|+||||++++++||+++|++||++.+|++..|||++|+++.+++|++|+|++.|+|||
T Consensus       242 ~l~~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~mGl~~~F~~~~Adfs~ms~~~~l~vs~v~qka~ievdE  321 (370)
T cd02044         242 EINYEKLNKWTSPSTMAEAKVKVYLPRFKMEKMYDLKSVLESLGMKDAFSEGRANFSGMSETKGLALSNVIHKASLEINE  321 (370)
T ss_pred             HhCHHHHHHhhccccceeeEEEEEeeEEEEeeEEccHHHHHHcCchhhCCCCCCChhhcCCCCCeeEeeeeEeeEEEECC
Confidence            999999999974  677889999999999999999999999999999999756999999976689999999999999999


Q ss_pred             Cccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         261 QGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       261 ~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +|++|+|+|...+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       322 ~Gt~aaa~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P  370 (370)
T cd02044         322 DGTEAAEVTGAVMLQRSVKEEFNADHPFLFIIRHNKTNCILFFGKFSSP  370 (370)
T ss_pred             CccccccccceeeeccCCCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence            99999999987555 5556789999999999999999999999999998

Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia.

>cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages

Probab=100.00  E-value=1.6e-58  Score=452.91  Aligned_cols=294  Identities=24%  Similarity=0.408  Sum_probs=255.6

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc---c-c
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL---T-A   81 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l---~-~   81 (357)
                      ..++++||++||+.+... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++..       +.+...+   . +
T Consensus         2 ~~~~~~F~~~l~~~~~~~-~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~   80 (372)
T cd02057           2 QLANTAFAVDLFKKLCEK-EPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGFQTVTSDVSKLSSF   80 (372)
T ss_pred             cchhhHHHHHHHHHHhcc-CCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCChhHHHHHHHHHHHHHhcCCcc
Confidence            357899999999999876 67899999999999999999999999999999999999761       2333333   1 2


Q ss_pred             ceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeec
Q psy5102          82 HSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLG  126 (357)
Q Consensus        82 ~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvn  126 (357)
                      +.++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++++|+++|+|
T Consensus        81 ~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~l~~~~~i~~~t~l~lvN  160 (372)
T cd02057          81 YSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILVVN  160 (372)
T ss_pred             chhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhccChhhhcCCCCCCCCCCceeeee
Confidence            334444   4443                     5788    233   99999   9999 9999988899999999999


Q ss_pred             c-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C----CCCh
Q psy5102         127 S-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K----NPDL  177 (357)
Q Consensus       127 a-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~----~~~L  177 (357)
                      |       ++||+++.|.+++||..              . +|+|.++++|++|+  |++++++|+|||| +    ..+|
T Consensus       161 a~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~~~~~L  240 (372)
T cd02057         161 AAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQNKHLSMLILLPKDIEDESTGL  240 (372)
T ss_pred             hheeccccCCCCCccccccCCCEECCCceEeeEhhheeceEEeEEeCCcCceEEEeecCCCCEEEEEEecCccccccccH
Confidence            9       89999999999999986              1 56788999999999  9988999999999 5    4689


Q ss_pred             hHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEE
Q psy5102         178 SEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVD  255 (357)
Q Consensus       178 ~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~  255 (357)
                      .++++.|+.+.+..|..  .++.+.|+|+||||+++.++||+++|++||++++|+...|||++|+++++++|++|+|++.
T Consensus       241 ~~l~~~l~~~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~~~adfs~i~~~~~l~vs~v~hk~~  320 (372)
T cd02057         241 EKLEKQLTSESLSQWTNPSMMANAKVKVSLPKFKVEKMIDLKAMLESLGLKHIFNEDASDFSGMSETKGVALSNVIHKVC  320 (372)
T ss_pred             HHHHHhcChhHHHHhhchhcceeEEEEEECCcEEEEEEechHHHHHHcCChhhcCCcccccccccCCCceEEEeeeeeeE
Confidence            99999999999999963  4677899999999999999999999999999999997569999999876799999999999


Q ss_pred             EEEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         256 IEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       256 iev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |||||+|++|+++|..... ..+..|++||||+|+|+|+.++.|||+|+|.+|
T Consensus       321 ieVdE~Gt~a~a~t~~~~~-~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~p  372 (372)
T cd02057         321 LEVNEDGGESIEVPGARIL-QHKDEFNADHPFIFIIRHNKTRNIIFFGRFCSP  372 (372)
T ss_pred             EEECCCCeecchhcceecc-CCCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence            9999999999999875332 234689999999999999999999999999998

Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

Probab=100.00  E-value=1.4e-58  Score=455.83  Aligned_cols=295  Identities=28%  Similarity=0.456  Sum_probs=258.6

Q ss_pred             HHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---------hhHHhhc---c-
Q psy5102          14 RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---------RSLSNKL---T-   80 (357)
Q Consensus        14 ~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---------~~ll~~l---~-   80 (357)
                      ++.++||++||+++... ++++|+|+||+||+.+|+||+.||+|+|++||.++||++..         +++...+   . 
T Consensus         2 ~~~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (388)
T cd02048           2 EAIAELSVDLYNALRAS-KEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEEFSFLKDLSSMITAKEK   80 (388)
T ss_pred             chhhHHHHHHHHHhhcc-CCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCCChHHHHHHHHHHHHHhccCCC
Confidence            57789999999999876 67899999999999999999999999999999999999761         2233333   1 


Q ss_pred             cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEeec
Q psy5102          81 AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLG  126 (357)
Q Consensus        81 ~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvn  126 (357)
                      +..++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++.+++++|+++|+|
T Consensus        81 ~~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~~~~~~~~~IN~wv~~~T~g~I~~l~~~~~l~~~t~lvlvN  160 (388)
T cd02048          81 EYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQVKAVAEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVN  160 (388)
T ss_pred             ccchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHHHhccCchhhcCCCccCCHHHHHHhhh
Confidence            3344444   4433                     5788   233   99999   9999 9999988899999999999


Q ss_pred             c-------cCCCCCCCceeeeeeec------------c---cccccCC------CCeEEEe--ecCCeEEEEEEec-CCC
Q psy5102         127 S-------DGQTKDELTHFMGVATG------------R---SLSNNPE------AYASFLE--KMRNEVYMYFILP-KNP  175 (357)
Q Consensus       127 a-------~~~F~~~~T~~~~F~~~------------~---~~~~~~~------~~~~vve--y~~~~~sm~iiLP-~~~  175 (357)
                      |       ++||++..|..++||..            .   +|++.++      .+++||+  |++++++|+|||| +..
T Consensus       161 ai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~  240 (388)
T cd02048         161 ALYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMIILSRQEV  240 (388)
T ss_pred             eEEEeeeccCCCCHHHCeeccEEECCCceEEeehhcccCcEEEEeccccccccccCcEEEEEecCCCceEEEEEccCCCC
Confidence            9       89999999999999986            1   4445555      7799999  9998999999999 889


Q ss_pred             ChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEE
Q psy5102         176 DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVD  255 (357)
Q Consensus       176 ~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~  255 (357)
                      +|.++++.|+...+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++++++|++++|++.
T Consensus       241 ~l~~l~~~l~~~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~lGi~~~F~~-~adfs~i~~~~~l~vs~v~hka~  319 (388)
T cd02048         241 PLATLEPLVKAPLIEEWANSVKKQKVEVYLPRFKVEQKIDLKDVLKNLGITEIFSG-GADLSGISDSKELYVSKVFHKVF  319 (388)
T ss_pred             CHHHHHHHhChHHHHHHHHhCceeEEEEEccEEEEEEEechHHHHHHcCCchhhcC-ccCcccccCCCCeEEEEEEeeeE
Confidence            99999999999999999999999999999999999999999999999999999997 79999999876899999999999


Q ss_pred             EEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         256 IEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       256 iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |+|||+|++|+|+|.+... ++  .+.+|++||||+|+|+|+.||.|||+|+|.+|+.
T Consensus       320 ieV~E~Gt~a~a~t~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P~~  377 (388)
T cd02048         320 LEVNEEGSEAAASSGMIAISRMAVLYPQVIVDHPFFFLIRNRRTGSILFMGRVMHPET  377 (388)
T ss_pred             EEECCCcceehhhcccccccccCCCCceEEecCCEEEEEEECCCCeEEEEEEecCCCc
Confidence            9999999999999976543 33  3468999999999999999999999999999974

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily.

>cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis

Probab=100.00  E-value=1e-57  Score=446.89  Aligned_cols=290  Identities=21%  Similarity=0.340  Sum_probs=247.7

Q ss_pred             HHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch------------hhH----
Q psy5102          12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG------------RSL----   75 (357)
Q Consensus        12 ~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~------------~~l----   75 (357)
                      +++++++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++..            +++    
T Consensus         2 ~~~~~~~f~~~l~~~l~~~-~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~   80 (372)
T cd02054           2 LAMLVNVLGLRMYGMLSEL-WVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKVLSTL   80 (372)
T ss_pred             hHHHHHHHHHHHHHHHHhh-CCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccccccccccHHHHHHHH
Confidence            5778999999999999876 67899999999999999999999999999999999999731            122    


Q ss_pred             ---Hhhc---c-cceeeee---eccc----------------------cCCH---HHH---HHHHH---hCCC-cccCCC
Q psy5102          76 ---SNKL---T-AHSLRRG---ITQM----------------------TLDM---ERA---IRSVM---TKNQ-NVVFAP  113 (357)
Q Consensus        76 ---l~~l---~-~~~l~~a---f~~~----------------------~~dF---~~a---IN~wv---T~g~-~~~l~~  113 (357)
                         ...+   + +..+..+   |+++                      .+||   +.+   ||+||   |+|+ ++++++
T Consensus        81 ~~~~~~~~~~~~~~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~~~~~a~~~IN~WV~~~T~g~I~~ll~~  160 (372)
T cd02054          81 QAIQSLVDAQGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTEPDVAEEKINNFVQATSDGKVKSSLKG  160 (372)
T ss_pred             HHHHHHHcCCCCccEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCCChHHHHHHHHHHHHHHhcCchhhhccC
Confidence               2222   1 2344444   4443                      4688   333   99999   9999 999964


Q ss_pred             CCCCccceeEeecc-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecCCeEEEEEEe
Q psy5102         114 LSIVGALALVLLGS-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRNEVYMYFIL  171 (357)
Q Consensus       114 ~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~~~sm~iiL  171 (357)
                        ++++|+++|+||       ++||++..|.+..|+..            . +|.+.++++++|++  |++ +++|+|||
T Consensus       161 --~~~~t~lvLvNaiyFkg~W~~~F~~~~T~~f~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~-~~sm~iiL  237 (372)
T cd02054         161 --LSPDSDLLFATSVHFQGNWKTASQLEEPQEFWVDNNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPLSK-RACLLLVQ  237 (372)
T ss_pred             --CCCCCeEEEEEEEEEEHhhcCCCCcccceeEEeCCCCEEEEeeeeccCcEEEEEecCCCcEEEEEeeCC-CeEEEEEe
Confidence              889999999999       89999999984333322            1 45556778999999  875 59999999


Q ss_pred             c-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeee
Q psy5102         172 P-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV  250 (357)
Q Consensus       172 P-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v  250 (357)
                      | +..+|.++++.|+.+.+..|.++++.+.|+|+||||+++.++||+++|++||++++|+. .|||++|++ .+++|++|
T Consensus       238 P~~~~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~i~~-~~l~vs~v  315 (372)
T cd02054         238 PHEGSDLDKVEGKLPQQNSSNWLKNLSPRTIELTLPKFSLQGSYDLQDLLAQMELPALLGS-EANLSKLSN-DRFTVGKV  315 (372)
T ss_pred             CCCCCCHHHHHHhhCHHHHHHHHHhCCceEEEEECCeEEEEEEeccHHHHHHcCCcccccC-ccccccccC-CCceeeee
Confidence            9 88899999999999999999999999999999999999999999999999999999987 799999995 48999999


Q ss_pred             eEEEEEEEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +||+.|||||+|++|+|+|.+.. ...+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       316 ~hka~ieVdE~GteAaaat~~~~-~~~~~~f~~drPF~f~I~d~~t~~iLF~G~v~~P  372 (372)
T cd02054         316 LNKVFFELSEDGTEVQESTQQLN-KPEVLEVTLNRPFLFAVYEANSNAILFLGRVTNP  372 (372)
T ss_pred             eeeEEEEEccCceeccccccccc-CCCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence            99999999999999999997532 1235689999999999999999999999999998

It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones]

Probab=100.00  E-value=1.2e-58  Score=423.26  Aligned_cols=299  Identities=23%  Similarity=0.410  Sum_probs=266.0

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch--------hhHHhhc--
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG--------RSLSNKL--   79 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~--------~~ll~~l--   79 (357)
                      ..+.+++|.|+++||.++++.....+|+.|||.||+.+++|-|.||.|.|++||..+++++..        +++...+  
T Consensus        36 y~ia~ANNaF~FdlyS~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~n~~vl~~~~~~~nd~i~s  115 (410)
T COG4826          36 YDIAAANNAFAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDKINS  115 (410)
T ss_pred             cchhhcccchhHHHHHHHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheeccccchHhhhhHHhhcccccC
Confidence            457789999999999999966235789999999999999999999999999999999999852        3333333  


Q ss_pred             -c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCcccee
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALAL  122 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~l  122 (357)
                       + ++.+..+   |+++                     .+||    +.|   ||+||   |+|+ +++++.+.+.+|+++
T Consensus       116 p~~~y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtINkWvEekT~gkIkdlVp~~~i~~d~rl  195 (410)
T COG4826         116 PNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIKDLVPEDYIGPDTRL  195 (410)
T ss_pred             CccchhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHHHHHHHHhhcchHhhcCCccccCCceeE
Confidence             2 5555555   5554                     7899    233   99999   9999 999999999999999


Q ss_pred             Eeecc-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCCCChhHH
Q psy5102         123 VLLGS-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKNPDLSEF  180 (357)
Q Consensus       123 vLvna-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~~~L~~l  180 (357)
                      +|+||       ...||++.|.++.|+..            . .|.|.+..++++|+  |+++++||+|+||+...+.++
T Consensus       196 vltnAiYFnGkW~~efDk~~t~krtFy~a~~~d~sv~mMs~~g~fny~et~kakiveLPy~gd~lSmYIvLPk~nNi~~F  275 (410)
T COG4826         196 VLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGDDLSMYIVLPKDNNITEF  275 (410)
T ss_pred             EEEeeEEEcCeeccccchhhccceeeecCChhhhcchhHHhcCCCCcccCcCceEEEcccCCCceEEEEEeeCCCChHHH
Confidence            99999       78899999999999987            2 77888999999999  999999999999955699999


Q ss_pred             hhccChhHHHHHHHhcCce-eEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEc
Q psy5102         181 TKDLDYDKFSRIIESTNKV-DVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVT  259 (357)
Q Consensus       181 ~~~L~~~~l~~~~~~l~~~-~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~  259 (357)
                      ++.|+.+.+.+|..+|+.+ .|++.||||+.+.+..|++.|.+||+-++|+. .||||||++. ++.|++|+|+++|+|+
T Consensus       276 e~nft~e~y~elk~~m~~~~~v~v~iPkFkfetk~el~~aLieMGvvdAF~n-~AnFSgI~~~-~L~Is~V~Hqa~idv~  353 (410)
T COG4826         276 ENNFTLEKYTELKSNMEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFEN-TANFSGISDR-RLEISDVFHQAFIDVD  353 (410)
T ss_pred             HhhccHHHHHHHHhcCCccceEEEEecceeeeehhhhhHHHHHhhHHHHhhc-ccCcccccCC-cccHHHHhhhhheecc
Confidence            9999999999999999877 89999999999999999999999999999996 7999999987 6999999999999999


Q ss_pred             cCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         260 EQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       260 E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |+|++|+|+|++.+. .+   .-.+|++||||+|+|.|+.||.|||||+|.+|+.
T Consensus       354 EeGteAaAAT~v~~~a~~~~~~~~e~~vD~PFlf~i~D~~s~~IlFiG~Vv~P~~  408 (410)
T COG4826         354 EEGTEAAAATAVVFKAVCAKGGWVEFVVDHPFLFVIEDRRSGCILFIGKVVNPEY  408 (410)
T ss_pred             ccchhhhhhceeeeeeeeecccceEEEecCceEEEEecCCcceEEEEeeecCCCC
Confidence            999999999988776 33   3459999999999999999999999999999974

>cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like

Probab=100.00  E-value=1.3e-57  Score=447.27  Aligned_cols=298  Identities=26%  Similarity=0.426  Sum_probs=258.5

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch------hhHHhhc-c--
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG------RSLSNKL-T--   80 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~------~~ll~~l-~--   80 (357)
                      ..+..+.++|+++||+++... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++..      +.+.+.+ +  
T Consensus         5 ~~~~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~l~~~l~~~~   83 (377)
T cd02051           5 SSLEELGSDFGIQVFNQVAQA-RPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKINGVAKALKKLNKAIVSKK   83 (377)
T ss_pred             HHHHHHHhHHHHHHHHHHHhc-CCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCChhHHHHHHHHHHHHHhccC
Confidence            457789999999999999876 68899999999999999999999999999999999999762      3333333 1  


Q ss_pred             -cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCC-CCCccceeEe
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPL-SIVGALALVL  124 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~-~l~~~t~lvL  124 (357)
                       +..++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++. .++++|.++|
T Consensus        84 ~~~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~~~~~a~~~IN~Wv~~~T~g~I~~~l~~~~~i~~~t~l~l  163 (377)
T cd02051          84 NKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPETAAFSINDWVKNETKGMIDNLLSPDLADDALTRLVL  163 (377)
T ss_pred             CccchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCCCHHHHHHHHHHHHHHhcCCCccccCCCCCCCCccceEEE
Confidence             2233433   4333                     5789   333   99999   9999 9999876 6888999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec------------c---cccccC---CCCeEEEe--ecCCeEEEEEEec-CC-C
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG------------R---SLSNNP---EAYASFLE--KMRNEVYMYFILP-KN-P  175 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~------------~---~~~~~~---~~~~~vve--y~~~~~sm~iiLP-~~-~  175 (357)
                      +||       +.||++..|.+++||..            .   +|++.+   +.++++|+  |++++++|+|||| +. .
T Consensus       164 vnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~  243 (377)
T cd02051         164 VNALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGESISMLIALPTEKST  243 (377)
T ss_pred             EeeeEeeeeecCCCChhhCcccccCcCCCcEEeehhhcccCceeeEeeccccccccEEEEEecCCCeEEEEEEeccccCC
Confidence            999       89999999999999976            1   333333   34589999  9999999999999 55 4


Q ss_pred             ChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEE
Q psy5102         176 DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVD  255 (357)
Q Consensus       176 ~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~  255 (357)
                      +|.+++++|+.+.+..|.++++++.|+|.||||++++++||+++|++||++++|++..|||++|+++++++|++++|++.
T Consensus       244 ~L~~l~~~l~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGl~~~F~~~~Adfs~i~~~~~l~v~~v~hka~  323 (377)
T cd02051         244 PLSAIIPHISTKTIQSWMGTMVPKRMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISRSESLHVSHALQKAK  323 (377)
T ss_pred             CHHHHHHhcCHHHHHHHHHhCCceEEEEEccCEEEEEecChHHHHHHCCCcccccCCCCCcccccCCCCEEEEeEEEEEE
Confidence            79999999999999999999999999999999999999999999999999999997579999999877899999999999


Q ss_pred             EEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         256 IEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       256 iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |+|||+|++|+|+|.+... ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       324 iev~E~Gt~aaa~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~~LF~G~v~~P  377 (377)
T cd02051         324 IEVNEDGTKASAATTAILIARSSPPWFIVDRPFLFFIRHNPTGTILFMGQINKP  377 (377)
T ss_pred             EEECCCccchhhhcceeeeccCCCCeEEeeCCEEEEEEeCCCCcEEEEEEecCC
Confidence            9999999999999987655 5567789999999999999999999999999998

Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>KOG2392|consensus

Probab=100.00  E-value=9.5e-58  Score=447.15  Aligned_cols=299  Identities=30%  Similarity=0.453  Sum_probs=268.4

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h------hhHHhh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G------RSLSNK   78 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~------~~ll~~   78 (357)
                      ...+.....+|+++||+.+... .+++|+||||+||..+|+|+++||+|.|++||+++|+++.    +      +.++..
T Consensus         4 ~~~~~~~~~~f~~~l~~~~~~~-~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~~~~~~~~~~~~   82 (380)
T KOG2392|consen    4 MASLSQSEADFALDLYRQLAKS-APDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENEVHESFQSLLLL   82 (380)
T ss_pred             hhhhhhhhhHHHHHHHHHHHhh-CCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHHHHHHHHHHHHH
Confidence            4556778899999999999976 6899999999999999999999999999999999999985    1      333332


Q ss_pred             c---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          79 L---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        79 l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      +   . ++.++++   |+++                     .+||    +.+   ||.|+   |+|+ .+++.++++++.
T Consensus        83 ~~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~T~gkI~~ll~~~~~~~~  162 (380)
T KOG2392|consen   83 LNSTESGYELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEHTNGKIKDLLSPDSIDSL  162 (380)
T ss_pred             hccccCCceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHHcCCchhhhcCCCCCCcc
Confidence            2   2 5667666   6555                     6788    233   99999   9999 999999999989


Q ss_pred             ceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN  174 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~  174 (357)
                      |.++|+||       +.+|+++.|+.++||..              . .|.++.++.|++++  |.+.+++|+|+|| +.
T Consensus       163 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~VpmM~~~~~f~~~~~~~l~~~vl~LpY~~~~~sm~i~LP~~~  242 (380)
T KOG2392|consen  163 TVLVLVNAIYFKGKWEKKFDKELTKESDFFLSEGTSVKVPMMHQEGSFRYAEDEDLFAVVLELPYKGSNLSMLILLPDER  242 (380)
T ss_pred             hhheeeehheeehhhcCCCChhhccccccEECCCeEEEeechhccCccceEEeCCcceEEEECccCCCCeEEEEEeCCCC
Confidence            99999999       99999999999999987              1 46788899999999  9998899999999 88


Q ss_pred             CChhHHhhccChhHHHHHH-HhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEE
Q psy5102         175 PDLSEFTKDLDYDKFSRII-ESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK  253 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~-~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk  253 (357)
                      .+|.+++++|+.+.+..|. ..+..+.|+|.||||+++.++||+++|++|||+++|+...|||++|+++.+++|++++||
T Consensus       243 ~gL~~le~~L~~~~~~~~~~~~~~~~~v~v~lPKfkie~~~dL~~~L~~lGi~~~F~~~~adls~ls~~~~l~vs~v~Hk  322 (380)
T KOG2392|consen  243 DGLKELEKKLTSETLVEWLFSRMSEKVVEVSLPKFKIEFDYDLKEVLKQLGITDIFSESKADLSGLSESSNLYISKVIHK  322 (380)
T ss_pred             CCHHHHHHHhChhhHHHhhhhhhhceeEEEECCCEEEEEEechHHHHHHcCChhccCCCccccccCccCCCeeeeeeeEE
Confidence            8999999999999999999 789999999999999999999999999999999999985599999999778999999999


Q ss_pred             EEEEEccCccccccccceeee-ecC--CCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         254 VDIEVTEQGTVAAASTGIIIT-RIS--KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       254 ~~iev~E~G~~aaa~t~~~~~-~s~--~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +.|||||+|++|+|+|++.+. ++.  +.+|+|||||+|+|+++.|+.|||+|+|.+|
T Consensus       323 a~ieV~E~GteAaaat~~~~~~~~~~~~~~f~adhPFlF~I~~~~t~~iLF~G~v~~P  380 (380)
T KOG2392|consen  323 AFIEVDEEGTEAAAATAVEIVLRSLPPPEEFVADHPFLFVIRDNKTGSILFLGRVVDP  380 (380)
T ss_pred             EEEEECCCCchhhhhhhhHHhhccCCCCCeEECCCCEEEEEEECCCCcEEEEEEccCC
Confidence            999999999999999988766 443  4899999999999999999999999999998

>cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

Probab=100.00  E-value=1.3e-57  Score=449.01  Aligned_cols=295  Identities=27%  Similarity=0.452  Sum_probs=260.3

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch--------------------
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG--------------------   72 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~--------------------   72 (357)
                      ..++++||++||+.+... .+++|+|+||+||+.+|+||+.||+|+|++||.++||++..                    
T Consensus         2 ~~~~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~   80 (389)
T cd02059           2 SAANTEFCFDLFKELKKN-HKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGV   80 (389)
T ss_pred             cchhhHHHHHHHHHHhhc-CCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccccccccccccccHHHH
Confidence            357899999999999876 67899999999999999999999999999999999999630                    


Q ss_pred             ----hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cc
Q psy5102          73 ----RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NV  109 (357)
Q Consensus        73 ----~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~  109 (357)
                          +.++..+   + +..++++   |+++                     .+||    +.+   ||+|+   |+|+ ++
T Consensus        81 ~~~~~~l~~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~  160 (389)
T cd02059          81 HSQFKDLLSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKINSWVESQTNGKIKN  160 (389)
T ss_pred             HHHHHHHHHHHcCCCCCcEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHHHHHHHHHHhccchhhh
Confidence                2234333   2 4556665   6554                     6788    233   99999   9999 99


Q ss_pred             cCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeE
Q psy5102         110 VFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEV  165 (357)
Q Consensus       110 ~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~  165 (357)
                      ++.+++++++++++|+||       +.||++..|..++||..              . +|++.++++++||+  |+++++
T Consensus       161 ~~~~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~~vl~LPy~~~~~  240 (389)
T cd02059         161 LFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENKPVQMMYQIGKFKLASIEEPKMKILELPYAGGGL  240 (389)
T ss_pred             cCCCCCCCcccceeeEeeeEEeeeccCCCCcccCccCccEeCCCceEEeehhcccCcEEEEEeCCCCcEEEEeecCCCce
Confidence            999889999999999999       89999999999999976              1 55678899999999  999899


Q ss_pred             EEEEEec-CCCChhHHhhccChhHHHHHH--HhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC
Q psy5102         166 YMYFILP-KNPDLSEFTKDLDYDKFSRII--ESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD  242 (357)
Q Consensus       166 sm~iiLP-~~~~L~~l~~~L~~~~l~~~~--~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~  242 (357)
                      +|+|||| +..+|.+++++|+.+.+..|.  ..++.+.|+|.||||++++++||+++|++||++++|++..|||++|+++
T Consensus       241 sm~iiLP~~~~~L~~l~~~l~~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~mGi~~~F~~~~adfs~~~~~  320 (389)
T cd02059         241 SMIVLLPDEISGLEQLESKLTYEKLMEWTSSENMRERKVEVYLPRFKLEEKYNLKSVLKAMGMTDIFSESKADLSGISSS  320 (389)
T ss_pred             EEEEEccCCCCCHHHHHHHhCHHHHHHhhhhhcceeeEEEEECCCEEeeeeecHHHHHHHcCCccccCCccccccccCCC
Confidence            9999999 888999999999999988886  4678899999999999999999999999999999999745999999987


Q ss_pred             CCceeeeeeEEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         243 RGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       243 ~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      .+++|++|+|++.|+|||+|++|+++|..... ++  .+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       321 ~~l~v~~v~hka~ieV~E~G~~a~a~t~~~~~~~~~~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v~~P  389 (389)
T cd02059         321 KSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSLPVSEEFRADHPFLFFIRHNKTNTILFFGRFSSP  389 (389)
T ss_pred             CCceEeeeeeeEEEEECCCceeecccccceeeecCCCCCceEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence            78999999999999999999999999986554 43  45689999999999999999999999999998

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin.

>cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2)

Probab=100.00  E-value=9.6e-58  Score=448.72  Aligned_cols=295  Identities=29%  Similarity=0.485  Sum_probs=259.4

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-----------hhHHhhc--
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-----------RSLSNKL--   79 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-----------~~ll~~l--   79 (357)
                      ..+.++||++||+++... .+++|+|+||+||+.+|+||+.||+|+|++||.++||++..           +.+++.+  
T Consensus         2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~~~~   80 (380)
T cd02058           2 SAANTSFALNLFKKLAES-SPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDIHSGFQSLLSEINK   80 (380)
T ss_pred             chhhhHHHHHHHHHHhhc-CCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccchHHHHHHHHHHHHHHhC
Confidence            457899999999999876 67899999999999999999999999999999999999651           2344444  


Q ss_pred             -c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCcccee
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALAL  122 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~l  122 (357)
                       + +..++++   |+++                     .+||    +.|   ||+||   |+|+ ++++++.++++++++
T Consensus        81 ~~~~~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l  160 (380)
T cd02058          81 PGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLTRL  160 (380)
T ss_pred             CCCccEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHHhcccchhhcCCcCCCChhHHh
Confidence             2 4455555   5554                     5788    234   99999   9999 999998899999999


Q ss_pred             Eeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC---
Q psy5102         123 VLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN---  174 (357)
Q Consensus       123 vLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~---  174 (357)
                      +|+||       +.||++..|..++||..              . +|.+.+++++++|+  |++++++|+|||| +.   
T Consensus       161 vlvna~~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~~  240 (380)
T cd02058         161 VLVNAIYFKGNWEEKFLKENTRERPFRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGKELSMFILLPDEIEDV  240 (380)
T ss_pred             HhhheeEEccccCCCCCcccCCcccccCCCCceEEeechhhcCceeeEEcCCCCcEEEEccCCCCceEEEEEeccccccc
Confidence            99999       89999999999999975              1 56777899999999  9988999999999 76   


Q ss_pred             -CChhHHhhccChhHHHHHH--HhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeee
Q psy5102         175 -PDLSEFTKDLDYDKFSRII--ESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVF  251 (357)
Q Consensus       175 -~~L~~l~~~L~~~~l~~~~--~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~  251 (357)
                       .+|.+++++|+...+..|.  ..++++.|+|+||||++++++||.++|++||++.+|+...|||++|+.+.+++|++|+
T Consensus       241 ~~~L~~l~~~l~~~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGl~~~F~~~~adfs~i~~~~~l~vs~v~  320 (380)
T cd02058         241 TTGLEKLEKELTYEKLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAFDPGKADFSGMSSANDLFLSKVF  320 (380)
T ss_pred             cchHHHHHHHhCHHHHHHhhhhhcceeeEEEEEeeEEEEeeeeccHHHHHHcCccccCCcccccccCCCCCCCCcccccc
Confidence             8899999999999999986  3578899999999999999999999999999999999756999999877689999999


Q ss_pred             EEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |++.|+|||+|++|+++|..... ++  .+.+|++||||+|+|+|+.++.|||+|+|.+|
T Consensus       321 hk~~ieV~E~G~~a~a~t~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P  380 (380)
T cd02058         321 HKAFVEVNEEGTEAAAATAAIMMLRCLMPSPRFNADHPFLFFIRHNKTNTILFFGRFCSP  380 (380)
T ss_pred             eeeEEEECCCCcccccccchheeeccCCCCCeEEEECCEEEEEEECCCCeEEEEEEecCC
Confidence            99999999999999999976544 33  35789999999999999999999999999998

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration.

>cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen

Probab=100.00  E-value=4.3e-57  Score=441.72  Aligned_cols=291  Identities=19%  Similarity=0.305  Sum_probs=252.4

Q ss_pred             HHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h-----hhHHhhc---
Q psy5102          12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G-----RSLSNKL---   79 (357)
Q Consensus        12 ~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~-----~~ll~~l---   79 (357)
                      +..++++||++||+++... .+++|+|+||+||+.+|+|++.||+|+|++||.++||+..    .     ++++..+   
T Consensus         3 ~~~~~~~f~~~l~~~~~~~-~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~~   81 (366)
T cd02046           3 LADRSAGLAFNLYHAMAKD-KGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEHVHTGLSELLNEVSNS   81 (366)
T ss_pred             hhhhhhHHHHHHHHHhhcc-CCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCCCcHHHHHHHHHHHHHhhcC
Confidence            4567899999999999876 6789999999999999999999999999999999999863    1     3444444   


Q ss_pred             -c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeE
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALV  123 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lv  123 (357)
                       . +..++++   |+++                     .+||   +.+   ||+||   |+|+ +++++.  ++++|+++
T Consensus        82 ~~~~~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~l~  159 (366)
T cd02046          82 TARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKRSALNSINEWAAQTTDGKLPEVTKD--VEKTDGAL  159 (366)
T ss_pred             CCCCcEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCCChHHHHHHHHHHHHHhcCCchhHhhcc--CCcchHhh
Confidence             1 3456665   6554                     6788   333   99999   9999 999864  88999999


Q ss_pred             eecc-------cCCCCCCCceeeeeeec------------c---cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChh
Q psy5102         124 LLGS-------DGQTKDELTHFMGVATG------------R---SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLS  178 (357)
Q Consensus       124 Lvna-------~~~F~~~~T~~~~F~~~------------~---~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~  178 (357)
                      |+||       +.||++..|..++||..            .   +|.+.++.++++|+  |++++++|+|||| +..+|.
T Consensus       160 lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~y~~~~~~~~~vl~LPy~~~~~sm~iiLP~~~~~L~  239 (366)
T cd02046         160 IVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAHKLSSMIFIMPYHVEPLE  239 (366)
T ss_pred             hhheEEEcchhcCCCCHHhceeccEEeCCCeEEEhhHhhccCceeeEEeCCCCeEEEEEEcCCCcEEEEEEecCCCCCHH
Confidence            9999       99999999999999986            1   45556678999999  9988999999999 889999


Q ss_pred             HHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEE
Q psy5102         179 EFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEV  258 (357)
Q Consensus       179 ~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev  258 (357)
                      ++++.|+.+.+..|.++++.+.|+|+||||++++++||+++|++||++++|++..|||++|+++++++|++|+|++.|||
T Consensus       240 ~l~~~L~~~~l~~~~~~~~~~~v~l~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~l~vs~v~hka~ieV  319 (366)
T cd02046         240 RLEKLLTREQLKTWISKMKKRAVAISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYLSNVFHAAALEW  319 (366)
T ss_pred             HHHHHhCHHHHHHHHHhcceeEEEEEcceEEeeEEEcHHHHHHHcCCccccCCCCCCcccCCCCCceeeeeeEEEEEEEE
Confidence            99999999999999999999999999999999999999999999999999986579999999876899999999999999


Q ss_pred             ccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         259 TEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       259 ~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      ||+|++|++++........+..|++||||+|+|+|..|+.|||+|+|
T Consensus       320 ~E~G~~aaa~~~~~~~~~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v  366 (366)
T cd02046         320 DTEGNPFDPDIYGREEMRNPKLFYADHPFIFLVKDNKTNSILFIGRL  366 (366)
T ss_pred             CCCcchhhhhhhhcccCCCCCEEEecCCEEEEEEECCCCcEEEEEeC
Confidence            99999998764311111135689999999999999999999999996

It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H.

>cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade

Probab=100.00  E-value=8.8e-57  Score=447.57  Aligned_cols=295  Identities=23%  Similarity=0.381  Sum_probs=258.1

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-----------h-----h
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-----------G-----R   73 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-----------~-----~   73 (357)
                      ..+..++++||++||+++....++++|+++||+||+.+|+|++.||+|+|++||.++||+++           .     +
T Consensus        63 ~~~~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~~~~~~~~~~~~  142 (436)
T cd02047          63 QRLNILNANFGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNLFR  142 (436)
T ss_pred             hHHHHHHhHHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhcccccccccccccHHHHHHHHH
Confidence            45667899999999999975314688999999999999999999999999999999999963           1     2


Q ss_pred             hHHhhc---c-cceeeee---eccc---------------------cCCH--H-HH--HHHHH---hCCC-cccCCCCCC
Q psy5102          74 SLSNKL---T-AHSLRRG---ITQM---------------------TLDM--E-RA--IRSVM---TKNQ-NVVFAPLSI  116 (357)
Q Consensus        74 ~ll~~l---~-~~~l~~a---f~~~---------------------~~dF--~-~a--IN~wv---T~g~-~~~l~~~~l  116 (357)
                      .+.+.+   . +..++++   |+++                     .+||  + .+  ||+||   |+|+ ++++..  +
T Consensus       143 ~l~~~l~~~~~~~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~~~~IN~wV~~~T~g~I~~~l~~--i  220 (436)
T cd02047         143 KLTHRLFRRNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPAFITKTNNRIQKLTKGLIKEALEN--V  220 (436)
T ss_pred             HHHHHhhcCCCCcEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCCCHHHHHHHHHHHHHhcCCcccccccc--C
Confidence            233333   2 4566666   6554                     5788  2 33  99999   9999 999964  8


Q ss_pred             CccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec
Q psy5102         117 VGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP  172 (357)
Q Consensus       117 ~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP  172 (357)
                      +++|+++|+||       +.+|++..|..++||..              . .|++.+++++++++  |++ ++||+||||
T Consensus       221 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~MM~~~~~~~y~~~~~l~~~vleLPy~~-~~SM~iiLP  299 (436)
T cd02047         221 DPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTKGNFLAAADPELDCDILQLPYVG-NISMLIVVP  299 (436)
T ss_pred             CcccceeeeeeeEEechhhCcCCcccccCcCCEeCCCCEEEEehhcccceEEEEEcCCcCcEEEEecCCC-CeeEEEEeC
Confidence            99999999999       89999999999999986              1 55667889999999  887 499999999


Q ss_pred             -CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeee
Q psy5102         173 -KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVF  251 (357)
Q Consensus       173 -~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~  251 (357)
                       +..+|.+++++|+.+.+..|.++++.+.|+|+||||++++++||+++|++||++++|+. .|||++|+++ +++|++|+
T Consensus       300 ~~~~gL~~l~~~L~~~~l~~~~~~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~lF~~-~adfs~is~~-~l~vs~v~  377 (436)
T cd02047         300 HKLSGMKTLEKQITPQVVERWQKSMTNRTREVVLPKFKLEKNYNLIESLKLMGITDLFTE-KGNMAGVSDE-KIAIDLFK  377 (436)
T ss_pred             cccCCHHHHHHHhCHHHHHHHHHhCceeEEEEEeccEEEEeeecHHHHHHhcChhhhcCC-cccccccCCC-CeEEEeee
Confidence             88999999999999999999999999999999999999999999999999999999997 7999999876 79999999


Q ss_pred             EEEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |++.|+|||+|++|+|+|.+.+. ++.+.+|++||||+|+|+++.|+.|||+|+|.+|.
T Consensus       378 hka~IeVdE~GteAaa~T~~~~~~~~~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~  436 (436)
T cd02047         378 HQGTITVNEEGTEAAAVTTVGFMPLSTQVRFIVDRPFLFLIYEHRTNCLLFMGRVANPS  436 (436)
T ss_pred             eeeEEEEcCCcccchhccccccccCCCCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence            99999999999999999976544 44557899999999999999999999999999994

HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily.

>cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation

Probab=100.00  E-value=3.7e-57  Score=444.50  Aligned_cols=295  Identities=25%  Similarity=0.421  Sum_probs=255.7

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h------hhHHhh
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G------RSLSNK   78 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~------~~ll~~   78 (357)
                      .+..++++||++||+++.....+++|+|+||+||+.+|+|++.||.|.|++||.++||++.      +      +.+...
T Consensus         4 ~~~~~~~~Fa~~l~~~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~~   83 (381)
T cd02045           4 ELSKANSRFALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFAKLNCR   83 (381)
T ss_pred             hhhhhhhHHHHHHHHHHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccccHHHHHHHHHHHHHH
Confidence            4677899999999999975313678999999999999999999999999999999999963      1      222222


Q ss_pred             c----c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          79 L----T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        79 l----~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +    + +..+.++   |+++                     .+||    +.+   ||+||   |+|+ +++++++++++
T Consensus        84 ~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~ll~~~~l~~  163 (381)
T cd02045          84 LYRKANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWIANKTENRITDVIPEGAIDT  163 (381)
T ss_pred             HhcccCCcchhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHHHHHHHHhhHHHhhCCCCCCCC
Confidence            2    1 2344444   4443                     5788    233   99999   9999 99998888999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~  173 (357)
                      +|+++|+||       ++||++..|..++||..              . +|++.+++++++|+  |++++++|+|||| +
T Consensus       164 ~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~l~LPy~~~~~sm~iilP~~  243 (381)
T cd02045         164 NTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQESKFRYAKIPEDKVQVLELPYKGDDITMVLILPKE  243 (381)
T ss_pred             ccceeeEeeeEEeccccCCCCcccCcccccCcCCCcEEEEeccCccceeeeEecCCCCcEEEEeecCCCceEEEEEeCCC
Confidence            999999999       89999999999999986              1 56667889999999  9988999999999 8


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC--CCceeeeee
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD--RGVAVDQVF  251 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~~l~vs~v~  251 (357)
                      ..+|.++++.|+.+.+..|.++++.+.|+|.||||+++.++||+++|++||++++|++..|||++|+.+  .+++|++|+
T Consensus       244 ~~~l~~l~~~l~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~vs~v~  323 (381)
T cd02045         244 GTTLSEVEQNLTLDKLQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGGRTDLYVSDAF  323 (381)
T ss_pred             CCCHHHHHHhcCHHHHHHHHHhCcCcEEEEECCCEEEeeEecHHHHHHHcCCcccCCCCCCCccccccCCCCCceeeccc
Confidence            899999999999999999999999999999999999999999999999999999999756999999853  479999999


Q ss_pred             EEEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      |++.|+|||+|++|+|+|.+.+. ++   .+++|++||||+|+|+|+.|+.|||+|||
T Consensus       324 hka~ieV~E~GteAaaat~~~~~~~s~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v  381 (381)
T cd02045         324 HKAFLEVNEEGSEASAATAVVITGRSLNINRIIFVANRPFLLFIREVAINAIIFMGRV  381 (381)
T ss_pred             eeeEEEECCCCeehhhhhhhhhhhccCCCCCCEEEeeCCEEEEEEECCCCcEEEEEeC
Confidence            99999999999999999976554 44   23689999999999999999999999996

It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily.

>cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like

Probab=100.00  E-value=8.9e-57  Score=440.67  Aligned_cols=293  Identities=22%  Similarity=0.346  Sum_probs=254.9

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h-----hhHHhhc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G-----RSLSNKL   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~-----~~ll~~l   79 (357)
                      -..+..+.++||++||+++... .+++|+++||+||+.+|+|++.||+|+|++||.++||++.    .     +++++.+
T Consensus        12 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l   90 (374)
T cd02052          12 RNKLAAAVSNFGYDLYRQQASR-DPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLASL   90 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcc-CCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCCChHHHHHHHHHHHHHh
Confidence            3567789999999999999876 6789999999999999999999999999999999999863    1     3444444


Q ss_pred             -c-cceeeee---eccc---------------------cCCH-H-HH--HHHHH---hCCC-cccCCCCCCCccceeEee
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM-E-RA--IRSVM---TKNQ-NVVFAPLSIVGALALVLL  125 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF-~-~a--IN~wv---T~g~-~~~l~~~~l~~~t~lvLv  125 (357)
                       . +..++.+   |+++                     .+|| . .+  ||+||   |+|+ ++++++  ++++|+++|+
T Consensus        91 ~~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~~~~~~~~IN~wv~~~T~g~I~~~l~~--i~~~t~l~lv  168 (374)
T cd02052          91 TAPAKGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNALDLQEINDWVQQQTGGKVDRFVKE--IPRNVSILLL  168 (374)
T ss_pred             cCCCccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccCCHHHHHHHHHHHHHhhcCcHHHhCCC--CCCccceEEE
Confidence             2 2334444   5443                     4566 3 23  99999   9999 999975  9999999999


Q ss_pred             cc-------cCCCCCCCceeeeeeec---------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCC-Chh
Q psy5102         126 GS-------DGQTKDELTHFMGVATG---------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNP-DLS  178 (357)
Q Consensus       126 na-------~~~F~~~~T~~~~F~~~---------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~-~L~  178 (357)
                      ||       ..||++..|..++||..               . +|++.+++++++|+  |++ ++||+|||| +.. +|.
T Consensus       169 Na~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vveLPy~~-~~sm~iiLP~~~~~~L~  247 (374)
T cd02052         169 GSAYFKGQWITKFDKRNTVLTDFHLDEQRTVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTG-GVSIMFFLPDKVTQNLT  247 (374)
T ss_pred             eeEEEechhcCCCCcccCccccEEcCCCcEEEEEeeccCCcceeeEEcCCCCcEEEEEecCC-CeEEEEEecCCCCCCHH
Confidence            99       89999999999999987               1 45667888999999  876 599999999 653 799


Q ss_pred             HHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEE
Q psy5102         179 EFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEV  258 (357)
Q Consensus       179 ~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev  258 (357)
                      .+++.|+.+.+..|.++++.+.|+|.||||+++.++||+++|++||++++|+.  |||++|+++ +++|++|+|++.|+|
T Consensus       248 ~l~~~l~~~~~~~~~~~~~~~~v~v~lPKF~i~~~~~l~~~L~~lGl~~~F~~--adfs~i~~~-~l~v~~v~hk~~ieV  324 (374)
T cd02052         248 LIEESLTSEFVHDIDRELKTVKAVLTLPKLKLSYETELLPSLQELKLQSLFAS--PDFTKITSK-PIKLSHVHHKAVLEL  324 (374)
T ss_pred             HHHhhcCHHHHHHHHHhCeEEEEEEECccEEEEEEechHHHHHhcCCcccccc--cchhhcccc-ceEeEeeEEEEEEEE
Confidence            99999999999999999999999999999999999999999999999999984  999999875 799999999999999


Q ss_pred             ccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         259 TEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       259 ~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      ||+|++|+|+|.....++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       325 dE~Gt~aaa~t~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  374 (374)
T cd02052         325 NEDGAETAPTPGSATALTFPLEYHVDRPFLFVLRDEDTGALLFIGKVLDP  374 (374)
T ss_pred             CCCccccccccccccccCCCeEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence            99999999999764433456789999999999999999999999999998

PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily.

>PHA02948 serine protease inhibitor-like protein; Provisional

Probab=100.00  E-value=1.5e-56  Score=438.22  Aligned_cols=292  Identities=21%  Similarity=0.328  Sum_probs=248.2

Q ss_pred             HHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch------hhHHhhc-c----
Q psy5102          12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG------RSLSNKL-T----   80 (357)
Q Consensus        12 ~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~------~~ll~~l-~----   80 (357)
                      ...+.++||++||+++... ++++|+++||+||+.+|+|++.||+|+|++||.++||++.+      +++++.+ .    
T Consensus        17 ~~~~~~~f~~~l~~~l~~~-~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~l~~~~~~~~~~   95 (373)
T PHA02948         17 RLQGFTNAGILAYKNIQDG-NEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRKRDLGPAFTELISGLAKLKTS   95 (373)
T ss_pred             hhccchHHHHHHHHHHHhc-CCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCchhHHHHHHHHHHHHhccccc
Confidence            3447899999999999876 67899999999999999999999999999999999999762      3343333 1    


Q ss_pred             ccee-eee---eccc------------------cCCH-HHH---HHHHH-hCCC-cccCCCCCCCccceeEeecc-----
Q psy5102          81 AHSL-RRG---ITQM------------------TLDM-ERA---IRSVM-TKNQ-NVVFAPLSIVGALALVLLGS-----  127 (357)
Q Consensus        81 ~~~l-~~a---f~~~------------------~~dF-~~a---IN~wv-T~g~-~~~l~~~~l~~~t~lvLvna-----  127 (357)
                      +..+ ..+   |+++                  .+|| +++   ||+|| ...+ ++++++++++++|+++|+||     
T Consensus        96 ~~~~~~~an~~~v~~~~~~~~~f~~~~~~~~v~~vdF~~~a~~~IN~WV~~~T~I~~~~~~~~i~~~t~lvLvNaiyFkg  175 (373)
T PHA02948         96 KYTYTDLTYQSFVDNTVCIKPSYYQQYHRFGLYRLNFRRDAVNKINSIVERRSGMSNVVDSTMLDNNTLWAIINTIYFKG  175 (373)
T ss_pred             CcchHHHHHHHHHhcCCCccHHHHHHHhhCceEecCccHHHHHHHHHHHHhcCCCcccCCCCCCCCCceEEEEEEEEEee
Confidence            1221 222   4332                  5788 434   99999 3347 89998888999999999999     


Q ss_pred             --cCCCCCCCceeeeeeec-----------c-c----ccccCCCCeEEEe--ecCCeEEEEEEecCCCChhHHhhccChh
Q psy5102         128 --DGQTKDELTHFMGVATG-----------R-S----LSNNPEAYASFLE--KMRNEVYMYFILPKNPDLSEFTKDLDYD  187 (357)
Q Consensus       128 --~~~F~~~~T~~~~F~~~-----------~-~----~~~~~~~~~~vve--y~~~~~sm~iiLP~~~~L~~l~~~L~~~  187 (357)
                        +.||++..|.+++||..           . .    |.+.++.++++++  |+++++||+||||+  ++.++++.|+.+
T Consensus       176 ~W~~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~vl~LPY~~~~~sM~iiLP~--~l~~l~~~l~~~  253 (373)
T PHA02948        176 TWQYPFDITKTHNASFTNKYGTKTVPMMNVVTKLQGNTITIDDEEYDMVRLPYKDANISMYLAIGD--NMTHFTDSITAA  253 (373)
T ss_pred             eecCCCCcccCeeceeEeCCCCEEchhheeccccccceeeccCcCceEEEEecCCCcEEEEEEcCC--cHHHHHHHhCHH
Confidence              89999999999999966           1 1    2345778899999  99889999999993  388999999999


Q ss_pred             HHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCcccccc
Q psy5102         188 KFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAA  267 (357)
Q Consensus       188 ~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aaa  267 (357)
                      .+..|.++++.+.|+|+||||++++++||+++|+ +|++++|+++.|||++|+++ +++|++|+||+.|+|||+|++|+|
T Consensus       254 ~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~-~~i~~~F~~~~Adfs~is~~-~l~vs~v~hka~IeVdE~GteAaA  331 (373)
T PHA02948        254 KLDYWSSQLGNKVYNLKLPRFSIENKRDIKSIAE-MMAPSMFNPDNASFKHMTRD-PLYIYKMFQNAKIDVDEQGTVAEA  331 (373)
T ss_pred             HHHHHHHhCcceEEEEEeeCEeeeeeccHHHHHH-hhhHhhCCCCcCchhhhccC-ceEEEeeEEEEEEEECCCceEEee
Confidence            9999998999999999999999999999999995 67999998646999999865 799999999999999999999999


Q ss_pred             ccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         268 STGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       268 ~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +|.+... ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       332 aT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  373 (373)
T PHA02948        332 STIMVATARSSPEELEFNTPFVFIIRHDITGFILFMGKVESP  373 (373)
T ss_pred             cceeeeeccCCCCeEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence            9986554 4456689999999999999999999999999998

>cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like

Probab=100.00  E-value=1.4e-56  Score=437.69  Aligned_cols=285  Identities=26%  Similarity=0.429  Sum_probs=251.5

Q ss_pred             HhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHhhc---c
Q psy5102          15 GITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSNKL---T   80 (357)
Q Consensus        15 ~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~~l---~   80 (357)
                      ++++|+++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +++++.+   .
T Consensus         1 ~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~~~   79 (361)
T cd02056           1 ANADFAFRLYRQLASE-SPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEEIHQGFQHLLHLLNQPD   79 (361)
T ss_pred             CccHHHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHHHHHHHHHHHHHHHcCCC
Confidence            4689999999999876 6789999999999999999999999999999999999964      1     3444444   1


Q ss_pred             -cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEee
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLL  125 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLv  125 (357)
                       +..++++   |+++                     .+||   +.+   ||+||   |+|+ +++++.  ++++++++++
T Consensus        80 ~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~~~~~~~~~IN~wv~~~T~g~I~~~~~~--i~~~t~lvlv  157 (361)
T cd02056          80 SGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQDSAEAKKQINDYVEKKTHGKIVDLVKD--LDSDTVMVLV  157 (361)
T ss_pred             CcceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCCChHHHHHHHHHHHHHHhhhhHHhhcCC--CCCCceEEEE
Confidence             4455555   5543                     5788   233   99999   9999 999974  9999999999


Q ss_pred             cc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHH
Q psy5102         126 GS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEF  180 (357)
Q Consensus       126 na-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l  180 (357)
                      ||       +.||++..|..++||..              . +|++.+++++++|+  |++ +++|+|||| +. +|.++
T Consensus       158 na~~Fk~~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~~veLPy~~-~~sm~iiLP~~~-~l~~l  235 (361)
T cd02056         158 NYIYFKGKWEKPFDPELTQEEDFFVDEKTTVKVPMMHQTGRYDYLHDSELSCTVVQMPYKG-NATAFFVLPDEG-KMKQV  235 (361)
T ss_pred             EEEeeeehccCCCCcccCcccCCEeCCCcEEEeecccccCcEeeEEcCCCCcEEEEEecCC-CcEEEEEecCcc-hHHHH
Confidence            99       89999999999999976              1 56677788999999  876 499999999 65 89999


Q ss_pred             hhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEcc
Q psy5102         181 TKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTE  260 (357)
Q Consensus       181 ~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E  260 (357)
                      ++.|+.+.+..|.+.++++.|+|+||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+|++.|+|||
T Consensus       236 ~~~l~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~~Gi~~~F~~-~adfs~i~~~~~l~vs~v~qk~~iev~E  314 (361)
T cd02056         236 EAALSRDTLKKWSKLLSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSD-KADLSGITEQPNLKVSKAVHKAVLDVDE  314 (361)
T ss_pred             HHhhCHHHHHHHHHhCceeEEEEEeeeEEEeeeechHHHHHhcChhhhcCC-cCCccccCCCCCEEEEeeeeeeEEEEcC
Confidence            999999999999999999999999999999999999999999999999987 7999999986689999999999999999


Q ss_pred             Cccccccccceeee-ec-CCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         261 QGTVAAASTGIIIT-RI-SKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       261 ~G~~aaa~t~~~~~-~s-~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      +|++|+|+|.+... ++ .+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus       315 ~Gt~aaa~t~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v  361 (361)
T cd02056         315 KGTEAAAATGVEITPMSALPPILKFNRPFLLLIFDRTTESILFLGKV  361 (361)
T ss_pred             CCcccccccchhhhcccCCCCEEEEeCCEEEEEEECCCCcEEEEEeC
Confidence            99999999987555 44 56789999999999999999999999996

This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.

>PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively

Probab=100.00  E-value=4.1e-56  Score=434.96  Aligned_cols=293  Identities=29%  Similarity=0.473  Sum_probs=258.9

Q ss_pred             HHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc--h-------hhHHhhc----c
Q psy5102          14 RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT--G-------RSLSNKL----T   80 (357)
Q Consensus        14 ~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~--~-------~~ll~~l----~   80 (357)
                      +++++||++||+.+.+. .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.  .       +.+++.+    .
T Consensus         1 ~a~~~f~~~L~~~~~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~~~~~   79 (371)
T PF00079_consen    1 AANNQFALKLFKALSKS-NPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGSDDEEIHEYFKKLLQSLNSSPS   79 (371)
T ss_dssp             HHHHHHHHHHHHHHHHH-STTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTSTHHHHHHHHHHHHHHHHSCST
T ss_pred             ChHHHHHHHHHHHHHhh-CCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhcccccccchhhhhhhhhhhhcccc
Confidence            47899999999999988 6799999999999999999999999999999999999974  1       3344444    1


Q ss_pred             -cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEee
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLL  125 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLv  125 (357)
                       +..++.+   |+++                     .+||   .++   ||+|+   |+|+ +++++++++++++.++|+
T Consensus        80 ~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~~~~IN~wv~~~T~g~I~~~v~~~~i~~~t~~vli  159 (371)
T PF00079_consen   80 DNPQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFSDPPQAAKEINKWVSEKTNGKIKNLVSPNDIDPDTRLVLI  159 (371)
T ss_dssp             SSSEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETTSHHHHHHHHHHHHHHHTTTSSSTSSSTTSSSTTEEEEEE
T ss_pred             ccccceeeeeeecccccccccccchhhhhccccccccccccccchhhhhhcchhhhhccceeeccccccchhhHHHHhhc
Confidence             4555555   6554                     5788   223   99999   9999 999999999999999999


Q ss_pred             cc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHH
Q psy5102         126 GS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEF  180 (357)
Q Consensus       126 na-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l  180 (357)
                      ||       +.||++..|..++||..              . +|.+.+++++++|+  |.+ +++|+|||| +..+|.++
T Consensus       160 na~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~l~~~~v~Lp~~~-~~sm~iilP~~~~~l~~l  238 (371)
T PF00079_consen  160 NAIYFKGKWKYPFDPENTEKRPFYVSDGKSVSVPMMHQSGRFRYAEDEDLDAQVVELPYKG-NFSMLIILPDEGDGLDEL  238 (371)
T ss_dssp             EEEEEEEEBSSTEEGGGEEEEEEECSSSEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBST-SEEEEEEEESSTTTHHHH
T ss_pred             ccccccccccccccccccccccccccccccceEEEEecccccccccccccceeEEEecccc-ceeeEEEEeccccchhhh
Confidence            99       88999999999999976              2 66677888999999  877 799999999 88899999


Q ss_pred             hhccChhHHHHHHHhcCceeEE--EEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEE
Q psy5102         181 TKDLDYDKFSRIIESTNKVDVI--YTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEV  258 (357)
Q Consensus       181 ~~~L~~~~l~~~~~~l~~~~v~--l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev  258 (357)
                      +++|+.+.+..|.++++.+.++  |.||||++++++||+++|++||++++|++..|||++|+++.+++|++++|++.|+|
T Consensus       239 ~~~l~~~~l~~~~~~~~~~~~~~~l~lPkf~i~~~~dl~~~L~~lGi~~~F~~~~adfs~i~~~~~~~v~~v~qk~~i~v  318 (371)
T PF00079_consen  239 EKKLTSERLQEIISNLKMRKVDEELSLPKFKIESSIDLKELLKKLGIKDLFDPDSADFSGISDDEPLYVSDVIQKAVIEV  318 (371)
T ss_dssp             HHHHSHHHHHHHHHHCEEEEEEEEEEEEEEEEEEEEEHHHHHHHTTTTGGGSTTTSSCTTTBSSSTEEEEEEEEEEEEEE
T ss_pred             hhhcccccccccccccccccccceeeecccccccccccceeeehhhcccccccccccccccccceeeeeeeccceeeecc
Confidence            9999999999999999999998  99999999999999999999999999994479999999777999999999999999


Q ss_pred             ccCccccccccceeee---ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         259 TEQGTVAAASTGIIIT---RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       259 ~E~G~~aaa~t~~~~~---~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      ||+|++|+++|.+...   ...+.+|++||||+|+|+|+.+|.|||+|+|.+|
T Consensus       319 ~E~G~~a~a~t~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P  371 (371)
T PF00079_consen  319 DEEGTEAAAATAVMASISSPPPPIEFIADRPFLFFIRDRSTGSILFMGKVVDP  371 (371)
T ss_dssp             ESSEEEEEEEEEEEEEESSSSSSEEEECSSEEEEEEEETTTTEEEEEEEESST
T ss_pred             ccccccccccccccccccccccCcEEEEcCCEEEEEEECCCCcEEEEEEecCC
Confidence            9999999999943111   2267899999999999999999999999999998

In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L ....

>cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

Probab=100.00  E-value=2.7e-56  Score=435.92  Aligned_cols=288  Identities=31%  Similarity=0.505  Sum_probs=257.1

Q ss_pred             hhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc--h-------hhHHhhc---c-cc
Q psy5102          16 ITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT--G-------RSLSNKL---T-AH   82 (357)
Q Consensus        16 ~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~--~-------~~ll~~l---~-~~   82 (357)
                      +++||++||+++... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++.  .       +.+++.+   . +.
T Consensus         2 ~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~~   80 (364)
T cd00172           2 NNDFALDLYKQLAKS-EPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDEDVHQAFKSLLSSLKDSEKGV   80 (364)
T ss_pred             cchHHHHHHHHHhhc-CCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            578999999999876 5789999999999999999999999999999999999984  1       3444444   1 34


Q ss_pred             eeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc-
Q psy5102          83 SLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-  127 (357)
Q Consensus        83 ~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-  127 (357)
                      .++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++++++++++++|+|| 
T Consensus        81 ~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~lvnai  160 (364)
T cd00172          81 ELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFANPEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVNAI  160 (364)
T ss_pred             eeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCCChHHHHHHHHHHHHhhhcccchhhCCCCCCCcccceeeeehe
Confidence            56665   6554                     5788   333   99999   9999 99999888999999999999 


Q ss_pred             ------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHHhhc
Q psy5102         128 ------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEFTKD  183 (357)
Q Consensus       128 ------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~~  183 (357)
                            +.||++..|..++||..              . +|++.+++++++|+  |++++++|+|||| +..+|.+++++
T Consensus       161 ~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vv~lpy~~~~~sm~iilP~~~~~l~~l~~~  240 (364)
T cd00172         161 YFKGKWKTPFDPELTRKRPFYVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGSDLSMLIILPKEVTGLAELEEK  240 (364)
T ss_pred             eeeeccCCCCChhhceecccEeCCCcEEEEeCccccCcEEEEEcCccCcEEEEeecCCCceEEEEEecCCCCcHHHHHHh
Confidence                  89999999999999986              2 66667778999999  9988999999999 88899999999


Q ss_pred             cChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCcc
Q psy5102         184 LDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGT  263 (357)
Q Consensus       184 L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~  263 (357)
                      |+.+.+..|.++++.+.|+|+||||++++++||+++|++||++.+|+. .|+|++++.+.+++|++|+|++.|+|||+|+
T Consensus       241 l~~~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~~Gl~~~F~~-~a~~~~~~~~~~l~v~~v~hk~~ievdE~Gt  319 (364)
T cd00172         241 LSAEKLDDLLSNLKEREVEVTLPKFKIESSLDLKEVLQALGITDLFSP-SADLSSISSDEPLYVSKVIHKAFIEVNEEGT  319 (364)
T ss_pred             cCHHHHHHHHHhCCeEEEEEEeeEEEEeeeeCcHHHHHHcCCccccCC-ccccccCCCCCCeEEEeeeeeeEEEECCCce
Confidence            999999999999999999999999999999999999999999999998 7999999877789999999999999999999


Q ss_pred             ccccccceeeee---cCCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         264 VAAASTGIIITR---ISKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       264 ~aaa~t~~~~~~---s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      +|+++|.+....   ..+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus       320 ~aaa~t~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v  364 (364)
T cd00172         320 EAAAATAVSIVPRRPSPPVEFKADRPFLFLIRDDTTGTILFLGRV  364 (364)
T ss_pred             ehhcccceeeccccCCCCCEEEEECCEEEEEEECCCCeEEEEEEC
Confidence            999999876542   256789999999999999999999999996

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.

>smart00093 SERPIN SERine Proteinase INhibitors

Probab=100.00  E-value=2.6e-56  Score=435.35  Aligned_cols=282  Identities=30%  Similarity=0.497  Sum_probs=248.2

Q ss_pred             HHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-----------hhHHhhc---c-cceee
Q psy5102          21 LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-----------RSLSNKL---T-AHSLR   85 (357)
Q Consensus        21 ~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-----------~~ll~~l---~-~~~l~   85 (357)
                      ++||+.+... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++..           +.+++.+   + +..++
T Consensus         1 ~~l~~~l~~~-~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~l~   79 (359)
T smart00093        1 FDLYKELAKE-SPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEADIHQGFQHLLQLLNRPDSQLELK   79 (359)
T ss_pred             ChHHHHHhcc-CCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHHhCCCCcceEE
Confidence            3689999876 67899999999999999999999999999999999999751           2344444   1 34566


Q ss_pred             ee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc---
Q psy5102          86 RG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS---  127 (357)
Q Consensus        86 ~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna---  127 (357)
                      .+   |+++                     .+||    +.+   ||+||   |+|+ ++++++  ++++++++|+||   
T Consensus        80 ~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~lvlvnaiyF  157 (359)
T smart00093       80 TANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIKDLLSD--LDSDTRLVLVNAIYF  157 (359)
T ss_pred             eeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHHHhccc--CCCCceEEEEeeEEE
Confidence            55   6554                     5688    224   99999   9999 999975  999999999999   


Q ss_pred             ----cCCCCCCCceeeeeeec------------c-c---ccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHHhhcc
Q psy5102         128 ----DGQTKDELTHFMGVATG------------R-S---LSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEFTKDL  184 (357)
Q Consensus       128 ----~~~F~~~~T~~~~F~~~------------~-~---~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~~L  184 (357)
                          +.||++..|.+++||..            . .   |++.+++++++|+  |++ +++|+|||| + .+|.+++++|
T Consensus       158 kg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~y~~~~~~~~~vv~Lpy~~-~~sm~iilP~~-~~l~~l~~~l  235 (359)
T smart00093      158 KGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKG-NASMLIILPDE-GGLEKLEKAL  235 (359)
T ss_pred             eeECCCCCCcccceecccEeCCCeEEEEeceeccCceeEEEEcCCCCcEEEEEecCC-CeeEEEEccCc-cHHHHHHHhh
Confidence                89999999999999975            1 3   3455788999999  887 699999999 6 6899999999


Q ss_pred             ChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccc
Q psy5102         185 DYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV  264 (357)
Q Consensus       185 ~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~  264 (357)
                      +...+..|.++++.+.|+|+||||++++++||+++|++||++++|+. .|||++|+++++++|++|+|++.|+|||+|++
T Consensus       236 ~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~~l~~~L~~lGl~~~F~~-~adfs~i~~~~~l~vs~v~hka~ieVdE~Gt~  314 (359)
T smart00093      236 TPETLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSN-KADLSGISEDKDLKVSKVLHKAVLEVNEEGTE  314 (359)
T ss_pred             CHHHHHHHHHhccceEEEEEccEEEEEEEecHHHHHHHcCcchhccC-ccCcccccCCCCeEEEeeeeEEEEEEcCCCcc
Confidence            99999999999999999999999999999999999999999999996 79999999876899999999999999999999


Q ss_pred             cccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         265 AAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       265 aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |+|+|.+... ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       315 aaa~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P  359 (359)
T smart00093      315 AAAATGVIAVPRSLPPEFKANRPFLFLIRDNKTGSILFMGKVVNP  359 (359)
T ss_pred             ccccccccccccCCCceEEecCCEEEEEEECCCCeEEEEEecCCC
Confidence            9999987655 4456789999999999999999999999999998

>cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup

Probab=100.00  E-value=7.9e-56  Score=432.77  Aligned_cols=289  Identities=25%  Similarity=0.361  Sum_probs=253.8

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-h--------hhHHhhc---c
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-G--------RSLSNKL---T   80 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-~--------~~ll~~l---~   80 (357)
                      ..++++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++. +        +.+...+   +
T Consensus         2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~~~   80 (364)
T cd02049           2 NDANTRFGFKLFSELNKE-DVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLEDLNSALATLMDQLNTHD   80 (364)
T ss_pred             cchhhHHHHHHHHHHhhc-CCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhcCC
Confidence            457899999999999876 6789999999999999999999999999999999999975 1        3344444   1


Q ss_pred             -cceeeee---eccc---------------------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEeec
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLG  126 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvn  126 (357)
                       +..++++   |+++                     .+||  +.+   ||+||   |+|+ ++++++  ++++|+++|+|
T Consensus        81 ~~~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~~~~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~lvlvn  158 (364)
T cd02049          81 KTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQSPAAAEEINRWVKEKTKGKIDKIVDK--IDPDDVMFLIN  158 (364)
T ss_pred             CCcEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCCCHHHHHHHHHHHHHhhcChHHHhcCC--CCCCceEEEEe
Confidence             3556665   5554                     5788  223   99999   9999 999976  99999999999


Q ss_pred             c-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHHhhc
Q psy5102         127 S-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEFTKD  183 (357)
Q Consensus       127 a-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~~  183 (357)
                      |       +.||++..|.+++|+..            . .+.|.+..++++++  |.+++++|+|||| +..+|.+++++
T Consensus       159 a~~fk~~W~~~F~~~~T~~~~F~~~~~~~~~v~mM~~~~~~~y~~~~~~~~l~Lpy~~~~~sm~iiLP~~~~~l~~l~~~  238 (364)
T cd02049         159 AVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDGRLSMYVFLPKENVSLREFVKT  238 (364)
T ss_pred             eEEEeeeecCCCChhhcccCcCCCCCCCEEECcccCCcCcEeeEEcCCCeEEEeecCCCcEEEEEEecCCCCCHHHHHHH
Confidence            9       89999999999999976            2 44555667889999  9888999999999 88999999999


Q ss_pred             cChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCcc
Q psy5102         184 LDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGT  263 (357)
Q Consensus       184 L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~  263 (357)
                      |+.+.+..|.++++.+.|+|+||||++++++||.++|++||++.+|++..|||+++++. +++|++++|++.|+|||+|+
T Consensus       239 l~~~~~~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~mGi~~~F~~~~a~~s~~~~~-~l~vs~v~hka~iev~E~G~  317 (364)
T cd02049         239 LTAEKWRKWIEQFRMREGSLSLPRFQLEYEIELRDALKALGMEEAFTPDAADFSKLGEG-NLYISKVIHKTFIEVNEEGT  317 (364)
T ss_pred             hCHHHHHHHHHhCceeEEEEEeeeEEccceechHHHHHHCcccccCCCCcCCCCCCCCC-CeEEEeeeeeEEEEEccCce
Confidence            99999999999999999999999999999999999999999999999767999999765 89999999999999999999


Q ss_pred             ccccccceeee-ec----CCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         264 VAAASTGIIIT-RI----SKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       264 ~aaa~t~~~~~-~s----~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      +|+++|.+... ++    .+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus       318 ~a~a~t~~~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v  364 (364)
T cd02049         318 EAAAATSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSILFMGAV  364 (364)
T ss_pred             eecccceeeeeeccCCCCCCceEEeeCCEEEEEEECCCCcEEEEEeC
Confidence            99999987554 32    34689999999999999999999999996

Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors.

>cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10)

Probab=100.00  E-value=4.2e-56  Score=434.56  Aligned_cols=288  Identities=23%  Similarity=0.386  Sum_probs=248.5

Q ss_pred             HHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc---h---------hhHHhhc
Q psy5102          12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT---G---------RSLSNKL   79 (357)
Q Consensus        12 ~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~---~---------~~ll~~l   79 (357)
                      |+++.++||++||+++...  +++|+|+||+||+.+|+|++.||+|+|++||.++||++.   .         +.+.+.+
T Consensus         2 ~~~~~~~Fa~~l~~~~~~~--~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~~~~   79 (365)
T cd02055           2 FAEETANFGFNLLRKIAMK--HDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNI   79 (365)
T ss_pred             cchhhhHHHHHHHHHHhcC--CCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccccHHHHHHHHHHHHHHh
Confidence            6778999999999999764  578999999999999999999999999999999999864   0         1222222


Q ss_pred             c-c--ceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcccee
Q psy5102          80 T-A--HSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALAL  122 (357)
Q Consensus        80 ~-~--~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~l  122 (357)
                      . +  ..+..+   |+++                     .+||   +++   ||+||   |+|+ ++++++  ++++|++
T Consensus        80 ~~~~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~l  157 (365)
T cd02055          80 SRNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQNASQAKFLINHNIKKETKGKIPELFDE--IDPESKL  157 (365)
T ss_pred             cCCcceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHHHhhcchHHHHhhc--CCccchh
Confidence            1 1  111111   3332                     6788   334   99999   9999 999965  8999999


Q ss_pred             Eeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCCh
Q psy5102         123 VLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDL  177 (357)
Q Consensus       123 vLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L  177 (357)
                      +|+||       +.||++..|..++||..              . +|.+++++++++|+  |++ +.+|+|||| +..+|
T Consensus       158 ~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~-~~sm~iiLP~~~~~l  236 (365)
T cd02055         158 ILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADKFASTFDENFRCHVIKLPYKG-KATMLIVIMEKGEDH  236 (365)
T ss_pred             hhhHHHHHHHHHhCCCChhhCccceEEcCCCcEEEehhhcccCceeeEEeCCCCeEEEEeeeCC-CcEEEEEEcCCCCCH
Confidence            99999       89999999999999986              1 55677889999999  886 489999999 88899


Q ss_pred             hHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCC-CCCCceeeeeeEEEEE
Q psy5102         178 SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNML-DDRGVAVDQVFHKVDI  256 (357)
Q Consensus       178 ~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is-~~~~l~vs~v~qk~~i  256 (357)
                      .++++.|+.+.+..|.++++++.|+|+||||+++.++||+++|++||++++|+. .|||++|+ ++++++|++|+|++.|
T Consensus       237 ~~l~~~l~~~~l~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~-~adls~i~~~~~~l~vs~v~hka~i  315 (365)
T cd02055         237 LALEDHLTMDLVESWLANMKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFAP-FADLSELLADGKHLQVSQVLQKAVI  315 (365)
T ss_pred             HHHHHHhhHHHHHHHHHhccceEEEEEEEEEEEEEEeehHHHHHHcCcchhhcC-cCCcccccCCCCcEEEEeeeEEEEE
Confidence            999999999999999999999999999999999999999999999999999997 79999986 4458999999999999


Q ss_pred             EEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         257 EVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       257 ev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      ||||+|++|+|+|.+... ++.+..|++||||+|+|+|+.++.|||+|+|
T Consensus       316 evdE~Gt~aaa~t~~~~~~~~~~~~f~~nrPF~f~I~~~~~~~~LF~G~v  365 (365)
T cd02055         316 EVDEKGTEAAAAIGSEIIAFSMPPVIKVDRPFHFMIFEETFGMLLFIGRV  365 (365)
T ss_pred             EEccCCchhhhhhcceecccCCCCeEEeeCCEEEEEEECCCCcEEEEEeC
Confidence            999999999999986554 4456689999999999999999999999986

ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms.

>cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots

Probab=100.00  E-value=5.8e-55  Score=424.65  Aligned_cols=283  Identities=23%  Similarity=0.374  Sum_probs=240.8

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---hhHHhhc---c-cceee
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---RSLSNKL---T-AHSLR   85 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---~~ll~~l---~-~~~l~   85 (357)
                      ..++++||++||+++... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++..   +++++.+   . +..++
T Consensus         2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~~~~~~l~   80 (351)
T cd02053           2 ARAMMGFSTDLLSEVAQE-STKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLPCLHHLLSRLRQDLGPGALR   80 (351)
T ss_pred             CcchhhHHHHHHHHHHhh-CCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCChHHHHHHHHHHhccCCccEee
Confidence            356789999999999877 78899999999999999999999999999999999999763   4444444   1 34455


Q ss_pred             ee---eccc-------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc-----
Q psy5102          86 RG---ITQM-------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-----  127 (357)
Q Consensus        86 ~a---f~~~-------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-----  127 (357)
                      ++   |+++                   .++|    +.+   ||+||   |+|+ +++++.  ++++|.++|+||     
T Consensus        81 ~an~i~v~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~IN~wv~~~T~g~I~~~~~~--~~~~t~~vlvNaiyFkg  158 (351)
T cd02053          81 LATRMYLQKGFEIKESFLEESEKLYGAKPVSLTGTKEDDLANINKWVKEATEGQIPNFLSD--LPHDTVLLLLNAIHFKG  158 (351)
T ss_pred             hhhHHHHhCCCchhHHHHHHHHHHcCCEEeecCCCCHHHHHHHHHHHHHhccCchhHhcCC--CCcchHhheeeEEEEee
Confidence            54   5544                   3444    233   99999   9999 999864  889999999999     


Q ss_pred             --cCCCCCCCceeeeeeec-------------c---cccccCCCCeEEEe--ecCCeEEEEEEec-CCC-ChhHHhhccC
Q psy5102         128 --DGQTKDELTHFMGVATG-------------R---SLSNNPEAYASFLE--KMRNEVYMYFILP-KNP-DLSEFTKDLD  185 (357)
Q Consensus       128 --~~~F~~~~T~~~~F~~~-------------~---~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~-~L~~l~~~L~  185 (357)
                        ++||++..|.+++||..             .   +|.++++++++|++  |+++ +||+|||| +.. +|.++++.|+
T Consensus       159 ~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vleLPy~~~-~Sm~iiLP~~~~~~l~~~~~~l~  237 (351)
T cd02053         159 FWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYPLRWFHLEQPEIQVAKFPFKGN-MSFVVLMPTPFTWNVSQVLANLN  237 (351)
T ss_pred             eecCCCChhcCeecceEECCCceEEeehhcccccceeeEecCCCCeEEEEEecCCC-eEEEEEecccccccHHHHHHhCC
Confidence              89999999999999986             1   33456789999999  8875 99999999 655 5999999998


Q ss_pred             hhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCcccc
Q psy5102         186 YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVA  265 (357)
Q Consensus       186 ~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~a  265 (357)
                      .+.+..+.  .+.+.++|+||||++++++||+++|++||++++|+.  |||++|+++ +++|++|+|++.|||||+|++|
T Consensus       238 ~~~l~~~~--~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~--adfs~i~~~-~~~vs~v~hka~ieVdE~Gt~a  312 (351)
T cd02053         238 WDDLYRRL--PKERPTKVKLPKLKLDYQLELNEALSQLGLQELFQA--PDLSGISDE-PLFVSSVQHQSTLELSEKGVEA  312 (351)
T ss_pred             HHHHHHhh--ccceEEEEEccCEEEEeeechHHHHHhCCchhcccc--ccccccCCC-CceeeeeeEEEEEEECCCccee
Confidence            87776653  356678999999999999999999999999999984  999999875 7999999999999999999999


Q ss_pred             ccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         266 AASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       266 aa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      +|+|.+.+.++ ...|++||||+|+|+|+.||.|||+|+|
T Consensus       313 aa~t~~~~~~~-~~~f~~drPF~f~I~~~~t~~~LF~G~v  351 (351)
T cd02053         313 SAATSVATSRS-LSSFSVNRPFLFFIFEDTMGLPLFMGSV  351 (351)
T ss_pred             hhcceeecccc-cCeEEcCCCEEEEEEECCCCCEEEEEeC
Confidence            99997654332 3489999999999999999999999996

Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily.

>cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family

Probab=100.00  E-value=5.8e-55  Score=424.83  Aligned_cols=284  Identities=21%  Similarity=0.360  Sum_probs=240.3

Q ss_pred             HhhHHHHHHHHHHHhccC-CCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch----hhHHhhc----------
Q psy5102          15 GITQMTLDMERAIRSVMT-KNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG----RSLSNKL----------   79 (357)
Q Consensus        15 ~~~~Fa~~l~~~l~~~~~-~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~----~~ll~~l----------   79 (357)
                      ++++||++||+++... . +++|+|+||+||+.+|+|++.||+|+|++||.++||++.+    ...++.+          
T Consensus         1 ~~~~F~~~l~~~~~~~-~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~l~~~~~l~~an   79 (352)
T cd02050           1 ALGEFSLKLYQHLSES-AKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDFACVHSALKKLKNKLGLLSAS   79 (352)
T ss_pred             CcchHHHHHHHHHhhc-cCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCchhHHHHHHHHhhhcchhHHHH
Confidence            4679999999999876 4 7899999999999999999999999999999999999862    1222222          


Q ss_pred             ----c-cceeeeeeccc----------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc-------c
Q psy5102          80 ----T-AHSLRRGITQM----------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-------D  128 (357)
Q Consensus        80 ----~-~~~l~~af~~~----------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-------~  128 (357)
                          + ++.++..|.+.          .++|  +.+   ||+||   |+|+ +++++.  ++++|+++++||       +
T Consensus        80 ~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~~~~a~~~IN~wv~~~T~g~I~~~~~~--i~~~t~l~lvnaiyFkg~W~  157 (352)
T cd02050          80 QIFHHPDLHLRESFTNESWQFYKARPRELSNNSELNLEMINSWVAKATNNKIPRLLDS--LPSETRLVLLNAVYFQAQWK  157 (352)
T ss_pred             HHHHhCCCCccHHHHHHHHHHhCCcceeecCChHHHHHHHHHHHHHHhcchHHHHhcc--cCCCceEEEEeeEEEeeecC
Confidence                1 22222223222          4556  333   99999   9999 999964  999999999999       8


Q ss_pred             CCCCCCCceeeeeeec----------c-----cccccCCCCeEEEe--ecCCeEEEEEEec-CC-CChhHHhhccChhHH
Q psy5102         129 GQTKDELTHFMGVATG----------R-----SLSNNPEAYASFLE--KMRNEVYMYFILP-KN-PDLSEFTKDLDYDKF  189 (357)
Q Consensus       129 ~~F~~~~T~~~~F~~~----------~-----~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~-~~L~~l~~~L~~~~l  189 (357)
                      +||++..|..++|+..          .     .|.+.+++++++++  |.+ ++||+|||| +. .+|.+++++|+.+.+
T Consensus       158 ~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~~~~~~~~l~~~v~~lp~~~-~~sm~iiLP~~~~~~l~~l~~~l~~~~~  236 (352)
T cd02050         158 KKFDTKHTVLLPFKRNGDPVKVPVMYSKKYPVASFTDPRLKAQVGRLELSG-GLSLVVLVPRGPKEDLEAVERALTPPAF  236 (352)
T ss_pred             CCCCcccCccCceeECCceEEeeEeecCccceeeEEcCCcCeEEEEecCCC-ceEEEEEeeCCCCCCHHHHHHhcCHHHH
Confidence            9999999999999976          1     12345788999999  764 599999999 64 689999999999999


Q ss_pred             HHHHHhc---CceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccc
Q psy5102         190 SRIIEST---NKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA  266 (357)
Q Consensus       190 ~~~~~~l---~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aa  266 (357)
                      ..|.+++   ..+.++|.||||++++++||+++|++||++++|+.  |||++|+.+.+++|++++|++.|+|||+|++|+
T Consensus       237 ~~~~~~l~~~~~~~v~l~lPKF~i~~~~dl~~~L~~lGi~~~F~~--adfs~i~~~~~l~v~~v~hk~~ieVdE~Gt~Aa  314 (352)
T cd02050         237 LAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFLD--ANLCGLYQDPELAVDAAQHRAVLTLTEKGVEAA  314 (352)
T ss_pred             HHHHHhhhhcCceEEEEEcceEEEeeccchHHHHHHcCChhhccc--cchhhccCCCCeEEEeeEEeeEEEECCCchhhh
Confidence            9998877   35789999999999999999999999999999974  999999987789999999999999999999999


Q ss_pred             cccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEE
Q psy5102         267 ASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSI  305 (357)
Q Consensus       267 a~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v  305 (357)
                      |+|.+.+.++ +.+|++||||+|+|+|+.||.|||+|+|
T Consensus       315 a~t~~~~~~~-~~~f~~drPF~f~I~~~~t~~~LF~G~v  352 (352)
T cd02050         315 AATATSFART-ALSFEALQPFLFVLWDDQAKVPLFMGRV  352 (352)
T ss_pred             hhcccccccc-cceEEcCCCEEEEEEECCCCceEEEEeC
Confidence            9997654332 3689999999999999999999999996

It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily.

>cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup

Probab=100.00  E-value=1.7e-54  Score=425.71  Aligned_cols=293  Identities=26%  Similarity=0.369  Sum_probs=245.2

Q ss_pred             HhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc------c-
Q psy5102          15 GITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL------T-   80 (357)
Q Consensus        15 ~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l------~-   80 (357)
                      .+++||++||+.+....++++|+|+||+||+.+|+||++||+|+|++||.++||++..       +++.+.+      . 
T Consensus         2 ~~~~~~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~l~~~~~~~~~~~~   81 (381)
T cd02043           2 NQCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAASIVDLVLADASASG   81 (381)
T ss_pred             chHHHHHHHHHHHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCChHHHHHHHHHHHHHHhhhcccCC
Confidence            4678999999999876127899999999999999999999999999999999999762       2333322      1 


Q ss_pred             cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEee
Q psy5102          81 AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLL  125 (357)
Q Consensus        81 ~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLv  125 (357)
                      +..++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++++|+++++
T Consensus        82 ~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~lv  161 (381)
T cd02043          82 GPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKLVLA  161 (381)
T ss_pred             CcEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHHHHhcChHHhhCCCCCcCCCceEEEE
Confidence            2345554   5443                     6788    233   99999   9999 999988889999999999


Q ss_pred             cc-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecCC------eEEEEEEec-CCCC
Q psy5102         126 GS-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRN------EVYMYFILP-KNPD  176 (357)
Q Consensus       126 na-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~------~~sm~iiLP-~~~~  176 (357)
                      ||       ++||++..|.+++||..            . .+.|....++++|+  |+++      ++||+|||| +..+
T Consensus       162 nai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~veLPy~~~~~~~~~~~sm~iiLP~~~~~  241 (381)
T cd02043         162 NALYFKGAWSSKFDASDTKDRDFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDKKDG  241 (381)
T ss_pred             eeeEEeeeeccCCccccCccccceeCCCCeEEeeeeeccCcccccccCCCEEEEcCCCCCCCCCCCcEEEEEEccCCCCC
Confidence            99       89999999999999976            1 22333345699999  9765      599999999 8899


Q ss_pred             hhHHhhccChh--HHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCC--CCCceeeeeeE
Q psy5102         177 LSEFTKDLDYD--KFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLD--DRGVAVDQVFH  252 (357)
Q Consensus       177 L~~l~~~L~~~--~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~--~~~l~vs~v~q  252 (357)
                      |.+++++|+..  .+..|...++.+.++|+||||++++++||+++|++||++++|+. .++++++..  ..+++|++|+|
T Consensus       242 L~~l~~~l~~~~~~~~~~~~~~~~~~v~l~lPKF~i~~~~dl~~~L~~mGl~~~F~~-~~~~~~~~~~~~~~l~vs~v~h  320 (381)
T cd02043         242 LADLLEKLVSEPGFLDRHIPASEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDP-GGALLSMSSPEGENLYVSSVYH  320 (381)
T ss_pred             HHHHHHhhccChhhhhhhcccceeeEEEEEcccEEEEeecchHHHHHHCCCccccCC-ccccccCccCCCCCeeEEeeee
Confidence            99999999653  36667777778889999999999999999999999999999997 567776642  34799999999


Q ss_pred             EEEEEEccCccccccccceeee-ec----CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         253 KVDIEVTEQGTVAAASTGIIIT-RI----SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~~-~s----~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      ++.|+|||+|++|+|+|.+... ++    .+.+|++||||+|+|+|..|+.|||+|+|.+|
T Consensus       321 ka~ieVdE~Gt~aaa~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P  381 (381)
T cd02043         321 KACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFLFLIREDKTGVVLFLGQVMNP  381 (381)
T ss_pred             EEEEEECCCcceehhccceeeccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence            9999999999999999987554 33    24579999999999999999999999999998

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>PHA02660 serpin-like protein; Provisional

Probab=100.00  E-value=3.1e-51  Score=399.56  Aligned_cols=287  Identities=19%  Similarity=0.300  Sum_probs=232.5

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch----hh--HHhhc--c
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG----RS--LSNKL--T   80 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~----~~--ll~~l--~   80 (357)
                      +..+.....+||++||+++.     ++|+|+||+||+.+|+|++.||+|+|++||.++||+...    ..  ....+  +
T Consensus         8 ~~~~~~~~~~f~~~l~~~~~-----~~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~l~~an~l~v~   82 (364)
T PHA02660          8 NNNIIKMSLDLGFCILKSLH-----RFNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYSPIRKNHIHNITKVYVD   82 (364)
T ss_pred             cchHHHHHHHHHHHHHHhcC-----CCCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCccccccchhhHHHHHHHHHh
Confidence            34567788999999999984     479999999999999999999999999999999998631    11  11222  2


Q ss_pred             -cceeeeeecc-------c--cCCH----HHH---HHHHH---hCCCcccCCCCCCCccceeEeecc-------cCCCCC
Q psy5102          81 -AHSLRRGITQ-------M--TLDM----ERA---IRSVM---TKNQNVVFAPLSIVGALALVLLGS-------DGQTKD  133 (357)
Q Consensus        81 -~~~l~~af~~-------~--~~dF----~~a---IN~wv---T~g~~~~l~~~~l~~~t~lvLvna-------~~~F~~  133 (357)
                       +..++..|.+       +  .+||    +++   ||+||   |+ -.++++   ++++|+++|+||       ++||++
T Consensus        83 ~~~~l~~~F~~~~~~~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~-I~~~~~---~~~~t~l~LvNaiyFkg~W~~~F~~  158 (364)
T PHA02660         83 SHLPIHSAFVASMNDMGIDVILADLANHAEPIRRSINEWVYEKTN-IINFLH---YMPDTSILIINAVQFNGLWKYPFLR  158 (364)
T ss_pred             cCCchhHHHHHHHHHcCCceEEeccccCHHHHHHHHHHHHHhccC-Cccccc---cCCCchhhhhhhhhcccHhhcCCCc
Confidence             3444333322       2  6899    233   99999   66 445552   778999999999       899999


Q ss_pred             CCceeeeeeec------------c-cccccCCCCeEEEe--ecCC-eEEEEEEec-CC--CChhHHhhccChhHHHHHHH
Q psy5102         134 ELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRN-EVYMYFILP-KN--PDLSEFTKDLDYDKFSRIIE  194 (357)
Q Consensus       134 ~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~-~~sm~iiLP-~~--~~L~~l~~~L~~~~l~~~~~  194 (357)
                      ..|.+++||..            . .|.|....++++++  |+++ .++|+|||| +.  .+|.++++.|+.+.+..|.+
T Consensus       159 ~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~vleLPY~~~~~~sM~iiLP~~~~~~~L~~l~~~l~~~~l~~~~~  238 (364)
T PHA02660        159 KKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRYHQSNIIEIPYDNCSRSHMWIVFPDAISNDQLNQLENMMHGDTLKAFKH  238 (364)
T ss_pred             ccCcccccccCCCceEeceeccccCeeeeeecCCCeEEECccCCCCceEEEEEeeCCcccchHHHHHHhhhHHHHHHHHh
Confidence            99999999976            1 23333345689999  9874 579999999 53  57999999999999999988


Q ss_pred             hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCC----Cce--eeeeeEEEEEEEccCccccccc
Q psy5102         195 STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR----GVA--VDQVFHKVDIEVTEQGTVAAAS  268 (357)
Q Consensus       195 ~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~----~l~--vs~v~qk~~iev~E~G~~aaa~  268 (357)
                      .+..+.|+|+||||+++.++||+++|++||++++|+.  |||++|+++.    +++  |++|+||+.|||||+|++|+|+
T Consensus       239 ~~~~~~v~l~LPKFki~~~~~L~~~L~~lGi~~~F~~--Adfs~i~~~~~~~~~l~~~vs~v~hka~ieVdE~GteAaaa  316 (364)
T PHA02660        239 ASRKKYLEISIPKFRIEHSFNAEHLLPSAGIKTLFTN--PNLSRMITQGDKEDDLYPLPPSLYQKIILEIDEEGTNTKNI  316 (364)
T ss_pred             hCceeEEEEEccceEeeeeechHHHHHHcCchhhccc--cCccccccCCCcccccccccccceEeeEEEECCCCcHHHHh
Confidence            8889999999999999999999999999999999974  9999997532    477  7999999999999999999988


Q ss_pred             cceeeeec----------CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         269 TGIIITRI----------SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       269 t~~~~~~s----------~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |.......          .+.+|++||||+|+|++  ++.|||+|+|.+|
T Consensus       317 t~~~~~~~~~~~~~~~~~~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P  364 (364)
T PHA02660        317 AKKMRRNPQDEDTQQHLFRIESIYVNRPFIFIIEY--ENEILFIGRISIP  364 (364)
T ss_pred             hhhhhhcccccccccccCCCceEEcCCCEEEEEec--CCeEEEEEEecCC
Confidence            74311111          12479999999999986  5899999999998

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	357
4dy0_A	379	Crystal Structure Of Native Protease Nexin-1 With H		2e-16
1c5g_A	402	Plasminogen Activator Inhibitor-1 Length = 402		6e-16
4aqh_A	383	Plasminogen Activator Inhibitor Type-1 In Complex W		8e-16
3q02_A	379	Crystal Structure Of Plasminogen Activator Inhibito		8e-16
3lw2_A	379	Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Len		8e-16
1dvn_A	379	Latent Form Of Plasminogen Activator Inhibitor-1 (P		9e-16
3nda_A	377	Crystal Structure Of Serpin From Tick Ixodes Ricinu		2e-15
1dvm_A	379	Active Form Of Human Pai-1 Length = 379		3e-15
3cvm_A	392	High Resolution Structure Of A Stable Plasminogen A		3e-15
3eox_A	379	High Quality Structure Of Cleaved Pai-1-Stab Length		3e-15
1by7_A	382	Human Plasminogen Activator Inhibitor-2. Loop (66-9		3e-15
2arq_A	382	Human Plasminogen Activator Inhibitor-2.[loop (66-9		3e-15
3ut3_A	375	A Novel Pai-i Inhibitor And Its Structural Mechanis		3e-15
1db2_A	377	Crystal Structure Of Native Plasminogen Activator I		3e-15
1b3k_A	379	Plasminogen Activator Inhibitor-1 Length = 379		4e-15
1a7c_A	379	Human Plasminogen Activator Inhibitor Type-1 In Com		4e-15
3r4l_A	379	Human Very Long Half Life Plasminogen Activator Inh		7e-15
4if8_A	414	Structure Of Vaspin Length = 414		9e-15
1oo8_A	394	Crystal Structure Of A1pi-Pittsburgh In The Native		7e-14
3t1p_A	371	Crystal Structure Of An Alpha-1-Antitrypsin Trimer		1e-13
2dut_A	423	Crystal Structure Of A M-Loop Deletion Variant Of M		1e-13
2b4x_I	427	Crystal Structure Of Antithrombin-Iii Length = 427		2e-13
3kcg_I	432	Crystal Structure Of The Antithrombin-Factor Ixa- P		2e-13
2b4x_L	427	Crystal Structure Of Antithrombin-Iii Length = 427		2e-13
1ath_A	432	The Intact And Cleaved Human Antithrombin Iii Compl		2e-13
2h4r_A	415	Crystal Structure Of Wildtype Ment In The Native Co		2e-13
4eb1_I	440	Hyperstable In-Frame Insertion Variant Of Antithrom		2e-13
1dzg_I	432	N135q-S380c-Antithrombin-Iii Length = 432		2e-13
1atu_A	374	Uncleaved Alpha-1-Antitrypsin Length = 374		2e-13
3ne4_A	424	1.8 Angstrom Structure Of Intact Native Wild-Type A		3e-13
2hij_I	432	Crystal Structure Of P14 Alanine Variant Of Antithr		3e-13
1kct_A	394	Alpha1-Antitrypsin Length = 394		3e-13
1psi_A	394	Intact Recombined Alpha1-Antitrypsin Mutant Phe 51		3e-13
3drm_A	404	2.2 Angstrom Crystal Structure Of Thr114phe Alpha1-		3e-13
1qlp_A	394	2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsi		3e-13
1dzh_I	432	P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length		3e-13
3dru_A	404	Crystal Structure Of Gly117phe Alpha1-Antitrypsin L		3e-13
2qug_A	394	Crystal Structure Of Alpha-1-Antitrypsin, Crystal F		3e-13
1hp7_A	394	A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-An		4e-13
2hi9_A	363	Crystal Structure Of Human Native Protein C Inhibit		5e-13
2ol2_A	395	High Resolution Structure Of Native Pci In Space Gr		7e-13
2gd4_I	443	Crystal Structure Of The Antithrombin-S195a Factor		8e-13
1tb6_I	432	2.5a Crystal Structure Of The Antithrombin-Thrombin		9e-13
1iz2_A	394	Interactions Causing The Kinetic Trap In Serpin Pro		1e-12
1xu8_A	380	The 2.8 A Structure Of A Tumour Suppressing Serpin		2e-12
1wz9_A	375	The 2.1 A Structure Of A Tumour Suppressing Serpin		3e-12
1xqg_A	389	3.10 A Crystal Structure Of Maspin, Space Group P 4		5e-12
3f5n_A	407	Structure Of Native Human Neuroserpin Length = 407		6e-12
3fgq_A	397	Crystal Structure Of Native Human Neuroserpin Lengt		6e-12
1qmn_A	401	Alpha1-Antichymotrypsin Serpin In The Delta Conform		4e-11
2pee_A	387	Crystal Structure Of A Thermophilic Serpin, Tengpin		1e-10
2pef_A	373	Crystal Structure Of A Thermophilic Serpin, Tengpin		1e-10
2vh4_A	381	Structure Of A Loop C-sheet Serpin Polymer Length =		1e-10
1att_A	429	Crystal Structure Of Cleaved Bovine Antithrombin Ii		2e-10
3vvj_A	392	Structure Of Ovalbumin From Emu (Dromaius Novaeholl		3e-10
3dlw_A	411	Antichymotrypsin Length = 411		3e-10
4ajt_A	427	The Cystal Structure Of Mouse Protein-Z Dependent P		1e-09
3pzf_A	397	1.75a Resolution Structure Of Serpin-2 From Anophel		2e-09
2r9y_A	430	Structure Of Antiplasmin Length = 430		5e-09
2vdx_A	373	Crystal Structure Of The Reactive Loop Cleaved Cort		5e-09
2h4p_A	394	Crystal Structure Of Wildtype Ment In The Cleaved C		1e-08
1jti_A	385	Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin		1e-08
1oyh_I	432	Crystal Structure Of P13 Alanine Variant Of Antithr		1e-08
1lq8_A	346	Crystal Structure Of Cleaved Protein C Inhibitor Le		2e-08
3dy0_A	336	Crystal Structure Of Cleaved Pci Bound To Heparin L		2e-08
3f1s_A	385	Crystal Structure Of Protein Z Complexed With Prote		3e-08
3h5c_A	423	X-Ray Structure Of Protein Z-Protein Z Inhibitor Co		4e-08
1ova_C	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		4e-08
2h4q_A	382	Crystal Structure Of A M-Loop Deletion Variant Of M		4e-08
2ceo_A	379	Thyroxine-Binding Globulin Complex With Thyroxine L		6e-08
1ova_A	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		7e-08
1ova_B	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		7e-08
1imv_A	398	2.85 A Crystal Structure Of Pedf Length = 398		7e-08
1uhg_A	385	Crystal Structure Of S-ovalbumin At 1.9 Angstrom Re		9e-08
9pai_A	346	Cleaved Substrate Variant Of Plasminogen Activator		2e-07
4ga7_A	389	Crystal Structure Of Human Serpinb1 Mutant Length =		4e-07
1d5s_A	334	Crystal Structure Of Cleaved Antitrypsin Polymer Le		5e-07
1ezx_A	335	Crystal Structure Of A Serpin:protease Complex Leng		5e-07
7api_A	347	The S Variant Of Human Alpha1-Antitrypsin, Structur		6e-07
2d26_A	358	Active Site Distortion Is Sufficient For Proteinase		6e-07
3ndf_A	343	Cleaved Antitrypsin With P8-P6 Asp Length = 343		6e-07
2zv6_A	401	Crystal Structure Of Human Squamous Cell Carcinoma		8e-07
1jmo_A	480	Crystal Structure Of The Heparin Cofactor Ii-S195a		9e-07
1jmj_A	480	Crystal Structure Of Native Heparin Cofactor Ii Len		1e-06
3ndd_A	343	Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Len		1e-06
2ach_A	360	Crystal Structure Of Cleaved Human Alpha1-antichymo		1e-06
3le2_A	393	Structure Of Arabidopsis Atserpin1. Native Stressed		2e-06
1qmb_A	326	Cleaved Alpha-1-Antitrypsin Polymer Length = 326		3e-06
1c8o_A	300	2.9 A Structure Of Cleaved Viral Serpin Crma Length		6e-06
1m93_B	245	1.65 A Structure Of Cleaved Viral Serpin Crma Lengt		6e-06
4caa_A	341	Cleaved Antichymotrypsin T345r Length = 341		7e-06
1jjo_C	261	Crystal Structure Of Mouse Neuroserpin (Cleaved For		7e-06
3caa_A	341	Cleaved Antichymotrypsin A347r Length = 341		8e-06
1as4_A	341	Cleaved Antichymotrypsin A349r Length = 341		8e-06
2v95_A	371	Struture Of Corticosteroid-Binding Globulin In Comp		2e-05
4bb2_A	340	Crystal Structure Of Cleaved Corticosteroid-binding		2e-05
3f02_A	359	Cleaved Human Neuroserpin Length = 359		3e-05
1k9o_I	378	Crystal Structure Of Michaelis Serpin-Trypsin Compl		3e-05
1sek_A	378	The Structure Of Active Serpin K From Manduca Sexta		3e-05
1f0c_A	305	Structure Of The Viral Serpin Crma Length = 305		1e-04
2oay_A	390	Crystal Structure Of Latent Human C1-Inhibitor Leng		2e-04

>pdb|4DY0|A Chain A, Crystal Structure Of Native Protease Nexin-1 With Heparin Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 45/113 (39%), Positives = 67/113 (59%), Gaps = 4/113 (3%)
Query: 198 KVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNML-DDRGVAVDQVFHKVDI 256
           +V VI  +PK    + T+L+  L  + +T MFD SK++ + +      + V  +  K  I
Sbjct: 269 RVQVI--LPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTGSENLHVSHILQKAKI 326
Query: 257 EVTEQGTVA-AASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           EV+E GT A AA+T I+I R S P   ++RPF+FFI H PT +++F G I KP
Sbjct: 327 EVSEDGTKASAATTAILIARSSPPWFIVDRPFLFFIRHNPTGAVLFMGQINKP 379

>pdb|1C5G|A Chain A, Plasminogen Activator Inhibitor-1 Length = 402

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 3/145 (2%)
Query: 167 MYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
           M+   P  K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + 
Sbjct: 258 MFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLG 317
Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKI 283
           +T MF   ++D +++ D   + V Q   KV IEV E GTVA++ST +I++ R++   + +
Sbjct: 318 MTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIM 377
Query: 284 NRPFIFFIYHKPTDSIVFWGSIYKP 308
           +RPF+F + H PT +++F G + +P
Sbjct: 378 DRPFLFVVRHNPTGTVLFMGQVMEP 402

>pdb|4AQH|A Chain A, Plasminogen Activator Inhibitor Type-1 In Complex With The Inhibitor Az3976 Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 3/145 (2%)
Query: 167 MYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
           M+   P  K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + 
Sbjct: 239 MFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLG 298
Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKI 283
           +T MF   ++D +++ D   + V Q   KV IEV E GTVA++ST +I++ R++   + +
Sbjct: 299 MTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIM 358
Query: 284 NRPFIFFIYHKPTDSIVFWGSIYKP 308
           +RPF+F + H PT +++F G + +P
Sbjct: 359 DRPFLFVVRHNPTGTVLFMGQVMEP 383

>pdb|3Q02|A Chain A, Crystal Structure Of Plasminogen Activator Inhibitor-1 In A Metastable Active Conformation. Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 75/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V Q   KV IEV E GTVA++ST +I++ R++   + ++RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 79/145 (54%), Gaps = 3/145 (2%)
Query: 167 MYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
           M+   P  K+  LS  T  LD +   +   +  ++  +  +PK  + +  +LR  L  + 
Sbjct: 235 MFIAAPFEKDVHLSALTNILDAELIRQWKGNMTRLPRLLILPKFSLETEVDLRGPLEKLG 294
Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT-VKI 283
           +  MF  + +D +++ D   ++V Q   KV IEV E GTVA++ST  +I+    PT + I
Sbjct: 295 MPDMFSATLADFTSLSDQEQLSVAQALQKVRIEVNESGTVASSSTAFVISARMAPTEMVI 354
Query: 284 NRPFIFFIYHKPTDSIVFWGSIYKP 308
           +R F+F + H PT++I+F G + +P
Sbjct: 355 DRSFLFVVRHNPTETILFMGQVMEP 379

>pdb|1DVN|A Chain A, Latent Form Of Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 3/145 (2%)
Query: 167 MYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
           M+   P  K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + 
Sbjct: 235 MFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLG 294
Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKI 283
           +T MF   ++D +++ D   + V Q   KV IEV E GTVA++ST +I++ R++   + +
Sbjct: 295 MTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIM 354
Query: 284 NRPFIFFIYHKPTDSIVFWGSIYKP 308
           +RPF+F + H PT +++F G + +P
Sbjct: 355 DRPFLFVVRHNPTGTVLFMGQVMEP 379

>pdb|3NDA|A Chain A, Crystal Structure Of Serpin From Tick Ixodes Ricinus Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 82/146 (56%), Gaps = 7/146 (4%)
Query: 167 MYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M  +LPK N  +    ++L  D+F   +    +  +   +PK K+ +   L+  L ++ +
Sbjct: 233 MAILLPKENTGVEGLKQNLTIDRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQSLGI 292
Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS---KPTV- 281
             +F+ S +DLS  ++D  + V  V HK  +EV E+GTVAAA+TG++I   S   +P V 
Sbjct: 293 KQIFE-SGADLSG-INDGSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPYSLGPEPVVF 350
Query: 282 KINRPFIFFIYHKPTDSIVFWGSIYK 307
           +++ PF+FFI +  TD I F G + K
Sbjct: 351 RVDHPFLFFIRNTRTDDIFFVGQVNK 376

>pdb|1DVM|A Chain A, Active Form Of Human Pai-1 Length = 379

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|3CVM|A Chain A, High Resolution Structure Of A Stable Plasminogen Activator Inhibitor Type-1 In Its Protease Cleaved Form Length = 392

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 256 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 315
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 316 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 375
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 376 RHNPTGTVLFMGQVMEP 392

>pdb|3EOX|A Chain A, High Quality Structure Of Cleaved Pai-1-Stab Length = 379

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRPF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|1BY7|A Chain A, Human Plasminogen Activator Inhibitor-2. Loop (66-98) Deletion Mutant Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 163 NEVYMYFILPK-----NPDLSEFTKDLDYDKFSRIIESTNKV---DVIYTIPKMKVTSST 214
            +V M+ +LP      +  L     ++ YDK ++   S +K+   +V   IP+ K+    
Sbjct: 227 GDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWT-SKDKMAEDEVEVYIPQFKLEEHY 285
Query: 215 ELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           ELR++L +M +   F+  +++ S M +   + + +VFH+  ++V E+GT AAA TG ++T
Sbjct: 286 ELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMT 345
Query: 275 RIS---KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +    P    + PF+F I HK T+ I+F+G    P
Sbjct: 346 GRTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382

>pdb|2ARQ|A Chain A, Human Plasminogen Activator Inhibitor-2.[loop (66-98) Deletion Mutant] Complexed With Peptide N-Acetyl-Teaaagdggvmtgr-Oh Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 163 NEVYMYFILPK-----NPDLSEFTKDLDYDKFSRIIESTNKV---DVIYTIPKMKVTSST 214
            +V M+ +LP      +  L     ++ YDK ++   S +K+   +V   IP+ K+    
Sbjct: 227 GDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWT-SKDKMAEDEVEVYIPQFKLEEHY 285
Query: 215 ELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           ELR++L +M +   F+  +++ S M +   + + +VFH+  ++V E+GT AAA TG ++T
Sbjct: 286 ELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMT 345
Query: 275 RIS---KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +    P    + PF+F I HK T+ I+F+G    P
Sbjct: 346 GRTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382

>pdb|3UT3|A Chain A, A Novel Pai-i Inhibitor And Its Structural Mechanism Length = 375

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 239 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 298
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 299 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 358
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 359 RHNPTGTVLFMGQVMEP 375

>pdb|1DB2|A Chain A, Crystal Structure Of Native Plasminogen Activator Inhibitor- 1 Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 241 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRPF 300
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 301 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 360
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 361 RHNPTGTVLFMGQVMEP 377

>pdb|1B3K|A Chain A, Plasminogen Activator Inhibitor-1 Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V     KV IEV E GTVA++ST +I++ R++   + I+RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|1A7C|A Chain A, Human Plasminogen Activator Inhibitor Type-1 In Complex With A Pentapeptide Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V Q   KV IEV E GTV ++ST +I++ R++   + ++RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVAQALQKVKIEVNESGTVESSSTAVIVSARMAPEEIIMDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|3R4L|A Chain A, Human Very Long Half Life Plasminogen Activator Inhibitor Type-1 Length = 379

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 74/137 (54%), Gaps = 1/137 (0%)
Query: 173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVS 232
           K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + +T MF   
Sbjct: 243 KEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 233 KSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFI 291
           ++D +++ D   + V Q   KV IEV E  TVA++ST +I++ R++   + ++RPF+F +
Sbjct: 303 QADFTSLSDQEPLHVAQALQKVKIEVNESCTVASSSTAVIVSARMAPEEIIMDRPFLFVV 362
Query: 292 YHKPTDSIVFWGSIYKP 308
            H PT +++F G + +P
Sbjct: 363 RHNPTGTVLFMGQVMEP 379

>pdb|4IF8|A Chain A, Structure Of Vaspin Length = 414

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 75/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           FILP    L    K L  D FSR     ++  V  ++P++ +T + +L+  L+ + V+ +
Sbjct: 272 FILPDEGKLKHLEKGLQVDTFSRWKTLLSRRVVDVSVPRLHMTGTFDLKKTLSYIGVSKI 331
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-TVKINRPF 287
           F+    DL+ +   R + V +  HK ++++ E+GT  AA TG     +  P  VKI++P+
Sbjct: 332 FE-EHGDLTKIAPHRSLKVGEAVHKAELKMDERGTEGAAGTGAQTLPMETPLVVKIDKPY 390
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +  IY +   S++F G I  P
Sbjct: 391 LLLIYSEKIPSVLFLGKIVNP 411

>pdb|1OO8|A Chain A, Crystal Structure Of A1pi-Pittsburgh In The Native Conformation Length = 394

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGI-IITRISKPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +  I R   P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPRSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F I  + T + +F G +  P
Sbjct: 371 VFLIIEQNTKAPLFMGRVVNP 391

>pdb|3T1P|A Chain A, Crystal Structure Of An Alpha-1-Antitrypsin Trimer Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 229 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLCITGTYDLKSVLGQLGITKV 288
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGI-IITRISKPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +  I R   P VK N+PF
Sbjct: 289 FS-NGADLSGVTEEAPLKLSKAVHKAVLCIDEKGTEAAGAMFLEAIPRSIPPEVKFNKPF 347
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 348 VFLMIEQNTKSPLFMGKVVNP 368

>pdb|2DUT|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Native Conformation Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 158 LEKMRNEVYMYFILPKN-----PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI--PKMKV 210
           L  ++ E+ M+ +LP +       L +  ++L Y++ S   +S    + +  +  PK  +
Sbjct: 260 LPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSL 319
Query: 211 TSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTG 270
               +LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT AAA+T 
Sbjct: 320 EDRIDLRDTLRNMGMTTAF-TTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATA 378
Query: 271 IIITRISKP-----TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           +II+  +         K++ PF FFI H  + +I+F+G    P
Sbjct: 379 VIISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 421

>pdb|2B4X|I Chain I, Crystal Structure Of Antithrombin-Iii Length = 427

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 273 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 332
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 333 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 390
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 391 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 425

>pdb|3KCG|I Chain I, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide Complex Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|2B4X|L Chain L, Crystal Structure Of Antithrombin-Iii Length = 427

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 273 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 332
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 333 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 390
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 391 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 425

>pdb|1ATH|A Chain A, The Intact And Cleaved Human Antithrombin Iii Complex As A Model For Serpin-Proteinase Interactions Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|2H4R|A Chain A, Crystal Structure Of Wildtype Ment In The Native Conformation Length = 415

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 158 LEKMRNEVYMYFILPKN-----PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI--PKMKV 210
           L  ++ E+ M+ +LP +       L +  ++L Y++ S   +S    + +  +  PK  +
Sbjct: 252 LPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSL 311
Query: 211 TSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTG 270
               +LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT AAA+T 
Sbjct: 312 EDRIDLRDTLRNMGMTTAF-TTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATA 370
Query: 271 IIITRISKP-----TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           +II+  +         K++ PF FFI H  + +I+F+G    P
Sbjct: 371 VIISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 413

>pdb|4EB1|I Chain I, Hyperstable In-Frame Insertion Variant Of Antithrombin Length = 440

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 285 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 344
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 345 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 402
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 403 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 437

>pdb|1DZG|I Chain I, N135q-S380c-Antithrombin-Iii Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G  AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGCEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|1ATU|A Chain A, Uncleaved Alpha-1-Antitrypsin Length = 374

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 232 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 291
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 292 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 350
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F I  + T + +F G +  P
Sbjct: 351 VFLIIEQNTKAPLFMGRVVNP 371

>pdb|3NE4|A Chain A, 1.8 Angstrom Structure Of Intact Native Wild-Type Alpha-1-Antitrypsin Length = 424

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 282 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 341
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 342 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 400
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 401 VFLMIEQNTKSPLFMGKVVNP 421

>pdb|2HIJ|I Chain I, Crystal Structure Of P14 Alanine Variant Of Antithrombin Length = 432

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G  AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGAEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|1KCT|A Chain A, Alpha1-Antitrypsin Length = 394

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 371 VFLMIEQNTKSPLFMGKVVNP 391

>pdb|1PSI|A Chain A, Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 To Leu Length = 394

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 371 VFLMIEQNTKSPLFMGKVVNP 391

>pdb|3DRM|A Chain A, 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- Antitrypsin Length = 404

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 262 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 321
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 322 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 380
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 381 VFLMIEQNTKSPLFMGKVVNP 401

>pdb|1QLP|A Chain A, 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsin: A Canonical Template For Active Serpins Length = 394

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 371 VFLMIEQNTKSPLFMGKVVNP 391

>pdb|1DZH|I Chain I, P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length = 432

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G  AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGXEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|3DRU|A Chain A, Crystal Structure Of Gly117phe Alpha1-Antitrypsin Length = 404

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 262 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 321
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 322 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 380
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 381 VFLMIEQNTKSPLFMGKVVNP 401

>pdb|2QUG|A Chain A, Crystal Structure Of Alpha-1-Antitrypsin, Crystal Form A Length = 394

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 371 VFLMIEQNTKSPLFMGKVVNP 391

>pdb|1HP7|A Chain A, A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-Antitrypsin Shows Variability Of The Reactive Center And Other Loops Length = 394

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P VK N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F +  + T S +F G +  P
Sbjct: 371 VFLMIDQNTKSPLFMGKVVNP 391

>pdb|2HI9|A Chain A, Crystal Structure Of Human Native Protein C Inhibitor Length = 363

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           FILP    + +    L      + ++   K  +   +PK  +  S +L  VL ++ ++++
Sbjct: 224 FILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNV 283
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT----RISKPTVKIN 284
           F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T    R++   +  N
Sbjct: 284 F-TSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLNSQRLVFN 342
Query: 285 RPFIFFIYHKPTDSIVFWGSIYKP 308
           RPF+ FI     ++I+F G + +P
Sbjct: 343 RPFLMFIVD---NNILFLGKVNRP 363

>pdb|2OL2|A Chain A, High Resolution Structure Of Native Pci In Space Group P21 Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           FILP    + +    L      + ++   K  +   +PK  +  S +L  VL ++ ++++
Sbjct: 256 FILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNV 315
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT----RISKPTVKIN 284
           F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T    R++   +  N
Sbjct: 316 F-TSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLNSQRLVFN 374
Query: 285 RPFIFFIYHKPTDSIVFWGSIYKP 308
           RPF+ FI     ++I+F G + +P
Sbjct: 375 RPFLMFIVD---NNILFLGKVNRP 395

>pdb|2GD4|I Chain I, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide Complex Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 288 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 347
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F  + S L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 348 DMGLVDLFSPAASALPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 405
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 406 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 440

>pdb|1TB6|I Chain I, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex Length = 432

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ +   +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               +   K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|1IZ2|A Chain A, Interactions Causing The Kinetic Trap In Serpin Protein Folding Length = 394

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 75/141 (53%), Gaps = 2/141 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-KPTVKINRPF 287
           F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S  P  K N+PF
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEAKFNKPF 370
Query: 288 IFFIYHKPTDSIVFWGSIYKP 308
           +F I  + T + +F G +  P
Sbjct: 371 VFLIIDQNTKAPLFMGRVVNP 391

>pdb|1XU8|A Chain A, The 2.8 A Structure Of A Tumour Suppressing Serpin Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 167 MYFILPKNPD-----LSEFTKDLDYDKFSRIIESTNKVD--VIYTIPKMKVTSSTELRTV 219
           M+ +LPK+ +     L +  K L+ +  S+    +   +  V  +IPK KV    + +  
Sbjct: 233 MFILLPKDVEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKAC 292
Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L  + +  +F    SD S M + +GVA+  V HKV +E+TE G  +    G  I +  K 
Sbjct: 293 LENLGLKHIFSEDTSDFSGMSETKGVALSNVIHKVCLEITEDGGDSIEVPGARILQ-HKD 351
Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            +  + PFI+ I H  T +I+F+G    P
Sbjct: 352 ELNADHPFIYIIRHNKTRNIIFFGKFCSP 380

>pdb|1WZ9|A Chain A, The 2.1 A Structure Of A Tumour Suppressing Serpin Length = 375

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 167 MYFILPKNPD-----LSEFTKDLDYDKFSRIIESTNKVD--VIYTIPKMKVTSSTELRTV 219
           M+ +LPK+ +     L +  K L+ +  S+    +   +  V  +IPK KV    + +  
Sbjct: 228 MFILLPKDVEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKAC 287
Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L  + +  +F    SD S M + +GVA+  V HKV +E+TE G  +    G  I +  K 
Sbjct: 288 LENLGLKHIFSEDTSDFSGMSETKGVALSNVIHKVXLEITEDGGDSIEVPGARILQ-HKD 346
Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            +  + PFI+ I H  T +I+F+G    P
Sbjct: 347 ELNADHPFIYIIRHNKTRNIIFFGKFXSP 375

>pdb|1XQG|A Chain A, 3.10 A Crystal Structure Of Maspin, Space Group P 4 21 2 Length = 389

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 167 MYFILPKNPD-----LSEFTKDLDYDKFSRIIESTNKVD--VIYTIPKMKVTSSTELRTV 219
           M+ +LPK+ +     L +  K L+ +  S+    +   +  V  +IPK KV    + +  
Sbjct: 242 MFILLPKDVEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKAS 301
Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L  + +  +F    SD S M + +GVA+  V HKV +E+TE G  +    G  I +  K 
Sbjct: 302 LENLGLKHIFSEDTSDFSGMSETKGVALSNVIHKVSLEITEDGGDSIEVPGARILQ-HKD 360
Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            +  + PFI+ I H  T +I+F+G    P
Sbjct: 361 ELNADHPFIYIIRHNKTRNIIFFGKFSSP 389

>pdb|3F5N|A Chain A, Structure Of Native Human Neuroserpin Length = 407

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 69/118 (58%), Gaps = 4/118 (3%)
Query: 195 STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV 254
           S  K  V   +P+  V    +L+ VL  + +T +F +  ++L+ + D++ + + +  HK 
Sbjct: 279 SVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF-IKDANLTGLSDNKEIFLSKAIHKS 337
Query: 255 DIEVTEQGTVAAASTGII-ITRIS--KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
            +EV E+G+ AAA +G+I I+R++   P V ++ PF F I ++ T +I+F G +  PE
Sbjct: 338 FLEVNEEGSEAAAVSGMIAISRMAVLYPQVIVDHPFFFLIRNRRTGTILFMGRVMHPE 395

>pdb|3FGQ|A Chain A, Crystal Structure Of Native Human Neuroserpin Length = 397

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 69/118 (58%), Gaps = 4/118 (3%)
Query: 195 STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV 254
           S  K  V   +P+  V    +L+ VL  + +T +F +  ++L+ + D++ + + +  HK 
Sbjct: 279 SVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF-IKDANLTGLSDNKEIFLSKAIHKS 337
Query: 255 DIEVTEQGTVAAASTGII-ITRIS--KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
            +EV E+G+ AAA +G+I I+R++   P V ++ PF F I ++ T +I+F G +  PE
Sbjct: 338 FLEVNEEGSEAAAVSGMIAISRMAVLYPQVIVDHPFFFLIRNRRTGTILFMGRVMHPE 395

>pdb|1QMN|A Chain A, Alpha1-Antichymotrypsin Serpin In The Delta Conformation (Partial Loop Insertion) Length = 401

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 254 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 312
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-----KPTV 281
             F  SK+DLS +   R +AV QV HK  ++V E+GT A+A+T + IT +S     +  V
Sbjct: 313 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIV 371
Query: 282 KINRPFIFFIYHKPTDSIVFWGSIYKPE 309
           + NRPF+  I    T +I F   +  P+
Sbjct: 372 RFNRPFLMIIVPTDTQNIFFMSKVTNPK 399

>pdb|2PEE|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Native State Length = 387

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 170 ILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           ILP +N  ++E+ K L   KF  +I++     V  ++PK K   + ++   L ++ +T  
Sbjct: 242 ILPDENISVNEYIKTLTGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDA 301
Query: 229 FDVSKSDLSNM--LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP----TVK 282
           F   K+D S +   D   + + +V HK  I V E GT A A T + IT    P    TVK
Sbjct: 302 FLPDKADFSKLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIPVNFKTVK 361
Query: 283 INRPFIFFIYHKPTDSIVFWGSI 305
           +NRPFIF I    T+  +F G++
Sbjct: 362 LNRPFIFAIIDNSTNLPIFIGTV 384

>pdb|2PEF|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Latent State Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 170 ILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           ILP +N  ++E+ K L   KF  +I++     V  ++PK K   + ++   L ++ +T  
Sbjct: 227 ILPDENISVNEYIKTLTGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDA 286
Query: 229 FDVSKSDLSNM--LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP----TVK 282
           F   K+D S +   D   + + +V HK  I V E GT A A T + IT    P    TVK
Sbjct: 287 FLPDKADFSKLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIPVNFKTVK 346
Query: 283 INRPFIFFIYHKPTDSIVFWGSI 305
           +NRPFIF I    T+  +F G++
Sbjct: 347 LNRPFIFAIIDNSTNLPIFIGTV 369

>pdb|2VH4|A Chain A, Structure Of A Loop C-sheet Serpin Polymer Length = 381

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 170 ILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           ILP +N  ++E+ K L   KF  +I++     V  ++PK K   + ++   L ++ +T  
Sbjct: 235 ILPDENISVNEYIKTLTGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDA 294
Query: 229 FDVSKSDLSNM--LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP----TVK 282
           F   K+D S +   D   + + +V HK  I V E GT A A T + IT    P    TVK
Sbjct: 295 FLPDKADFSKLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIPVNFKTVK 354
Query: 283 INRPFIFFIYHKPTDSIVFWGSI 305
           +NRPFIF I    T+  +F G++
Sbjct: 355 LNRPFIFAIIDNSTNLPIFIGTV 377

>pdb|1ATT|A Chain A, Crystal Structure Of Cleaved Bovine Antithrombin Iii At 3.2 Angstroms Resolution Length = 429

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  ++L  D     ++   +  ++  +P+ ++  S  ++  L 
Sbjct: 274 DDITMVLILPKLEKTLAKVEQELTPDMLQEWLDELTETLLVVHMPRFRIEDSFSVKEQLQ 333
Query: 222 TMNVTSMFDVSKSDLSNMLDD--RGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-- 277
            M +  +F   KS L  ++ +    + V   FHK  +EV E+G+ AAAST I I   S  
Sbjct: 334 DMGLEDLFSPEKSRLPGIVAEGRSDLYVSDAFHKAFLEVNEEGSEAAASTVISIAGRSLN 393
Query: 278 --KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             + T K NRPF+  I     ++I+F G +  P
Sbjct: 394 SDRVTFKANRPFLVLIREVALNTIIFMGRVANP 426

>pdb|3VVJ|A Chain A, Structure Of Ovalbumin From Emu (Dromaius Novaehollandiae) Length = 392

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 7/151 (4%)
Query: 163 NEVYMYFILPKN-PDLSEFTKDLDYDKFSRIIESTNKVD---VIYTIPKMKVTSSTELRT 218
            E+ M+ +LP +   L +    +  +K S    S    D    +Y +P MK+     L +
Sbjct: 238 GELSMFVLLPDDISGLEQLETTISIEKLSEWTSSNMMEDRKMKVY-LPHMKIEEKYNLTS 296
Query: 219 VLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS- 277
           VL  + +T +F  S ++LS +   + + + +  H   +E+ E G+  A STG+++   S 
Sbjct: 297 VLVALGMTDLFSPS-ANLSGISTAQTLKMSEAIHGAYVEIYEAGSEMATSTGVLVEAASV 355
Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               +++ PF+F I H P++SI+F+G    P
Sbjct: 356 SEEFRVDHPFLFLIKHNPSNSILFFGRCIFP 386

>pdb|3DLW|A Chain A, Antichymotrypsin Length = 411

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 264 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 322
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-----KPTV 281
             F  SK+DLS +   R +AV QV HK  ++V E+GT A+ +T + IT +S     +   
Sbjct: 323 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASGTTAVKITLLSALVETRTIT 381
Query: 282 KINRPFIFFIYHKPTDSIVFWGSIYKPE 309
           + NRPF+  I    T +I F   +  P+
Sbjct: 382 RFNRPFLMIIVPTDTQNIFFMSKVTNPK 409

>pdb|4AJT|A Chain A, The Cystal Structure Of Mouse Protein-Z Dependent Protease Inhibitor(Mzpi) Length = 427

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 61/116 (52%), Gaps = 7/116 (6%)
Query: 196 TNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSK--SDLSNMLDDRGVAVDQVFHK 253
           T K++V +  PK K+    E+  +L  M +  +F  S   S+LS M   R + V +V  +
Sbjct: 313 TRKMEVFF--PKFKLNQRYEMHELLKQMGIRRLFSTSADLSELSAMA--RNLQVSRVLQQ 368
Query: 254 VDIEVTEQGTVAAAST-GIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +EV E+GT A + T   II     P +K+NRPF F IY + +  ++F G +  P
Sbjct: 369 SVLEVDERGTEAVSGTLSEIIAYSMPPAIKVNRPFHFIIYEEMSRMLLFLGRVVNP 424

>pdb|3PZF|A Chain A, 1.75a Resolution Structure Of Serpin-2 From Anopheles Gambiae Length = 397

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 163 NEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           N++ MYFILP NPD  +++    ++     + +    + +V  T+PK K   S +L   L
Sbjct: 242 NKLAMYFILP-NPDNTVNQVLDRINSASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPL 300
Query: 221 NTMNVTSMFDVSKSDLSNMLDDRG----VAVDQVFHKVDIEVTEQGTVAAASTGI-IITR 275
             + +  +F  + S L  +   RG    V V ++F K  I + E G+ A A+T I ++ +
Sbjct: 301 QQVGIREIFSQNAS-LPLLARGRGARDEVRVSRIFQKAGITINELGSEAYAATEIQLVNK 359
Query: 276 ISKPTVKI---NRPFIFFIYHKPTDSIVFWGSIYKP 308
                V+I   NRPFIFFI  +   +++F G I  P
Sbjct: 360 FGGDGVQIFNANRPFIFFIEDETLGTMLFAGKIENP 395

>pdb|2R9Y|A Chain A, Structure Of Antiplasmin Length = 430

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 176 DLSEFTKDLDYDKF--SRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSK 233
           ++SE   +L +D      + E   KV     +PK+ +    +L   L+ + +  +F    
Sbjct: 248 NVSEVLANLTWDTLYHPSLQERPTKV----WLPKLHLQQQLDLVATLSQLGLQELFQ--G 301
Query: 234 SDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYH 293
            DL   + ++ + V  V H+  +E++E G  AAA+T + + R+S  +  +NRPF+FFI  
Sbjct: 302 PDLRG-ISEQNLVVSSVQHQSTMELSEAGVEAAAATSVAMNRMSLSSFTVNRPFLFFIME 360
Query: 294 KPTDSIVFWGSIYKPEPQR-PYHENERNN 321
                 +F GS+  P P   P  + +R++
Sbjct: 361 DTIGVPLFVGSVRNPNPSALPQLQEQRDS 389

>pdb|2VDX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Corticosteroid Binding Globulin Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 2/143 (1%)
Query: 167 MYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           ++FILP    ++     L  D  +R         V   IPK+ ++   +L  VL  M + 
Sbjct: 231 VFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIA 290
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTV-KINR 285
            +F  ++++ S +  D  +   +V HK  +++ E+GT AA +  +     SKP + + N+
Sbjct: 291 DLF-TTQANFSRITQDAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKPIILRFNQ 349
Query: 286 PFIFFIYHKPTDSIVFWGSIYKP 308
           PFI  I+   T S +F   +  P
Sbjct: 350 PFIIMIFDHFTWSSLFLARVMNP 372

>pdb|2H4P|A Chain A, Crystal Structure Of Wildtype Ment In The Cleaved Conformation Length = 394

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 64/121 (52%), Gaps = 8/121 (6%)
Query: 161 MRNEVYMYFILPKN-----PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI--PKMKVTSS 213
           ++ E+ M+ +LP +       L +  ++L Y++ S   +S    + +  +  PK  +   
Sbjct: 275 VKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDR 334
Query: 214 TELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII 273
            +LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT AAA+T +II
Sbjct: 335 IDLRDTLRNMGMTTAF-TTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVII 393
Query: 274 T 274
           +
Sbjct: 394 S 394

>pdb|1JTI|A Chain A, Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin Mutant R339t Length = 385

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGT- 263
           +P+MK+     L +VL  M +T +F  S ++LS +     + + Q  H    E+ E GT 
Sbjct: 282 LPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAESLKISQAVHAAHAEINEAGTE 340
Query: 264 -VAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            V +A  G+    +S+   + + PF+F I H  T++++F+G    P
Sbjct: 341 VVGSAEAGVDAASVSE-EFRADHPFLFCIKHIATNAVLFFGRCVSP 385

>pdb|1OYH|I Chain I, Crystal Structure Of P13 Alanine Variant Of Antithrombin Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 163 NEVYMYFILPK-NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336
Query: 222 TMNVTSMFDVSKSDLSNML----DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            M +  +F   KS L  ++    DD  + V   FHK  +EV E+G+ AAAST ++I   S
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDD--LYVSDAFHKAFLEVNEEGSAAAASTAVVIAGRS 394
Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               + T K NRPF+ FI   P ++I+F G +  P
Sbjct: 395 LNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>pdb|1LQ8|A Chain A, Crystal Structure Of Cleaved Protein C Inhibitor Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 1/106 (0%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           FILP    + +    L      + ++   K  +   +PK  +  S +L  VL ++ ++++
Sbjct: 238 FILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNV 297
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T
Sbjct: 298 F-TSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFT 342

>pdb|3DY0|A Chain A, Crystal Structure Of Cleaved Pci Bound To Heparin Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 1/106 (0%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           FILP    + +    L      + ++   K  +   +PK  +  S +L  VL ++ ++++
Sbjct: 231 FILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNV 290
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T
Sbjct: 291 F-TSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFT 335

>pdb|3F1S|A Chain A, Crystal Structure Of Protein Z Complexed With Protein Z-Dependent Inhibitor Length = 385

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 196 TNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNM-LDDRGVAVDQVFHKV 254
           T  ++V +  PK K+    E+  +L  M +  +F    +DLS +    R + V +V  + 
Sbjct: 271 TRNMEVFF--PKFKLDQKYEMHELLRQMGIRRIFS-PFADLSELSATGRNLQVSRVLQRT 327
Query: 255 DIEVTEQGTVAAASTGIIITRIS-KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            IEV E+GT A A     IT  S  P +K++RPF F IY + +  ++F G +  P
Sbjct: 328 VIEVDERGTEAVAGILSEITAYSMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNP 382

>pdb|3H5C|A Chain A, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 196 TNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNM-LDDRGVAVDQVFHKV 254
           T  ++V +  PK K+    E+  +L  M +  +F    +DLS +    R + V +V  + 
Sbjct: 309 TRNMEVFF--PKFKLDQKYEMHELLRQMGIRRIFS-PFADLSELSATGRNLQVSRVLQRT 365
Query: 255 DIEVTEQGTVAAASTGIIITRIS-KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            IEV E+GT A A     IT  S  P +K++RPF F IY + +  ++F G +  P
Sbjct: 366 VIEVDERGTEAVAGILSEITAYSMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNP 420

>pdb|1OVA|C Chain C, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG-- 262
           +P+MK+     L +VL  M +T +F  S ++LS +     + + Q  H    E+ E G  
Sbjct: 283 LPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAESLKISQAVHAAHAEINEAGRE 341
Query: 263 TVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            V +A  G+    +S+   + + PF+F I H  T++++F+G    P
Sbjct: 342 VVGSAEAGVDAASVSE-EFRADHPFLFCIKHIATNAVLFFGRCVSP 386

>pdb|2H4Q|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Cleaved Conformation Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 63/121 (52%), Gaps = 8/121 (6%)
Query: 161 MRNEVYMYFILPKN-----PDLSEFTKDLDYDKFSRIIESTNKVDVIYTI--PKMKVTSS 213
           ++ E+ M+ +LP +       L +  ++L Y++ S   +S    + +  +  PK  +   
Sbjct: 263 VKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDR 322
Query: 214 TELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII 273
            +LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT A A+T +II
Sbjct: 323 IDLRDTLRNMGMTTAF-TTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAVAATAVII 381
Query: 274 T 274
           +
Sbjct: 382 S 382

>pdb|2CEO|A Chain A, Thyroxine-Binding Globulin Complex With Thyroxine Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 169 FILPKNPDLSEFTKDLD---YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           F+LPK   +      +      K++R+++    VD+   +PK  ++++ +L   L  M +
Sbjct: 233 FVLPKEGQMESVEAAMSSKTLKKWNRLLQK-GWVDLF--VPKFSISATYDLGATLLKMGI 289
Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK-----PT 280
              +    +D S + +D G+ +    HK  + + E+GT AAA   + ++   +     P 
Sbjct: 290 QHAYS-ENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPI 348
Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           ++I+R F+  I  + T SI+F G +  P
Sbjct: 349 IQIDRSFMLLILERSTRSILFLGKVVNP 376

>pdb|1OVA|A Chain A, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG-- 262
           +P+MK+     L +VL  M +T +F  S ++LS +     + + Q  H    E+ E G  
Sbjct: 283 LPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAESLKISQAVHAAHAEINEAGRE 341
Query: 263 TVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            V  A  G+    +S+   + + PF+F I H  T++++F+G    P
Sbjct: 342 VVGXAEAGVDAASVSE-EFRADHPFLFCIKHIATNAVLFFGRCVSP 386

>pdb|1OVA|B Chain B, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG-- 262
           +P+MK+     L +VL  M +T +F  S ++LS +     + + Q  H    E+ E G  
Sbjct: 283 LPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAESLKISQAVHAAHAEINEAGRE 341
Query: 263 TVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            V  A  G+    +S+   + + PF+F I H  T++++F+G    P
Sbjct: 342 VVGXAEAGVDAASVSE-EFRADHPFLFCIKHIATNAVLFFGRCVSP 386

>pdb|1IMV|A Chain A, 2.85 A Crystal Structure Of Pedf Length = 398

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 12/132 (9%)
Query: 178 SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLS 237
           SEF  D+D +           V  + T+PK+K++   E+   L  M + S+FD    D S
Sbjct: 275 SEFIHDIDRE--------LKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFD--SPDFS 324
Query: 238 NMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-TVKINRPFIFFIYHKPT 296
             +  + + + QV H+   E  E G     S G+    ++ P    +N+PFIF +    T
Sbjct: 325 K-ITGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLRDTDT 383
Query: 297 DSIVFWGSIYKP 308
            +++F G I  P
Sbjct: 384 GALLFIGKILDP 395

>pdb|1UHG|A Chain A, Crystal Structure Of S-ovalbumin At 1.9 Angstrom Resolution Length = 385

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG-- 262
           +P+MK+     L +VL  M +T +F  S ++LS +     + + Q  H    E+ E G  
Sbjct: 282 LPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAEXLKISQAVHAAHAEINEAGRE 340
Query: 263 TVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            V  A  G+    +S+   + + PF+F I H  T++++F+G    P
Sbjct: 341 VVGXAEAGVDAASVSE-EFRADHPFLFCIKHIATNAVLFFGRCVSP 385

>pdb|9PAI|A Chain A, Cleaved Substrate Variant Of Plasminogen Activator Inhibitor-1 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 2/110 (1%)
Query: 167 MYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMN 224
           M+   P  K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L  + 
Sbjct: 235 MFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLG 294
Query: 225 VTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           +T MF   ++D +++ D   + V Q   KV IEV E GTV ++ST +I++
Sbjct: 295 MTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVPSSSTAVIVS 344

>pdb|4GA7|A Chain A, Crystal Structure Of Human Serpinb1 Mutant Length = 389

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 65/118 (55%), Gaps = 3/118 (2%)
Query: 194 ESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK 253
           E+ + ++V  ++P+ K+  S  L + L  + V  +F+ SK+DLS M   R + + ++ HK
Sbjct: 272 ENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIFISKIVHK 331
Query: 254 VDIEVTEQGTVAAASTGIIITRI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +EV E+GT AAA+T  I T      +     + PF+FFI H  + SI+F G    P
Sbjct: 332 SFVEVNEEGTEAAAATAGIATFCMDDPEENFTADHPFLFFIRHNSSGSILFLGRFSSP 389

>pdb|1D5S|A Chain A, Crystal Structure Of Cleaved Antitrypsin Polymer Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 233 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 292
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 293 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 331

>pdb|1EZX|A Chain A, Crystal Structure Of A Serpin:protease Complex Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 229 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 288
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 289 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 327

>pdb|7API|A Chain A, The S Variant Of Human Alpha1-Antitrypsin, Structure And Implications For Function And Metabolism Length = 347

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 241 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 300
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 301 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 339

>pdb|2D26|A Chain A, Active Site Distortion Is Sufficient For Proteinase Inhibit Second Crystal Structure Of Covalent Serpin-Proteinase Complex Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 252 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 311
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 312 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 350

>pdb|3NDF|A Chain A, Cleaved Antitrypsin With P8-P6 Asp Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 237 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 296
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 297 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 335

>pdb|2ZV6|A Chain A, Crystal Structure Of Human Squamous Cell Carcinoma Antigen 1 Length = 401

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +P+ KV  S +L+  L TM +  +F+   +DLS M   RG+ +  V HK  +EVTE+G  
Sbjct: 295 LPRFKVEESYDLKDTLRTMGMVDIFN-GDADLSGMTGSRGLVLSGVLHKAFVEVTEEGAE 353
Query: 265 AAASTGIIITRISKPT-----VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           AAA+T ++    S PT        N PF+FFI    T+SI+F+G    P
Sbjct: 354 AAAATAVVGFG-SSPTSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 401

>pdb|1JMO|A Chain A, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex Length = 480

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +PK K+  +  L   L  M +  +FD    +++ + D R +A+D   H+  I V E+GT 
Sbjct: 375 LPKFKLEKNYNLVESLKLMGIRMLFD-KNGNMAGISDQR-IAIDLFKHQGTITVNEEGTQ 432
Query: 265 AAASTGIIITRIS-KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           A   T +    +S +    ++RPF+F IY   T  ++F G +  P
Sbjct: 433 ATTVTTVGFMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANP 477

>pdb|1JMJ|A Chain A, Crystal Structure Of Native Heparin Cofactor Ii Length = 480

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 205 IPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTV 264
           +PK K+  +  L   L  M +  +FD    +++ + D R +A+D   H+  I V E+GT 
Sbjct: 375 LPKFKLEKNYNLVESLKLMGIRMLFD-KNGNMAGISDQR-IAIDLFKHQGTITVNEEGTQ 432
Query: 265 AAASTGIIITRIS-KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           A   T +    +S +    ++RPF+F IY   T  ++F G +  P
Sbjct: 433 ATTVTTVGFMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANP 477

>pdb|3NDD|A Chain A, Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 54/98 (55%), Gaps = 1/98 (1%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL  + +T +
Sbjct: 237 FFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKV 296
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA 266
           F  + +DLS + ++  + + +  HK  + + E+GT AA
Sbjct: 297 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAA 333

>pdb|2ACH|A Chain A, Crystal Structure Of Cleaved Human Alpha1-antichymotrypsin At 2.7 Angstroms Resolution And Its Comparison With Other Serpins Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 4/108 (3%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 253 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 311
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             F  SK+DLS +   R +AV QV HK  ++V E+GT A+A+T + IT
Sbjct: 312 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKIT 358

>pdb|3LE2|A Chain A, Structure Of Arabidopsis Atserpin1. Native Stressed Conforma Length = 393

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 11/116 (9%)
Query: 203 YTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD----RGVAVDQVFHKVDIEV 258
           + IPK K +   +   VL  + +TS F   +  L+ M++     + + V  +FHK  IEV
Sbjct: 277 FKIPKFKFSFGFDASNVLKGLGLTSPFS-GEEGLTEMVESPEMGKNLCVSNIFHKACIEV 335
Query: 259 TEQGT-VAAASTGIIITR---ISKPTVKI--NRPFIFFIYHKPTDSIVFWGSIYKP 308
            E+GT  AAAS G+I  R   + +  +    + PF+  +    T  ++F G +  P
Sbjct: 336 NEEGTEAAAASAGVIKLRGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDP 391

>pdb|1QMB|A Chain A, Cleaved Alpha-1-Antitrypsin Polymer Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSM 228
           F LP    L     +L +D  ++ +E+  +   ++ +PK+ +T + +L++VL  + +T +
Sbjct: 227 FFLPDEGKLQHLENELTHDIITKFLENDRRSASLH-LPKLSITGTYDLKSVLGQLGITKV 285
Query: 229 FDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAAS 268
           F  + +DLS + ++  + + +  HK  + + E+GT AA +
Sbjct: 286 FS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGA 324

>pdb|1C8O|A Chain A, 2.9 A Structure Of Cleaved Viral Serpin Crma Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M  ILP N D L    ++L    F +  +S + + +   IPK KVT S  L   L  + +
Sbjct: 196 MVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGL 255
Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII 272
           T +F  S  D SNM  +  V+VD + HK  I+V E+ T AAA+T  +
Sbjct: 256 TEVFG-STGDYSNM-SNSDVSVDAMIHKTYIDVNEEYTEAAAATSAL 300

>pdb|1M93|B Chain B, 1.65 A Structure Of Cleaved Viral Serpin Crma Length = 245

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M  ILP N D L    ++L    F +  +S + + +   IPK KVT S  L   L  + +
Sbjct: 141 MVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGL 200
Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII 272
           T +F  S  D SNM  +  V+VD + HK  I+V E+ T AAA+T  +
Sbjct: 201 TEVFG-STGDYSNM-SNSDVSVDAMIHKTYIDVNEEYTEAAAATSAL 245

>pdb|4CAA|A Chain A, Cleaved Antichymotrypsin T345r Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 234 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 292
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             F  SK+DLS +   R +AV QV HK  ++V E+G  A+A+T + IT
Sbjct: 293 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGREASAATAVKIT 339

>pdb|1JJO|C Chain C, Crystal Structure Of Mouse Neuroserpin (Cleaved Form) Length = 261

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 195 STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV 254
           S  K  V   +P+  V    +L+ +L  + VT +F +  ++L+ M D + + + +  HK 
Sbjct: 182 SVKKQKVEVYLPRFTVEQEIDLKDILKALGVTEIF-IKDANLTAMSDKKELFLSKAVHKS 240
Query: 255 DIEVTEQGTVAAASTGII 272
            IEV E+G+ AAA++G+I
Sbjct: 241 CIEVNEEGSEAAAASGMI 258

>pdb|3CAA|A Chain A, Cleaved Antichymotrypsin A347r Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 234 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 292
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             F  SK+DLS +   R +AV QV HK  ++V E+GT  +A+T + IT
Sbjct: 293 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGTERSAATAVKIT 339

>pdb|1AS4|A Chain A, Cleaved Antichymotrypsin A349r Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 169 FILPKNPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           FILP    + E    L  +   R  +S    ++  +Y +PK  ++    L  +L  + + 
Sbjct: 234 FILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELY-LPKFSISRDYNLNDILLQLGIE 292
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             F  SK+DLS +   R +AV QV HK  ++V E+GT A+ +T + IT
Sbjct: 293 EAF-TSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASRATAVKIT 339

>pdb|2V95|A Chain A, Struture Of Corticosteroid-Binding Globulin In Complex With Cortisol Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 3/142 (2%)
Query: 168 YFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTS 227
           +FILP    +      L  D   R  +      V   IPK  ++ + +L+ VL  +N+  
Sbjct: 231 FFILPDQGQMDTVIAALSRDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKD 290
Query: 228 MFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-TVKINRP 286
           +   ++SD S    D  + +  V HK  +++ E   +  ++ G  +   S+P  +K N+P
Sbjct: 291 LL-TNQSDFSGNTKDVPLTLTMV-HKAMLQLDEGNVLPNSTNGAPLHLRSEPLDIKFNKP 348
Query: 287 FIFFIYHKPTDSIVFWGSIYKP 308
           FI  ++ K T S +    +  P
Sbjct: 349 FILLLFDKFTWSSLMMSQVVNP 370

>pdb|4BB2|A Chain A, Crystal Structure Of Cleaved Corticosteroid-binding Globulin In Complex With Progesterone Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 51/107 (47%), Gaps = 1/107 (0%)
Query: 167 MYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVT 226
           ++FILP    ++     L  D  +R         V   IPK+ ++   +L  VL  M + 
Sbjct: 232 VFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIA 291
Query: 227 SMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII 273
            +F  ++++ S +  D  +   +V HK  +++ E+G   A STG+ +
Sbjct: 292 DLF-TNQANFSRITQDAQLKSSKVVHKAVLQLNEEGVDTAGSTGVTL 337

>pdb|3F02|A Chain A, Cleaved Human Neuroserpin Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 48/82 (58%), Gaps = 2/82 (2%)
Query: 195 STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV 254
           S  K  V   +P+  V    +L+ VL  + +T +F +  ++L+ + D++ + + +  HK 
Sbjct: 279 SVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF-IKDANLTGLSDNKEIFLSKAIHKS 337
Query: 255 DIEVTEQGTVAAASTGII-ITR 275
            +EV E+G+ AAA +G+I I+R
Sbjct: 338 FLEVNEEGSEAAAVSGMIAISR 359

>pdb|1K9O|I Chain I, Crystal Structure Of Michaelis Serpin-Trypsin Complex Length = 378

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 151 PEAYASFLEKMR--NEVYMYFILPKNPD-LSEFTKDL-DYDKFSRIIESTNKVDVIYTIP 206
           PE  A  +E     ++  M  ILP   D ++   + L D    SR  E     +V  T+P
Sbjct: 215 PELDAKMIEMSYEGDQASMIIILPNQVDGITALEQKLKDPKALSRAEERLYNTEVEITLP 274
Query: 207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR-GVAVDQVFHKVDIEVTEQGTVA 265
           K K+ ++T+L+ VL+ MN+  +F    + L N+L  +  + VD    K  IEV E+G  A
Sbjct: 275 KFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLTVDAAIQKAFIEVNEEGAEA 334
Query: 266 AAST--GII-ITRISKPTVKINRPFIFFIYHKPTDSI-VFWGSIYKP 308
           AA+   GI+  + I  P V I+RPF F +     D I +F G + +P
Sbjct: 335 AAANAFGIVPKSLILYPEVHIDRPFYFELK---IDGIPMFNGKVIEP 378

>pdb|1SEK|A Chain A, The Structure Of Active Serpin K From Manduca Sexta And A Model For Serpin-Protease Complex Formation Length = 378

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 151 PEAYASFLEKMR--NEVYMYFILPKNPD-LSEFTKDL-DYDKFSRIIESTNKVDVIYTIP 206
           PE  A  +E     ++  M  ILP   D ++   + L D    SR  E     +V   +P
Sbjct: 215 PELDAKMIEMSYEGDQASMIIILPNQVDGITALEQKLKDPKALSRAEERLYNTEVEIYLP 274
Query: 207 KMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR-GVAVDQVFHKVDIEVTEQGTVA 265
           K K+ ++T+L+ VL+ MN+  +F    + L N+L  +  + VD    K  IEV E+G  A
Sbjct: 275 KFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLYVDAAIQKAFIEVNEEGAEA 334
Query: 266 AASTGIIITRIS---KPTVKINRPFIF 289
           AA+    IT  S    P V+IN+PF F
Sbjct: 335 AAANAFKITTYSFHFVPKVEINKPFFF 361

>pdb|1F0C|A Chain A, Structure Of The Viral Serpin Crma Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 167 MYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNV 225
           M  ILP N D L    ++L    F +  +S + + +   IPK KVT S  L   L  + +
Sbjct: 196 MVVILPDNIDGLESIEQNLTDTNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGL 255
Query: 226 TSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGT 263
           T +F  S  D SNM +   V+VD + HK  I+V E+ T
Sbjct: 256 TEVFG-STGDYSNMCN-SDVSVDAMIHKTYIDVNEEYT 291

>pdb|2OAY|A Chain A, Crystal Structure Of Latent Human C1-Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 5/108 (4%)
Query: 202 IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKS-DLSNMLDDRGVAVDQVFHKVDIEVTE 260
           + T+P++KVT+S ++   L+ M     FD S   +L  + +D  + V  + H+  +E+TE
Sbjct: 285 LLTLPRIKVTTSQDM---LSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTE 341
Query: 261 QGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            G  AAA++ I + R +    ++ +PF+F ++ +     VF G +Y P
Sbjct: 342 TGVEAAAASAISVAR-TLLVFEVQQPFLFMLWDQQHKFPVFMGRVYDP 388

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	357
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	9e-46
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	8e-07
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	3e-05
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	3e-44
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	1e-06
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	2e-05
2vdx_A	373	Corticosteroid-binding globulin; transport protein	5e-44
2vdx_A	373	Corticosteroid-binding globulin; transport protein	4e-07
2vdx_A	373	Corticosteroid-binding globulin; transport protein	7e-06
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	5e-44
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	1e-06
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	2e-05
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	3e-43
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	4e-07
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	3e-06
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	9e-43
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	3e-07
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	3e-06
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	9e-43
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	1e-06
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	2e-05
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	1e-42
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	4e-07
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	7e-06
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	1e-42
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	1e-06
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	3e-06
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	2e-42
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	8e-09
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	1e-07
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	2e-42
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	3e-06
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	4e-06
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	3e-42
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	7e-07
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	3e-06
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	4e-42
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	7e-07
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	3e-06
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	4e-42
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	7e-06
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	1e-04
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	5e-42
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	4e-06
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	1e-04
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	6e-42
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	2e-06
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	2e-05
2v95_A	371	Corticosteroid-binding globulin; transport protein	2e-41
2v95_A	371	Corticosteroid-binding globulin; transport protein	4e-06
2v95_A	371	Corticosteroid-binding globulin; transport protein	5e-05
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	3e-41
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	3e-08
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	3e-07
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	3e-41
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	4e-06
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	1e-05
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	7e-41
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	3e-07
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	3e-06
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	7e-41
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	3e-07
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	5e-06
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	9e-40
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	2e-08
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	4e-07
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	1e-39
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	8e-07
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	3e-06
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	2e-39
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	3e-07
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	2e-06
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	3e-39
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	5e-05
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	4e-04
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	3e-39
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	1e-07
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	1e-06
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	4e-39
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	6e-08
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	1e-06
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	2e-38
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	3e-08
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	3e-07
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	5e-38
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	7e-07
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	2e-06
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	1e-35
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	3e-08
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	1e-06
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	5e-35
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	2e-07
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	3e-06
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	1e-34
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	1e-06
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	1e-06
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	9e-29
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	2e-06
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	6e-06
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	1e-28
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	3e-07
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	6e-06
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	3e-28
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	3e-06
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	2e-05
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	1e-27
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	6e-05
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	6e-05
1m93_B	245	Serine proteinase inhibitor 2; serpin, CRMA, apopt	1e-27
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	2e-27
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	2e-06
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	6e-06
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	2e-27
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	3e-07
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	2e-06
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	4e-27
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	1e-06
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	7e-06
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	5e-26
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	3e-08
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	2e-06
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	2e-24
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	3e-07
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	5e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
3f02_C	48	Neuroserpin; cleaved form, fenib, human, disease M	1e-07
1hle_B	31	Horse leukocyte elastase inhibitor; hydrolase inhi	1e-07
2h4p_B	34	MENT, heterochromatin-associated protein MENT; ser	2e-07
3ndd_B	36	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	3e-06
1m93_A	55	Serine proteinase inhibitor 2; serpin, CRMA, apopt	4e-06
1m93_A	55	Serine proteinase inhibitor 2; serpin, CRMA, apopt	4e-06
2xn6_B	35	Thyroxine-binding globulin; transport, cleaved pro	5e-05
2riv_B	40	Thyroxine-binding globulin; TBG, serpin, cleaved,	9e-05
1as4_B	37	Antichymotrypsin, ACT; serpin, serine protease inh	3e-04

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392

 Score =  160 bits (406), Expect = 9e-46
 Identities = 33/155 (21%), Positives = 63/155 (40%), Gaps = 1/155 (0%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
               +  ++P + + L    K L  ++    +    K  V  ++PK  V  + +L+  L 
Sbjct: 229 KLSSLIILMPHHVEPLERLEKLLTKEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLA 288

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTV 281
            + +T   D +K+DLS M   + + +  VFH    E   +G              S    
Sbjct: 289 GLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAFEWDTEGNPFDQDIYGREELRSPKLF 348

Query: 282 KINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHE 316
             + PFIF +    + S++F G + +P+  +   E
Sbjct: 349 YADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDE 383

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392

 Score = 49.5 bits (119), Expect = 8e-07
 Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 2/83 (2%)

Query: 81  AHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           A +L      +   + +A+       +N++ +P+ +  +L LV LG    T  +    + 
Sbjct: 6   AATLAERSAGLAFSLYQAMAK-DQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLS 64

Query: 141 VATGRSLSNNPEAYASFLEKMRN 163
            A               L  + N
Sbjct: 65  -AEQLRDEEVHAGLGELLRSLSN 86

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 10/52 (19%), Positives = 22/52 (42%), Gaps = 1/52 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
          L      +   + +A+       +N++ +P+ +  +L LV LG    T  + 
Sbjct: 9  LAERSAGLAFSLYQAMAK-DQAVENILLSPVVVASSLGLVSLGGKATTASQA 59

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379

 Score =  155 bits (394), Expect = 3e-44
 Identities = 44/149 (29%), Positives = 78/149 (52%), Gaps = 3/149 (2%)

Query: 163 NEVYMYFILP--KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           + + M+   P  K   LS  T  L     S    +  ++  +  +PK  + +  +LR  L
Sbjct: 231 DTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPL 290

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP- 279
             + +T MF   ++D +++ D   + V Q   KV IEV E GTVA++ST +I++    P 
Sbjct: 291 ENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPE 350

Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            + ++RPF+F + H PT +++F G + +P
Sbjct: 351 EIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 13/60 (21%), Positives = 31/60 (51%), Gaps = 1/60 (1%)

Query: 81  AHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
              +    +   + + + +    +K++NVVF+P  +   LA++ L + G+T+ ++   MG
Sbjct: 5   PSYVAHLASDFGVRVFQQVAQ-ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMG 63

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 13/57 (22%), Positives = 31/57 (54%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +    +   + + + +    +K++NVVF+P  +   LA++ L + G+T+ ++   MG
Sbjct: 8  VAHLASDFGVRVFQQVAQ-ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMG 63

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373

 Score =  154 bits (392), Expect = 5e-44
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 2/148 (1%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                ++FILP    ++     L  D  +R         V   IPK+ ++   +L  VL 
Sbjct: 226 VGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLE 285

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-T 280
            M +  +F  ++++ S +  D  +   +V HK  +++ E+GT AA +  +     SKP  
Sbjct: 286 EMGIADLFT-TQANFSRITQDAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKPII 344

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           ++ N+PFI  I+   T S +F   +  P
Sbjct: 345 LRFNQPFIIMIFDHFTWSSLFLARVMNP 372

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
             L          + + + + ++  +N+  +P+SI  ALA++ LG+ G T+ +L   +G 
Sbjct: 5   RGLASANVDFAFSLYKHLVA-LSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGF 63

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T RS +   + +    +    
Sbjct: 64  NLTERSETEIHQGFQHLHQLFAK 86

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373

 Score = 46.4 bits (111), Expect = 7e-06
 Identities = 14/57 (24%), Positives = 30/57 (52%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L          + + + + ++  +N+  +P+SI  ALA++ LG+ G T+ +L   +G
Sbjct: 7  LASANVDFAFSLYKHLVA-LSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLG 62

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424

 Score =  155 bits (395), Expect = 5e-44
 Identities = 38/148 (25%), Positives = 76/148 (51%), Gaps = 2/148 (1%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                  F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL 
Sbjct: 275 LGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLG 334

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-T 280
            + +T +F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S P  
Sbjct: 335 QLGITKVFS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPE 393

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           VK N+PF+F +  + T S +F G +  P
Sbjct: 394 VKFNKPFVFLMIEQNTKSPLFMGKVVNP 421

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 21/127 (16%), Positives = 47/127 (37%), Gaps = 3/127 (2%)

Query: 38  VFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMER 97
           V   + ++  L  ++  S  +            T     +  T + +   + +    + R
Sbjct: 11  VSWGILLLAGLCCLVPVSLAEDPQGDAAQ-KTDTSHHDQDHPTFNKITPNLAEFAFSLYR 69

Query: 98  AIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV-ATGRSLSNNPEAYAS 156
            +    + + N+ F+P+SI  A A++ LG+   T DE+   +    T    +   E +  
Sbjct: 70  QLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQE 128

Query: 157 FLEKMRN 163
            L  +  
Sbjct: 129 LLRTLNQ 135

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 13/52 (25%), Positives = 27/52 (51%), Gaps = 1/52 (1%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
           +   + +    + R +    + + N+ F+P+SI  A A++ LG+   T DE+
Sbjct: 56  ITPNLAEFAFSLYRQLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEI 106

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379

 Score =  152 bits (387), Expect = 3e-43
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 4/150 (2%)

Query: 163 NEVYMYFILPK--NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
             + M   LP   +  LS     +        +       V   +PK    + T+L+  L
Sbjct: 230 ESISMLIALPTESSTPLSAIIPHISTKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPL 289

Query: 221 NTMNVTSMFDVSKSDLSNMLD-DRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
             + +T MFD SK++ + +      + V  +  K  IEV+E GT A+A+T  I+   S P
Sbjct: 290 KVLGITDMFDSSKANFAKITTGSENLHVSHILQKAKIEVSEDGTKASAATTAILIARSSP 349

Query: 280 -TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               ++RPF+FFI H PT +++F G I KP
Sbjct: 350 PWFIVDRPFLFFIRHNPTGAVLFMGQINKP 379

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 5/82 (6%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
            SL    +   + +   I      + N+V +P  I   L ++ LG+DG+TK +L   M  
Sbjct: 6   LSLEELGSNTGIQVFNQIVK-SRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRY 64

Query: 142 ATGRSLSNNPEAYASFLEKMRN 163
                ++   +      + + +
Sbjct: 65  ----GVNGVGKILKKINKAIVS 82

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 2/85 (2%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG-VA 70
          L    +   + +   I      + N+V +P  I   L ++ LG+DG+TK +L   M    
Sbjct: 8  LEELGSNTGIQVFNQIVK-SRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGV 66

Query: 71 TGRSLSNKLTAHSLRRGITQMTLDM 95
           G     K    ++     +  + +
Sbjct: 67 NGVGKILKKINKAIVSKKNKDIVTV 91

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407

 Score =  152 bits (386), Expect = 9e-43
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +E+ M  +L +    L+     +          S  K  V   +P+  V    +L+ VL 
Sbjct: 246 DEISMMLVLSRQEVPLATLEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLK 305

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS---K 278
            + +T +F    ++L+ + D++ + + +  HK  +EV E+G+ AAA +G+I         
Sbjct: 306 ALGITEIFI-KDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVLY 364

Query: 279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP 313
           P V ++ PF F I ++ T +I+F G +  PE    
Sbjct: 365 PQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMNT 399

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 20/73 (27%), Positives = 40/73 (54%), Gaps = 1/73 (1%)

Query: 68  GVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGS 127
           G       ++   A      I  ++++M   +R+   +++N++F+PLSI  A+ ++ LG+
Sbjct: 3   GSHHHHHHTDPTGATFPEEAIADLSVNMYNRLRA-TGEDENILFSPLSIALAMGMMELGA 61

Query: 128 DGQTKDELTHFMG 140
            G T+ E+ H MG
Sbjct: 62  QGSTQKEIRHSMG 74

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 18/58 (31%), Positives = 36/58 (62%), Gaps = 1/58 (1%)

Query: 11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
               I  ++++M   +R+   +++N++F+PLSI  A+ ++ LG+ G T+ E+ H MG
Sbjct: 18 FPEEAIADLSVNMYNRLRA-TGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMG 74

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398

 Score =  152 bits (385), Expect = 9e-43
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 6/153 (3%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIY-TIPKMKVTSSTELRTVL 220
                  FILP    + +    L  +   +   S     +    +PK  +++   L  VL
Sbjct: 247 TGNASALFILPDQGRMQQVEASLQPETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVL 306

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP- 279
           + + +  +F  +++DLS +   + + V QV HK  ++V E GT AAA+TG+    +S   
Sbjct: 307 SKLGIREVFS-TQADLSAITGTKDLRVSQVVHKAVLDVAETGTEAAAATGVKFVPMSAKL 365

Query: 280 ---TVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
              TV  NRPF+  I+   T+   F   I  P+
Sbjct: 366 YPLTVYFNRPFLIMIFDTETEIAPFIAKIANPK 398

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 23/87 (26%), Positives = 43/87 (49%), Gaps = 2/87 (2%)

Query: 78  KLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTH 137
           +L + +L    T     + + +      + N+VF+PLSI  ALALV LG+ G T +E+  
Sbjct: 21  QLDSLTLASINTDFAFSLYKELVL-KNPDTNIVFSPLSISAALALVSLGAKGNTLEEILE 79

Query: 138 FMGV-ATGRSLSNNPEAYASFLEKMRN 163
            +    T  S ++  + +   L+++  
Sbjct: 80  GLKFNLTETSEADIHQGFGHLLQRLNQ 106

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 1/56 (1%)

Query: 8  SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
           +L L    T     + + +      + N+VF+PLSI  ALALV LG+ G T +E+
Sbjct: 23 DSLTLASINTDFAFSLYKELVL-KNPDTNIVFSPLSISAALALVSLGAKGNTLEEI 77

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379

 Score =  151 bits (383), Expect = 1e-42
 Identities = 34/152 (22%), Positives = 65/152 (42%), Gaps = 6/152 (3%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                  F+LPK   +      +      +      K  V   +PK  ++++ +L   L 
Sbjct: 226 SKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLL 285

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK--- 278
            M +   +    +D S + +D G+ +    HK  + + E+GT AAA   + ++   +   
Sbjct: 286 KMGIQHAYS-ENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTF 344

Query: 279 --PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             P ++I+R F+  I  + T SI+F G +  P
Sbjct: 345 LHPIIQIDRSFMLLILERSTRSILFLGKVVNP 376

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 14/83 (16%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
           + +         ++ R      T ++N+ F+P+SI  AL ++  G+   T+ E+   +G 
Sbjct: 4   YKMSSINADFAFNLYRRFTV-ETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGF 62

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T   +      +   +  +  
Sbjct: 63  NLTDTPMVEIQHGFQHLICSLNF 85

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 13/57 (22%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +         ++ R      T ++N+ F+P+SI  AL ++  G+   T+ E+   +G
Sbjct: 6  MSSINADFAFNLYRRFTV-ETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLG 61

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373

 Score =  150 bits (382), Expect = 1e-42
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           N      ILP     ++E+ K L   KF  +I++     V  ++PK K   + ++   L 
Sbjct: 220 NHYSFVAILPDENISVNEYIKTLTGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLE 279

Query: 222 TMNVTSMFDVSKSDLSNMLD--DRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT----R 275
           ++ +T  F   K+D S +       + + +V HK  I V E GT A A T + IT     
Sbjct: 280 SLGMTDAFLPDKADFSKLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIP 339

Query: 276 ISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
           ++  TVK+NRPFIF I    T+  +F G++   +
Sbjct: 340 VNFKTVKLNRPFIFAIIDNSTNLPIFIGTVLSLK 373

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 15/65 (23%), Positives = 36/65 (55%), Gaps = 2/65 (3%)

Query: 100 RSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPEAYASFLE 159
           ++ +   +N + +PLS + ALA+   G+D +T  ++   +G     S+ +  +   ++++
Sbjct: 22  KNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALGK--DISIEDLNKYLYTYMK 79

Query: 160 KMRNE 164
           K+ NE
Sbjct: 80  KLPNE 84

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 11/41 (26%), Positives = 24/41 (58%)

Query: 28 RSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          ++ +   +N + +PLS + ALA+   G+D +T  ++   +G
Sbjct: 22 KNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALG 62

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432

 Score =  151 bits (384), Expect = 2e-42
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 7/153 (4%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +++ M  ILPK    L++  K+L  +     ++   ++ ++  +P+ ++     L+  L 
Sbjct: 277 DDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQ 336

Query: 222 TMNVTSMFDVSKSDLSNMLDD--RGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
            M +  +F   KS L  ++ +    + V   FHK  +EV E+G+ AAAST ++I   S  
Sbjct: 337 DMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLN 396

Query: 280 ----TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               T K NRPF+ FI   P ++I+F G +  P
Sbjct: 397 PNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 429

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 14/84 (16%), Positives = 30/84 (35%), Gaps = 2/84 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG- 140
             L +  ++      + +      N N+  +PLSI  A A+  LG+   T  +L      
Sbjct: 49  WELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKF 108

Query: 141 -VATGRSLSNNPEAYASFLEKMRN 163
              + ++       +A    ++  
Sbjct: 109 DTISEKTSDQIHFFFAKLNCRLYR 132

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 13/57 (22%), Positives = 23/57 (40%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
           L +  ++      + +      N N+  +PLSI  A A+  LG+   T  +L     
Sbjct: 51  LSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFK 107

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430

 Score =  151 bits (384), Expect = 2e-42
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 9/173 (5%)

Query: 162 RNEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTV 219
           +N +    ++P   +  +SE   +L +D             V   +PK+ +    +L   
Sbjct: 232 KNNMSFVVVMPTYFEWNVSEVLANLTWDTLYHPSLQERPTKV--WLPKLHLQQQLDLVAT 289

Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L+ + +  +F     DL  +  ++ + V  V H+  +E++E G  AAA+T + + R+S  
Sbjct: 290 LSQLGLQELF--QGPDLRGI-SEQNLVVSSVQHQSTMELSEAGVEAAAATSVAMNRMSLS 346

Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP--YHENERNNEAEELYQSE 330
           +  +NRPF+FFI        +F GS+  P P       E   + +   + Q++
Sbjct: 347 SFTVNRPFLFFIMEDTIGVPLFVGSVRNPNPSALPQLQEQRDSPDNRLIGQND 399

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 1/59 (1%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
             L + +   T D+   +    + + N+V +PLS+  AL+ + LG+  QT   L   + 
Sbjct: 19  RRLAQAMMAFTTDLFSLVAQ-TSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLH 76

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 20/84 (23%), Positives = 39/84 (46%), Gaps = 3/84 (3%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           L + +   T D+   +    + + N+V +PLS+  AL+ + LG+  QT   L   + + T
Sbjct: 21  LAQAMMAFTTDLFSLVAQ-TSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNT 79

Query: 72  GRSLSNKLTAHSLRRGITQMTLDM 95
           G  L + L      + +   T+ +
Sbjct: 80  GSCLPHLL--SHFYQNLGPGTIRL 101

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385

 Score =  150 bits (380), Expect = 3e-42
 Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 5/150 (3%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTV 219
             + M  +LP     L +    ++++K +    S    +  +   +P+MK+     L +V
Sbjct: 237 GTMSMLVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSV 296

Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L  M +T +F  S ++LS +     + + Q  H    E+ E G     S    +   S  
Sbjct: 297 LMAMGITDVFS-SSANLSGISSAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVS 355

Query: 280 -TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              + + PF+F I H  T++++F+G    P
Sbjct: 356 EEFRADHPFLFCIKHIATNAVLFFGRCVSP 385

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 13/58 (22%), Positives = 31/58 (53%), Gaps = 1/58 (1%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           S+     +   D+ + ++     N+N+ + P++I+ ALA+V LG+   T+ ++   + 
Sbjct: 2   SIGAASMEFCFDVFKELKV-HHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVR 58

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 12/57 (21%), Positives = 30/57 (52%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +     +   D+ + ++     N+N+ + P++I+ ALA+V LG+   T+ ++   + 
Sbjct: 3  IGAASMEFCFDVFKELKV-HHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVR 58

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375

 Score =  149 bits (379), Expect = 4e-42
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 8/153 (5%)

Query: 163 NEVYMYFILPKNPD-----LSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTE 215
             + M+ +LPK+ +     L +  K L+ +  S+    +      V  +IPK KV    +
Sbjct: 224 KHLSMFILLPKDVEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMID 283

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
            +  L  + +  +F    SD S M + +GVA+  V HKV +E+TE G  +    G  I +
Sbjct: 284 PKACLENLGLKHIFSEDTSDFSGMSETKGVALSNVIHKVCLEITEDGGDSIEVPGARILQ 343

Query: 276 ISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                +  + PFI+ I H  T +I+F+G    P
Sbjct: 344 HK-DELNADHPFIYIIRHNKTRNIIFFGKFCSP 375

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 13/81 (16%), Positives = 37/81 (45%), Gaps = 4/81 (4%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVA 142
           +L+   +   +D+ + +        NV+F+P+ +  +L+L  +G+ G T +E+   +   
Sbjct: 3   ALQLANSAFAVDLFKQLCE-KEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHF- 60

Query: 143 TGRSLSNNPEAYASFLEKMRN 163
              ++ + P  + +    +  
Sbjct: 61  --ENVKDVPFGFQTVTSDVNK 79

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 12/57 (21%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L+   +   +D+ + +        NV+F+P+ +  +L+L  +G+ G T +E+   + 
Sbjct: 4  LQLANSAFAVDLFKQLCE-KEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLH 59

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401

 Score =  150 bits (381), Expect = 4e-42
 Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 7/154 (4%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIY-TIPKMKVTSSTELRTVL 220
                  FILP    + E    L  +   R  +S    ++    +PK  ++    L  +L
Sbjct: 247 TGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDIL 306

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP- 279
             + +   F  SK+DLS +   R +AV QV HK  ++V E+GT A+A+T + IT +S   
Sbjct: 307 LQLGIEEAFT-SKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALV 365

Query: 280 ----TVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
                V+ NRPF+  I    T +I F   +  P+
Sbjct: 366 ETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPK 399

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
             L          + + +      ++NV+F+P SI  ALA + LG+   T  E+   +  
Sbjct: 25  LGLASANVDFAFSLYKQLVL-KAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKF 83

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T  S +   +++   L  +  
Sbjct: 84  NLTETSEAEIHQSFQHLLRTLNQ 106

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 14/57 (24%), Positives = 25/57 (43%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L          + + +      ++NV+F+P SI  ALA + LG+   T  E+   + 
Sbjct: 27 LASANVDFAFSLYKQLVL-KAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLK 82

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406

 Score =  150 bits (380), Expect = 5e-42
 Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 6/152 (3%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDK-FSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
                  +LP     L+  T+ L+ +K  S  +++  +  V   +PK  + ++ +L   L
Sbjct: 251 TRFTFVIVLPLEKWSLNGATELLNGNKVLSEYVKNLKETTVSLRLPKFTLKNTLDLVPTL 310

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP- 279
            ++ V  +FD  KSDLS +  +  + V++      +++ E G  A   T  I    S   
Sbjct: 311 KSIGVVDLFDPVKSDLSGITPNPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAII 370

Query: 280 ---TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                 +  PFI FIY +     +    +  P
Sbjct: 371 PEVDFHVTHPFICFIYDQQLTMPIMAAKVMNP 402

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 13/100 (13%), Positives = 34/100 (34%), Gaps = 6/100 (6%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVL--LGSDGQTKDELT--- 136
           ++        T      + +      N +  PL I+  L ++L   G+ G+T  ++    
Sbjct: 13  YANISSHKAFTHAYLSTVTA-DFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTM 71

Query: 137 HFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPD 176
                ++  + S   +   S  +++ N +          +
Sbjct: 72  RLKSTSSSWNSSEAQQEMKSLYQELNNSLTSEKTFLNEKE 111

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 15/82 (18%), Positives = 34/82 (41%), Gaps = 2/82 (2%)

Query: 32  TKNQNVVFAPLSIVGALALVL--LGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGIT 89
               N +  PL I+  L ++L   G+ G+T  ++   M + +  S  N   A    + + 
Sbjct: 34  FGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKSLY 93

Query: 90  QMTLDMERAIRSVMTKNQNVVF 111
           Q   +   + ++ + + +  V 
Sbjct: 94  QELNNSLTSEKTFLNEKEENVV 115

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382

 Score =  149 bits (378), Expect = 6e-42
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 10/157 (6%)

Query: 162 RNEVYMYFILPKNPD-----LSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSST 214
             +V M+ +LP         L     ++ YDK ++        + +V   IP+ K+    
Sbjct: 226 AGDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHY 285

Query: 215 ELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           ELR++L +M +   F+  +++ S M +   + + +VFH+  ++V E+GT AAA TG ++T
Sbjct: 286 ELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMT 345

Query: 275 RIS---KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             +    P    + PF+F I HK T+ I+F+G    P
Sbjct: 346 GRTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 17/82 (20%), Positives = 35/82 (42%), Gaps = 2/82 (2%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV- 141
            L    T   L++ + +    +  QN+  +P SI   +A+V +GS G T+D++   +   
Sbjct: 3   DLCVANTLFALNLFKHLAK-ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFN 61

Query: 142 ATGRSLSNNPEAYASFLEKMRN 163
             G +      ++ S    +  
Sbjct: 62  EVGAAADKIHSSFRSLSSAINA 83

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 15/57 (26%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L    T   L++ + +    +  QN+  +P SI   +A+V +GS G T+D++   + 
Sbjct: 4  LCVANTLFALNLFKHLAK-ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQ 59

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371

 Score =  147 bits (374), Expect = 2e-41
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 3/148 (2%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                 +FILP    +      L  D   R  +      V   IPK  ++ + +L+ VL 
Sbjct: 225 VGNGTAFFILPDQGQMDTVIAALSRDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLE 284

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-T 280
            +N+  +   ++SD S    D  + +  + HK  +++ E   +  ++ G  +   S+P  
Sbjct: 285 DLNIKDLLT-NQSDFSGNTKDVPLTLT-MVHKAMLQLDEGNVLPNSTNGAPLHLRSEPLD 342

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           +K N+PFI  ++ K T S +    +  P
Sbjct: 343 IKFNKPFILLLFDKFTWSSLMMSQVVNP 370

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 15/82 (18%), Positives = 34/82 (41%), Gaps = 3/82 (3%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
             L         ++ + + + +  ++N + +P+SI  ALA+V LGS      +   F   
Sbjct: 7   RGLAPTNVDFAFNLYQRLVA-LNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGFN-- 63

Query: 142 ATGRSLSNNPEAYASFLEKMRN 163
            T  S +   +++      ++ 
Sbjct: 64  LTETSEAEIHQSFQYLNYLLKQ 85

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 13/55 (23%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHF 66
          L         ++ + + + +  ++N + +P+SI  ALA+V LGS      +   F
Sbjct: 9  LAPTNVDFAFNLYQRLVA-LNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGF 62

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390

 Score =  147 bits (374), Expect = 3e-41
 Identities = 34/153 (22%), Positives = 73/153 (47%), Gaps = 8/153 (5%)

Query: 162 RNEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKV---DVIYTIPKMKVTSSTEL 216
            + + +  ++P+N    L +  + L    F  I+E          + T+P++KVT+S ++
Sbjct: 240 SHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDM 299

Query: 217 RTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRI 276
            +++  +           +L  + +D  + V  + H+  +E+TE G  AAA++ I + R 
Sbjct: 300 LSIMEKLEFFDFSY--DLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVART 357

Query: 277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
                ++ +PF+F ++ +     VF G +Y P 
Sbjct: 358 L-LVFEVQQPFLFMLWDQQHKFPVFMGRVYDPR 389

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 19/72 (26%), Positives = 29/72 (40%)

Query: 69  VATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSD 128
           V     L +  T   L   +   +L +  A  ++     N+ F+P SI   L  VLLG+ 
Sbjct: 17  VTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAG 76

Query: 129 GQTKDELTHFMG 140
             TK  L   + 
Sbjct: 77  ENTKTNLESILS 88

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 5/84 (5%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           L   +   +L +  A  ++     N+ F+P SI   L  VLLG+   TK  L   +    
Sbjct: 32  LGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYP- 90

Query: 72  GRSLSNKLTAHSLRRGITQMTLDM 95
                +    H   +G T   +  
Sbjct: 91  ----KDFTCVHQALKGFTTKGVTS 110

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385

 Score =  147 bits (373), Expect = 3e-41
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 4/151 (2%)

Query: 162 RNEVYMYFILPKNP-DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           +    M  +L +   D       L  D     + +    ++    PK K+    E+  +L
Sbjct: 234 QGNATMLVVLMEKMGDHLALEDYLTTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELL 293

Query: 221 NTMNVTSMFDVSKSDLSNMLDD-RGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
             M +  +F    +DLS +    R + V +V  +  IEV E+GT A A     IT  S P
Sbjct: 294 RQMGIRRIFS-PFADLSELSATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAYSMP 352

Query: 280 -TVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
             +K++RPF F IY + +  ++F G +  P 
Sbjct: 353 PVIKVDRPFHFMIYEETSGMLLFLGRVVNPT 383

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 12/59 (20%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
             L +  +     + R I      + N+VF+P  +  A+  ++LG+ G T+ ++   + 
Sbjct: 14  QQLAKETSNFGFSLLRKISM--RHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLH 70

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 15/66 (22%), Positives = 31/66 (46%), Gaps = 2/66 (3%)

Query: 3  HFLMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDE 62
           +LM S   L +  +     + R I      + N+VF+P  +  A+  ++LG+ G T+ +
Sbjct: 7  AWLMASRQQLAKETSNFGFSLLRKISM--RHDGNMVFSPFGMSLAMTGLMLGATGPTETQ 64

Query: 63 LTHFMG 68
          +   + 
Sbjct: 65 IKRGLH 70

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401

 Score =  147 bits (372), Expect = 7e-41
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 8/153 (5%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTV 219
            ++ M  +LP   D L +  + L  +K        N  +  V   +P+ KV  S +L+  
Sbjct: 250 KDLSMIVLLPNEIDGLQKLEEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDT 309

Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-- 277
           L TM +  +F+   +DLS M   RG+ +  V HK  +EVTE+G  AAA+T ++    S  
Sbjct: 310 LRTMGMVDIFN-GDADLSGMTGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPT 368

Query: 278 --KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                   N PF+FFI    T+SI+F+G    P
Sbjct: 369 STNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 401

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 17/60 (28%), Positives = 32/60 (53%), Gaps = 2/60 (3%)

Query: 81  AHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           ++SL    T+   D+ +  R   +K  N+ ++P+SI  AL +VLLG+   T  ++   + 
Sbjct: 12  SNSLSEANTKFMFDLFQQFRK--SKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLH 69

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 16/57 (28%), Positives = 29/57 (50%), Gaps = 2/57 (3%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L    T+   D+ +  R   +K  N+ ++P+SI  AL +VLLG+   T  ++   + 
Sbjct: 15 LSEANTKFMFDLFQQFRK--SKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLH 69

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398

 Score =  147 bits (372), Expect = 7e-41
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 6/151 (3%)

Query: 162 RNEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTV 219
              + + F LP      L+   + L  +    I      V  + T+PK+K++   E+   
Sbjct: 249 TGSMSIIFFLPLKVTQNLTLIEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKS 308

Query: 220 LNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP 279
           L  M + S+FD    D S +   + + + QV H+   E  E G     S G+    ++ P
Sbjct: 309 LQEMKLQSLFD--SPDFSKI-TGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFP 365

Query: 280 -TVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
               +N+PFIF +    T +++F G I  P 
Sbjct: 366 LDYHLNQPFIFVLRDTDTGALLFIGKILDPR 396

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 17/72 (23%), Positives = 34/72 (47%), Gaps = 1/72 (1%)

Query: 69  VATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSD 128
           +        K+  + L   ++    D+ R   S M+   NV+ +PLS+  AL+ + LG+D
Sbjct: 19  LVEEEDPFFKVPVNKLAAAVSNFGYDLYRVRSS-MSPTTNVLLSPLSVATALSALSLGAD 77

Query: 129 GQTKDELTHFMG 140
            +T+  +   + 
Sbjct: 78  ERTESIIHRALY 89

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 16/57 (28%), Positives = 30/57 (52%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L   ++    D+ R   S M+   NV+ +PLS+  AL+ + LG+D +T+  +   + 
Sbjct: 34 LAAAVSNFGYDLYRVRSS-MSPTTNVLLSPLSVATALSALSLGADERTESIIHRALY 89

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480

 Score =  145 bits (368), Expect = 9e-40
 Identities = 35/149 (23%), Positives = 62/149 (41%), Gaps = 4/149 (2%)

Query: 162 RNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
              + M  ++P     +      L      R  +S         +PK K+  +  L   L
Sbjct: 331 VGGISMLIVVPHKMSGMKTLEAQLTPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESL 390

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP- 279
             M +  +FD    +++ +  D+ +A+D   H+  I V E+GT A   T +    +S   
Sbjct: 391 KLMGIRMLFD-KNGNMAGI-SDQRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLSTQV 448

Query: 280 TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              ++RPF+F IY   T  ++F G +  P
Sbjct: 449 RFTVDRPFLFLIYEHRTSCLLFMGRVANP 477

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 3/93 (3%)

Query: 68  GVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGS 127
                +    K     L     +   ++ R ++  +    N+  AP+ I  A+ ++ LG 
Sbjct: 91  AGNILQLFHGKSRIQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGL 150

Query: 128 DGQTKDELT---HFMGVATGRSLSNNPEAYASF 157
            G+T +++    HF       S       +  F
Sbjct: 151 KGETHEQVHSILHFKDFVNASSKYEITTIHNLF 183

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 16/75 (21%), Positives = 32/75 (42%), Gaps = 3/75 (4%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELT---HFMG 68
           L     +   ++ R ++  +    N+  AP+ I  A+ ++ LG  G+T +++    HF  
Sbjct: 107 LNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKD 166

Query: 69  VATGRSLSNKLTAHS 83
                S     T H+
Sbjct: 167 FVNASSKYEITTIHN 181

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395

 Score =  143 bits (363), Expect = 1e-39
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +      FILP    + +    L      + ++   K  +   +PK  +  S +L  VL 
Sbjct: 249 QGNATALFILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLP 308

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT----RIS 277
           ++ ++++F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T    R++
Sbjct: 309 SLGISNVFT-SHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLN 367

Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              +  NRPF+ FI      +I+F G + +P
Sbjct: 368 SQRLVFNRPFLMFIVDN---NILFLGKVNRP 395

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 2/88 (2%)

Query: 77  NKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELT 136
           + + A          T D+ RA+ S    +QN+ F+P+SI  +LA++ LG+   TK ++ 
Sbjct: 23  HMVGATVAPSSRRDFTFDLYRALAS-AAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQIL 81

Query: 137 HFMGV-ATGRSLSNNPEAYASFLEKMRN 163
             +G+     S       +   L+++  
Sbjct: 82  EGLGLNLQKSSEKELHRGFQQLLQELNQ 109

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 1/64 (1%)

Query: 5  LMRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELT 64
           M    +        T D+ RA+ S    +QN+ F+P+SI  +LA++ LG+   TK ++ 
Sbjct: 23 HMVGATVAPSSRRDFTFDLYRALAS-AAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQIL 81

Query: 65 HFMG 68
            +G
Sbjct: 82 EGLG 85

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377

 Score =  142 bits (361), Expect = 2e-39
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 7/150 (4%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
            +  M  +LPK    +    ++L  D+F   +    +  +   +PK K+ +   L+  L 
Sbjct: 229 LDYTMAILLPKENTGVEGLKQNLTIDRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQ 288

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-- 279
           ++ +  +F+ S +DLS + +D  + V  V HK  +EV E+GTVAAA+TG++I   S    
Sbjct: 289 SLGIKQIFE-SGADLSGI-NDGSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPYSLGPE 346

Query: 280 --TVKINRPFIFFIYHKPTDSIVFWGSIYK 307
               +++ PF+FFI +  TD I F G + K
Sbjct: 347 PVVFRVDHPFLFFIRNTRTDDIFFVGQVNK 376

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 21/83 (25%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
             L +   +  L + RA+ S     +NV F+P S+  A+ +   G+ GQT+ EL+  +G 
Sbjct: 5   AKLTKANNRFGLRLLRALPS--GPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGF 62

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
                + +   +AY    E++++
Sbjct: 63  SDVDLTDAGVLDAYTHHTERLKS 85

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 2/63 (3%)

Query: 6  MRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTH 65
          M+    L +   +  L + RA+ S     +NV F+P S+  A+ +   G+ GQT+ EL+ 
Sbjct: 1  MQEEAKLTKANNRFGLRLLRALPS--GPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQ 58

Query: 66 FMG 68
           +G
Sbjct: 59 GLG 61

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397

 Score =  142 bits (361), Expect = 3e-39
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           N++ MYFILP   + +++    ++     + +    + +V  T+PK K   S +L   L 
Sbjct: 242 NKLAMYFILPNPDNTVNQVLDRINSASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQ 301

Query: 222 TMNVTSMFDVSKSDLSNMLDDRG----VAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
            + +  +F    + L  +   RG    V V ++F K  I + E G+ A A+T I +    
Sbjct: 302 QVGIREIFS-QNASLPLLARGRGARDEVRVSRIFQKAGITINELGSEAYAATEIQLVNKF 360

Query: 278 KP----TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                     NRPFIFFI  +   +++F G I  P
Sbjct: 361 GGDGVQIFNANRPFIFFIEDETLGTMLFAGKIENP 395

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 9/72 (12%)

Query: 76  SNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSD------- 128
              +      +   +  L   + I      N NVV +P S+   L L+   SD       
Sbjct: 10  QQDVHGPFQGQRQNEFDLMFVKEIFK--NHNSNVVLSPFSVKILLTLIYEASDTSFGNAV 67

Query: 129 GQTKDELTHFMG 140
             TK EL+  + 
Sbjct: 68  SNTKRELSSVIQ 79

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 11/74 (14%)

Query: 32  TKNQNVVFAPLSIVGALALVLLGSD-------GQTKDELT---HFMGVATGRSLSNKLTA 81
             N NVV +P S+   L L+   SD         TK EL+       +   RS   +L  
Sbjct: 36  NHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQLL- 94

Query: 82  HSLRRGITQMTLDM 95
            S ++      L++
Sbjct: 95  ESAQQDNKDYDLNI 108

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415

 Score =  142 bits (361), Expect = 3e-39
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 13/158 (8%)

Query: 163 NEVYMYFILPK-----NPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTE 215
            E+ M+ +LP         L +  ++L Y++ S   +S    +  V   +PK  +    +
Sbjct: 257 RELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDRID 316

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
           LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT AAA+T +II+ 
Sbjct: 317 LRDTLRNMGMTTAFT-TNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVIISF 375

Query: 276 IS-----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            +         K++ PF FFI H  + +I+F+G    P
Sbjct: 376 TTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 413

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 1/87 (1%)

Query: 78  KLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTH 137
           +++   +   I   T+D+   +     +++N+ F+P SI  ALAL  L + G T  E+  
Sbjct: 3   EISMEQVSASIGNFTVDLFNKLNE-TNRDKNIFFSPWSISSALALTYLAAKGSTAREMAE 61

Query: 138 FMGVATGRSLSNNPEAYASFLEKMRNE 164
            +         ++  A  S     R  
Sbjct: 62  VLHFTEAVRAESSSVARPSRGRPKRRR 88

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 16/57 (28%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +   I   T+D+   +     +++N+ F+P SI  ALAL  L + G T  E+   + 
Sbjct: 9  VSASIGNFTVDLFNKLNE-TNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLH 64

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453

 Score =  143 bits (362), Expect = 4e-39
 Identities = 27/148 (18%), Positives = 61/148 (41%), Gaps = 4/148 (2%)

Query: 162 RNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
                +  I P    DL +             ++  +   +  T+P++ +  S +L+ +L
Sbjct: 305 TESACLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLL 364

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT 280
               + ++   ++ +L  + +DR + V +V + +  E+         ST  +        
Sbjct: 365 AQAELPAILH-TELNLQKLSNDR-IRVGEVLNSIFFELEADEREPTESTQQLNKPEV-LE 421

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           V +NRPF+F +Y +   ++ F G +  P
Sbjct: 422 VTLNRPFLFAVYDQSATALHFLGRVANP 449

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 18/88 (20%), Positives = 31/88 (35%), Gaps = 1/88 (1%)

Query: 54  GSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSV-MTKNQNVVFA 112
            S    K      + VA      +KL A  +      +   +      +    +   V +
Sbjct: 44  TSPVDEKALQDQLVLVAAKLDTEDKLRAAMVGMLANFLGFRIYGMHSELWGVVHGATVLS 103

Query: 113 PLSIVGALALVLLGSDGQTKDELTHFMG 140
           P ++ G LA + LG+   T D L   +G
Sbjct: 104 PTAVFGTLASLYLGALDHTADRLQAILG 131

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 15/73 (20%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 12  LRRGITQMTLDMERAIRSV-MTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV- 69
           +      +   +      +    +   V +P ++ G LA + LG+   T D L   +GV 
Sbjct: 74  VGMLANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVP 133

Query: 70  ATGRSLSNKLTAH 82
              ++ +++L AH
Sbjct: 134 WKDKNCTSRLDAH 146

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453

 Score =  141 bits (358), Expect = 2e-38
 Identities = 28/149 (18%), Positives = 66/149 (44%), Gaps = 5/149 (3%)

Query: 163 NEVYMYFILPKNP-DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
               +  I P    DL      +  +     IE+     +  T+P++++  S  L+ +L 
Sbjct: 305 ERATLLLIQPHCISDLDRVEALIFQNDLLTWIENPPPRAIRLTLPQLEIRGSYNLQDLLA 364

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-T 280
              + ++   ++++L+N+  D    V +V + + +E+   G     +T +      +   
Sbjct: 365 EDKLPTLLG-AEANLNNI-GDTNPRVGEVLNSILLELKA-GEEEQPTTSVQQPGSPEALD 421

Query: 281 VKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
           V ++ PF+F IY + + ++ F G +  P+
Sbjct: 422 VTLSSPFLFAIYEQDSGTLHFLGRVNNPQ 450

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 17/107 (15%), Positives = 34/107 (31%)

Query: 34  NQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTL 93
           N +V   P S    + +    S    K      +  A      ++  A  +      +  
Sbjct: 23  NPSVETLPESTFEPVPIQAKTSPVNEKTLHDQLVLAAEKLEDEDRKRAAQVAMITNFVGF 82

Query: 94  DMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
            M + +    +     + +P ++ G L    LGS   T  +L   + 
Sbjct: 83  RMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLD 129

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 12/74 (16%), Positives = 27/74 (36%), Gaps = 1/74 (1%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV-A 70
           +      +   M + +    +     + +P ++ G L    LGS   T  +L   + V  
Sbjct: 73  VAMITNFVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPV 132

Query: 71  TGRSLSNKLTAHSL 84
                +++L  H +
Sbjct: 133 KEGDCTSRLDGHKV 146

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378

 Score =  138 bits (351), Expect = 5e-38
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKF-SRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           ++  M  ILP   D ++   + L   K  SR  E     +V   +PK K+ ++T+L+ VL
Sbjct: 229 DQASMIIILPNQVDGITALEQKLKDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVL 288

Query: 221 NTMNVTSMFDVSKSDLSNMLDDR-GVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-- 277
           + MN+  +F    + L N+L  +  + VD    K  IEV E+G  AAA+    IT  S  
Sbjct: 289 SNMNIKKLFTPGAARLENLLKTKESLYVDAAIQKAFIEVNEEGAEAAAANAFKITTYSFH 348

Query: 278 -KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             P V+IN+PF F + +      +F G   +P
Sbjct: 349 FVPKVEINKPFFFSLKYNRN--SMFSGVCVQP 378

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 17/59 (28%), Positives = 25/59 (42%), Gaps = 1/59 (1%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
             LR    Q T  M   +       QNVV +  S++  L  + L S G++ DEL   + 
Sbjct: 9   KILRESNDQFTAQMFSEVVK-ANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALA 66

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 17/57 (29%), Positives = 25/57 (43%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          LR    Q T  M   +       QNVV +  S++  L  + L S G++ DEL   + 
Sbjct: 11 LRESNDQFTAQMFSEVVK-ANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALA 66

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376

 Score =  132 bits (335), Expect = 1e-35
 Identities = 34/155 (21%), Positives = 65/155 (41%), Gaps = 14/155 (9%)

Query: 162 RNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           +    +  +L    + L      +        +     V+V   +PK K+ S+ + + VL
Sbjct: 227 KGGASLTIVLSNQIEGLVSLESKIKRSFLPHNLTKQ-LVNV--ALPKFKIESTVDFKKVL 283

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRG-VAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS-- 277
             + V   F   ++DLS +  ++G + +  +  K  I+V+E+G  AAA+T I +      
Sbjct: 284 KKLGVKKAFG-DEADLSGIAGEKGDLVISNIVQKSFIDVSEEGVEAAAATYIPVILPEMA 342

Query: 278 ----KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                    ++ PFIF+I       I+F G +   
Sbjct: 343 LPDSPKQFIVDHPFIFYIKV--KGMILFAGRVTTL 375

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376

 Score = 53.7 bits (130), Expect = 3e-08
 Identities = 20/87 (22%), Positives = 32/87 (36%), Gaps = 4/87 (4%)

Query: 80  TAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFM 139
           T       +   T  + + +    T+  N + +P S    LAL   G  G T +E+   +
Sbjct: 7   TLQEFPNAVNSFTPSVYKEVLK--TEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVL 64

Query: 140 GVATGRSLSNNPEAYASFLEKMRNEVY 166
                R  +    A    L K+ NE Y
Sbjct: 65  HFVGDREKAE--GAVKEVLSKLTNEEY 89

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 12/57 (21%), Positives = 22/57 (38%), Gaps = 2/57 (3%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
              +   T  + + +    T+  N + +P S    LAL   G  G T +E+   + 
Sbjct: 11 FPNAVNSFTPSVYKEVLK--TEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLH 65

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370

 Score =  130 bits (330), Expect = 5e-35
 Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 13/157 (8%)

Query: 163 NEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNT 222
           +E+ +  +LP   + +           + +   +    V   +P+ ++T   +L  VL  
Sbjct: 219 DELAVDVLLPPGTNAA---AVPTAPLLTALHRRSASTSVELALPRFELTQPHQLVEVLAE 275

Query: 223 MNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS----- 277
             V ++F  + +DLS +     + VD V H+  + V E+G   AA+T  ++         
Sbjct: 276 AGVRTLFT-ASADLSGI-STVPLYVDTVIHQARLRVDERGAEGAAATAAMMLLAGAMPPR 333

Query: 278 -KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP 313
                 ++RPF   +      +I+F GSI  P    P
Sbjct: 334 RTIRFSVDRPFHIVVRR--RGAILFLGSIADPHDPGP 368

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 16/65 (24%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 76  SNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 135
           S  ++   LR    +  L + R +      +  V+++P S+  AL ++  G+   T+ EL
Sbjct: 2   SVSMSGGFLRDDHLEFALHLHRRLAE-AVPDGEVIWSPYSVAXALGVLAAGARATTRTEL 60

Query: 136 THFMG 140
           T  +G
Sbjct: 61  TTLLG 65

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 15/57 (26%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          LR    +  L + R +      +  V+++P S+  AL ++  G+   T+ ELT  +G
Sbjct: 10 LRDDHLEFALHLHRRLAE-AVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG 65

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393

 Score =  130 bits (328), Expect = 1e-34
 Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 14/159 (8%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKF--SRIIESTNKVDVIYTIPKMKVTSSTELRTV 219
            +  MYF LP   + LS+    +          I         + IPK K +   +   V
Sbjct: 234 RQFSMYFYLPDANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNV 293

Query: 220 LNTMNVTSMFDVSKSDLSNMLDD----RGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
           L  + +TS F   +  L+ M++     + + V  +FHK  IEV E+GT AAA++  +I  
Sbjct: 294 LKGLGLTSPFS-GEEGLTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKL 352

Query: 276 IS------KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
                   +     + PF+  +    T  ++F G +  P
Sbjct: 353 RGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDP 391

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 16/52 (30%), Positives = 35/52 (67%)

Query: 17 TQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
           Q+++++ + + + +++N NV+F+P SI   L+++  GS G TKD++  F+ 
Sbjct: 13 NQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLK 64

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 16/52 (30%), Positives = 35/52 (67%)

Query: 89  TQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
            Q+++++ + + + +++N NV+F+P SI   L+++  GS G TKD++  F+ 
Sbjct: 13  NQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLK 64

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336

 Score =  113 bits (284), Expect = 9e-29
 Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 1/113 (0%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +      FILP    + +    L      + ++   K  +   +PK  +  S +L  VL 
Sbjct: 224 QGNATALFILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLP 283

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           ++ ++++F  S +DLS + +   + V ++ HK  +EV E GT AAA+TG I T
Sbjct: 284 SLGISNVFT-SHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFT 335

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 21/84 (25%), Positives = 39/84 (46%), Gaps = 2/84 (2%)

Query: 81  AHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           A          T D+ RA+ S    +QN+ F+P+SI  +LA++ LG+   TK ++   +G
Sbjct: 2   ATVAPSSRRDFTFDLYRALAS-AAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLG 60

Query: 141 V-ATGRSLSNNPEAYASFLEKMRN 163
           +     S       +   L+++  
Sbjct: 61  LNLQKSSEKELHRGFQQLLQELNQ 84

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336

 Score = 46.4 bits (111), Expect = 6e-06
 Identities = 18/58 (31%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +        T D+ RA+ S    +QN+ F+P+SI  +LA++ LG+   TK ++   +G
Sbjct: 4  VAPSSRRDFTFDLYRALAS-AAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLG 60

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350

 Score =  113 bits (284), Expect = 1e-28
 Identities = 24/119 (20%), Positives = 46/119 (38%), Gaps = 1/119 (0%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                  F+LPK   +      +      +      K  V   +PK  ++++ +L   L 
Sbjct: 231 SKNALALFVLPKEGQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLL 290

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPT 280
            M +   +    +D S + +D G+ +    HK  + + E+GT AA +  +     S P 
Sbjct: 291 KMGIQHAYS-ENADFSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSIPN 348

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 16/91 (17%), Positives = 35/91 (38%), Gaps = 2/91 (2%)

Query: 74  SLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKD 133
           S     T + +         ++ R      T ++N+ F+P+SI  AL ++  G+   T+ 
Sbjct: 1   SSQPNATLYKMSSINADFAFNLYRRFTV-ETPDKNIFFSPVSISAALVMLSFGACCSTQT 59

Query: 134 ELTHFMGV-ATGRSLSNNPEAYASFLEKMRN 163
           E+   +G   T   +      +   +  +  
Sbjct: 60  EIVETLGFNLTDTPMVEIQHGFQHLICSLNF 90

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 13/57 (22%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +         ++ R      T ++N+ F+P+SI  AL ++  G+   T+ E+   +G
Sbjct: 11 MSSINADFAFNLYRRFTV-ETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLG 66

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343

 Score =  111 bits (280), Expect = 3e-28
 Identities = 25/113 (22%), Positives = 54/113 (47%), Gaps = 1/113 (0%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
                  F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L++VL 
Sbjct: 230 LGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLG 289

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
            + +T +F  + +DLS + ++  + + +  HK  + + E+GT AA        
Sbjct: 290 QLGITKVFS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAPDDDDEAI 341

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 16/83 (19%), Positives = 35/83 (42%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
           + +   + +    + R +    + + N+ F+P+SI  A A++ LG+   T DE+   +  
Sbjct: 9   NKITPNLAEFAFSLYRQLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF 67

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T    +   E +   L  +  
Sbjct: 68  NLTEIPEAQIHEGFQELLRTLNQ 90

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 13/52 (25%), Positives = 27/52 (51%), Gaps = 1/52 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
          +   + +    + R +    + + N+ F+P+SI  A A++ LG+   T DE+
Sbjct: 11 ITPNLAEFAFSLYRQLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEI 61

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305

 Score =  109 bits (275), Expect = 1e-27
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 3/115 (2%)

Query: 162 RNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
             +  M  ILP N D L    ++L    F +  +S + + +   IPK KVT S  L   L
Sbjct: 191 VGDTSMVVILPDNIDGLESIEQNLTDTNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDAL 250

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
             + +T +F  S  D SNM  +  V+VD + HK  I+V E+ T AAA+T  ++  
Sbjct: 251 VKLGLTEVFG-STGDYSNM-CNSDVSVDAMIHKTYIDVNEEYTEAAAATCALVAD 303

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305

 Score = 43.3 bits (103), Expect = 6e-05
 Identities = 15/48 (31%), Positives = 28/48 (58%), Gaps = 1/48 (2%)

Query: 21 LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +D+ R I S   K +NV  +P SI   L ++  G++G T ++L+ ++ 
Sbjct: 1  MDIFREIAS-SMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVE 47

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305

 Score = 43.3 bits (103), Expect = 6e-05
 Identities = 15/48 (31%), Positives = 28/48 (58%), Gaps = 1/48 (2%)

Query: 93  LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           +D+ R I S   K +NV  +P SI   L ++  G++G T ++L+ ++ 
Sbjct: 1   MDIFREIAS-SMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVE 47

>1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 245

 Score =  107 bits (271), Expect = 1e-27
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 3/112 (2%)

Query: 162 RNEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
             +  M  ILP N D L    ++L    F +  +S + + +   IPK KVT S  L   L
Sbjct: 136 VGDTSMVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHIPKFKVTGSYNLVDAL 195

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII 272
             + +T +F  S  D SNM  +  V+VD + HK  I+V E+ T AAA+T  +
Sbjct: 196 VKLGLTEVFG-STGDYSNM-SNSDVSVDAMIHKTYIDVNEEYTEAAAATSAL 245

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341

 Score =  109 bits (275), Expect = 2e-27
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 2/114 (1%)

Query: 162 RNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIY-TIPKMKVTSSTELRTVL 220
                  FILP    + E    L  +   R  +S    ++    +PK  ++    L  +L
Sbjct: 227 TGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDIL 286

Query: 221 NTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
             + +   F  SK+DLS +   R +AV QV HK  ++V E+GT A+ +T + IT
Sbjct: 287 LQLGIEEAFT-SKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASRATAVKIT 339

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
             L          + + +      ++NV+F+PLSI  ALA + LG+   T  E+   +  
Sbjct: 5   LGLASANVDFAFSLYKQLVL-KAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKF 63

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T  S +   +++   L  +  
Sbjct: 64  NLTETSEAEIHQSFQHLLRTLNQ 86

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341

 Score = 46.4 bits (111), Expect = 6e-06
 Identities = 16/60 (26%), Positives = 28/60 (46%), Gaps = 1/60 (1%)

Query: 9  NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +L L          + + +      ++NV+F+PLSI  ALA + LG+   T  E+   + 
Sbjct: 4  DLGLASANVDFAFSLYKQLVL-KAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLK 62

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359

 Score =  109 bits (275), Expect = 2e-27
 Identities = 27/113 (23%), Positives = 54/113 (47%), Gaps = 2/113 (1%)

Query: 163 NEVYMYFILPKNPD-LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLN 221
           +E+ M  +L +    L+     +          S  K  V   +P+  V    +L+ VL 
Sbjct: 246 DEISMMLVLSRQEVPLATLEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLK 305

Query: 222 TMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
            + +T +F    ++L+ + D++ + + +  HK  +EV E+G+ AAA +G+I  
Sbjct: 306 ALGITEIFI-KDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAI 357

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 20/73 (27%), Positives = 40/73 (54%), Gaps = 1/73 (1%)

Query: 68  GVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGS 127
           G       ++   A      I  ++++M   +R+   +++N++F+PLSI  A+ ++ LG+
Sbjct: 3   GSHHHHHHTDPTGATFPEEAIADLSVNMYNRLRA-TGEDENILFSPLSIALAMGMMELGA 61

Query: 128 DGQTKDELTHFMG 140
            G T+ E+ H MG
Sbjct: 62  QGSTQKEIRHSMG 74

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 18/61 (29%), Positives = 36/61 (59%), Gaps = 1/61 (1%)

Query: 8  SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFM 67
                  I  ++++M   +R+   +++N++F+PLSI  A+ ++ LG+ G T+ E+ H M
Sbjct: 15 GATFPEEAIADLSVNMYNRLRA-TGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSM 73

Query: 68 G 68
          G
Sbjct: 74 G 74

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345

 Score =  108 bits (273), Expect = 4e-27
 Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 7/119 (5%)

Query: 163 NEVYMYFILPK-----NPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTE 215
            E+ M  +LP      +  L +  K L  DK     +  N    +V   +P+ K+  S +
Sbjct: 225 KELSMIILLPDDIEDESTGLEKIEKQLTLDKLREWTKPENLYLAEVNVHLPRFKLEESYD 284

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           L + L  + V  +F+  K+DLS M   R + V ++ HK  +++ E+GT AAA+T   I 
Sbjct: 285 LTSHLARLGVQDLFNRGKADLSGMSGARDLFVSKIIHKSFVDLNEEGTEAAAATAGTIL 343

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 1/59 (1%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
             L    T   +D+ RA+        N+  +PLSI  ALA++ LG+ G T  +++  + 
Sbjct: 3   EQLSTANTHFAVDLFRALNE-SDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALY 60

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          L    T   +D+ RA+        N+  +PLSI  ALA++ LG+ G T  +++  + 
Sbjct: 5  LSTANTHFAVDLFRALNE-SDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALY 60

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394

 Score =  106 bits (266), Expect = 5e-26
 Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 8/119 (6%)

Query: 163 NEVYMYFILPK-----NPDLSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTE 215
            E+ M+ +LP         L +  ++L Y++ S   +S    +  V   +PK  +    +
Sbjct: 277 RELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDRID 336

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT 274
           LR  L  M +T+ F  + +D   M D + +A+ +V H+  + V E+GT AAA+T +II+
Sbjct: 337 LRDTLRNMGMTTAFT-TNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVIIS 394

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 4/83 (4%)

Query: 53  LGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFA 112
           +GS         H  G+    S   +++   +   I   T+D+   +     +++N+ F+
Sbjct: 1   MGSSHHHHH---HSSGLVPRGSHELEISMEQVSASIGNFTVDLFNKLNE-TNRDKNIFFS 56

Query: 113 PLSIVGALALVLLGSDGQTKDEL 135
           P SI  ALAL  L + G T  E+
Sbjct: 57  PWSISSALALTYLAAKGSTAREM 79

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 16/52 (30%), Positives = 27/52 (51%), Gaps = 1/52 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
          +   I   T+D+   +     +++N+ F+P SI  ALAL  L + G T  E+
Sbjct: 29 VSASIGNFTVDLFNKLNE-TNRDKNIFFSPWSISSALALTYLAAKGSTAREM 79

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323

 Score =  100 bits (252), Expect = 2e-24
 Identities = 24/111 (21%), Positives = 50/111 (45%), Gaps = 5/111 (4%)

Query: 163 NEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNT 222
           +E+ +  +LP   + +           + +   +    V   +P+ ++T   +L  VL  
Sbjct: 215 DELAVDVLLPPGTNAA---AVPTAPLLTALHRRSASTSVELALPRFELTQPHQLVEVLAE 271

Query: 223 MNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII 273
             V ++F  + +DLS +     + VD V H+  + V E+G   AA+T  ++
Sbjct: 272 AGVRTLFT-ASADLSGI-STVPLYVDTVIHQARLRVDERGAEGAAATAAMM 320

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 15/62 (24%), Positives = 30/62 (48%), Gaps = 1/62 (1%)

Query: 79  LTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHF 138
           ++   LR    +  L + R +      +  V+++P S+  AL ++  G+   T+ ELT  
Sbjct: 1   MSGGFLRDDHLEFALHLHRRLAE-AVPDGEVIWSPYSVACALGVLAAGARATTRTELTTL 59

Query: 139 MG 140
           +G
Sbjct: 60  LG 61

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323

 Score = 46.8 bits (112), Expect = 5e-06
 Identities = 15/57 (26%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          LR    +  L + R +      +  V+++P S+  AL ++  G+   T+ ELT  +G
Sbjct: 6  LRDDHLEFALHLHRRLAE-AVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG 61

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 1e-09
 Identities = 58/338 (17%), Positives = 105/338 (31%), Gaps = 105/338 (31%)

Query: 58  QTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMTLD---MERAIRS--------VMTKN 106
             + EL           L +K   + L      + L      +A  +        + T+ 
Sbjct: 229 SIQAELRRL--------LKSKPYENCL------LVLLNVQNAKAWNAFNLSCKILLTTRF 274

Query: 107 QNVV-FAPLSIVGALALVLLGSDGQTKDE----LTHFMGVATG----RSLSNNPEAYASF 157
           + V  F   +    ++L    S   T DE    L  ++           L+ NP   +  
Sbjct: 275 KQVTDFLSAATTTHISLDHH-SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333

Query: 158 LEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELR 217
            E +R+               +  K ++ DK + IIES+  ++V+            E R
Sbjct: 334 AESIRD----------GLATWDNWKHVNCDKLTTIIESS--LNVL---------EPAEYR 372

Query: 218 ------TVLN-----TMNVTSMF--DVSKSDLSNMLD---DRGVAVDQVF------HKVD 255
                 +V          + S+   DV KSD+  +++      +   Q          + 
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 256 IEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPT-DSIVFW--GSIYKPEPQR 312
           +E+  +     A    I+         I + F       P  D   +   G         
Sbjct: 433 LELKVKLENEYALHRSIVDH-----YNIPKTFDSDDLIPPYLDQYFYSHIG--------- 478

Query: 313 PYH-ENERNNEAEELYQSEIFRLDFGNPASARFVNNYI 349
            +H +N  + E   L+   +F LDF      RF+   I
Sbjct: 479 -HHLKNIEHPERMTLF-RMVF-LDF------RFLEQKI 507

>3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E Length = 48

 Score = 46.7 bits (111), Expect = 1e-07
 Identities = 12/38 (31%), Positives = 20/38 (52%)

Query: 276 ISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP 313
           +  P V ++ PF F I ++ T +I+F G +  PE    
Sbjct: 3   VLYPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMNT 40

>1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 31

 Score = 46.1 bits (110), Expect = 1e-07
 Identities = 12/31 (38%), Positives = 17/31 (54%)

Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           +     + PFIFFI H P+ +I+F G    P
Sbjct: 1   EENFNADHPFIFFIRHNPSANILFLGRFSSP 31

>2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B Length = 34

 Score = 45.8 bits (109), Expect = 2e-07
 Identities = 11/31 (35%), Positives = 17/31 (54%)

Query: 278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
               K++ PF FFI H  + +I+F+G    P
Sbjct: 2   VLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 32

>3ndd_B Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 1ezx_B 3ndf_B 7api_B* 8api_B* 9api_B* 2d26_B Length = 36

 Score = 42.4 bits (100), Expect = 3e-06
 Identities = 12/30 (40%), Positives = 18/30 (60%)

Query: 279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           P VK N+PF+F +  + T S +F G +  P
Sbjct: 4   PEVKFNKPFVFLMIEQNTKSPLFMGKVVNP 33

>1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55

 Score = 42.7 bits (101), Expect = 4e-06
 Identities = 11/31 (35%), Positives = 19/31 (61%)

Query: 33 KNQNVVFAPLSIVGALALVLLGSDGQTKDEL 63
          K +NV  +P SI   L ++  G++G T ++L
Sbjct: 12 KGENVFISPPSISSVLTILYYGANGSTAEQL 42

>1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55

 Score = 42.7 bits (101), Expect = 4e-06
 Identities = 11/31 (35%), Positives = 19/31 (61%)

Query: 105 KNQNVVFAPLSIVGALALVLLGSDGQTKDEL 135
           K +NV  +P SI   L ++  G++G T ++L
Sbjct: 12  KGENVFISPPSISSVLTILYYGANGSTAEQL 42

>2xn6_B Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn5_B* 2xn7_B* Length = 35

 Score = 39.1 bits (91), Expect = 5e-05
 Identities = 11/30 (36%), Positives = 18/30 (60%)

Query: 279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           P ++I+R F+  I  + T SI+F G +  P
Sbjct: 3   PIIQIDRSFMLLILERSTRSILFLGKVVNP 32

>2riv_B Thyroxine-binding globulin; TBG, serpin, cleaved, mutation, glycoprotein, secreted, signaling protein; 1.50A {Homo sapiens} PDB: 2riw_B* 2xn3_B* Length = 40

 Score = 38.4 bits (89), Expect = 9e-05
 Identities = 11/30 (36%), Positives = 18/30 (60%)

Query: 279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           P ++I+R F+  I  + T SI+F G +  P
Sbjct: 8   PIIQIDRSFMLLILERSTRSILFLGKVVNP 37

>1as4_B Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_B* 3caa_B 4caa_B Length = 37

 Score = 36.8 bits (85), Expect = 3e-04
 Identities = 10/32 (31%), Positives = 15/32 (46%)

Query: 277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
           +   V+ NRPF+  I    T +I F   +  P
Sbjct: 3   TGTIVRFNRPFLMIIVPTDTQNIFFMSKVTNP 34

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	357
4ga7_A	389	Leukocyte elastase inhibitor; serpin, conformation	100.0
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	100.0
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	100.0
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	100.0
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	100.0
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	100.0
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	100.0
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	100.0
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	100.0
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	100.0
2vdx_A	373	Corticosteroid-binding globulin; transport protein	100.0
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	100.0
4ajt_A	427	Protein Z-dependent protease inhibitor; blood clot	100.0
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	100.0
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	100.0
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	100.0
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	100.0
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	100.0
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	100.0
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	100.0
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	100.0
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	100.0
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	100.0
2v95_A	371	Corticosteroid-binding globulin; transport protein	100.0
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	100.0
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	100.0
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	100.0
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	100.0
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	100.0
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	100.0
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	100.0
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	100.0
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	100.0
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	100.0
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	100.0
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	100.0
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	100.0
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	100.0
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	100.0
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	100.0
4afx_A	387	Protein Z dependent protease inhibitor; hydrolase	100.0
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	100.0
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	100.0
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	100.0
1m93_B	245	Serine proteinase inhibitor 2; serpin, CRMA, apopt	100.0
1m93_A	55	Serine proteinase inhibitor 2; serpin, CRMA, apopt	99.35
3ndd_B	36	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	99.26
1hle_B	31	Horse leukocyte elastase inhibitor; hydrolase inhi	99.24
4afx_B	36	Protein Z dependent protease inhibitor; hydrolase	99.23
2xn6_B	35	Thyroxine-binding globulin; transport, cleaved pro	99.23
2h4p_B	34	MENT, heterochromatin-associated protein MENT; ser	99.21
2riv_B	40	Thyroxine-binding globulin; TBG, serpin, cleaved,	99.2
1as4_B	37	Antichymotrypsin, ACT; serpin, serine protease inh	99.19
3f02_C	48	Neuroserpin; cleaved form, fenib, human, disease M	99.14
1m93_C	41	Serine proteinase inhibitor 2; serpin, CRMA, apopt	99.07
1mtp_B	43	Serine proteinase inhibitor (serpin), chain B; str	99.02
3dy0_B	29	C-terminus plasma serine protease inhibitor; serpi	98.94

>4ga7_A Leukocyte elastase inhibitor; serpin, conformational change, serine protease inhibitor, Ca inhibitor, chymase inhibitor, chymotrypsin inhibitor; 2.90A {Homo sapiens}

Probab=100.00  E-value=1.3e-64  Score=497.00  Aligned_cols=299  Identities=27%  Similarity=0.397  Sum_probs=262.1

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc--
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL--   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l--   79 (357)
                      +..+..++++||++||+++.+. .+++|+||||+||+.+|+|+++||+|+|++||.++||++..       +.|+..+  
T Consensus        11 ~~~l~~~~~~Fa~~L~~~l~~~-~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~   89 (389)
T 4ga7_A           11 MEQLSSANTRFALDLFLALSEN-NPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADINK   89 (389)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGCTTHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHhHHHHHHHHHHhhc-CCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhC
Confidence            5678999999999999999877 67899999999999999999999999999999999999761       5566666  


Q ss_pred             -c-cceeeee---eccc---------------------cCCH-H---HH---HHHHH---hCCC-cccCCCCCCCcccee
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM-E---RA---IRSVM---TKNQ-NVVFAPLSIVGALAL  122 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF-~---~a---IN~wv---T~g~-~~~l~~~~l~~~t~l  122 (357)
                       + ++.++++   |+++                     .+|| +   .|   ||+||   |+|+ ++++++++++++|++
T Consensus        90 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~l~~~t~l  169 (389)
T 4ga7_A           90 RGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNMTKL  169 (389)
T ss_dssp             TTCSSEEEEEEEEEEETTSCBCHHHHHHHHHHTSCCEEEECHHHHHHHHHHHHHHHHHHHTTTSSTTSSCTTSSCTTCCE
T ss_pred             CCCCcEEEEeeeeeecCCCccCHHHHHHHHHHhCCeeEecccccCHHHHHHHHHHHHHHhhCCchhhccCCCCCCCCceE
Confidence             2 5677776   7665                     6789 2   33   99999   9999 999999899999999


Q ss_pred             Eeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC---
Q psy5102         123 VLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN---  174 (357)
Q Consensus       123 vLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~---  174 (357)
                      +|+||       +.||++..|.+++||..              . +|+++++++|+||+  |.+++++|+|||| +.   
T Consensus       170 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~  249 (389)
T 4ga7_A          170 VLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGEELSMVILLPDDIEDE  249 (389)
T ss_dssp             EEEEEEEEECCBSSCCCTTTCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEESSCCSS
T ss_pred             EEEEEEEEEeeecCCCCccCccccceEeCCCcEEEEEEEEEeeeEEEEEECCCCEEEEEEECCCCCEEEEEEecCCCccc
Confidence            99999       89999999999999976              2 57788999999999  9998999999999 76   


Q ss_pred             -CChhHHhhccChhHHHHHH--HhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeee
Q psy5102         175 -PDLSEFTKDLDYDKFSRII--ESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVF  251 (357)
Q Consensus       175 -~~L~~l~~~L~~~~l~~~~--~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~  251 (357)
                       .+|.+++++|+.+.+..|.  ..++.+.|+|.||||++++++||+++|++||++++|+++.||||+|+++.+++|++|+
T Consensus       250 ~~~L~~le~~L~~~~l~~~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~v~  329 (389)
T 4ga7_A          250 STGLKKIEEQLTLEKLHEWTKPENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIFISKIV  329 (389)
T ss_dssp             SSSCHHHHHHCCHHHHHHHHSGGGCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBCCSSCCEEEEE
T ss_pred             cccHHHHHHHhCHHHHHHHhhhhcCcceEEEEEeccEEEEEeechHHHHHHcCcHhhcCCCcCCcccccCCCCcceeeEE
Confidence             8999999999999999998  5788999999999999999999999999999999999657999999987789999999


Q ss_pred             EEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      ||+.|+|||+|++|+|+|++.+. ++  .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus       330 hka~ieVnE~GteAaAaT~~~~~~~s~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  389 (389)
T 4ga7_A          330 HKSFVEVNEEGTEAAAATAGIATFCMDDPEENFTADHPFLFFIRHNSSGSILFLGRFSSP  389 (389)
T ss_dssp             EEEEEEECSCBC----------CCCSSSCEEEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             EEEEEEecCCCcccccccccccccccCCCCCcEEccCCEEEEEEECCCCcEEEEEEecCC
Confidence            99999999999999999987765 44  34689999999999999999999999999998

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B

Probab=100.00  E-value=1.3e-64  Score=497.61  Aligned_cols=307  Identities=18%  Similarity=0.261  Sum_probs=266.7

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc--h-------hhHHhhc-
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT--G-------RSLSNKL-   79 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~--~-------~~ll~~l-   79 (357)
                      ..+.+++++||++||+++++. ++++|+||||+||+.+|+|+++||+|+|++||.++||++.  .       +++++.+ 
T Consensus         7 ~~l~~~~~~Fa~~L~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~   85 (392)
T 4au2_A            7 ATLAERSAGLAFSLYQAMAKD-QAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLS   85 (392)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC-TTCCSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTSCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhhc-CCCCeEEECHHHHHHHHHHHHhhcCcHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHh
Confidence            568999999999999999987 7889999999999999999999999999999999999976  1       4455555 


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                         . ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  ++++|+
T Consensus        86 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~l~~~--~~~~t~  163 (392)
T 4au2_A           86 NSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQSINEWAAQTTDGKLPEVTKD--VERTDG  163 (392)
T ss_dssp             C-----CCCEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTSHHHHHHHHHHHHHHHTTTSSCCSCSC--CCCSSS
T ss_pred             cCCCCCceEEEEEEEEeecCCchhHHHHHHHHHhhCCeeEEecCCChHHHHHHHHHHHHHhcCCCccchhcc--cCCcch
Confidence               2 4566666   6665                     6888   334   99999   9999 999975  999999


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCC
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPD  176 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~  176 (357)
                      ++|+||       +.||++..|.+++||..              . +|.++++++|++|+  |+++.++|+|+|| +..+
T Consensus       164 lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~illP~~~~~  243 (392)
T 4au2_A          164 ALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHKLSSLIILMPHHVEP  243 (392)
T ss_dssp             EEEEEEEEECCCBSSCCCTTSEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSSCC
T ss_pred             hhheehhheeccccCCCCccccccCceecCCCceeEEeeeeecceeeEEeeccCceeEEEeecCCCcEEEEEEeCCCCCc
Confidence            999999       89999999999999987              2 67778899999999  9999999999999 8899


Q ss_pred             hhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEE
Q psy5102         177 LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDI  256 (357)
Q Consensus       177 L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~i  256 (357)
                      +..+++.|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+.+.||||+|+++++++|++|+||+.|
T Consensus       244 l~~le~~l~~~~l~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~hka~i  323 (392)
T 4au2_A          244 LERLEKLLTKEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATAF  323 (392)
T ss_dssp             THHHHHHCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCTTTCTTTCCCHHHHSSSCCCEEEEEEEEEE
T ss_pred             HHHHHHHhhHHHHHHHHhcccceEEEEEecceEEEEEechHHHHHhcCCcccCCCCCCccccCCCCCCeEEEeeEEEEEE
Confidence            99999999999999999999999999999999999999999999999999999976799999998889999999999999


Q ss_pred             EEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCCCCcccccc
Q psy5102         257 EVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRPYHENER  319 (357)
Q Consensus       257 ev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~~~~~~~~~  319 (357)
                      +|||+|++|+|+|........|..|++||||+|+|+|+.||.|||+|+|.+|..-+.+|+..-
T Consensus       324 eVnE~GteAaaat~~~~~~~~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~~k~~d~l~~  386 (392)
T 4au2_A          324 EWDTEGNPFDQDIYGREELRSPKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKGDKMRDELLE  386 (392)
T ss_dssp             EECSCBCSCC--------CCSCEEEECCSCEEEEEEETTTCCEEEEEEESCCSSCBC------
T ss_pred             EECCCcccchhhheecccCCCCCEEEeeCCEEEEEEECCCCcEEEEEEEeCCCCCccHHHHHh
Confidence            999999999998876544335778999999999999999999999999999998888887653

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-64  Score=496.18  Aligned_cols=302  Identities=25%  Similarity=0.425  Sum_probs=263.8

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h-----hhHHhhc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G-----RSLSNKL   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~-----~~ll~~l   79 (357)
                      +..+.+++++||++||+++.+. .+++|+||||+||+.+|+|+++||+|+|++||.++||++.    +     +.++..+
T Consensus        16 ~~~l~~~~~~Fa~~L~~~l~~~-~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l   94 (407)
T 3f5n_A           16 ATFPEEAIADLSVNMYNRLRAT-GEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNMV   94 (407)
T ss_dssp             ---CTHHHHHHHHHHHHHHHHT-TTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHCCC----CCCHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHHHHHHhh-CCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Confidence            3467889999999999999876 6789999999999999999999999999999999999975    1     4556655


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                         + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++++++++|+
T Consensus        95 ~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~  174 (407)
T 3f5n_A           95 TAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYINKWVENNTNNLVKDLVSPRDFDAATY  174 (407)
T ss_dssp             TC-CCSCEEEEEEEEEEETTCCBCTTHHHHHHHTSCCEEEEECTTSHHHHHHHHHHHHHHTTTTCSCCCCCGGGCCTTCC
T ss_pred             hccCCCcEEEEEEEEEEeCCCccCHHHHHHHHHhhcCceEEcCCCChHHHHHHHHHHHHHhhCCchhhcCCcccCCCCce
Confidence               2 5677776   6665                     6788   333   99999   9999 99999888999999


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCC------eEEEe--ecCCeEEEEEEe
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAY------ASFLE--KMRNEVYMYFIL  171 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~------~~vve--y~~~~~sm~iiL  171 (357)
                      ++|+||       +.||++..|.+++||..              . +|+++++++      |+||+  |.+++++|+|||
T Consensus       175 lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~~~~~~~vleLPY~~~~~sm~iiL  254 (407)
T 3f5n_A          175 LALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVL  254 (407)
T ss_dssp             EEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECC-----CEEEEEEEEBTTSSEEEEEEE
T ss_pred             EEEEEeeeeecccccCCCccCceeeeEEcCCCeEEEEeEEEEeeeeeeEEccccccccCcceEEEEEECCCCcEEEEEEE
Confidence            999999       89999999999999976              2 566777877      99999  999999999999


Q ss_pred             c-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeee
Q psy5102         172 P-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV  250 (357)
Q Consensus       172 P-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v  250 (357)
                      | +..+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .||||+|+++.+++|++|
T Consensus       255 P~~~~~L~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v  333 (407)
T 3f5n_A          255 SRQEVPLATLEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLSDNKEIFLSKA  333 (407)
T ss_dssp             CCTTCCGGGTGGGCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTBSCTTCCCCEE
T ss_pred             CCCCCCHHHHHHHhCHHHHHHHHHhCcceEEEEECCCEEEeeecChHHHHHhCCchhhcCC-CCCcccccCCCCceeeeE
Confidence            9 88899999999999999999999999999999999999999999999999999999996 799999998779999999


Q ss_pred             eEEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCCC
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQR  312 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~~  312 (357)
                      +||+.|+|||+|++|+|+|++.+. ++  .+.+|++||||+|+|+|+.|+.|||+|+|.+|+..+
T Consensus       334 ~hka~ieVnE~GteAAAaT~~~~~~~~~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~~~  398 (407)
T 3f5n_A          334 IHKSFLEVNEEGSEAAAVSGMIAISRMAVLYPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMN  398 (407)
T ss_dssp             EEEEEEEECSCBCCCCC-----CCSSSEEEECEEECCSCEEEEEEETTTCCEEEEEEESCCCCC-
T ss_pred             EEEEEEEecCCccccccccceeeccccCCCCCcEEecCCEEEEEEECCCCcEEEEEEeCCcCCCC
Confidence            999999999999999999987665 33  335899999999999999999999999999998643

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B

Probab=100.00  E-value=2.6e-63  Score=491.71  Aligned_cols=297  Identities=21%  Similarity=0.367  Sum_probs=266.9

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSN   77 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~   77 (357)
                      ...+..++++||++||+++.+. .+++|++|||+||+.+|+|+++||+|+|++||.++||++.      +     +.|++
T Consensus        53 ~~~l~~~~~~Fa~~L~~~l~~~-~~~~Ni~~SP~SI~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~i~~~f~~ll~  131 (424)
T 3ne4_A           53 FNKITPNLAEFAFSLYRQLAHQ-SNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLR  131 (424)
T ss_dssp             -CTTHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHhh-CCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            3578899999999999999877 6789999999999999999999999999999999999974      1     45555


Q ss_pred             hc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          78 KL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        78 ~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      .+   + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ +++++  +++++
T Consensus       132 ~l~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~gkI~~ll~--~l~~~  209 (424)
T 3ne4_A          132 TLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVK--ELDRD  209 (424)
T ss_dssp             HHTCSSCSSCCEEEEEEEEETTSCBCHHHHHHHHTTTCCEEEEECTTSHHHHHHHHHHHHHHHTTTSSCSCCC--CCCTT
T ss_pred             HhcCCCCCcEEEEEEEEEEcCCCCcCHHHHHHHHHhhcceEEEecCCChHHHHHHHHHHHHHhhCCCcccccc--CCCCc
Confidence            55   2 5666666   7665                     6788   334   99999   9999 99998  49999


Q ss_pred             ceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCCC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKNP  175 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~~  175 (357)
                      |+++|+||       +.||++..|.+++||..              . +|+++++++|+||+  |.++ ++|+||||+..
T Consensus       210 t~lvLvNaiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~-~sm~iiLP~~~  288 (424)
T 3ne4_A          210 TVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGN-ATAIFFLPDEG  288 (424)
T ss_dssp             CCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-EEEEEEEECTT
T ss_pred             chhhhhhHHhhehhhhcCCCcccceeEeeeccCCcEEEEEEEEeecceeEEEecCCCeEEEEEecCCC-eEEEEEEcCcC
Confidence            99999999       89999999999999976              2 67778899999999  8876 89999999337


Q ss_pred             ChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEE
Q psy5102         176 DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVD  255 (357)
Q Consensus       176 ~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~  255 (357)
                      +|.++++.|+.+.+.+|.+.++.+.|+|.||||++++++||+++|++|||+++|+. .||||+|+++.+++|++|+||+.
T Consensus       289 ~l~~le~~L~~~~l~~~~~~l~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~Vs~v~hka~  367 (424)
T 3ne4_A          289 KLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAVHKAV  367 (424)
T ss_dssp             CHHHHHHHCCHHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTBSSSCCCCCEEEEEEE
T ss_pred             CHHHHHHHhCHHHHHHHHHhCccceEEEEcCCEEEEeecchhhhhhhCChhhhcCC-CCCcccccCCCCcceeeEEEEEE
Confidence            89999999999999999999999999999999999999999999999999999998 79999999877999999999999


Q ss_pred             EEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         256 IEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       256 iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |+|||+|++|+|+|++.+. ++.+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus       368 ieVnE~GteAAAaT~~~~~~~s~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~  423 (424)
T 3ne4_A          368 LTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ  423 (424)
T ss_dssp             EEECSSSSSSCCCCCCCCCCSSCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred             EEEcCCCcccccccceeeeecCCCCceeccCCEEEEEEECCCCeEEEEEEecCCCC
Confidence            9999999999999988765 556778999999999999999999999999999973

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C

Probab=100.00  E-value=1.5e-63  Score=488.07  Aligned_cols=298  Identities=26%  Similarity=0.430  Sum_probs=254.6

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch------hhHHhhc---c
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG------RSLSNKL---T   80 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~------~~ll~~l---~   80 (357)
                      ..+.+++++||++||+++.+. ++++|+||||+||+.+|+|++.||+|+|++||.++||++..      +.+.+.+   .
T Consensus         6 ~~l~~~~~~f~~~L~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~l~~~l~~~~   84 (379)
T 4dy0_A            6 LSLEELGSNTGIQVFNQIVKS-RPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVNGVGKILKKINKAIVSKK   84 (379)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTSCSTTTHHHHHHHHHHHHCGG
T ss_pred             cCHHHHhhHHHHHHHHHHHhh-CcCCcEEECHHHHHHHHHHHHHHcChHHHHHHHHHhCCChhHHHHHHHHHHHHHhccC
Confidence            568899999999999999987 78999999999999999999999999999999999999762      3444444   2


Q ss_pred             -cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc-ceeEe
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA-LALVL  124 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~-t~lvL  124 (357)
                       +..+.++   |+++                     .+||   ++|   ||+||   |+|+ ++++++++++++ |+++|
T Consensus        85 ~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~g~I~~ll~~~~~~~~~T~lvL  164 (379)
T 4dy0_A           85 NKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFEDPASACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVL  164 (379)
T ss_dssp             GSSCCEEEEEEEESCTTSSCHHHHHHHHHHHCEEEEECCTTSHHHHHHHHHHHHHHHTTTCCCCCCCGGGCCTTTCCEEE
T ss_pred             CCceeeeeeeeeeEccccccchhhhhhhhcCCcEEEEeccCChHHHHHHHHHHHHHhcCCcccccCCcccCCcccceEEE
Confidence             4556655   6665                     6899   334   99999   9999 999998888764 99999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec------------c---cc---cccCCCCeEEEe--ecCCeEEEEEEec-C-CC
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG------------R---SL---SNNPEAYASFLE--KMRNEVYMYFILP-K-NP  175 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~------------~---~~---~~~~~~~~~vve--y~~~~~sm~iiLP-~-~~  175 (357)
                      +||       +.||++..|.+++||..            .   +|   .+.++++|++|+  |++++++|+|||| + ..
T Consensus       165 vNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~l~~~vl~LPy~~~~~sm~iiLP~~~~~  244 (379)
T 4dy0_A          165 VNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALPTESST  244 (379)
T ss_dssp             EEEEEECCCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESSTTS
T ss_pred             EEEEEEEeeecCCCchhhCeeeeEEeCCCceEEeeeeEeeeeecccccccccccceEEEEeccCCCceEEEEEecCcccc
Confidence            999       89999999999999977            1   22   234578899999  9999999999999 4 45


Q ss_pred             ChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC-CCceeeeeeEEE
Q psy5102         176 DLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD-RGVAVDQVFHKV  254 (357)
Q Consensus       176 ~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~~l~vs~v~qk~  254 (357)
                      +|..+++.|+.+.+..|.+.++.+.|+|.||||++++++||+++|++||++++|+.+.|||++|++. ++++|++|+||+
T Consensus       245 ~l~~~~~~l~~~~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~~l~vs~v~hka  324 (379)
T 4dy0_A          245 PLSAIIPHISTKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTGSENLHVSHILQKA  324 (379)
T ss_dssp             CGGGTSTTCCHHHHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTTCCCTTTCC---CCCCCEEEEEE
T ss_pred             chhHhhhhcCHHHHHHHHHhccceEEEEeccceEEEEEeechHhHHhCCchhhcCCCCCCcccccCCCCCeEeeeeEEEE
Confidence            7999999999999999999999999999999999999999999999999999997767999999863 589999999999


Q ss_pred             EEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      .|+|||+|++|+|+|++.+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       325 ~ieVnE~GteAaAaT~~~~~~~s~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P  379 (379)
T 4dy0_A          325 KIEVSEDGTKASAATTAILIARSSPPWFIVDRPFLFFIRHNPTGAVLFMGQINKP  379 (379)
T ss_dssp             EEEECSCBC------------CCCCCEEECCSCEEEEEEETTTTEEEEEEEESCC
T ss_pred             EEEECCCceeecccceeeeccCCCCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence            99999999999999988776 6678899999999999999999999999999999

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A

Probab=100.00  E-value=1.2e-63  Score=489.87  Aligned_cols=296  Identities=21%  Similarity=0.393  Sum_probs=267.2

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----------------h--
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----------------G--   72 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----------------~--   72 (357)
                      .+..++++||++||+++.+. ++++|+|+||+||+.+|+|++.||+|+|++||.++||++.                +  
T Consensus         2 ~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~   80 (385)
T 1uhg_A            2 SIGAASMEFCFDVFKELKVH-HANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVH   80 (385)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTT
T ss_pred             chhhHHHHHHHHHHHHHHhc-CCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCcccccccccccccchHHHHH
Confidence            36789999999999999876 6789999999999999999999999999999999999853                2  


Q ss_pred             ---hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-ccc
Q psy5102          73 ---RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVV  110 (357)
Q Consensus        73 ---~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~  110 (357)
                         +.+++.+   + ++.++++   |+++                     .+||    +.|   ||+||   |+|+ +++
T Consensus        81 ~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~gkI~~l  160 (385)
T 1uhg_A           81 SSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNV  160 (385)
T ss_dssp             HHHHHHHHHHTSCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSCCC
T ss_pred             HHHHHHHHHHhCCCCCcEEEEEEEeeccCCCCccHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhh
Confidence               3344555   2 4567666   6665                     6788    333   99999   9999 999


Q ss_pred             CCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEE
Q psy5102         111 FAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVY  166 (357)
Q Consensus       111 l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~s  166 (357)
                      +++++++++|+++|+||       +.||++..|.+++||..              . +|++.++++|+||+  |+++++|
T Consensus       161 ~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~s  240 (385)
T 1uhg_A          161 LQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMS  240 (385)
T ss_dssp             SCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEE
T ss_pred             CCcccCCCccceEeeeeeEEeeeecCCCCcCCCcCcEEEECCCeEEEEEEEEeeceEEEEEeCCCCeEEEEeccCCCcEE
Confidence            99999999999999999       89999999999999976              2 66778899999999  9999999


Q ss_pred             EEEEec-CCCChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCC
Q psy5102         167 MYFILP-KNPDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR  243 (357)
Q Consensus       167 m~iiLP-~~~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~  243 (357)
                      |+|||| +..+|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.
T Consensus       241 m~iiLP~~~~~l~~l~~~L~~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~  319 (385)
T 1uhg_A          241 MLVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SANLSGISSAE  319 (385)
T ss_dssp             EEEEEESSTTCHHHHHHHCCHHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTBCST
T ss_pred             EEEEeCCCCCCHHHHHHHhChhHHHHHhhhhcccceEEEEEccceeecceecHHHHHHHcChhhhhcC-ccccccccCCC
Confidence            999999 8889999999999999999987  6888999999999999999999999999999999995 79999999877


Q ss_pred             CceeeeeeEEEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         244 GVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       244 ~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +++|++|+||+.|+|||+|++|+|+|++.+. ++.|.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       320 ~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  385 (385)
T 1uhg_A          320 SLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVSEEFRADHPFLFCIKHIATNAVLFFGRCVSP  385 (385)
T ss_dssp             TCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTCCCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred             CeEEEEEEEEEEEEecCCCcccccccchheeccCCCCEEEeeCCEEEEEEECCCCcEEEEEEcCCC
Confidence            8999999999999999999999999987665 5567899999999999999999999999999998

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B

Probab=100.00  E-value=4.9e-63  Score=484.52  Aligned_cols=299  Identities=26%  Similarity=0.454  Sum_probs=267.9

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch--------hhHHhhc-
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG--------RSLSNKL-   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~--------~~ll~~l-   79 (357)
                      +..+..++++||++||+++.+. .+++|+|+||+||+.+|+|++.||+|+|++||.++||++..        +++++.+ 
T Consensus         5 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~l~   83 (379)
T 1lj5_A            5 PSYVAHLASDFGVRVFQQVAQA-SKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELM   83 (379)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH-STTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhc-CCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHHHh
Confidence            4578899999999999999844 47899999999999999999999999999999999999751        4555555 


Q ss_pred             --c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcccee
Q psy5102          80 --T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALAL  122 (357)
Q Consensus        80 --~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~l  122 (357)
                        + +..++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++++++++|++
T Consensus        84 ~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~Wv~~~T~g~I~~l~~~~~l~~~t~l  163 (379)
T 1lj5_A           84 GPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRL  163 (379)
T ss_dssp             CGGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTSHHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCCE
T ss_pred             CCCCCcEEEEEEeeeeeCCcchhHHHHHHHHHHhCCEEEEECCCChHHHHHHHHHHHHhhcCCccccccCcccCCCccce
Confidence              2 5667776   6665                     6788   333   99999   9999 999999999999999


Q ss_pred             Eeecc-------cCCCCCCCceeeeeeec--------------c-ccc--ccCC-CCeEEEe--ecCCeEEEEEEec--C
Q psy5102         123 VLLGS-------DGQTKDELTHFMGVATG--------------R-SLS--NNPE-AYASFLE--KMRNEVYMYFILP--K  173 (357)
Q Consensus       123 vLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~--~~~~-~~~~vve--y~~~~~sm~iiLP--~  173 (357)
                      +|+||       +.||++..|.+++||..              . +|+  +.++ ++|++++  |++++++|+||||  +
T Consensus       164 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~gl~~~vleLPy~~~~~sm~iiLP~~~  243 (379)
T 1lj5_A          164 VLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEK  243 (379)
T ss_dssp             EEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESST
T ss_pred             eeeeeeeecccccCCCCcccccceeEEeCCCeEEEEeEEeeEeeeceeeeEcCCCCceEEEEEecCCCcEEEEEEEecCC
Confidence            99999       89999999999999976              1 443  5567 8999999  9999999999999  4


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEE
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK  253 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk  253 (357)
                      ..+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|++..|||++|+++.+++|++|+||
T Consensus       244 ~~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~hk  323 (379)
T 1lj5_A          244 EVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQK  323 (379)
T ss_dssp             TSCTHHHHTTCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCEEEEEEE
T ss_pred             CCCHHHHHHHhCHHHHHHHHHhCcceEEEEEeeEEEEeeeechHHHHHhcCCccCCCCCCCCccccCCCCCeEEeeeeEE
Confidence            57899999999999999999999999999999999999999999999999999999974599999998778999999999


Q ss_pred             EEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         254 VDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       254 ~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +.|+|||+|++|+|+|++.+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       324 a~ieV~E~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  379 (379)
T 1lj5_A          324 VKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP  379 (379)
T ss_dssp             EEEEECSSEEEEEEEEEEEESSCCCCCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred             eEEEecCCCcCcccccceeecccCCCCEEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence            999999999999999987665 5567789999999999999999999999999998

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus}

Probab=100.00  E-value=3.4e-63  Score=485.09  Aligned_cols=297  Identities=27%  Similarity=0.437  Sum_probs=267.7

Q ss_pred             hccchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-----h------hh
Q psy5102           6 MRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-----G------RS   74 (357)
Q Consensus         6 ~~~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-----~------~~   74 (357)
                      |+-+..+.+++++||++||+++... . ++|+|+||+||+.+|+|+++||+|+|++||.++||++.     +      +.
T Consensus         1 ~~~~~~l~~~~~~Fa~~l~~~l~~~-~-~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~   78 (377)
T 3nda_A            1 MQEEAKLTKANNRFGLRLLRALPSG-P-EKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAGVLDAYTH   78 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHSCCB-T-TBCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTTGGGTCCHHHHHHHHHH
T ss_pred             CchHHHHHHHHHHHHHHHHHHHhhc-C-CCCEEEecHHHHHHHHHHHhhccchhHHHHHHHhCCCCcCCCHHHHHHHHHH
Confidence            3446789999999999999999876 4 89999999999999999999999999999999999974     1      34


Q ss_pred             HHhhc---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCC
Q psy5102          75 LSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLS  115 (357)
Q Consensus        75 ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~  115 (357)
                      +++.+   + ++.++++   |+++                     .+||    +.|   ||+||   |+|+ ++++ +++
T Consensus        79 l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~ll-~~~  157 (377)
T 3nda_A           79 HTERLKSTPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLF-NEP  157 (377)
T ss_dssp             HHHHHHHCCCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSCCCSC-SSC
T ss_pred             HHHHhcCCCCCcEEEEEeEEEEeCCCCchHHHHHHHHHhccCceEEecCCCCHHHHHHHHHHHHHHHhcCchhhhc-CCC
Confidence            45555   2 5677776   7665                     6788    234   99999   9999 9999 778


Q ss_pred             CCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEe
Q psy5102         116 IVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFIL  171 (357)
Q Consensus       116 l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiL  171 (357)
                      ++++|+++|+||       +.||++..|.+++||..              . +|+++++++|++|+  |.+++++|+|||
T Consensus       158 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~~~sm~iiL  237 (377)
T 3nda_A          158 LDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGLDYTMAILL  237 (377)
T ss_dssp             CCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEETTTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEE
T ss_pred             CCCCceEEEEehheeccccccCCCCccccccceecCCCeEEEEeeEeeECeEEEEEEcCCCeEEEEEecCCCcEEEEEEE
Confidence            999999999999       89999999999999976              2 67778889999999  999899999999


Q ss_pred             c-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeee
Q psy5102         172 P-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV  250 (357)
Q Consensus       172 P-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v  250 (357)
                      | +..+|.+++++|+.+.+.+|.++++.+.|+|.||||++++++||+++|++||++++|++ .||||+|++ .+++|++|
T Consensus       238 P~~~~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~-~~l~vs~v  315 (377)
T 3nda_A          238 PKENTGVEGLKQNLTIDRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQSLGIKQIFES-GADLSGIND-GSLRVSAV  315 (377)
T ss_dssp             ESSTTCHHHHHHHCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHS-SCEEEEEE
T ss_pred             cCCCCCHHHHHHHhCHHHHHHHHHhCCeEEEEEEecceEeEeecCHHHHHHhCCchhhcCC-CCCCcccCC-CCceEeEE
Confidence            9 89999999999999999999999999999999999999999999999999999999998 799999998 69999999


Q ss_pred             eEEEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcC
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYK  307 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~  307 (357)
                      +||+.|+|||+|++|+|+|++.+. ++   .+.+|++||||+|+|+|+.||.|||+|+|.+
T Consensus       316 ~hka~ieV~E~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~  376 (377)
T 3nda_A          316 EHKAVVEVNEEGTVAAATTGVVIVPYSLGPEPVVFRVDHPFLFFIRNTRTDDIFFVGQVNK  376 (377)
T ss_dssp             EEEEEEEECSSEEEEEEEEEEEEEEC---CCCCEEECCSCEEEEEEETTTCCEEEEEEECC
T ss_pred             EEEEEEEECCCCccccccceeeeecccCCCCCCeEEeeCCEEEEEEECCCCcEEEEEEEec
Confidence            999999999999999999988766 44   3578999999999999999999999999986

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A*

Probab=100.00  E-value=8.1e-63  Score=483.83  Aligned_cols=296  Identities=22%  Similarity=0.335  Sum_probs=266.6

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHH
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLS   76 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll   76 (357)
                      ....+..++++||++||+++.+. .++ |+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.++
T Consensus        12 ~~~~l~~~~~~Fa~~l~~~l~~~-~~~-Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~   89 (385)
T 3f1s_A           12 SRQQLAKETSNFGFSLLRKISMR-HDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGL   89 (385)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHH-CCS-CEEECHHHHHHHHHHHTTTCCTHHHHHHHHHTTCTTCCCSSTTHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHhhC-CCC-cEEEchHHHHHHHHHHHHhcchHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            45678899999999999999876 566 999999999999999999999999999999999974      1     4455


Q ss_pred             hhc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          77 NKL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        77 ~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +.+   + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ ++++  +++++
T Consensus        90 ~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~l~--~~l~~  167 (385)
T 3f1s_A           90 RETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYINKETRGKIPKLF--DEINP  167 (385)
T ss_dssp             HHHHHHCSSSCEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECCSSHHHHHHHHHHHHHHHTTTSSSCCC--SCCCT
T ss_pred             HHhhcCCCCcEEEEEEEEEEECCCchhHHHHHHHHHHhCCeeEEeCCCChHHHHHHHHHHHHHHhcCchhhHh--hccCC
Confidence            555   2 5667766   6665                     6788   333   99999   9999 9999  45999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~  173 (357)
                      +|+++|+||       +.||++..|.+++||..              . +|+++++++|++|+  | +++++|+|||| +
T Consensus       168 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy-~~~~sm~iiLP~~  246 (385)
T 3f1s_A          168 ETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPY-QGNATMLVVLMEK  246 (385)
T ss_dssp             TCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEE-TTTEEEEEEEECT
T ss_pred             CCeEEEEEhhhccchhcCCCCccCccceEEEECCCEEEEEEEEeccCcccEEEeCCCCeEEEEecC-CCcEEEEEEeCCC
Confidence            999999999       89999999999999976              2 67778899999999  9 88899999999 8


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCC-CCCceeeeeeE
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLD-DRGVAVDQVFH  252 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~-~~~l~vs~v~q  252 (357)
                      ..+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|++ +.+++|++|+|
T Consensus       247 ~~~L~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~~l~vs~v~h  325 (385)
T 3f1s_A          247 MGDHLALEDYLTTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSATGRNLQVSRVLQ  325 (385)
T ss_dssp             TSCHHHHGGGCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBCCCSCCCCCEEEE
T ss_pred             CCCHHHHHHHhhHHHHHHHHHhccceeeEEeeeEEEEEeeecHHHHHHhcCccccccC-CCCcccccCCCCCeEEEEEEE
Confidence            8999999999999999999999999999999999999999999999999999999996 799999998 66899999999


Q ss_pred             EEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         253 KVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |+.|+|||+|++|+|+|++.+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       326 ka~ieV~E~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  383 (385)
T 3f1s_A          326 RTVIEVDERGTEAVAGILSEITAYSMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNPT  383 (385)
T ss_dssp             EEEEEECSCBCCCCCCCCCCCCSSCCCCEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred             eeEEEecCCcceeccccccccccCCCCCEEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence            9999999999999999987665 44678999999999999999999999999999996

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A

Probab=100.00  E-value=4.1e-63  Score=485.61  Aligned_cols=296  Identities=28%  Similarity=0.471  Sum_probs=252.8

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHhhc
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSNKL   79 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~~l   79 (357)
                      .+..++++||++||+++.+. ++++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.+++.+
T Consensus         3 ~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l   81 (382)
T 2arr_A            3 DLCVANTLFALNLFKHLAKA-SPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAADKIHSSFRSLSSAI   81 (382)
T ss_dssp             CTTHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTTTTC-----CHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHhhc-CCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCccccHHHHHHHHHHHHHHH
Confidence            57789999999999999876 6789999999999999999999999999999999999964      1     4455555


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccc
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGAL  120 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t  120 (357)
                         + ++.++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++++|
T Consensus        82 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t  161 (382)
T 2arr_A           82 NASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDT  161 (382)
T ss_dssp             HCCCSSEEEEEEEEEEEETTCCCCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCCSCTTSSCTTE
T ss_pred             hCCCCCcEEEeeeehHHhCCCCccHHHHHHHHHHhCCEEEEecCcCcHHHHHHHHHHHHHHHhcCchhhhCCCcCCCCcc
Confidence               2 4567666   6665                     6799    233   99999   9999 9999999999999


Q ss_pred             eeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC-
Q psy5102         121 ALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN-  174 (357)
Q Consensus       121 ~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~-  174 (357)
                      +++|+||       +.||++..|.+++||..              . +|++.++++|++++  |++ ++||+|||| +. 
T Consensus       162 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~-~~sm~iiLP~~~~  240 (382)
T 2arr_A          162 RMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAG-DVSMFLLLPDEIA  240 (382)
T ss_dssp             EEEEEEEEEEEECBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEEGGGTEEEEEEEBSS-SEEEEEEEEC--C
T ss_pred             eEEEEEeeEecccccCCCChhhcccceEecCCCceeeeeEEeccCcEeEEEECCCCeEEEEecCCC-cEEEEEEecCCCc
Confidence            9999999       89999999999999976              2 66778899999999  999 899999999 77 


Q ss_pred             ---CChhHHhhccChhHHHHHHHh--cCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeee
Q psy5102         175 ---PDLSEFTKDLDYDKFSRIIES--TNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQ  249 (357)
Q Consensus       175 ---~~L~~l~~~L~~~~l~~~~~~--l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~  249 (357)
                         .+|.+++++|+.+.+..|.+.  ++.+.|+|.||||++++++||+++|++||++++|+++.|||++|+++.+++|++
T Consensus       241 ~~~~~l~~l~~~L~~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~  320 (382)
T 2arr_A          241 DVSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSE  320 (382)
T ss_dssp             CSSSSCHHHHHHCCHHHHHHHHCC--CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCTTTCTTCCEEEEE
T ss_pred             cccccHHHHHHHhCHHHHHHHhhhccccceEEEEECcCEEeeccccHHHHHHhcCccccCCCCCCChhhcCCCCCeEEEE
Confidence               899999999999999999864  788999999999999999999999999999999986469999999877899999


Q ss_pred             eeEEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         250 VFHKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       250 v~qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |+||+.|+|||+|++|+|+|++.+. ++  .+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       321 v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  382 (382)
T 2arr_A          321 VFHQAMVDVNEEGTEAAAGTGGVMTGRTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP  382 (382)
T ss_dssp             EEEEEEEEECCCBC----------CCCCCCCSCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             EEEeeeeeecCCCcccccccchhhccccCCCCCeEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence            9999999999999999999987765 44  34789999999999999999999999999998

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A*

Probab=100.00  E-value=1.4e-62  Score=480.45  Aligned_cols=295  Identities=22%  Similarity=0.343  Sum_probs=262.8

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSN   77 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~   77 (357)
                      ...+..++++||++||+++... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.+++
T Consensus         4 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~   82 (373)
T 2vdx_A            4 HRGLASANVDFAFSLYKHLVAL-SPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQ   82 (373)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHhc-CCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            4568899999999999999876 6789999999999999999999999999999999999963      1     34555


Q ss_pred             hc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          78 KL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        78 ~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      .+   + +..++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  ++++
T Consensus        83 ~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~l~~~--l~~~  160 (373)
T 2vdx_A           83 LFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSG--LDSP  160 (373)
T ss_dssp             HHHSCCSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHHHHHHHTTTCSCCSSCC---CCC
T ss_pred             HhhccCCcccceeEEEEEEECCCChHHHHHHHHHHHhCCeeEeecCcchHHHHHHHHHHHHHHhcCchhhhccC--CCCC
Confidence            55   2 4667766   6665                     6788   333   99999   9999 999975  9999


Q ss_pred             ceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN  174 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~  174 (357)
                      |+++|+||       +.||++..|.+++||..              . +|+++++++|++|+  |+++ .+|+|||| ++
T Consensus       161 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-~sm~iiLP~~~  239 (373)
T 2vdx_A          161 AILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGN-GTVFFILPDKG  239 (373)
T ss_dssp             CSEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEECSSSSEEEEEEEBSSS-EEEEEEEECTT
T ss_pred             CeEEEEEHHhhhhhhhCcCCccccccceEEeCCCcEEEEEEEEeeeeEeeEEeCCCCeEEEEEecCCC-eEEEEEecCCC
Confidence            99999999       89999999999999975              2 67778899999999  8886 79999999 65


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV  254 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~  254 (357)
                       +|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+||+
T Consensus       240 -~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v~hka  317 (373)
T 2vdx_A          240 -KMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTT-QANFSRITQDAQLKSSKVVHKA  317 (373)
T ss_dssp             -CHHHHHHTCSHHHHHHHHHHCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSCCEEEEEEEEEE
T ss_pred             -CHHHHHHHhCHHHHHHHHHhhhceeeEEeeeEEEeecccchHHHHHhcCchhhccC-CCCcccccCCCCeEEeeeeeee
Confidence             89999999999999999999999999999999999999999999999999999996 7999999987789999999999


Q ss_pred             EEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      .|+|||+|++|+|+|++.+. ++.|.+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       318 ~ieVnE~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  373 (373)
T 2vdx_A          318 VLQLNEEGTEAAGAMFLEAIPRSKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV  373 (373)
T ss_dssp             EEEECSSEEEEEEEEEEEEEEC-CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred             eEEecCCcccccccccccccccCCCceEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence            99999999999999988766 55678999999999999999999999999999994

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A

Probab=100.00  E-value=5.4e-63  Score=489.49  Aligned_cols=300  Identities=25%  Similarity=0.439  Sum_probs=262.4

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----------------
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----------------   71 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----------------   71 (357)
                      .+..+..++++||++||+++.+. ++++|+||||+||+.+|+|++.||+|+|++||.++||++.                
T Consensus         5 ~~~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~   83 (415)
T 2h4r_A            5 SMEQVSASIGNFTVDLFNKLNET-NRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGR   83 (415)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTT-CSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSCCC---------------
T ss_pred             hHHHHHHHHHHHHHHHHHHHhcc-CCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCccccccccccccccccc
Confidence            45678899999999999999876 6789999999999999999999999999999999999963                


Q ss_pred             -------------h------hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH--
Q psy5102          72 -------------G------RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA--   98 (357)
Q Consensus        72 -------------~------~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a--   98 (357)
                                   +      +.++..+   + ++.++++   |+++                     .+||    +.|  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~  163 (415)
T 2h4r_A           84 PKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRK  163 (415)
T ss_dssp             ------------CHHHHHHHHHHHHHHTCSSCSSEEEEEEEEEEETTSCBCHHHHHHHHHHHSCCCEEECTTTCHHHHHH
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHhCCCCCcEEEEEEeehhhCCCCcCHHHHHHHHHHhCCeEEEecCCCCHHHHHH
Confidence                         1      2344444   2 5667776   7665                     6788    333  


Q ss_pred             -HHHHH---hCCC-cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccC
Q psy5102          99 -IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNP  151 (357)
Q Consensus        99 -IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~  151 (357)
                       ||+||   |+|+ ++++++++++++|+++|+||       +.||++..|.+++||..              . +|++.+
T Consensus       164 ~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~  243 (415)
T 2h4r_A          164 EINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIME  243 (415)
T ss_dssp             HHHHHHHHHTTTSCCCCSCGGGCCSSCCEEEEEEEEEECBBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEET
T ss_pred             HHHHHHHHHhcCchhhhcCccccCCcceEEEEEhheEeceecCCCCcccCeeeEEEecCCcEEEeeEEeecCcEeEEEeC
Confidence             99999   9999 99999888999999999999       89999999999999976              2 677889


Q ss_pred             CCCeEEEe--ecCCeEEEEEEec-CC----CChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhh
Q psy5102         152 EAYASFLE--KMRNEVYMYFILP-KN----PDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNT  222 (357)
Q Consensus       152 ~~~~~vve--y~~~~~sm~iiLP-~~----~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~  222 (357)
                      +++|+||+  |++++++|+|||| +.    .+|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++
T Consensus       244 ~l~~~vleLPY~~~~~sm~iiLP~~~~~~~~~L~~le~~L~~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~  323 (415)
T 2h4r_A          244 KMNFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDRIDLRDTLRN  323 (415)
T ss_dssp             TTTEEEEEEEBGGGSEEEEEEEESSCCSSSSSCHHHHTTCCHHHHHHHHTCTTCEEEEEEEEEECEEECCEEECHHHHHH
T ss_pred             CCCEEEEEeeCCCCcEEEEEEecCCCcccccCHHHHHHHhCHhHHHHHhhhhcccceeEEEECCeEEEeeeecHHHHHHH
Confidence            99999999  9998999999999 77    89999999999999999987  6888999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccccccceeee-ecC----CCEEEEcCceEEEEEECCCC
Q psy5102         223 MNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RIS----KPTVKINRPFIFFIYHKPTD  297 (357)
Q Consensus       223 lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s~----~~~f~~nrPFlf~I~d~~t~  297 (357)
                      ||++++|+. .|||++|+++.+++|++|+||+.|+|||+|++|+|+|++.+. ++.    +.+|++||||+|+|+|+.||
T Consensus       324 lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~  402 (415)
T 2h4r_A          324 MGMTTAFTT-NADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVIISFTTSVINHVLKFKVDHPFHFFIRHNKSK  402 (415)
T ss_dssp             TTCCGGGST-TCCCTTTBSSSCCCCCEEEEEEEEEECSSBSSCCC---------------CEEEECCSCEEEEEEETTTT
T ss_pred             cChhhhhcC-ccccccccCCCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCcEEEecCCEEEEEEECCCC
Confidence            999999996 799999998778999999999999999999999999987665 442    26899999999999999999


Q ss_pred             cEEEEEEEcCCC
Q psy5102         298 SIVFWGSIYKPE  309 (357)
Q Consensus       298 ~iLF~G~v~~P~  309 (357)
                      .|||+|+|.+|.
T Consensus       403 ~iLF~G~v~~P~  414 (415)
T 2h4r_A          403 TILFFGRFCCPV  414 (415)
T ss_dssp             EEEEEEEECSCC
T ss_pred             cEEEEEEeCCCC
Confidence            999999999996

>4ajt_A Protein Z-dependent protease inhibitor; blood clotting, ZPI; 2.50A {Mus musculus}

Probab=100.00  E-value=7.5e-63  Score=488.52  Aligned_cols=297  Identities=21%  Similarity=0.348  Sum_probs=259.8

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-------h-----hhH
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-------G-----RSL   75 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-------~-----~~l   75 (357)
                      +...+..++++||++||+++... .++ |+||||+||+.+|+|+++||+|+|++||.++||++.       +     +.|
T Consensus        54 ~~~~l~~~~~~Fa~~L~~~l~~~-~~~-Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~i~~~f~~l  131 (427)
T 4ajt_A           54 ASQQLSNETSSFGFNLLRKISMR-HDG-NVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQALSQAGPLILPALFKKV  131 (427)
T ss_dssp             HTHHHHHHHHHHHHHHHHHHHHH-CCS-CEEECHHHHHHHHHHHHHHCCTHHHHHHHHHHTCHHHHTSCTTHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhc-CCC-CEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCccccCCHHHHHHHHHHH
Confidence            34789999999999999999876 455 999999999999999999999999999999999972       1     345


Q ss_pred             Hhhc--c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          76 SNKL--T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        76 l~~l--~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      ++.+  + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++  +++++
T Consensus       132 ~~~l~~~~~~~L~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~  209 (427)
T 4ajt_A          132 KETFSSNRDLGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINFQNSSQARGLINHCIVKETEGKIPKLF--DEINP  209 (427)
T ss_dssp             HHHHHTCTTSCEEEEEEEEEETTSCCCHHHHHHHHHHSCCCEEEECTTSHHHHHHHHHHHHHHHTTTSSCSCC--SCCCT
T ss_pred             HHHhCCCCCceehhhhHHHHccCCchhHHHHHHHHHhhcceeEEcCCCChHHHHHHHHHHHHHhhCCcccccc--cCCCC
Confidence            5555  2 5667666   6665                     6788   333   99999   9999 9999  45999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~  173 (357)
                      +|+++|+||       +.||++..|..++||..              . +|+++++++|+||+  |.+ +++|+|||| +
T Consensus       210 ~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~~~~~~~l~~~vleLPY~~-~~sm~iiLP~~  288 (427)
T 4ajt_A          210 ETKLILVDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPMMYREGNFTSTFDKKFRCHILKLPYQG-NATMLVVLMEK  288 (427)
T ss_dssp             TCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEEGG-GEEEEEEEECT
T ss_pred             cceeEEeeeeeeeeeecCCCChhhccccceeccCCCEEEEEEEEecCceeEEEecCCceEEEEEEcCC-CeEEEEEecCC
Confidence            999999999       89999999999999976              2 56788899999999  998 899999999 7


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCC-CCCceeeeeeE
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLD-DRGVAVDQVFH  252 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~-~~~l~vs~v~q  252 (357)
                      ..+|.++++.|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .||||+|++ +.+++|++|+|
T Consensus       289 ~~~L~~le~~L~~~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~~l~Vs~v~h  367 (427)
T 4ajt_A          289 TGDYLALEDYLTVDLVETWLQNMKTRKMEVFFPKFKLNQRYEMHELLKQMGIRRLFST-SADLSELSAMARNLQVSRVLQ  367 (427)
T ss_dssp             TSCHHHHTTTCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSCSSCCCCEEEE
T ss_pred             CCCHHHHHHhcCHHHHHHHHHhCcceEEEEeccCEEEEeccChHHHHHHcCCchhhcC-CCCcccccCCCCCceEEEEEE
Confidence            6799999999999999999999999999999999999999999999999999999998 799999998 66899999999


Q ss_pred             EEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         253 KVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |+.|+|||+|++|+|+|++.+. ++.|..|++||||+|+|+|+.||.|||+|+|.+|..
T Consensus       368 ka~ieVnEeGteAAAaT~~~~~~~s~p~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~  426 (427)
T 4ajt_A          368 QSVLEVDERGTEAVSGTLSEIIAYSMPPAIKVNRPFHFIIYEEMSRMLLFLGRVVNPTV  426 (427)
T ss_dssp             EEEEEECSCBCC-------CCBCCSSCCEEECCSCEEEEEEETTTTEEEEEEEESSCC-
T ss_pred             EEEEEECCCcccccccceeeecccCCCCEEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            9999999999999999988766 556789999999999999999999999999999973

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium}

Probab=100.00  E-value=3e-63  Score=489.76  Aligned_cols=299  Identities=19%  Similarity=0.275  Sum_probs=252.3

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHc--CCCchhHHHHHHhhCCCc-----------h-----
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLL--GSDGQTKDELTHFMGVAT-----------G-----   72 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~--Ga~g~T~~eL~~~Lg~~~-----------~-----   72 (357)
                      .+..++++||++||+++... .+++|+||||+||+.+|+|+++  ||+|+|++||.++||++.           +     
T Consensus        14 ~~~~~~~~Fa~~l~~~l~~~-~~~~Ni~~SP~Si~~aLaml~~~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~~~   92 (406)
T 3sto_A           14 ANISSHKAFTHAYLSTVTAD-FGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKSL   92 (406)
T ss_dssp             --CCHHHHHHHHHHHHHTGG-GTTSCEEECHHHHHHHHHHHHHTSCSCHHHHHHHHHHTTCSTTSSSCCHHHHHHHHHHH
T ss_pred             hccchhhHHHHHHHHHHhhc-CCCCCEEEccHHHHHHHHHHHhccccCchHHHHHHHHhCCCcccccccccCCHHHHHHH
Confidence            45678999999999999875 5789999999999999999999  999999999999999972           1     


Q ss_pred             -hhHHhhc-c---------cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-
Q psy5102          73 -RSLSNKL-T---------AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-  107 (357)
Q Consensus        73 -~~ll~~l-~---------~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-  107 (357)
                       +.|++.+ .         ++.++++   |+++                     .+||   +.|   ||+||   |+|+ 
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI  172 (406)
T 3sto_A           93 YQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDFSNRTSATVDINDWVDQQSNGLL  172 (406)
T ss_dssp             HHHHHHHHHTCEECC---CEESEEEEEEEEEETTSCCCHHHHHHHHTCSSEEEEEECTTSHHHHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHhccCcccccCCCcEEEEEeeeeecCCCccCHHHHHHHHHHhCCeEEEeCCCChHHHHHHHHHHHHHHhcCcc
Confidence             3444444 1         2456666   7665                     6788   334   99999   9999 


Q ss_pred             cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCC
Q psy5102         108 NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRN  163 (357)
Q Consensus       108 ~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~  163 (357)
                      +++++++ ++++|+++|+||       +.||++..|.+++||..              . +|+++++++|+||+  |.++
T Consensus       173 ~~ll~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~  251 (406)
T 3sto_A          173 EKFFTDD-IPDDTAMILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKPLNNT  251 (406)
T ss_dssp             ---------CCSCCEEEEEEEEECEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSST
T ss_pred             hhhccCC-CCCCceEEEEEeeEEEeecccCCCccCCcCceEECCCCeEEEEeEEEeeCceEEEEEcCCCeEEEEEecCCC
Confidence            9999987 999999999999       89999999999999976              2 66777889999999  9998


Q ss_pred             eEEEEEEec-CCCChhHHhhccC-hhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCC
Q psy5102         164 EVYMYFILP-KNPDLSEFTKDLD-YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLD  241 (357)
Q Consensus       164 ~~sm~iiLP-~~~~L~~l~~~L~-~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~  241 (357)
                      +++|+|||| +..+|.+++++|+ .+.+..|.++++.+.|+|.||||++++++||+++|++||++++|++..|||++|++
T Consensus       252 ~~sm~iiLP~~~~~l~~l~~~L~~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~  331 (406)
T 3sto_A          252 RFTFVIVLPLEKWSLNGATELLNGNKVLSEYVKNLKETTVSLRLPKFTLKNTLDLVPTLKSIGVVDLFDPVKSDLSGITP  331 (406)
T ss_dssp             TEEEEEEEESSSSCCTTHHHHHSSSSCHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCS
T ss_pred             cEEEEEEecCCCCCHHHHHHHcCchHHHHHHHHhCcEeEEEEEecCEEEeeecChhhhhhhCCchhhcCCCCCCcccccC
Confidence            999999999 8899999999999 89999999999999999999999999999999999999999999975699999998


Q ss_pred             CCCceeeeeeEEEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCC
Q psy5102         242 DRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQ  311 (357)
Q Consensus       242 ~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~  311 (357)
                      +.+++|++|+||+.|+|||+|++|+|+|++.+. ++   .+.+|++||||+|+|+|+.||.|||+|+|.+|..+
T Consensus       332 ~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~  405 (406)
T 3sto_A          332 NPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAIIPEVDFHVTHPFICFIYDQQLTMPIMAAKVMNPVLQ  405 (406)
T ss_dssp             STTCCCSEEEEEEEEEECSSEESCCC-------CCCSCCCSEEEECCSCEEEEEEETTTTEEEEEEEESSCC--
T ss_pred             CCCceEEEEEEEEEEEecCCcccccccceeeeecccCCCCCceEEeeCCEEEEEEECCCCcEEEEEEeCCccCC
Confidence            778999999999999999999999999988765 44   24689999999999999999999999999999865

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-62  Score=480.41  Aligned_cols=296  Identities=21%  Similarity=0.337  Sum_probs=260.0

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSN   77 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~   77 (357)
                      ...+..++++||++||+++... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.+++
T Consensus         3 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~   81 (379)
T 2ceo_A            3 LYKMSSINADFAFNLYRRFTVE-TPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLIC   81 (379)
T ss_dssp             -CHHHHHHHHHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHhc-CCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCCcCCCHHHHHHHHHHHHH
Confidence            3578899999999999999876 6789999999999999999999999999999999999964      1     34555


Q ss_pred             hc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          78 KL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        78 ~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      .+   + +..++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  ++++
T Consensus        82 ~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~l~~~--l~~~  159 (379)
T 2ceo_A           82 SLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQD--LKPN  159 (379)
T ss_dssp             HHSSCCTTEEEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECTTCHHHHHHHHHHHHHHHTTTSSCCCCCC--CCSS
T ss_pred             HhhCCCCCcEEEEeEhhhhhCCCChhHHHHHHHHHHhCCeeeecCCCCHHHHHHHHHHHHHHHhCCcchhhccC--CCCC
Confidence            55   2 4667766   6665                     6788   333   99999   9999 999975  9999


Q ss_pred             ceeEeecc-------cCCCCCCCceeee-eeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMG-VATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKN  174 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~-F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~  174 (357)
                      |+++|+||       +.||++..|.+++ ||..              . +|+++++++|++|+  |+++. +|+||||+.
T Consensus       160 t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~-sm~iiLP~~  238 (379)
T 2ceo_A          160 TIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNA-LALFVLPKE  238 (379)
T ss_dssp             CCEEEEEEEEEEEBBSSCCCGGGCEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSE-EEEEEEECT
T ss_pred             CEEEEEEHhhhhchhcCCCChhhCccCCceEeCCCcEEEEEEEEeeeeEeEEEeCCCCeEEEEeecCCCe-eEEEEeeCC
Confidence            99999999       8999999999999 9976              2 67778899999999  98875 999999933


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV  254 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~  254 (357)
                      .+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+||+
T Consensus       239 ~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka  317 (379)
T 2ceo_A          239 GQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTEDNGLKLSNAAHKA  317 (379)
T ss_dssp             TCHHHHHHHCSHHHHHHHHHHCEEEEEEEEEECEEEEEEEETHHHHHHHTCCTTTST-TCCCTTTBSSSCCCCCEEEEEE
T ss_pred             CcHHHHHHHhCHHHHHHHHHhcccCcceEECCcEEEeeeecHHHHHHhcCccccccC-CCCcccCCCCCCeEEeccceeE
Confidence            789999999999999999999999999999999999999999999999999999986 7999999987789999999999


Q ss_pred             EEEEccCccccccccceeee-ecCC----CEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RISK----PTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s~~----~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      .|+|||+|++|+|+|++.+. ++.+    .+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       318 ~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  377 (379)
T 2ceo_A          318 VLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPT  377 (379)
T ss_dssp             EEEECSSBSSCCCCCC--------CCSCSCEEECCSCEEEEEEETTTTEEEEEEEESCSB
T ss_pred             EEEecCCCcccccccchhhccccCCCCCCCeEEecCCEEEEEEECCCCcEEEEEecCCCC
Confidence            99999999999999987665 4422    7899999999999999999999999999996

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A

Probab=100.00  E-value=7.7e-63  Score=482.49  Aligned_cols=295  Identities=22%  Similarity=0.402  Sum_probs=256.1

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc---c
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL---T   80 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l---~   80 (357)
                      .+..++++||++||+++.+. ++++|+|+||+||+.+|+|++.||+|+|++||.++||++..       +.+++.+   +
T Consensus         3 ~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~   81 (375)
T 1wz9_A            3 ALQLANSAFAVDLFKQLCEK-EPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNKLS   81 (375)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-CTTSCCEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCHHHHHHHHHHHHHHHT
T ss_pred             hHhHHHHHHHHHHHHHHhcc-CCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHhhcCC
Confidence            67889999999999999876 67899999999999999999999999999999999999751       4566665   2


Q ss_pred             -cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEe
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVL  124 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvL  124 (357)
                       ++.++++   |+++                     .+||    +.|   ||+||   |+|+ ++++++++++++|+++|
T Consensus        82 ~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t~lvL  161 (375)
T 1wz9_A           82 SFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILV  161 (375)
T ss_dssp             TTSEEEEEEEEEEEGGGCCCHHHHHHHTTTTTTTEEEECTTTCHHHHHHHHHHHHHHHTTTSCSCTTTTSCCCTTCCEEE
T ss_pred             CCcEEEEeeeeeeeCCcchhHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhccCcccCCccchhhh
Confidence             5677776   6655                     5788    333   99999   9999 99999989999999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec----C-CC
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP----K-NP  175 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP----~-~~  175 (357)
                      +||       +.||++..|.+++||..              . +|++.++++|+||+  |+++++||+||||    + ..
T Consensus       162 vNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~~~  241 (375)
T 1wz9_A          162 VNAAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNKHLSMFILLPKDVEDEST  241 (375)
T ss_dssp             EEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSCCCHHH
T ss_pred             eeheeeecccCCCCCccCceeeeEEeCCCeEEEEEEEEeeeeEeeEEeCCcceEEEEeecCCCeEEEEEEecCcccccCc
Confidence            999       89999999999999975              2 67788999999999  9999999999999    4 35


Q ss_pred             ChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEE
Q psy5102         176 DLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK  253 (357)
Q Consensus       176 ~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk  253 (357)
                      +|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++||++++|+++.|||++|+++.+++|++|+||
T Consensus       242 ~l~~l~~~L~~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~v~hk  321 (375)
T 1wz9_A          242 GLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKACLENLGLKHIFSEDTSDFSGMSETKGVALSNVIHK  321 (375)
T ss_dssp             HHHHHHHHCCHHHHHHHTCGGGCEEEEEEEEEECEEEEEEECHHHHHHHHTCCSTTCTTTCCCTTTCCCTTCCEEEEEEE
T ss_pred             cHHHHHHHhCHHHHHHHhhhhcceeeeEEEEcceEEecceechHHHHhhCChhhhcCCCCCcccccCCCCCeEEEEEEEe
Confidence            8999999999999999987  78889999999999999999999999999999999954799999998778999999999


Q ss_pred             EEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         254 VDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       254 ~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +.|+|||+|++|+|+|++.+. ++  .+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       322 a~ieV~E~GteAaAaT~~~~~~~~--~~f~~drPFlf~I~~~~t~~iLF~G~v~~P  375 (375)
T 1wz9_A          322 VCLEITEDGGDSIEVPGARILQHK--DELNADHPFIYIIRHNKTRNIIFFGKFCSP  375 (375)
T ss_dssp             EEEEECSCC------------CEE--EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             eeEEecCCCcccccccchhhcccC--CEEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence            999999999999999987665 44  689999999999999999999999999998

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} SCOP: e.1.1.1 PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ...

Probab=100.00  E-value=1.7e-62  Score=487.25  Aligned_cols=298  Identities=26%  Similarity=0.411  Sum_probs=263.8

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h------hhHHhh
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G------RSLSNK   78 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~------~~ll~~   78 (357)
                      .+..++++||++||+++.....+++|++|||+||+.+|+|+++||+|+|++||.++||++.      +      +.|+..
T Consensus        50 ~l~~~~~~Fa~~L~k~l~~~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~i~~~f~~l~~~  129 (432)
T 3kcg_I           50 ELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCR  129 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCTTSCCCBCHHHHHHHHHHHHTTCCHHHHHHHHHHTTCTTSCHHHHHTHHHHHHHHHHH
T ss_pred             HHHHHHhHHHHHHHHHHhhccCCCCCEEEcHHHHHHHHHHHHhhcccHHHHHHHHHhCCCccccccHHHHHHHHHHHHHH
Confidence            5788999999999999986314588999999999999999999999999999999999973      1      344444


Q ss_pred             c----c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          79 L----T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        79 l----~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +    + +..+.++   |+++                     .+||    +.+   ||+||   |+|+ +++++++++++
T Consensus       130 l~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~  209 (432)
T 3kcg_I          130 LYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINE  209 (432)
T ss_dssp             HHHHHTTTEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCSSCTTSSCT
T ss_pred             HhcccCCCcEEEEEEEEEEcCCCccCHHHHHHHHHHhCCeEEeccCCCCHHHHHHHHHHHHHhhccCchhccCCcccCCC
Confidence            4    2 4566666   6665                     6789    223   99999   9999 99999999999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~  173 (357)
                      +|+++|+||       +.||++..|..++||..              . +|+++++ +|+||+  |.++.++|+|||| +
T Consensus       210 ~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~-~~~vleLPy~~~~~sm~iiLP~~  288 (432)
T 3kcg_I          210 LTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAE-GTQVLELPFKGDDITMVLILPKP  288 (432)
T ss_dssp             TCCEEEEEEEEEEECBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEECGG-GCEEEEEEBTTSSEEEEEEECCT
T ss_pred             CceEEEEeHHhhhhhhhcCCCcccceeeeEEECCCeEEEEEEEEecceeeEEEecC-CcEEEEEEcCCCceEEEEEecCC
Confidence            999999999       89999999999999976              1 5666667 999999  9999999999999 8


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC--CCceeeeee
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD--RGVAVDQVF  251 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~~l~vs~v~  251 (357)
                      +.+|.+++++|+.+.+.+|.++++.+.|+|.||||++++++||+++|++||++++|+++.||||+|+++  .+++|++|+
T Consensus       289 ~~~L~~le~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~~~l~vs~v~  368 (432)
T 3kcg_I          289 EKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAF  368 (432)
T ss_dssp             TSCHHHHHHSCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTSCSSSSCCCCCEEE
T ss_pred             CCCHHHHHHHcCHHHHHHHHHhCceeeEEEEecCEEEecccchhhhHhhCCchhhccCccCCcccccccCCCCceeeeEE
Confidence            889999999999999999999999999999999999999999999999999999999557999999873  589999999


Q ss_pred             EEEEEEEccCccccccccceeee-ec-C--CCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RI-S--KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s-~--~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      ||+.|+|||+|++|+|+|++.+. ++ .  +..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus       369 hka~ieVnE~GteAaAaT~~~~~~~s~~~~~~~F~adrPFlf~I~d~~t~~iLF~G~V~~P~  430 (432)
T 3kcg_I          369 HKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPC  430 (432)
T ss_dssp             EEEEEEECSCBCCCCCCCCCCCEESSCCTTCEEEECCSCCEEEEEETTTTEEEEEC-CCCCC
T ss_pred             EEEEEEecCCCccccccchhhcccccCCCCCcEEecCCCEEEEEEECCCCcEEEEEEeCCCC
Confidence            99999999999999999987665 44 2  36799999999999999999999999999997

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-63  Score=488.13  Aligned_cols=297  Identities=27%  Similarity=0.428  Sum_probs=254.4

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-----------------
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-----------------   71 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-----------------   71 (357)
                      ...+..++++||++||+++.+. .+ +|+||||+||+.+|+|+++||+|+|++||.++||++.                 
T Consensus        12 ~~~~~~~~~~Fa~~l~~~l~~~-~~-~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~   89 (401)
T 2zv6_A           12 SNSLSEANTKFMFDLFQQFRKS-KE-NNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRS   89 (401)
T ss_dssp             -CHHHHHHHHHHHHHHHHHHHH-CC-SCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHTTC-------------------
T ss_pred             ccHHHHHHHHHHHHHHHHHhhC-CC-CCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccH
Confidence            3568899999999999999876 56 9999999999999999999999999999999999853                 


Q ss_pred             -h-----hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC
Q psy5102          72 -G-----RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ  107 (357)
Q Consensus        72 -~-----~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~  107 (357)
                       +     +.+++.+   + ++.++++   |+++                     .+||    +.|   ||+||   |+|+
T Consensus        90 ~~~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gk  169 (401)
T 2zv6_A           90 GNVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTNEK  169 (401)
T ss_dssp             -CTHHHHHHHHHHHHSCCSSCCEEEECCEEEETTSCCCHHHHHHHHHHHSCCEEEECTTTCHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHhhCCCCCcEEEEEEEEEecCCCChhHHHHHHHHHHhCCEEEEccCCCCHHHHHHHHHHHHHHhhCCc
Confidence             1     3455555   2 5667776   6665                     6788    333   99999   9999


Q ss_pred             -cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecC
Q psy5102         108 -NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMR  162 (357)
Q Consensus       108 -~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~  162 (357)
                       ++++++++++++|+++|+||       +.||++..|.+++||..              . +|++.++++|+||+  |++
T Consensus       170 I~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~~l~~~vleLPY~~  249 (401)
T 2zv6_A          170 IKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKG  249 (401)
T ss_dssp             SCCSSCTTTSCTTCCEEEEEEEEECCCBSSCCCTTSEEEEEECSSSSCCEEEEEEEEEEEEEECEETTTTEEEEEEEBTT
T ss_pred             cccccCcccCCCcceEEEEEhheeccccCCCCCCCCceeeEEEecCCceEEeEEEeccCceeEEEeCCCCEEEEEeecCC
Confidence             99999999999999999999       89999999999999976              2 67788999999999  999


Q ss_pred             CeEEEEEEec-CCCChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCC
Q psy5102         163 NEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNM  239 (357)
Q Consensus       163 ~~~sm~iiLP-~~~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~i  239 (357)
                      +++||+|||| +..+|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++||++++|+. .|||++|
T Consensus       250 ~~~sm~iiLP~~~~~L~~le~~L~~~~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsgi  328 (401)
T 2zv6_A          250 KDLSMIVLLPNEIDGLQKLEEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFNG-DADLSGM  328 (401)
T ss_dssp             SSSEEEEEEESSTTCHHHHHHHCCHHHHHHHTCGGGCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-TCCCHHH
T ss_pred             CcEEEEEEecCCCCCHHHHHHHhCHhHHHHHhhhcccceeEEEEEeeeEEEEEEecHHHHHHhcCccccCCC-ccccccc
Confidence            8999999999 8899999999999999999987  6888999999999999999999999999999999995 7999999


Q ss_pred             CCCCCceeeeeeEEEEEEEccCccccccccceeee-ecC---CCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         240 LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RIS---KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       240 s~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s~---~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +++.+++|++|+||+.|+|||+|++|+|+|++.+. ++.   +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       329 s~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P  401 (401)
T 2zv6_A          329 TGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP  401 (401)
T ss_dssp             HSSSCCCEEEEEEEEEEECCSCC-------------------CEEEECSSCEEEEECCTTTTCCCCEEEECCC
T ss_pred             CCCCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCEEEecCCEEEEEEECCCCeEEEEEEeCCC
Confidence            98778999999999999999999999999987665 442   2789999999999999999999999999998

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I

Probab=100.00  E-value=1.8e-62  Score=480.23  Aligned_cols=296  Identities=27%  Similarity=0.386  Sum_probs=263.2

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc-c-
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL-T-   80 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l-~-   80 (357)
                      ..+.+++++||++||+++.+. ++++|+|+||+||+.+|+|++.||+|+|++||.++||++..       +.+.+.+ . 
T Consensus         9 ~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~   87 (378)
T 1sek_A            9 KILRESNDQFTAQMFSEVVKA-NPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVRAV   87 (378)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT-STTSCEEECSTTTHHHHHHHHHHCCHHHHHHHHHHHTCCCHHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhc-CCCCCEEEcHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCCCchHHHHHHHHHHHHhcc
Confidence            368899999999999999876 67899999999999999999999999999999999999862       2333334 2 


Q ss_pred             -cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEee
Q psy5102          81 -AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLL  125 (357)
Q Consensus        81 -~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLv  125 (357)
                       +..++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++++++++|+++|+
T Consensus        88 ~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLv  167 (378)
T 1sek_A           88 KGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLV  167 (378)
T ss_dssp             TTEEEEEEEEEEEETTSCBCHHHHHHHHHTTCCEEEEECGGGHHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCCEEEE
T ss_pred             CCCeEEeeeehhhhCCCCHhHHHHHHHHHHhCCeeEeeCCcCHHHHHHHHHHHHHHHhCCcccccCCcccCCCCCeEEEE
Confidence             4566666   6654                     6788   333   99999   9999 999998889999999999


Q ss_pred             cc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHH
Q psy5102         126 GS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEF  180 (357)
Q Consensus       126 na-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l  180 (357)
                      ||       +.||++..|.+++||..              . +|++.++++|++|+  |+++++||+|||| +..+|.++
T Consensus       168 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~~~l~~l  247 (378)
T 1sek_A          168 NAIYFKGSWKDKFNKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQVDGITAL  247 (378)
T ss_dssp             EEEEEEECBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSEEEEEEEESSTTTHHHH
T ss_pred             EeeEEeccccCCCCCCCcccceEEeCCCEEEEeeEEEeeceEeEEEeCCCCeEEEEEECCCCcEEEEEEEeCCCCCHHHH
Confidence            99       89999999999999976              2 67778899999999  9998999999999 88999999


Q ss_pred             hhccC-hhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC-CCceeeeeeEEEEEEE
Q psy5102         181 TKDLD-YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD-RGVAVDQVFHKVDIEV  258 (357)
Q Consensus       181 ~~~L~-~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~~l~vs~v~qk~~iev  258 (357)
                      +++|+ .+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+...|||++|+++ .+++|++|+||+.|+|
T Consensus       248 ~~~L~~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~l~vs~v~hka~ieV  327 (378)
T 1sek_A          248 EQKLKDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLYVDAAIQKAFIEV  327 (378)
T ss_dssp             HHHTTSTTHHHHHHTTCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTTCCCTTTBTTCCCCCCCEEEEEEEEEE
T ss_pred             HHHhcchhHHHHHHHhccceEEEEEeeeEEeecccccHHHHHhcCCcccccCCcCCchhhcCCCCCeEEeeeeeEEEEEe
Confidence            99999 799999999999999999999999999999999999999999994337999999864 4799999999999999


Q ss_pred             ccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         259 TEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       259 ~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      ||+|++|+|+|++.+. ++  .+.+|++||||+|+|+|  +++|||+|+|.+|
T Consensus       328 ~E~GteAaAaT~~~~~~~~~~~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P  378 (378)
T 1sek_A          328 NEEGAEAAAANAFKITTYSFHFVPKVEINKPFFFSLKY--NRNSMFSGVCVQP  378 (378)
T ss_dssp             CSCBSSCTTSSTTCCCCSCCCCCCEEECCSCEEEEEEE--TTEEEEEEEESCC
T ss_pred             CCCCcccccccchhhccccCCCCCeEEecCCEEEEEEe--CCEEEEEEEecCC
Confidence            9999999999987665 44  34679999999999999  6899999999998

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus}

Probab=100.00  E-value=1.7e-61  Score=476.21  Aligned_cols=297  Identities=25%  Similarity=0.367  Sum_probs=261.0

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHH
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLS   76 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll   76 (357)
                      ....+..++++||++||+++... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.++
T Consensus        23 ~~~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~  101 (398)
T 1yxa_A           23 DSLTLASINTDFAFSLYKELVLK-NPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLL  101 (398)
T ss_dssp             ----CHHHHHHHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHhc-CCCCCEEEchHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccCCHHHHHHHHHHHH
Confidence            34678889999999999999876 6789999999999999999999999999999999999963      1     3455


Q ss_pred             hhc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          77 NKL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        77 ~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +.+   + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  +++
T Consensus       102 ~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~  179 (398)
T 1yxa_A          102 QRLNQPKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQPRQAKKLINDYVRKQTQGMIKELVSD--LDK  179 (398)
T ss_dssp             HHHSSCBTTBEEEEEEEEEEETTSCCCHHHHHHHHHHHSCEEEEECTTSHHHHHHHHHHHHHHHTTTSSSCCCCC--CCT
T ss_pred             HHHhCCCCCceeeeeeEEEEeCCCchhHHHHHHHHHHhCCceeecCCCCHHHHHHHHHHHHHHHhcCchhhhhhc--cCC
Confidence            555   2 4667776   6665                     6788   333   99999   9999 999975  999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec---------------c-cccccCCCCeEEEe--ecCCeEEEEEEecC
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG---------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPK  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~---------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~  173 (357)
                      +|+++|+||       +.||++..|.+++||..               . +|+++++++|++|+  |+++ .+|+||||+
T Consensus       180 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-~sm~iiLP~  258 (398)
T 1yxa_A          180 RTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGN-ASALFILPD  258 (398)
T ss_dssp             TCCEEEEEEEEEECBBSSCCCGGGCEEEEECCCCSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEEC
T ss_pred             CcEEEEEEHHhhhhhhhCCCCcccCeeeEEEeCCCeEEEEEEEEEcCceEEEEEeCCCCeEEEEEecCCC-eeEEEEecC
Confidence            999999999       89999999999999976               1 45667889999999  9887 499999993


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeE-EEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeE
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDV-IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFH  252 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~q  252 (357)
                      ..+|.+++++|+.+.+..|.+.++.+.| +|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+|
T Consensus       259 ~~~L~~le~~L~~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~h  337 (398)
T 1yxa_A          259 QGRMQQVEASLQPETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLSKLGIREVFST-QADLSAITGTKDLRVSQVVH  337 (398)
T ss_dssp             TTCHHHHHHTCSHHHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCCCCCEEEE
T ss_pred             cCcHHHHHHHhCHHHHHHHHHhccceeeeEEecceEEeecccchHHHHHHcCcccccCC-cCCcccCCCCCCeEEEEEEE
Confidence            3369999999999999999999999999 999999999999999999999999999996 79999999877899999999


Q ss_pred             EEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         253 KVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |+.|+|||+|++|+|+|++.+. ++   .+.+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       338 ka~ieVnE~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~  398 (398)
T 1yxa_A          338 KAVLDVAETGTEAAAATGVKFVPMSAKLYPLTVYFNRPFLIMIFDTETEIAPFIAKIANPK  398 (398)
T ss_dssp             EEEEEECSSBSSCCCCCSCCCCCCCCCSSCCEEECCSCEEEEEEETTTCCCSEEEEESCCC
T ss_pred             EEEEEEcCCccccccccchhhcccccCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence            9999999999999999987665 44   267899999999999999999999999999994

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A*

Probab=100.00  E-value=3.1e-61  Score=482.39  Aligned_cols=298  Identities=21%  Similarity=0.343  Sum_probs=265.5

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----------h-----
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----------G-----   72 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----------~-----   72 (357)
                      ....+..++++||++||+++.+...+++|+||||+||+.+|+|+++||+|+|++||.++||++.          .     
T Consensus       103 ~~~~l~~~~~~Fa~~L~k~l~~~~~~~~NivfSP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~~~i~~~  182 (480)
T 1jmo_A          103 RIQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNL  182 (480)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHhccCCCCCEEEcHHHHHHHHHHHHHhcCcHHHHHHHHHhCCCccccccccCCHHHHHHH
Confidence            3557889999999999999975102578999999999999999999999999999999999863          1     


Q ss_pred             -hhHHhhc---c-cceeeee---eccc---------------------cCCH---HHH--HHHHH---hCCC-cccCCCC
Q psy5102          73 -RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM---ERA--IRSVM---TKNQ-NVVFAPL  114 (357)
Q Consensus        73 -~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a--IN~wv---T~g~-~~~l~~~  114 (357)
                       +.+++.+   + ++.++++   |+++                     .+||   +.+  ||+||   |+|+ ++++  +
T Consensus       183 f~~ll~~l~~~~~~~~L~~AN~lfv~~~~~l~~~F~~~~~~~y~a~~~~vDF~~~~~~~~IN~WV~~~T~gkI~~ll--~  260 (480)
T 1jmo_A          183 FRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISKTNNHIMKLTKGLIKDAL--E  260 (480)
T ss_dssp             HHHHHHHHHSSCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHSCCEEEECTTCHHHHHHHHHHHHHHTTTSSCCTT--C
T ss_pred             HHHHHHHhhcCCCCceEEEEEEEeecCCCcccHHHHHHHHHhhccceeeecccCHHHHHHHHHHHHHhhCCChhhhh--c
Confidence             3455555   2 5677776   7665                     6788   114  99999   9999 9999  4


Q ss_pred             CCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEE
Q psy5102         115 SIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFI  170 (357)
Q Consensus       115 ~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~ii  170 (357)
                      +++++|+++|+||       +.||++..|.+++||..              . +|++.++++|+||+  |+ +++||+||
T Consensus       261 ~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~-~~~SM~Ii  339 (480)
T 1jmo_A          261 NIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYV-GGISMLIV  339 (480)
T ss_dssp             SCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEET-TTEEEEEE
T ss_pred             ccCCCCeEEEEehHeeeccccCCCCCCCceeEEEEeCCCcEEEEEEEEEecceeeEEeCCCceEEEEEecC-CcEEEEEE
Confidence            5999999999999       89999999999999976              2 67788899999999  99 88999999


Q ss_pred             ec-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeee
Q psy5102         171 LP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQ  249 (357)
Q Consensus       171 LP-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~  249 (357)
                      || +..+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++|||+++|+. .|||++|++ .+++|++
T Consensus       340 LP~~~~~L~~le~~L~~~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~LGi~~~F~~-~ADfsgis~-~~L~VS~  417 (480)
T 1jmo_A          340 VPHKMSGMKTLEAQLTPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAGISD-QRIAIDL  417 (480)
T ss_dssp             EESSGGGHHHHHHHCCHHHHHHHHHHCEEEEEEEEEECEEEECCEECHHHHHHHTCCGGGST-TSCCTTTCS-SCCCEEE
T ss_pred             ecCCCCCHHHHHHhhCHHHHHHHHhcccceEEEEEeccEEEEEeecHHHHHHhCCccccccC-CCCcCcccC-CCceecc
Confidence            99 88899999999999999999999999999999999999999999999999999999976 799999998 6899999


Q ss_pred             eeEEEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         250 VFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       250 v~qk~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |+||+.|+|||+|++|+|+|++.+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|..
T Consensus       418 v~HKa~IeVnEeGtEAAAaT~v~~~~~s~~~~F~aDrPFlF~I~d~~t~~iLF~G~v~~P~~  479 (480)
T 1jmo_A          418 FKHQGTITVNEEGTQATTVTTVGFMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR  479 (480)
T ss_dssp             EEEEEEEEECSCBSCCCCCCCCSEEECSCCCEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred             hheeEEEEccCCccccccccccccccccCCCcEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            9999999999999999999988766 554559999999999999999999999999999974

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A

Probab=100.00  E-value=1.2e-61  Score=477.76  Aligned_cols=294  Identities=24%  Similarity=0.348  Sum_probs=255.6

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHhhc
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSNKL   79 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~~l   79 (357)
                      .+..++++||++||+++... ++++|+|+||+||+.+|+|+++||+|+|++||.++||++.      +     +.+++.+
T Consensus        26 ~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l  104 (401)
T 1qmn_A           26 GLASANVDFAFSLYKQLVLK-APDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTL  104 (401)
T ss_dssp             -CHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhc-CCCCCEEEecHHHHHHHHHHHhhccCHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHH
Confidence            68899999999999999876 6789999999999999999999999999999999999964      1     3455555


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                         + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  ++++|+
T Consensus       105 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~t~  182 (401)
T 1qmn_A          105 NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKD--LDSQTM  182 (401)
T ss_dssp             CCCSSSCEEEEEEEEEEESSCCCCHHHHHHHHHHHCCEEEEECGGGHHHHHHHHHHHCSSEEEEEEEECC------CCCC
T ss_pred             hcCCCCceEEEEEEEEeeCCCchHHHHHHHHHHhcCCeEEecCccCHHHHHHHHHHHHHHHhcCchhhhccC--CCCCce
Confidence               2 4677776   6665                     6888   333   99999   9999 999975  999999


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec------------c----cccccCCCCeEEEe--ecCCeEEEEEEecCCCC
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG------------R----SLSNNPEAYASFLE--KMRNEVYMYFILPKNPD  176 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~------------~----~~~~~~~~~~~vve--y~~~~~sm~iiLP~~~~  176 (357)
                      ++|+||       +.||++..|.+++||..            .    +|+++++++|++|+  |+++. +|+||||+..+
T Consensus       183 lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~~-sm~iiLP~~~~  261 (401)
T 1qmn_A          183 MVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNA-SALFILPDQDK  261 (401)
T ss_dssp             EEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSE-EEEEEEECTTC
T ss_pred             EEEEEeeeeeehhcCCCChhcCccceEEcCCCcEEEeeEEEEcCceEEEEEeCCCceEEEEEecCCCe-EEEEEEECCCC
Confidence            999999       89999999999999976            1    34566788999999  98875 99999993378


Q ss_pred             hhHHhhccChhHHHHHHHhcCceeE-EEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEE
Q psy5102         177 LSEFTKDLDYDKFSRIIESTNKVDV-IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVD  255 (357)
Q Consensus       177 L~~l~~~L~~~~l~~~~~~l~~~~v-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~  255 (357)
                      |.+++++|+.+.+..|.++++.+.| +|.||||++++++||+++|++|||+++|+. .|||++|+++.+++|++|+||+.
T Consensus       262 L~~le~~L~~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~  340 (401)
T 1qmn_A          262 MEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITGARNLAVSQVVHKAV  340 (401)
T ss_dssp             HHHHHTTCSHHHHHHHHHSCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCEEEEEEEEEEE
T ss_pred             HHHHHHHhCHHHHHHHHHhCcceEcceEeeeeEEEeccccHHHHHHhcCccccccC-cCCcccccCCCCeEEEeeeeEEE
Confidence            9999999999999999999999999 999999999999999999999999999986 79999999877899999999999


Q ss_pred             EEEccCccccccccceeee-ecCC----CEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         256 IEVTEQGTVAAASTGIIIT-RISK----PTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       256 iev~E~G~~aaa~t~~~~~-~s~~----~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |+|||+|++|+|+|++.+. ++.+    .+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       341 ieVnE~GteAaAaT~~~~~~~s~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  399 (401)
T 1qmn_A          341 LDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPK  399 (401)
T ss_dssp             EEECSSEEESSCCCC-----CCCCCCCSCEEECCSCEEEEEEETTSSCCSEEEEESCTT
T ss_pred             EEeCCCccccccccchhhccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEcCCCC
Confidence            9999999999999987665 4433    7899999999999999999999999999996

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae}

Probab=100.00  E-value=3.1e-61  Score=473.57  Aligned_cols=292  Identities=22%  Similarity=0.317  Sum_probs=255.5

Q ss_pred             HHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchh------HHHHHHhhCCCch--------hhHHhhc
Q psy5102          14 RGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQT------KDELTHFMGVATG--------RSLSNKL   79 (357)
Q Consensus        14 ~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T------~~eL~~~Lg~~~~--------~~ll~~l   79 (357)
                      +.+++||++||+++.+.  +++|+||||+||+.+|+|+++||+|+|      .+|+.+.|++...        ++|++.+
T Consensus        20 ~~~~~Fa~~L~k~l~~~--~~~Ni~~SP~SI~~aLaml~~GA~G~T~~~~~~~~~~l~~l~~~~~~~~~~~~~~~ll~~l   97 (397)
T 3pzf_A           20 QRQNEFDLMFVKEIFKN--HNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQLLESA   97 (397)
T ss_dssp             CCCCHHHHHHHHHHHHT--CSSCEEECHHHHHHHHHHHHHHSGGGCC-CCCHHHHHGGGGSSTTCHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHhC--CCCCEEEchHHHHHHHHHHHhhcCCCCccChHHHHHHHHHcCCCCchHHHHHHHHHHHHHH
Confidence            36789999999999864  689999999999999999999999998      7777777776541        4555555


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                         + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ +++++++.++ +|+
T Consensus        98 ~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~~~-~t~  176 (397)
T 3pzf_A           98 QQDNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSNPTQTAATINNWVSEHTNGRLREIVTPDSLE-GAV  176 (397)
T ss_dssp             HCCCSSCEEEEEEEEEEETTCCBCHHHHHHHHHHHCEEEEEECTTSHHHHHHHHHHHHHHHTTTSCCCCCCGGGGT-TCS
T ss_pred             hcCCCCcEEEEeeeeeEeCCCccchHHHHHHHHHhCCeEEEeCCCChHHHHHHHHHHHHHHhCCcccccCCCCCcc-cce
Confidence               2 5677777   7665                     6788   333   99999   9999 9999987787 899


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCC
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPD  176 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~  176 (357)
                      ++|+||       +.||++..|.+++||..              . +|.++++++|+||+  |.++.++|+|||| +..+
T Consensus       177 lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~~~  256 (397)
T 3pzf_A          177 ITLVNVIYFKGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGNKLAMYFILPNPDNT  256 (397)
T ss_dssp             EEEEEEEEEEEEBSSCCCCCSCCEEEECCSSSSCEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEECTTSC
T ss_pred             eEEeeheecccccCccCCcccccccccccCCCcEEEEEEEEecCCcCeEEccCCCEEEEEEEcCCCceEEEEEECCCCCC
Confidence            999999       89999999999999976              2 66777889999999  9999999999999 8899


Q ss_pred             hhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCC----CceeeeeeE
Q psy5102         177 LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR----GVAVDQVFH  252 (357)
Q Consensus       177 L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~----~l~vs~v~q  252 (357)
                      |.+++++|+.+.+.+|.+.++.+.|+|.||||++++++||+++|++||++++|+. .||||+|+++.    +++|++|+|
T Consensus       257 l~~le~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~~~~~l~vs~v~h  335 (397)
T 3pzf_A          257 VNQVLDRINSASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQVGIREIFSQ-NASLPLLARGRGARDEVRVSRIFQ  335 (397)
T ss_dssp             HHHHHHHCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEESHHHHHHTTCCGGGST-TCCCTTTBCC-----CCCCCEEEE
T ss_pred             HHHHHHhhCHHHHHHHHhhCceEEEEEEcCcEEEEeccChHHHHHhCCchhhcCC-CCCcccccCCCCCCCceEEEeEEE
Confidence            9999999999999999999999999999999999999999999999999999998 59999999754    399999999


Q ss_pred             EEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         253 KVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |+.|+|||+|++|+|+|++.+. ++   .+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus       336 ka~ieVnE~GteAAAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  396 (397)
T 3pzf_A          336 KAGITINELGSEAYAATEIQLVNKFGGDGVQIFNANRPFIFFIEDETLGTMLFAGKIENPV  396 (397)
T ss_dssp             EEEEEECSSEESCCCCSCC--------CCCEEEECCSCEEEEEEETTTCCEEEEEEESSCC
T ss_pred             EEEEEECCCccccccccceeeeccccCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCc
Confidence            9999999999999999987665 32   223499999999999999999999999999996

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-61  Score=470.71  Aligned_cols=292  Identities=21%  Similarity=0.329  Sum_probs=238.7

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHH
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLS   76 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll   76 (357)
                      ....+..++++||++||+++... .+++|+|+||+||+.+|+|++.||   |++||.++||++.      +     +.++
T Consensus         5 ~~~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA---T~~el~~~L~~~~~~~~~~~~~~~~~~l~   80 (371)
T 2v95_A            5 SHRGLAPTNVDFAFNLYQRLVAL-NPDKNTLISPVSISMALAMVSLGS---AQTQSLQSLGFNLTETSEAEIHQSFQYLN   80 (371)
T ss_dssp             GGGTTHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHTTTC-----CHHHHHHTCCTTTSCHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcc-CCCCcEEEchHHHHHHHHHHHHHH---HHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            45678899999999999999876 678999999999999999999999   9999999999963      1     3455


Q ss_pred             hhc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          77 NKL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        77 ~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +.+   + +..++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  +++
T Consensus        81 ~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~l~~~--l~~  158 (371)
T 2v95_A           81 YLLKQSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFEDWTKASQQINQHVKDKTQGKIEHVFSD--LDS  158 (371)
T ss_dssp             HHHTTGGGSEEEEEEEEEEECTTCCBCHHHHHHHHHHSCCEEEECCCSSHHHHHHHHHHHHHHHTTTCCCCSCCC----C
T ss_pred             HHHhCCCCCcEEEEEEEEeEeCCCchhHHHHHHHHHHhCCceEEecCccHHHHHHHHHHHHHHHhcCchhhhccC--CCC
Confidence            555   2 4667666   6665                     6888   333   99999   9999 999975  999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K  173 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~  173 (357)
                      +|+++|+||       +.||++..|.+++||..              . +|+++++++|++|+  |+++ .+|+|||| +
T Consensus       159 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-~sm~iiLP~~  237 (371)
T 2v95_A          159 PASFILVNYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGN-GTAFFILPDQ  237 (371)
T ss_dssp             CCSEEEEEEEEEEECBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECT
T ss_pred             CceEEEEEHHhhhhhhhCcCCCcccceeEEEECCCeEEEEEEEEeeeeEeeEEeCCCCEEEEEEecCCC-eEEEEEecCC
Confidence            999999999       89999999999999976              2 67778899999999  8886 79999999 6


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEE
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK  253 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk  253 (357)
                      + +|.+++++|+.+.+..|.+.++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.+++|+ |+||
T Consensus       238 ~-~l~~le~~L~~~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs-v~hk  314 (371)
T 2v95_A          238 G-QMDTVIAALSRDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTN-QSDFSGNTKDVPLTLT-MVHK  314 (371)
T ss_dssp             T-CHHHHHHHCSHHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTSCSCCHHHHBCC-------------CCEE-EEEE
T ss_pred             C-CHHHHHHHhCHHHHHHHHHhhhcccceEeeeEEEeecccchHHHHHhcCCccccCC-CCCcCCCCCCCCeeEE-EEEE
Confidence            5 89999999999999999999999999999999999999999999999999999996 7999999987789999 9999


Q ss_pred             EEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         254 VDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       254 ~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      +.|+|||+|++|+|+|++.+. ++.|.+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       315 a~ieVnE~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  371 (371)
T 2v95_A          315 AMLQLDEGNVLPNSTNGAPLHLRSEPLDIKFNKPFILLLFDKFTWSSLMMSQVVNPA  371 (371)
T ss_dssp             EEEEESCCCCC----------CCCCCEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred             EEEEecCCcccccccccccccccCCCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence            999999999999999987766 55678899999999999999999999999999994

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A

Probab=100.00  E-value=1.2e-61  Score=473.82  Aligned_cols=295  Identities=23%  Similarity=0.297  Sum_probs=261.6

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc---h-----hhHHhhc-
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT---G-----RSLSNKL-   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~---~-----~~ll~~l-   79 (357)
                      ...+.+++++||++||+++.   .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.   +     +.+++.+ 
T Consensus         6 ~~~~~~~~~~Fa~~L~~~l~---~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~l~   82 (373)
T 2pef_A            6 DEKFIYNTADFSIELFKNSI---DDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISIEDLNKYLYTYMKKLP   82 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHTSC---CSSSCCEECHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHhh---CCCCCEEEccHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHHhh
Confidence            45788999999999999985   3579999999999999999999999999999999999864   1     4455555 


Q ss_pred             -c-cceeeee---ecc-c---------------------cCCH-HHH---HHHHH---hCCC-cccCCCCCCCccceeEe
Q psy5102          80 -T-AHSLRRG---ITQ-M---------------------TLDM-ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVL  124 (357)
Q Consensus        80 -~-~~~l~~a---f~~-~---------------------~~dF-~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvL  124 (357)
                       + ++.++++   |++ +                     .+|| +.+   ||+||   |+|+ ++++++  ++++|+++|
T Consensus        83 ~~~~~~l~~an~l~~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~t~lvL  160 (373)
T 2pef_A           83 NEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFDSSTVSDINNWVKSKTNGMIDKILNK--IDPEDVMYL  160 (373)
T ss_dssp             CBTTEEEEEEEEEEEETTTEEECHHHHHHHHHHHCCEEEEECCSHHHHHHHHHHHHHHTTTSCCCSCSC--CCTTCCEEE
T ss_pred             cCCCcEEEEEEEEEEecCCCchhHHHHHHHHHHhCCeeEecCchHHHHHHHHHHHHHhccCchhhhhcc--CCCCceEEE
Confidence             2 5667666   776 3                     5788 444   99999   9999 999974  999999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhHHh
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSEFT  181 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~l~  181 (357)
                      +||       +.||++..|.+++||..            . .+ |.++.+|++++  |.++++||+|||| +..+|.+++
T Consensus       161 vNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-y~~~~~~~vleLPy~~~~~sm~iiLP~~~~~L~~l~  239 (373)
T 2pef_A          161 INAVAFDAEWETVYEKASVHEDIFTDVYGNRQKVEFMNSEENL-YIEEENAVGFVKPYAKNHYSFVAILPDENISVNEYI  239 (373)
T ss_dssp             EEEEEEEEEBSSCCCGGGEEEEEEECTTSCEEEEEEEEEEEEE-EEEETTEEEEEEEBGGGSEEEEEEEECTTSCHHHHH
T ss_pred             EEeeeeeccccccCChhhccccceecCCCeEEEechhhccCeE-EeecCCeEEEEEecCCCcEEEEEEECCCCCCHHHHH
Confidence            999       89999999999999976            1 44 77889999999  9999999999999 888999999


Q ss_pred             hccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC--CCceeeeeeEEEEEEEc
Q psy5102         182 KDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD--RGVAVDQVFHKVDIEVT  259 (357)
Q Consensus       182 ~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~~l~vs~v~qk~~iev~  259 (357)
                      ++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|++..|||++|+++  .+++|++|+||+.|+||
T Consensus       240 ~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~~~l~vs~v~hka~ieVn  319 (373)
T 2pef_A          240 KTLTGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLPDKADFSKLGKSDIGNLYISEVLHKTFISVD  319 (373)
T ss_dssp             HHCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTEEETTSCCCCCCEEEEEEEEEC
T ss_pred             hhhhhhHHHHHHhhceeeEEEEECceEEeecccchHHHHHhcCCccccCCCcCchhhcccCCCCCeEEcchhheeEEEEC
Confidence            9999999999999999999999999999999999999999999999998547999999875  37999999999999999


Q ss_pred             cCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         260 EQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       260 E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |+|++|+|+|++.+. ++   .+.+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus       320 E~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~p~  373 (373)
T 2pef_A          320 ELGTKAGAVTSVDITAAGIPVNFKTVKLNRPFIFAIIDNSTNLPIFIGTVLSLK  373 (373)
T ss_dssp             SSEEEEEEEEEESCC-------CCSEEEEEEEEEEEEETTTTEEEEEEEEEEEC
T ss_pred             CCccccccccchhhccccCCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence            999999999987665 43   356899999999999999999999999999984

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A*

Probab=100.00  E-value=4.6e-61  Score=472.59  Aligned_cols=292  Identities=24%  Similarity=0.405  Sum_probs=252.6

Q ss_pred             chhHHHHh-hHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHH
Q psy5102           9 NLILRRGI-TQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLS   76 (357)
Q Consensus         9 ~~~~~~~~-~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll   76 (357)
                      ...+..++ ++||++||+++.+. .+++|+|+||+||+.+|+|++.||+|+|++||.++||++.      +     +.++
T Consensus        26 ~~~l~~~~~~~Fa~~L~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~l~  104 (395)
T 3b9f_I           26 GATVAPSSRRDFTFDLYRALASA-APSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLL  104 (395)
T ss_dssp             ----------CHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTC----CCHHHHHHHHHHHH
T ss_pred             HHHHHHhhHHHHHHHHHHHHhcc-CCCCCEEEcHHHHHHHHHHHHHHcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            45678899 99999999999876 6789999999999999999999999999999999999963      1     4455


Q ss_pred             hhc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCc
Q psy5102          77 NKL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVG  118 (357)
Q Consensus        77 ~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~  118 (357)
                      +.+   + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++  +++
T Consensus       105 ~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~  182 (395)
T 3b9f_I          105 QELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKGKIVDLLKN--LDS  182 (395)
T ss_dssp             HHTTSCCTTCCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHHHHHHHTTTSSCCCCSC--CCT
T ss_pred             HHHhCCCCCceeEEEEEEEEECCCccchHHHHHHHHHhCCEeEEcCCCCHHHHHHHHHHHHHHHhCCchhhhccC--CCC
Confidence            555   2 4667666   6665                     6788   333   99999   9999 999976  999


Q ss_pred             cceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCC
Q psy5102         119 ALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKN  174 (357)
Q Consensus       119 ~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~  174 (357)
                      +|+++|+||       +.||++..|.+++||..              . +|+++++++|++|+  |+++. +|+||||+.
T Consensus       183 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~-sm~iiLP~~  261 (395)
T 3b9f_I          183 NAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNA-TALFILPSE  261 (395)
T ss_dssp             TCSEEEEEEEEECCCEEECCCTTTCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSC-EEEEEEECT
T ss_pred             CceEEEEEhheeeccccCCCChhhCeeeEEEeCCCeEEEEEEEEeeeeEeEEEECCCCeEEEEEecCCCe-eEEEEEeCC
Confidence            999999999       89999999999999976              2 66778899999999  98875 999999933


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV  254 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~  254 (357)
                      .+|.+++++|+.+.+.+|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+||+
T Consensus       262 ~~L~~le~~L~~~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka  340 (395)
T 3b9f_I          262 GKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISNHSNIQVSEMVHKA  340 (395)
T ss_dssp             TCHHHHHHHCSHHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBSCSSCCCSEEEEEE
T ss_pred             CCHHHHHHHhCHHHHHHHHHhcceeEEEEEeeEEEEEEeecHHHHHHHcCCccccCC-CCCcccCcCCCCeeeeccceEE
Confidence            799999999999999999999999999999999999999999999999999999986 7999999987789999999999


Q ss_pred             EEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      .|+|||+|++|+|+|++.+. ++   .+.+|++||||+|+|+|   +.|||+|+|.+|
T Consensus       341 ~ieVnE~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~---~~iLF~G~v~~P  395 (395)
T 3b9f_I          341 VVEVDESGTRAAAATGTIFTFRSARLNSQRLVFNRPFLMFIVD---NNILFLGKVNRP  395 (395)
T ss_dssp             EEEECSCEEECCCSCSCSSBCCSCCCCCEEEECCSCEEEEEES---SSEEEEEEESCC
T ss_pred             EEEEcCCCcccccccchhhhhccCCCCCCEEEEeCCEEEEEEc---CCEEEEEEeCCC
Confidence            99999999999999987665 44   46789999999999999   899999999998

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor}

Probab=100.00  E-value=2.6e-61  Score=471.60  Aligned_cols=293  Identities=20%  Similarity=0.307  Sum_probs=255.9

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch--------hhHHhhc
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG--------RSLSNKL   79 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~--------~~ll~~l   79 (357)
                      ....+.+++++||++||+++..  .+++|+|+||+||+.+|+|+++||+|+|++||.++||++.+        +.++..+
T Consensus         7 ~~~~l~~~~~~Fa~~l~~~l~~--~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~l   84 (376)
T 3ozq_A            7 TLQEFPNAVNSFTPSVYKEVLK--TEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVGDREKAEGAVKEVLSKL   84 (376)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHH--HCCSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHhHHHHHHHHHHhh--CCCCCEEEcHHHHHHHHHHHHhHCchHHHHHHHHHHCCCCcHHHHHHHHHHHHHHh
Confidence            3567899999999999999983  47899999999999999999999999999999999999652        3344444


Q ss_pred             -c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeE
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALV  123 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lv  123 (357)
                       + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ ++++++++++++|+++
T Consensus        85 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~gkI~~ll~~~~l~~~t~lv  164 (376)
T 3ozq_A           85 TNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSEKNDAAKLMNAWVEEQTQHKIQNLVDPEILNNLTRVV  164 (376)
T ss_dssp             BCSSCEEEEEEEEEEETTSCCCHHHHHHHHHTTSCEEEEECCSSHHHHHHHHHHHHHHHTTTCSCCCSCGGGCCTTCCEE
T ss_pred             cCCCcEEeeehhHHHhCCCcchHHHHHHHHHhhCCeeEEecCCChHHHHHHHHHHHHhhhcCchhhccCcccCCCcceEE
Confidence             3 5667766   7665                     6788   334   99999   9999 9999888899999999


Q ss_pred             eecc-------cCCCCCCCceeeeeeec---------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCCh
Q psy5102         124 LLGS-------DGQTKDELTHFMGVATG---------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDL  177 (357)
Q Consensus       124 Lvna-------~~~F~~~~T~~~~F~~~---------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L  177 (357)
                      |+||       +.||++..|.+++||..               . +|+++++++|++|+  |.++ ++|+|||| +..+|
T Consensus       165 LvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vleLPy~~~-~sm~iiLP~~~~~l  243 (376)
T 3ozq_A          165 LINALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGG-ASLTIVLSNQIEGL  243 (376)
T ss_dssp             EEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS-CEEEEEEESSTTCH
T ss_pred             EEehhhhhhhhccCCCcccceeeeeEecCCcEEEEeehhhccCceeEEEecCCCeEEEEEeCCCC-EEEEEEeCCCCCCH
Confidence            9999       89999999999999975               1 46677889999999  9988 99999999 88899


Q ss_pred             hHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCC-CceeeeeeEEEEE
Q psy5102         178 SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR-GVAVDQVFHKVDI  256 (357)
Q Consensus       178 ~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~-~l~vs~v~qk~~i  256 (357)
                      .+++++|+.+.+.+   +++.+.|+|.||||++++++||+++|++||++++|+. .||||+|++++ +++|++|+||+.|
T Consensus       244 ~~l~~~L~~~~l~~---~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~is~~~~~l~vs~v~hka~i  319 (376)
T 3ozq_A          244 VSLESKIKRSFLPH---NLTKQLVNVALPKFKIESTVDFKKVLKKLGVKKAFGD-EADLSGIAGEKGDLVISNIVQKSFI  319 (376)
T ss_dssp             HHHHHTHHHHHSCC---CCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTSSSTTSCCEEEEEEEEEE
T ss_pred             HHHHHHhCHHHHHh---hCCeeEEEEEcccEEeecccchHHHHHhcCchhhcCC-CCCCccccCCCCCeEEeeeEeeEEE
Confidence            99999998876544   6788999999999999999999999999999999995 79999999876 8999999999999


Q ss_pred             EEccCccccccccceeee--ec----CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         257 EVTEQGTVAAASTGIIIT--RI----SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       257 ev~E~G~~aaa~t~~~~~--~s----~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      +|||+|++|+|+|++.+.  ++    .|.+|++||||+|+|+|+  +.|||+|+|.+|.
T Consensus       320 eV~E~GteAaAaT~~~~~~~~s~~~~~p~~f~~drPFlf~I~~~--~~iLF~G~v~~p~  376 (376)
T 3ozq_A          320 DVSEEGVEAAAATYIPVILPEMALPDSPKQFIVDHPFIFYIKVK--GMILFAGRVTTLN  376 (376)
T ss_dssp             EECSSEESCCCCCCCCC---------CCEEEECCSCEEEEEEET--TEEEEEEEECCCC
T ss_pred             EECCCCccccccceeeecccccccCCCCceEEeECCEEEEEEEC--CEEEEEEEecCCC
Confidence            999999999999987653  33    245799999999999998  9999999999983

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} SCOP: e.1.1.0

Probab=100.00  E-value=1.9e-60  Score=468.31  Aligned_cols=296  Identities=23%  Similarity=0.344  Sum_probs=251.1

Q ss_pred             hHHHHhhHHHHHHHHHH-HhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc---
Q psy5102          11 ILRRGITQMTLDMERAI-RSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL---   79 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l-~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l---   79 (357)
                      ....++++||++||+++ .+. .+++|++|||+||+.+|+|+++||+|+|++||.++||++..       +.|++.+   
T Consensus         7 ~~~~~~~~Fa~~L~~~l~~~~-~~~~Ni~~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~l~~~l~~~   85 (393)
T 3le2_A            7 ESISLQNQVSMNLAKHVITTV-SQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSSTDQLNSFSSEIVSAVLAD   85 (393)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTS-CTTCCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHHTCSSHHHHHHHHHHTHHHHHSC
T ss_pred             HHHHhhhHHHHHHHHHHhccc-CCCCCEEECHHHHHHHHHHHHhcCCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHhhcc
Confidence            46689999999999999 655 57899999999999999999999999999999999999862       3333333   


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH-H---HH---HHHHH---hCCC-cccCCCCCCCccc
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM-E---RA---IRSVM---TKNQ-NVVFAPLSIVGAL  120 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF-~---~a---IN~wv---T~g~-~~~l~~~~l~~~t  120 (357)
                         . ++.++++   |+++                     .+|| .   .|   ||+||   |+|+ ++++++++++++|
T Consensus        86 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t  165 (393)
T 3le2_A           86 GSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMT  165 (393)
T ss_dssp             CGGGTSCEEEEEEEEEEETTSCBCHHHHHHHHHHSCCEEEEECHHHHHHHHHHHHHHHHHHHTTTSCCCSSCTTCSCTTC
T ss_pred             ccCCCCcEEEeeeehhhcCCCCcChHHHHHHHHhhcceEEEecccccHHHHHHHHHHHHHHhhcCchhhhCCccCCCCCc
Confidence               1 4566666   6665                     6799 2   23   99999   9999 9999988999999


Q ss_pred             eeEeecc-------cCCCCCCCceeeeeeec------------c-cccccCCCCeEEEe--ecC----CeEEEEEEec-C
Q psy5102         121 ALVLLGS-------DGQTKDELTHFMGVATG------------R-SLSNNPEAYASFLE--KMR----NEVYMYFILP-K  173 (357)
Q Consensus       121 ~lvLvna-------~~~F~~~~T~~~~F~~~------------~-~~~~~~~~~~~vve--y~~----~~~sm~iiLP-~  173 (357)
                      +++|+||       +.||++..|.+++||..            . .+.|....+|++|+  |.+    ++++|+|||| +
T Consensus       166 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~vleLPy~~~~~~~~~sm~iiLP~~  245 (393)
T 3le2_A          166 KLIFANALYFKGTWNEKFDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLPDA  245 (393)
T ss_dssp             CEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEECCSCEEEEEETTEEEEEEEBCCTTCSCCEEEEEEEESS
T ss_pred             EEEEEEeeeEecccccCCChhhccccccEeCCCcEEEEccccccCeeeeeeccCcEEEEeecCCCCCCCcEEEEEEeCCC
Confidence            9999999       89999999999999975            1 22333446899999  987    5799999999 8


Q ss_pred             CCChhHHhhccChhHHHHHHHhcCceeE---EEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC----CCce
Q psy5102         174 NPDLSEFTKDLDYDKFSRIIESTNKVDV---IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD----RGVA  246 (357)
Q Consensus       174 ~~~L~~l~~~L~~~~l~~~~~~l~~~~v---~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~----~~l~  246 (357)
                      ..+|.+++++|+... ..|.+.+..+.+   +|.||||++++++||+++|++||++++|+. .||||+|+++    .+++
T Consensus       246 ~~~l~~l~~~L~~~~-~~l~~~~~~~~v~~~~l~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~~~~~~~~l~  323 (393)
T 3le2_A          246 NNGLSDLLDKIVSTP-GFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPFSG-EEGLTEMVESPEMGKNLC  323 (393)
T ss_dssp             TTCHHHHHHHHHHST-TTGGGCCCCSEEEEEEEEEECEEEEEEEETHHHHHHTTCCGGGST-TTCCTTTBSCHHHHTTCC
T ss_pred             CCCHHHHHHHHhcCH-HHHHHhhhhceeeecceECcEEeccCCcchHHHHHhCCchhhcCC-cCCccccccccccCCCee
Confidence            889999999997643 112223444443   789999999999999999999999999998 7999999986    6899


Q ss_pred             eeeeeEEEEEEEccCccccccccceeee-ec-C--C--CEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         247 VDQVFHKVDIEVTEQGTVAAASTGIIIT-RI-S--K--PTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       247 vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s-~--~--~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |++|+||+.|+|||+|++|+|+|++.+. ++ .  +  .+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus       324 vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  392 (393)
T 3le2_A          324 VSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDPL  392 (393)
T ss_dssp             CCEEEEEEEEEECSCBCSCCCCCCCHHHHHTTTSCCCEEEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred             EeEEEEEEEEEEcCCCchhhcccceeeeeccCCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence            9999999999999999999999987655 33 2  2  4799999999999999999999999999996

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1

Probab=100.00  E-value=6.8e-60  Score=464.71  Aligned_cols=294  Identities=21%  Similarity=0.330  Sum_probs=253.5

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h-----hhHHhhc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G-----RSLSNKL   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~-----~~ll~~l   79 (357)
                      ...+..++++||++||+++.+. .+++|+||||+||+.+|+|+++||+|+|++||.++||++.    +     +.+++.+
T Consensus        31 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l  109 (398)
T 1imv_A           31 VNKLAAAVSNFGYDLYRVRSSM-SPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTV  109 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHcc-CCCCCEEEChHHHHHHHHHHHHhcccHHHHHHHHHhCCCCCCcHHHHHHHHHHHHHh
Confidence            4578899999999999999876 6788999999999999999999999999999999999974    1     4455555


Q ss_pred             -c-cceeeee---eccc---------------------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEe
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVL  124 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvL  124 (357)
                       . +..+.++   |+++                     .+|-  +.|   ||+||   |+|+ +++++.  ++++|+++|
T Consensus       110 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vd~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~t~lvL  187 (398)
T 1imv_A          110 TAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNPRLDLQEINNWVQAQMKGKLARSTKE--IPDEISILL  187 (398)
T ss_dssp             TSTTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCSCHHHHHHHHHHHHHHHTTTCSCCCCSC--CCSSCSEEE
T ss_pred             hCCCCCeEEEEEEeecCCCcHHHHHHHHHHHHhCCcceecCCCHHHHHHHHHHHHHHhhcCchhhhhhc--cCCCceEEE
Confidence             2 3334444   7765                     2231  233   99999   9999 999974  999999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec---------------c-cccccCCCCeEEEe--ecCCeEEEEEEec--CCCCh
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG---------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP--KNPDL  177 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~---------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP--~~~~L  177 (357)
                      +||       +.||++..|.+++||..               . +|+++++++|++|+  |.++ ++|+||||  +..+|
T Consensus       188 vNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~f~~~~~~~l~~~vleLPY~~~-~sm~iiLP~~~~~~L  266 (398)
T 1imv_A          188 LGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGS-MSIIFFLPLKVTQNL  266 (398)
T ss_dssp             EEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-EEEEEEEESSCCSCC
T ss_pred             EEhhhhhhhhcCcCChhhCeeeEEEeCCCEEEEEEEEEEecceeEEEEecCCCeEEEEEccCCC-eEEEEEEeCCCCCCH
Confidence            999       89999999999999975               1 45677899999999  9876 99999999  55799


Q ss_pred             hHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEE
Q psy5102         178 SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIE  257 (357)
Q Consensus       178 ~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~ie  257 (357)
                      .+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++|||+++| . .|||++|++ .+++|++|+||+.|+
T Consensus       267 ~~le~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F-~-~Adfsgis~-~~l~vs~v~hka~ie  343 (398)
T 1imv_A          267 TLIEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLF-D-SPDFSKITG-KPIKLTQVEHRAGFE  343 (398)
T ss_dssp             HHHHTTCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHH-H-SCCCTTTCS-SCCCEEEEEEEEEEE
T ss_pred             HHHHHHhCHHHHHHHHHhcceeEEEEEeeeEEEEeEEchhHhhhhcChhhcc-c-ccCCCCCcC-CCEEEEEEEEEEEEE
Confidence            9999999999999999999999999999999999999999999999999999 6 799999998 589999999999999


Q ss_pred             EccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         258 VTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       258 v~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |||+|++|+|+|++.+. ++.+.+|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       344 VnE~GteAaAaT~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  396 (398)
T 1imv_A          344 WNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPR  396 (398)
T ss_dssp             ECSCEEECC--------CCCCCCEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred             ecCCccccccccccccccCCCCceEEccCCEEEEEEECCCCeEEEEEEeCCCC
Confidence            99999999999987665 44678999999999999999999999999999996

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1

Probab=100.00  E-value=9.7e-60  Score=459.60  Aligned_cols=293  Identities=21%  Similarity=0.331  Sum_probs=249.4

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc---h-hhHHhhc-c-cc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT---G-RSLSNKL-T-AH   82 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~---~-~~ll~~l-~-~~   82 (357)
                      ...+.+++++||++||+++.+. ++++|+|+||+||+.+|+|++.||+|+|++||.++|| ..   . +.| +.+ + ++
T Consensus         7 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~-~~~~~~~~~l-~~l~~~~~   83 (370)
T 1sng_A            7 GGFLRDDHLEFALHLHRRLAEA-VPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG-TDPAPLLAAL-DRAVTDSP   83 (370)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHT-STTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHT-SCHHHHHHHH-HHTTTTCT
T ss_pred             HHHHHHHHHHHHHHHHHHHHhc-CCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHHH-HHHHHHHHHH-HHHhCCCc
Confidence            4567789999999999999876 6789999999999999999999999999999999999 33   1 556 555 3 55


Q ss_pred             eeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc
Q psy5102          83 SLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS  127 (357)
Q Consensus        83 ~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna  127 (357)
                      .++++   |+++                     .+||    +.|   ||+||   |+|+ ++++++++++++|+++|+||
T Consensus        84 ~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~lvLvNa  163 (370)
T 1sng_A           84 DLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNA  163 (370)
T ss_dssp             TEEEEEEEEEETTSCCCHHHHHHHHTSTTEEEEEECTTTCHHHHHHHHHHHHHHHTTTSSCCSSCTTSCCTTCCEEEEEE
T ss_pred             eEEEeeeeeeeCCCcccHHHHHHHHhhhCCeEEEecCcCCHHHHHHHHHHHHHHHhcCchhhccCccccCCcccEEEEEE
Confidence            66665   6654                     6788    233   99999   9999 99998888999999999999


Q ss_pred             -------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEeecCCeEEEEEEecCCCChhHHhhccC
Q psy5102         128 -------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLD  185 (357)
Q Consensus       128 -------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vvey~~~~~sm~iiLP~~~~L~~l~~~L~  185 (357)
                             +.||++..|.+++|| .              . +|++.++++|++|+. +++++|+||||+ .+|.++++  +
T Consensus       164 iyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL-~~~~sm~iiLP~-~~L~~l~~--~  238 (370)
T 1sng_A          164 LWAKARWTTPFEAHLTRAGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPP-GTNAAAVP--T  238 (370)
T ss_dssp             EEEECCBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB-STTCEEEEEECC-GGGTTCCC--C
T ss_pred             EEEccccccCCCcccCeeeeEe-cCCeEEEeEEEEEeeeeeeEEeCCCCEEEEEE-CCCEEEEEEecC-CCHHHHhh--C
Confidence                   899999999999999 6              2 677788899999999 888999999998 88999988  8


Q ss_pred             hhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCcccc
Q psy5102         186 YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVA  265 (357)
Q Consensus       186 ~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~a  265 (357)
                      .+.+.+|.++++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++. ++|++|+||+.|+|||+|++|
T Consensus       239 ~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~-l~vs~v~hka~ieV~E~GteA  316 (370)
T 1sng_A          239 APLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGISTVP-LYVDTVIHQARLRVDERGAEG  316 (370)
T ss_dssp             HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTCSSC-CCCCEEEEEEEEEECSCC---
T ss_pred             HHHHHHHHHhCcceeEEEEcceEEEecccchHHHHHhcCcchhcCC-ccCcccCCCCC-eEEEEEEEEEEEEEcCCCccc
Confidence            8899999999999999999999999999999999999999999996 79999999875 999999999999999999999


Q ss_pred             ccccceeee-ec-----CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCCCC
Q psy5102         266 AASTGIIIT-RI-----SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP  313 (357)
Q Consensus       266 aa~t~~~~~-~s-----~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~~~  313 (357)
                      +|+|++.+. ++     .+.+|++||||+|+|+|+  +.|||+|+|.+|....|
T Consensus       317 aAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~~~  368 (370)
T 1sng_A          317 AAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRRR--GAILFLGSIADPHDPGP  368 (370)
T ss_dssp             -----------------CCEEEECCSCEEEEEEET--TEEEEEEEESSCCCCCC
T ss_pred             ccccchhhccccccCCCCCCEEEeeCCEEEEEEEC--CEEEEEEEcCCCCCCCC
Confidence            999987665 43     257899999999999998  99999999999975543

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus}

Probab=100.00  E-value=6.5e-59  Score=460.69  Aligned_cols=295  Identities=23%  Similarity=0.341  Sum_probs=248.2

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---hhHHhhc----c
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---RSLSNKL----T   80 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---~~ll~~l----~   80 (357)
                      ....+..++++||++||+++.+. .+++|+||||+||+.+|+|+++||+|+|++||.++||++..   +++++.+    .
T Consensus        17 ~~~~l~~~~~~Fa~~L~k~l~~~-~~~~Niv~SP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~l~~~~~   95 (430)
T 2r9y_A           17 ETRRLAQAMMAFTTDLFSLVAQT-STSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSCLPHLLSHFYQNLG   95 (430)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHH-CCSSSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCCTTSCHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhc-CCCCCEEECHHHHHHHHHHHHhhcCcHHHHHHHHHhCCCcHHHHHHHHHHHHhhcc
Confidence            45678899999999999999876 67899999999999999999999999999999999999762   3444443    2


Q ss_pred             cceeeee---eccc---------------------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc
Q psy5102          81 AHSLRRG---ITQM---------------------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS  127 (357)
Q Consensus        81 ~~~l~~a---f~~~---------------------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna  127 (357)
                      +..++++   |+++                     .+||  +.+   ||+||   |+|+ ++++++  ++++|+++|+||
T Consensus        96 ~~~L~~An~l~~~~~~~l~~~F~~~~~~~y~a~~~~~d~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~T~lvLvNA  173 (430)
T 2r9y_A           96 PGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGKQEEDLANINQWVKEATEGKIEDFLSE--LPDSTVLLLLNA  173 (430)
T ss_dssp             SSSEEEEEEEEECTTCCCCHHHHHHHHHHHSSCCEECCSCHHHHHHHHHHHHHHHTTTSCCCCCCC--CCSSCSEEEEEE
T ss_pred             CceEEeeehhhhhCCCcccHHHHHHHHHHhCCceeecCCCcHHHHHHHHHHHHHhcCCCccchhhc--cCcccceeEeee
Confidence            4555555   6655                     3455  333   99999   9999 999964  999999999999


Q ss_pred             -------cCCCCCCCceeeeeeec------------c----cccccCCCCeEEEe--ecCCeEEEEEEec-CC-CChhHH
Q psy5102         128 -------DGQTKDELTHFMGVATG------------R----SLSNNPEAYASFLE--KMRNEVYMYFILP-KN-PDLSEF  180 (357)
Q Consensus       128 -------~~~F~~~~T~~~~F~~~------------~----~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~-~~L~~l  180 (357)
                             +.||++..|..++||..            .    +|.+.++++|+||+  |.++ +||+|||| +. .+|.++
T Consensus       174 iyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLPY~~~-~SM~iiLP~~~~~~L~~l  252 (430)
T 2r9y_A          174 IHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKNN-MSFVVVMPTYFEWNVSEV  252 (430)
T ss_dssp             EEEECCEEECCCGGGCEEEEEESSSSEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEESSSCCCHHHH
T ss_pred             eEEecccCCCCCCCCcccceEEecCCeEEEEEeeeecccceeEEEecCCcEEEEEeecCCC-EEEEEEecCCCCCCHHHH
Confidence                   89999999999999976            1    24567899999999  8775 99999999 64 589999


Q ss_pred             hhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEcc
Q psy5102         181 TKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTE  260 (357)
Q Consensus       181 ~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E  260 (357)
                      +++|+.+.+..|  .++.+.|+|.||||++++++||+++|++|||+++|+.  |||++|+++ +++|++|+||+.|+|||
T Consensus       253 e~~L~~~~l~~~--~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~~F~~--Adfsgis~~-~l~Vs~v~Hka~ieVnE  327 (430)
T 2r9y_A          253 LANLTWDTLYHP--SLQERPTKVWLPKLHLQQQLDLVATLSQLGLQELFQG--PDLRGISEQ-NLVVSSVQHQSTMELSE  327 (430)
T ss_dssp             HTTCCHHHHSCC--CSCCEEEEEEEECEEEEEEEECHHHHHHHTTGGGGTC--CCCTTTCSS-CCCEEEEEEEEEEEECS
T ss_pred             HHhcCHHHHHHh--cccCceEEEEeccEEEEeeecHHHHHHhcCccccccc--ccccccCCC-CeEeeccceEEEEEecC
Confidence            999998876553  4677899999999999999999999999999999974  999999986 89999999999999999


Q ss_pred             CccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCC
Q psy5102         261 QGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQ  311 (357)
Q Consensus       261 ~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~  311 (357)
                      +|++|+|+|++.+.++...+|++||||+|+|+|+.||.|||+|+|.+|...
T Consensus       328 eGteAAAaT~~~~~~~s~~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~~  378 (430)
T 2r9y_A          328 AGVEAAAATSVAMNRMSLSSFTVNRPFLFFIMEDTIGVPLFVGSVRNPNPS  378 (430)
T ss_dssp             CEEECC---------CCCEEEECCSCEEEEEEETTTCCEEEEEEESCSCTT
T ss_pred             CCccccccccccccccCCceEEecCCEEEEEEECCCCcEEEEEEecCCCcc
Confidence            999999999876653334589999999999999999999999999999754

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A

Probab=100.00  E-value=3.6e-59  Score=466.05  Aligned_cols=294  Identities=17%  Similarity=0.222  Sum_probs=249.5

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCE-EEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---------------
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNV-VFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---------------   72 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~-v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---------------   72 (357)
                      ...+.+++++||++||+++.+. .+++|+ ||||+||+.+|+|+++||+|+|++||.++||++..               
T Consensus        70 ~~~l~~~~~~Fa~~L~~~l~~~-~~~~Ni~v~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~  148 (453)
T 2wxy_C           70 AAQVAMITNFVGFRMYKMLNEA-GSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCTSRLDGHKVLA  148 (453)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH-CCCSSEEEECHHHHHHHHHHHHHTCCTTHHHHHHHHTTCCCCTTCGGGSBCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhc-CCCCcEEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccccccccccHHHHHH
Confidence            3468889999999999999876 678999 99999999999999999999999999999999741               


Q ss_pred             --hhHHhhc-c--------cceeeee---eccc----------------------cCCH----HHH---HHHHH---hCC
Q psy5102          73 --RSLSNKL-T--------AHSLRRG---ITQM----------------------TLDM----ERA---IRSVM---TKN  106 (357)
Q Consensus        73 --~~ll~~l-~--------~~~l~~a---f~~~----------------------~~dF----~~a---IN~wv---T~g  106 (357)
                        +.++..+ .        ++.++++   |+++                      .+||    +.|   ||+||   |+|
T Consensus       149 ~~~~l~~~l~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~~a~~~IN~WV~~~T~g  228 (453)
T 2wxy_C          149 ALRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLSTDPVLATEKINRFIKAVTGW  228 (453)
T ss_dssp             HHHHHHHHHHC--------CEEEEEEEEEEECTTCCEEHHHHHHHHTTCSCEEEEECCCSSCHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhhccccCCCCccEEEEEEeEeEeCCCCccHHHHHHHHHHcCCCceeeecccCCHHHHHHHHHHHHHHhcCC
Confidence              1222222 1        1346555   5554                      5788    233   99999   999


Q ss_pred             C-cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ec
Q psy5102         107 Q-NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KM  161 (357)
Q Consensus       107 ~-~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~  161 (357)
                      + ++++++  ++++|+++|+||       +.||++..  +++||..              . +|+++++++|++++  |.
T Consensus       229 kI~~ll~~--l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~  304 (453)
T 2wxy_C          229 KMNLPLEG--VSTDSTLLFNTYVHFQGTMRGFSQLPG--VHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPLG  304 (453)
T ss_dssp             CCCCCCCC--CCTTCCEEEEEEEEEEEEEEEEEECSS--CEEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEESS
T ss_pred             chhhhhcc--cCCCCeEEEEehheeeccCCCCCCCcc--CCCcEeCCCeEEEEEEEEEeCCCCEEEecCCCcEEEEEECC
Confidence            9 999975  999999999999       89999987  8899976              2 66777899999999  87


Q ss_pred             CCeEEEEEEec-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCC
Q psy5102         162 RNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNML  240 (357)
Q Consensus       162 ~~~~sm~iiLP-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is  240 (357)
                      + +++|+|||| +..+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++|||+++|+. .|||++|+
T Consensus       305 ~-~~sm~iiLP~~~~~L~~le~~L~~~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsgis  382 (453)
T 2wxy_C          305 E-RATLLLIQPHCISDLDRVEALIFQNDLLTWIENPPPRAIRLTLPQLEIRGSYNLQDLLAEDKLPTLLGA-EANLNNIG  382 (453)
T ss_dssp             S-SEEEEEEEESSGGGHHHHHHHHTC-CCCTTCCCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCTTTTST-TCCCTTTB
T ss_pred             C-CEEEEEEecCCCCCHHHHHHHhCHHHHHHHHHhccccccEEecceEEEeccccHHHHHHhcChhhhhcc-cCCccccc
Confidence            5 699999999 88899999999999999999888999999999999999999999999999999999986 79999999


Q ss_pred             CCCCceeeeeeEEEEEEEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         241 DDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       241 ~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      ++ +++|++|+||+.|+|||+|++|+|+|++....+.+.+|++||||+|+|+|+.||.|||+|+|.+|..
T Consensus       383 ~~-~l~Vs~v~hka~ieVnEeGteAaAaT~~~~~~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~P~~  451 (453)
T 2wxy_C          383 DT-NPRVGEVLNSILLELKAGEEEQPTTSVQQPGSPEALDVTLSSPFLFAIYEQDSGTLHFLGRVNNPQS  451 (453)
T ss_dssp             SS-CCCBCCCEEEEEEEEEEEECCCC----------CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC-
T ss_pred             CC-CceeeEEEEEEEEEecCCCccccccccccccCCCCceEEeeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            87 5999999999999999999999999975433335678999999999999999999999999999963

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-58  Score=453.60  Aligned_cols=295  Identities=21%  Similarity=0.380  Sum_probs=247.1

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch----hhHHhhccccee
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG----RSLSNKLTAHSL   84 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~----~~ll~~l~~~~l   84 (357)
                      +..+.+++++||++||+++.....+++|+||||+||+.+|+|+++||+|+|++||.++||++..    .+.++.+....+
T Consensus        29 ~~~l~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~i~~~~~~l~~~~l  108 (390)
T 2oay_A           29 EAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGV  108 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCC----CCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTCCTTCTTHHHHHHTTCCSSE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCcHHHHHHHHHHHhhCch
Confidence            3468899999999999999742146789999999999999999999999999999999999763    222333311123


Q ss_pred             eee---eccc---------------------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc----
Q psy5102          85 RRG---ITQM---------------------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS----  127 (357)
Q Consensus        85 ~~a---f~~~---------------------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna----  127 (357)
                      +++   |+++                     .+|+  +.+   ||+||   |+|+ ++++++  ++++|+++|+||    
T Consensus       109 ~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~~~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~t~lvLvNaiyFk  186 (390)
T 2oay_A          109 TSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDS--LPSDTRLVLLNAIYLS  186 (390)
T ss_dssp             EEEEEEEECTTSCCCHHHHHHHHHHHSCCCEECCSCHHHHHHHHHHHHHHTTTTSCSCSCSC--CCTTCCEEEEEEEEEE
T ss_pred             hhhhhHhHhcCCcccHHHHHHHHHHhCceeeeccCChHHHHHHHHHHHHHhhCCcccccccc--cCcccceEEEeeEEEe
Confidence            333   5554                     4556  333   99999   9999 999964  999999999999    


Q ss_pred             ---cCCCCCCCceeeeeeec------------c-cccc--cCCCCeEEEe--ecCCeEEEEEEec-CC-CChhHHhhccC
Q psy5102         128 ---DGQTKDELTHFMGVATG------------R-SLSN--NPEAYASFLE--KMRNEVYMYFILP-KN-PDLSEFTKDLD  185 (357)
Q Consensus       128 ---~~~F~~~~T~~~~F~~~------------~-~~~~--~~~~~~~vve--y~~~~~sm~iiLP-~~-~~L~~l~~~L~  185 (357)
                         +.||++..|.+++||..            . +|.|  +++++++|++  |.+ ++||+|||| +. .+|.+++++|+
T Consensus       187 g~W~~~F~~~~T~~~~F~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLpy~~-~~sm~iiLP~~~~~~L~~le~~L~  265 (390)
T 2oay_A          187 AKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSH-NLSLVILVPQNLKHRLEDMEQALS  265 (390)
T ss_dssp             EEBSSCCCTTSCEEEEECC--CCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBST-TEEEEEEEESSTTSCHHHHHHHCC
T ss_pred             cccCCCCCccccEEeeeEECCceEEEEEEEeCceeEEEEecccCceEEEEEecCC-cEEEEEEeCCccCCCHHHHHHHhC
Confidence               89999999999999985            1 3333  3578999999  754 699999999 64 68999999999


Q ss_pred             hhHHHHHHHhcCc---eeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCc
Q psy5102         186 YDKFSRIIESTNK---VDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQG  262 (357)
Q Consensus       186 ~~~l~~~~~~l~~---~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G  262 (357)
                      .+.+..|.+++..   +.|+|.||||++++++||+++|++||+.+ |+. .|||++|+++.+++|++|+||+.|+|||+|
T Consensus       266 ~~~l~~~~~~l~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~-f~~-~Adfsgis~~~~l~vs~v~hka~ieVnE~G  343 (390)
T 2oay_A          266 PSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFD-FSY-DLNLCGLTEDPDLQVSAMQHQTVLELTETG  343 (390)
T ss_dssp             HHHHHHHHHHHHTCCEEEEEEEEECCEEEEEEEHHHHHGGGSSSC-GGG-GCCCTTTCSCCCCCCCCEEEEEEEEECSSE
T ss_pred             HHHHHHHHHhCcccccceeEEecceEEEeccccHHHHHhhcCccc-ccc-cCCccccCCCCCeEEcchhhcceEEECCCC
Confidence            9999999887754   46899999999999999999999999999 876 699999998778999999999999999999


Q ss_pred             cccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         263 TVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       263 ~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      ++|+|+|++.+.++ +..|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus       344 teAaAaT~~~~~~~-~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~  389 (390)
T 2oay_A          344 VEAAAASAISVART-LLVFEVQQPFLFMLWDQQHKFPVFMGRVYDPR  389 (390)
T ss_dssp             EEEEEEEEESCCCC-EEECCCCSCEEEEEEETTTTEEEEEEEECCC-
T ss_pred             ccccccccccccCC-CCeEEecCCEEEEEEECCCCCEEEEEEecCCC
Confidence            99999998755432 35799999999999999999999999999995

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B

Probab=100.00  E-value=8.3e-59  Score=463.49  Aligned_cols=294  Identities=17%  Similarity=0.218  Sum_probs=247.7

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCE--EEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------------
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNV--VFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------------   72 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~--v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------------   72 (357)
                      ....+..++++||++||+++.+. .+++|+  ||||+||+.+|+|+++||+|+|++||.++||++..             
T Consensus        70 ~~~~l~~~~~~Fa~~L~k~l~~~-~~~~Nin~v~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~  148 (453)
T 2wxw_A           70 RAAMVGMLANFLGFRIYGMHSEL-WGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKV  148 (453)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSCT-TTSCSBSSEECHHHHHHHHHHHHHSCCTTHHHHHHHHHTCCCCTTCTTTSBCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhc-CCCCCcCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCccccccccccHHHH
Confidence            34568899999999999999876 577899  99999999999999999999999999999999741             


Q ss_pred             ----hhHHhhc-c-c-------ceeeee---eccc----------------------cCCH---HHH---HHHHH---hC
Q psy5102          73 ----RSLSNKL-T-A-------HSLRRG---ITQM----------------------TLDM---ERA---IRSVM---TK  105 (357)
Q Consensus        73 ----~~ll~~l-~-~-------~~l~~a---f~~~----------------------~~dF---~~a---IN~wv---T~  105 (357)
                          +.++..+ . +       +.++++   |+++                      .+||   +.|   ||+||   |+
T Consensus       149 ~~~~~~l~~~l~~~~~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~a~~~IN~WV~~~T~  228 (453)
T 2wxw_A          149 LSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTELDVAAEKIDRFMQAVTG  228 (453)
T ss_dssp             HHHHHHHHHHHSCCTTTCSCCCEEEEEEEEEECCTTCCEEHHHHHHHHHHCSCEEECBCCTTSHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhhcccccCCCccEEEEEEeEeEECCCccCHHHHHHHHHHhCccceeeeCCCCHHHHHHHHHHHHHHHhc
Confidence                1222233 1 1       346655   5554                      5788   333   99999   99


Q ss_pred             CC-cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--e
Q psy5102         106 NQ-NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--K  160 (357)
Q Consensus       106 g~-~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y  160 (357)
                      |+ ++++++  ++++|+++|+||       +.||++..  +++||..              . +|+++++++|+||+  |
T Consensus       229 gkI~~ll~~--l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY  304 (453)
T 2wxw_A          229 WKTGCSLMG--ASVDSTLAFNTYVHFQGKMKGFSLLAE--PQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPF  304 (453)
T ss_dssp             SCCSCSSTT--CCSSCCCEEEEEEEEEEEETTEEECSS--CCCBCSSSSCCBCCCCEEEEEEEEEECCTTTTEEEEECCB
T ss_pred             CchhhhhcC--cCCCCeEEEEehhEEeccCCCCCCccc--CCCcEeCCCEEEEEEEEEEecccceEEecCCCeEEEEEec
Confidence            99 999975  999999999999       89999987  7899975              2 66777889999999  8


Q ss_pred             cCCeEEEEEEec-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCC
Q psy5102         161 MRNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNM  239 (357)
Q Consensus       161 ~~~~~sm~iiLP-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~i  239 (357)
                      .+ +++|+|||| ++.+|.+++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++|||+++|+. .|||++|
T Consensus       305 ~~-~~sm~iiLP~~~~~L~~le~~L~~~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~Adfsgi  382 (453)
T 2wxw_A          305 TE-SACLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHT-ELNLQKL  382 (453)
T ss_dssp             TT-TEEEEEEEESSCSCHHHHHHTTSCTTHHHHCCCCCEEEEEEEECCCEEEEEEEHHHHSCTTSCHHHHHS-SSCCCSS
T ss_pred             CC-cEEEEEEeCCCCCCHHHHHHHhCHHHHHHHHHhcccccceEecceEEecccccHHHHHHhcCchhhcCC-CCCCCcc
Confidence            76 599999999 88899999999999999999999999999999999999999999999999999999986 7999999


Q ss_pred             CCCCCceeeeeeEEEEEEEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         240 LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       240 s~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      +++ +++|++|+||+.|+|||+|++|+|+|.... .+.+.+|++||||+|+|+|+.||.|||+|+|.+|..
T Consensus       383 s~~-~l~Vs~v~hka~ieVnEeGteAaAat~~~~-~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~  451 (453)
T 2wxw_A          383 SND-RIRVGEVLNSIFFELEADEREPTESTQQLN-KPEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLS  451 (453)
T ss_dssp             CSS-CCCCSCCEEEEEEEEEECC-------------CCCEEEECCSCEEEEEEETTTTEECCEEEESCCC-
T ss_pred             cCC-CceEeEEEEEEEEEecCCCccccccccccc-CCCCCeEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            987 599999999999999999999998886432 335678999999999999999999999999999963

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A

Probab=100.00  E-value=3.4e-53  Score=411.84  Aligned_cols=263  Identities=23%  Similarity=0.381  Sum_probs=229.4

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---------hhHHhhc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---------RSLSNKL   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---------~~ll~~l   79 (357)
                      +..+.+++++||++||+++... .+++|+||||+||+.+|+|+++||+|+|++||.++||++..         +.++..+
T Consensus        16 ~~~l~~~~~~Fa~~L~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l   94 (359)
T 3f02_A           16 ATFPEEAIADLSVNMYNRLRAT-GEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNMV   94 (359)
T ss_dssp             -----CHHHHHHHHHHHHHHHH-STTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTCCC----CHHHHHHCC----
T ss_pred             cHHHHHHHHHHHHHHHHHHhhc-CCCCCEEEcHHHHHHHHHHHHhhcCChHHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Confidence            3467789999999999999876 67899999999999999999999999999999999999861         2333333


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                         + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++++++++|+
T Consensus        95 ~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~  174 (359)
T 3f02_A           95 TAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYINKWVENNTNNLVKDLVSPRDFDAATY  174 (359)
T ss_dssp             ------CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHHHHHHTTTTCSCCSSCGGGCSTTEE
T ss_pred             hcCCCCcEEEEEEEEEEeCCCccchHHHHHHHHHhcCceEEcCCCCHHHHHHHHHHHHHhhhCCcccccCCcccCCCCce
Confidence               2 5667766   7665                     6788   333   99999   9999 99999888999999


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCe------EEEe--ecCCeEEEEEEe
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYA------SFLE--KMRNEVYMYFIL  171 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~------~vve--y~~~~~sm~iiL  171 (357)
                      ++|+||       +.||++..|.+++||..              . +|+++++++|      +||+  |.+++++|+|||
T Consensus       175 lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~a~~~~~~~vleLPY~~~~~sm~iiL  254 (359)
T 3f02_A          175 LALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVL  254 (359)
T ss_dssp             EEEEEEEEEEEEBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECCC---CCEEEEEEEEBTTSSEEEEEEE
T ss_pred             EEEEeHHHHhHHhhccCCcccceeeeeEecCCcEEEccceEeeceEeEEEccCcCcccccccEEEEeEcCCCcEEEEEEE
Confidence            999999       89999999999999976              2 5677778887      9999  999999999999


Q ss_pred             c-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeee
Q psy5102         172 P-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV  250 (357)
Q Consensus       172 P-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v  250 (357)
                      | ++.+|.+++++|+.+.+..|.+.++.+.|+|.||||++++++||+++|++||++++|+. .||||+|+++.+++|++|
T Consensus       255 P~~~~~L~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v  333 (359)
T 3f02_A          255 SRQEVPLATLEPLVKAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLSDNKEIFLSKA  333 (359)
T ss_dssp             CCTTSCHHHHGGGCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTCSCTTEEEEEE
T ss_pred             cCCCCCHHHHHHHhCHHHHHHHHHhCcceEEEEEeeeeEeEeeechHHHHHHcCchhhcCC-CCCccccCCCCCeeEEEE
Confidence            9 88899999999999999999999999999999999999999999999999999999996 799999998779999999


Q ss_pred             eEEEEEEEccCccccccccceee
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~  273 (357)
                      +||+.|+|||+|++|+|+|++.+
T Consensus       334 ~hka~ieVnE~GteAaAaT~~~~  356 (359)
T 3f02_A          334 IHKSFLEVNEEGSEAAAVSGMIA  356 (359)
T ss_dssp             EEEEEEEECSSEEEEEEEEEEEE
T ss_pred             EEEEEEEECCCCchhhhhheeeh
Confidence            99999999999999999998754

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1

Probab=100.00  E-value=9e-53  Score=406.98  Aligned_cols=263  Identities=25%  Similarity=0.353  Sum_probs=237.1

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc---
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL---   79 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l---   79 (357)
                      ..+..++++||++||+++.+. ++++|+||||+||+.+|+|++.||+|+|++||.++||++..       +.+++.+   
T Consensus         3 ~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~   81 (345)
T 1hle_A            3 EQLSTANTHFAVDLFRALNES-DPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVEDIHSRFQSLNADINKP   81 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTGGGSTTHHHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHHHHHHHHHhhc-CCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCCHHHHHHHHHHHHHHHhCC
Confidence            368899999999999999876 67899999999999999999999999999999999999751       4556666   


Q ss_pred             c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeE
Q psy5102          80 T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALV  123 (357)
Q Consensus        80 ~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lv  123 (357)
                      + ++.++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++++|+++
T Consensus        82 ~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lv  161 (345)
T 1hle_A           82 GAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLV  161 (345)
T ss_dssp             SCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSSSCSSCTTSSCTTEEEE
T ss_pred             CCCcEEEEEEEeeecCCCchhHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHHHHHhcCchhhhcCCcCCCCcceEE
Confidence            2 5677776   7665                     6788    333   99999   9999 9999999999999999


Q ss_pred             eecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC----
Q psy5102         124 LLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN----  174 (357)
Q Consensus       124 Lvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~----  174 (357)
                      |+||       +.||++..|.+++||..              . +|++.++++|++|+  |++++++|+|||| +.    
T Consensus       162 LvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~~  241 (345)
T 1hle_A          162 LVNAIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDIEDES  241 (345)
T ss_dssp             EEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEEEEEEEESSCCSSS
T ss_pred             EEEeeEecccccCCCCcccCcceeEEeCCCeEEEEEEEEeeceEeeEEeCCCCeEEEEecCCCCeEEEEEEecCCCcccC
Confidence            9999       89999999999999975              2 67788899999999  9998999999999 77    


Q ss_pred             CChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFH  252 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~q  252 (357)
                      .+|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++||++++|++..|||++|+++.+++|++|+|
T Consensus       242 ~~l~~l~~~L~~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~h  321 (345)
T 1hle_A          242 TGLEKIEKQLTLDKLREWTKPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRGKADLSGMSGARDLFVSKIIH  321 (345)
T ss_dssp             SSCHHHHHTCCHHHHHHHHCGGGCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCHHHHSSSCEEEEEEEE
T ss_pred             cCHHHHHHHhCHHHHHHHhhhhccccceEEEEcceEeeecccchHHHHHhcChhhcCCCCCCCcccCCCCCCeEEeeEEE
Confidence            89999999999999999987  6888999999999999999999999999999999985479999999877899999999


Q ss_pred             EEEEEEccCccccccccceee
Q psy5102         253 KVDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~  273 (357)
                      |+.|+|||+|++|+|+|++.+
T Consensus       322 ka~ieV~E~GteAaAaT~~~~  342 (345)
T 1hle_A          322 KSFVDLNEEGTEAAAATAGTI  342 (345)
T ss_dssp             EEEEEECSSEEEEEEEEEEEE
T ss_pred             EEEEEECCCCeeeccccceee
Confidence            999999999999999997644

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A

Probab=100.00  E-value=5.7e-52  Score=401.04  Aligned_cols=263  Identities=19%  Similarity=0.330  Sum_probs=233.0

Q ss_pred             hccchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hh
Q psy5102           6 MRSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RS   74 (357)
Q Consensus         6 ~~~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~   74 (357)
                      -.+...+..++++||++||+++... .+++|+||||+||+.+|+|++.||+|+|++||.++||++.      +     +.
T Consensus         5 ~~~~~~l~~~~~~Fa~~l~~~l~~~-~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~   83 (343)
T 3ndd_A            5 LETFNKITPNLAEFAFSLYRQLAHQ-SNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQE   83 (343)
T ss_dssp             ----CTTHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHH
T ss_pred             chhHHHHHHHHhHHHHHHHHHHhhc-CCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            3456788999999999999999876 6789999999999999999999999999999999999974      1     44


Q ss_pred             HHhhc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCC
Q psy5102          75 LSNKL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSI  116 (357)
Q Consensus        75 ll~~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l  116 (357)
                      |+..+   + ++.++++   |+++                     .+||   +.|   ||+||   |+|+ +++++  ++
T Consensus        84 l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~g~I~~ll~--~l  161 (343)
T 3ndd_A           84 LLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVK--EL  161 (343)
T ss_dssp             HHHHHTSCCTTCEEEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTSHHHHHHHHHHHHHHHTTTSSCSCCS--CC
T ss_pred             HHHHHhCCCCCceEEeehhhHhhCCCChhHHHHHHHHHHhccccEeecCCCHHHHHHHHHHHHHHhhcCchhhhhh--cC
Confidence            55555   2 5677776   7665                     6788   334   99999   9999 99998  49


Q ss_pred             CccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec
Q psy5102         117 VGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP  172 (357)
Q Consensus       117 ~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP  172 (357)
                      +++|+++|+||       +.||++..|.+++||..              . +|+++++++|+||+  |.++ ++|+||||
T Consensus       162 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~l~~~vleLPY~~~-~sm~iiLP  240 (343)
T 3ndd_A          162 DRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLGN-ATAIFFLP  240 (343)
T ss_dssp             CTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBSSS-EEEEEEEE
T ss_pred             CCCceEEEEeHHHHhHHHhcccCCccccCcceecCCCcEEEEEEEEEEeeEEEEEeccCCeEEEEEecCCC-eEEEEEEe
Confidence            99999999999       89999999999999976              2 56778889999999  8876 89999999


Q ss_pred             CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeE
Q psy5102         173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFH  252 (357)
Q Consensus       173 ~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~q  252 (357)
                      +..+|.++++.|+.+.+..|.+.++.+.|+|.||||++++++||+++|++||++++|++ .|||++|+++.+++|++|+|
T Consensus       241 ~~~~l~~le~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~h  319 (343)
T 3ndd_A          241 DEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAVH  319 (343)
T ss_dssp             CTTCHHHHHHHCCHHHHHHHHHCCCCEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSSSCEEEEEEEE
T ss_pred             CccCHHHHHHHhCHHHHHHHHHhCCcceEEEecccEEEeeccchHHHHHhCCcHhhcCC-CCCCcccCCCCCeeEEEEEE
Confidence            33789999999999999999999999999999999999999999999999999999998 79999999877999999999


Q ss_pred             EEEEEEccCccccccccceee
Q psy5102         253 KVDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       253 k~~iev~E~G~~aaa~t~~~~  273 (357)
                      |+.|||||+|++|+|+|++.+
T Consensus       320 ka~ieV~E~GteAaAaT~~~~  340 (343)
T 3ndd_A          320 KAVLTIDEKGTEAAPDDDDEA  340 (343)
T ss_dssp             EEEEEECSSEEEEEEEEEEEE
T ss_pred             EEEEEECCCCcceecccceee
Confidence            999999999999999998754

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A

Probab=100.00  E-value=4e-52  Score=408.88  Aligned_cols=264  Identities=23%  Similarity=0.408  Sum_probs=235.7

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----------------
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----------------   71 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----------------   71 (357)
                      .+..+..++++||++||+++.+. ++++|+||||+||+.+|+|+++||+|+|++||.++||++.                
T Consensus        25 ~~~~l~~~~~~Fa~~L~k~l~~~-~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~  103 (394)
T 2h4p_A           25 SMEQVSASIGNFTVDLFNKLNET-NRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGR  103 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSSCC---------------
T ss_pred             hHHHHHHHHHHHHHHHHHHHhcc-CCCCCEEEChHHHHHHHHHHHHhccChHHHHHHHHhCCCccccccccccccccccc
Confidence            34578899999999999999876 6789999999999999999999999999999999999963                


Q ss_pred             -------------h------hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH--
Q psy5102          72 -------------G------RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA--   98 (357)
Q Consensus        72 -------------~------~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a--   98 (357)
                                   +      +.++..+   + ++.++++   |+++                     .+||    +.|  
T Consensus       104 ~~~~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~  183 (394)
T 2h4p_A          104 PKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRK  183 (394)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHTCCCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHH
T ss_pred             ccccccccccccHHHHHHHHHHHHHHhhcCCCCcEEEEEEEEEEeCCCCccHHHHHHHHHHhCCeeEEecCcCCHHHHHH
Confidence                         1      2344444   2 5677776   7665                     6788    333  


Q ss_pred             -HHHHH---hCCC-cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccC
Q psy5102          99 -IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNP  151 (357)
Q Consensus        99 -IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~  151 (357)
                       ||+||   |+|+ ++++++++++++|+++|+||       +.||++..|.+++||..              . +|++++
T Consensus       184 ~IN~WV~~~T~gkI~~ll~~~~l~~~T~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~  263 (394)
T 2h4p_A          184 EINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIME  263 (394)
T ss_dssp             HHHHHHHHHTTTCC-CCSCTTTSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEET
T ss_pred             HHHHHHHHhhCCchhhccCccccCCccceeeeeeeeEEceeCCCCCcccccceEEEecCCeEEECceEeccCceeeEEeC
Confidence             99999   9999 99999999999999999999       89999999999999976              2 677889


Q ss_pred             CCCeEEEe--ecCCeEEEEEEec-CC----CChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhh
Q psy5102         152 EAYASFLE--KMRNEVYMYFILP-KN----PDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNT  222 (357)
Q Consensus       152 ~~~~~vve--y~~~~~sm~iiLP-~~----~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~  222 (357)
                      +++|+||+  |.+++++|+|||| +.    .+|.+++++|+.+.+..|.+  .++.+.|+|.||||++++++||+++|++
T Consensus       264 ~l~~~vleLPY~~~~~sM~iiLP~~~~~~~~~L~~le~~L~~~~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~  343 (394)
T 2h4p_A          264 KMNFKMIELPYVKRELSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTETLVDLHLPKFSLEDRIDLRDTLRN  343 (394)
T ss_dssp             TTTEEEEEEEBGGGSEEEEEEEESSCCSSSSSCHHHHHSCCHHHHHHHHTCTTCEEEEEEEEEECEEEEEEEECHHHHHH
T ss_pred             CCCEEEEEeecCCCcEEEEEEecCCCcccCccHHHHHHHhCHHHHHHHhhhhccccceEEEecceEEEeeeechHHHHHh
Confidence            99999999  9998999999999 77    89999999999999999987  6888999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccccccceee
Q psy5102         223 MNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       223 lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~  273 (357)
                      |||+++|+. .|||++|+++.+++|++|+||+.|+|||+|++|+|+|++.+
T Consensus       344 lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~  393 (394)
T 2h4p_A          344 MGMTTAFTT-NADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVII  393 (394)
T ss_dssp             HTCCGGGST-TCCCTTSCSSSCCCEEEEEEEEEEEECSSEEEEEEEEEEEE
T ss_pred             cCCccccCC-ccCcccccCCCCeEEeeeEEEEEEEECCCCchhhcceeecc
Confidence            999999995 79999999877899999999999999999999999997643

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A*

Probab=100.00  E-value=6.1e-52  Score=401.79  Aligned_cols=265  Identities=20%  Similarity=0.266  Sum_probs=233.4

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSN   77 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~   77 (357)
                      ...+..++++||++||+++... ++++|+||||+||+.+|+|++.||+|+|++||.++||++.      +     +.+++
T Consensus         8 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~   86 (350)
T 2xn6_A            8 LYKMSSINADFAFNLYRRFTVE-TPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLIC   86 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHhc-CCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCccCCCHHHHHHHHHHHHH
Confidence            4578899999999999999876 6789999999999999999999999999999999999964      1     34555


Q ss_pred             hc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          78 KL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        78 ~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      .+   + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++  ++++
T Consensus        87 ~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~  164 (350)
T 2xn6_A           87 SLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSHVEMQTKGKVVGLIQD--LKPN  164 (350)
T ss_dssp             HHHSCBTTEEEEEEEEEEEETTCCBCHHHHHHHHHHSCEEEEEECTTSHHHHHHHHHHHHHHHTTTCSCCCCSC--CCTT
T ss_pred             HhhCCCCCcEEEEEEeehhhCCCcHHHHHHHHHHHHhCCEEEeeCCCCHHHHHHHHHHHHHHhhCCchhhhhcc--cCCC
Confidence            55   2 4667766   6665                     6788   333   99999   9999 999975  9999


Q ss_pred             ceeEeecc-------cCCCCCCCceeee-eeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMG-VATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKN  174 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~-F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~  174 (357)
                      |+++|+||       +.||++..|.+++ ||..              . +|+++++++|++|+  |+++ .+|+||||+.
T Consensus       165 t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vleLPy~~~-~sm~iiLP~~  243 (350)
T 2xn6_A          165 TIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKN-ALALFVLPKE  243 (350)
T ss_dssp             CCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECT
T ss_pred             ceeeeeeHHHHhhHhhccCChhhCccCCceEeCCCcEEEEEEEEEeeeEeEEEeCCCCeEEEEeecCCC-eEEEEEecCC
Confidence            99999999       8999999999999 9976              2 67778899999999  8887 4999999933


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV  254 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~  254 (357)
                      .+|.+++++|+.+.+..|.+.++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+||+
T Consensus       244 ~~l~~le~~L~~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v~hka  322 (350)
T 2xn6_A          244 GQMESVEAAMSSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTEDNGLKLSNAAHKA  322 (350)
T ss_dssp             TCHHHHHHHCSHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTBTTCCEEEEEEEEEE
T ss_pred             CCHHHHHHHhCHHHHHHHHHhhhcccceeeeeEEEEEeeecHHHHHHhcCchhhccC-cCCcccccCCCCceeeeeeEEE
Confidence            789999999999999999999999999999999999999999999999999999986 7999999987789999999999


Q ss_pred             EEEEccCccccccccceeee-ecCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RISK  278 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s~~  278 (357)
                      .|+|||+|++|+|+|++.+. ++.|
T Consensus       323 ~ieVnE~GteAaAaT~~~~~~~s~~  347 (350)
T 2xn6_A          323 VLHIGEKGTEAAGAMFLEAIPRSIP  347 (350)
T ss_dssp             EEEECSSEEEEEEEEEEEEEEC---
T ss_pred             EEEECCCceeeccccceeecccCCC
Confidence            99999999999999987665 4433

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A*

Probab=100.00  E-value=8.8e-52  Score=398.61  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=227.0

Q ss_pred             HHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHhhc--
Q psy5102          13 RRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSNKL--   79 (357)
Q Consensus        13 ~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~~l--   79 (357)
                      ..++++||++||+++... ++++|+||||+||+.+|+|++.||+|+|++||.++||++.      +     +.|++.+  
T Consensus         6 ~~~~~~Fa~~l~~~l~~~-~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~l~~~l~~   84 (336)
T 3dy0_A            6 PSSRRDFTFDLYRALASA-APSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELNQ   84 (336)
T ss_dssp             ----CCHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHHHHTTS
T ss_pred             cchhhHHHHHHHHHHhhh-CCCCCEEEchHHHHHHHHHHHhHCcHHHHHHHHHHhCCCCCcCCHHHHHHHHHHHHHHHhC
Confidence            467899999999999877 6789999999999999999999999999999999999975      1     3455555  


Q ss_pred             -c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeE
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALV  123 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lv  123 (357)
                       + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ +++++  +++++|+++
T Consensus        85 ~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~g~I~~l~~--~l~~~t~lv  162 (336)
T 3dy0_A           85 PRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVI  162 (336)
T ss_dssp             CCSSSEEEEEEEEEECTTCCBCHHHHHHHHHHHCCEEEECCTTSHHHHHHHHHHHHHHHTTTSSCCCCC--SCCSCEEEE
T ss_pred             CCCCcEEEEeehhhhCCCCCccHHHHHHHHHHhCCeeEEECCCChHHHHHHHHHHHHHhhcCcHhHhhc--CCCCCCeEE
Confidence             2 5677776   7665                     6888   334   99999   9999 99998  499999999


Q ss_pred             eecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCCCChhH
Q psy5102         124 LLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKNPDLSE  179 (357)
Q Consensus       124 Lvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~~~L~~  179 (357)
                      |+||       +.||++..|.+++||..              . +|.++++++|+||+  |.++ ++|+||||+..+|.+
T Consensus       163 LvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~~~~~~~l~~~vleLPy~~~-~sm~iiLP~~~~l~~  241 (336)
T 3dy0_A          163 MVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGN-ATALFILPSEGKMQQ  241 (336)
T ss_dssp             EEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-CEEEEEEECTTCHHH
T ss_pred             eEehheeeeeccCCCCcccccccceeccCCcEEEEeeEEEEeEEEEEEecCCCeEEEEeecCCC-eEEEEEecCCCCHHH
Confidence            9999       89999999999999976              2 66778899999999  8875 899999993379999


Q ss_pred             HhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEc
Q psy5102         180 FTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVT  259 (357)
Q Consensus       180 l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~  259 (357)
                      ++++|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|++ .||||+|+++.+++|++|+||+.||||
T Consensus       242 le~~L~~~~l~~~~~~l~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~~~~l~vs~v~hka~ieV~  320 (336)
T 3dy0_A          242 VENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISNHSNIQVSEMVHKAVVEVD  320 (336)
T ss_dssp             HHHHCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBCSTTCEEEEEEEEEEEEEC
T ss_pred             HHHHhCHHHHHHHHHhCCcceEEEEcCcEEEEeccchHHHHHhCChhhhhCC-CCCcccccCCCCceeeeeEEEEEEEEC
Confidence            9999999999999999999999999999999999999999999999999998 799999998778999999999999999


Q ss_pred             cCccccccccceee
Q psy5102         260 EQGTVAAASTGIII  273 (357)
Q Consensus       260 E~G~~aaa~t~~~~  273 (357)
                      |+|++|+|+|++.+
T Consensus       321 E~GteAaAaT~~~~  334 (336)
T 3dy0_A          321 ESGTRAAAATGTIF  334 (336)
T ss_dssp             SSEEEEEEEEEEEE
T ss_pred             CCcchhhhheeeee
Confidence            99999999998654

>4afx_A Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_A 3h5c_A* 3f1s_A*

Probab=100.00  E-value=1.1e-51  Score=404.37  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=233.8

Q ss_pred             ccchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h------hh
Q psy5102           7 RSNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G------RS   74 (357)
Q Consensus         7 ~~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~------~~   74 (357)
                      +....+..++++||++||+++... .++ |+||||+||+.+|+|+++||+|+|++||.++||++.      +      +.
T Consensus        49 ~~~~~l~~~~~~Fa~~L~~~l~~~-~~~-Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~~~~  126 (387)
T 4afx_A           49 ASRQQLAKETSNFGFSLLRKISMR-HDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKG  126 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHH-CCS-CEEECHHHHHHHHHHHHTTCCTHHHHHHHHHTTCTTCSCCCTTHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHhhc-CCC-CEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCccccCCHHHHHHHHHH
Confidence            345788999999999999999876 566 999999999999999999999999999999999974      1      34


Q ss_pred             HHhhc--c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCC
Q psy5102          75 LSNKL--T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIV  117 (357)
Q Consensus        75 ll~~l--~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~  117 (357)
                      |+..+  + ++.++++   |+++                     .+||   +.+   ||.||   |+|+ ++++  ++++
T Consensus       127 l~~~l~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~  204 (387)
T 4afx_A          127 LRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYINKETRGKIPKLF--DEIN  204 (387)
T ss_dssp             HHHHHHHCGGGCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHHHHHHHTTTSSSCSC--CCCC
T ss_pred             HHHHhccCCCceEEEEEEEeecCCCchhHHHHHHHHHHhccceEecCCCChHHHHHHHHHHHHHhcCCCccccc--cCCC
Confidence            44444  2 5666666   6665                     6788   334   99999   9999 9999  5699


Q ss_pred             ccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-
Q psy5102         118 GALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-  172 (357)
Q Consensus       118 ~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-  172 (357)
                      ++|+++|+||       +.||++..|..++||..              . +|+++++++|+||+  |.+ +++|+|||| 
T Consensus       205 ~~t~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~-~~sM~iiLP~  283 (387)
T 4afx_A          205 PETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQG-NATMLVVLME  283 (387)
T ss_dssp             TTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTT-SEEEEEEEES
T ss_pred             CCceEEEEeeeEEEeecccCCCcccceeeeeecCCCcEEEEEEEEeeeeEeEEEecCCceEEEEEEcCC-cEEEEEEecC
Confidence            9999999999       89999999999999976              2 66778899999999  988 899999999 


Q ss_pred             CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCC-CCCceeeeee
Q psy5102         173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLD-DRGVAVDQVF  251 (357)
Q Consensus       173 ~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~-~~~l~vs~v~  251 (357)
                      +..+|.+++++|+.+.+..|.+.+..+.|+|.||||++++++||+++|++|||+++|+. .|||++|++ +.+++|++|+
T Consensus       284 ~~~~L~~le~~L~~~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~ADfsgis~~~~~l~Vs~v~  362 (387)
T 4afx_A          284 KMGDHLALEDYLTTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSATGRNLQVSRVL  362 (387)
T ss_dssp             CCSSCCCGGGTCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBSSCCCCEEEEEE
T ss_pred             CCCCHHHHHHHhCHHHHHHHHHhCceeEEEEecCcEEEEeeccHHHHHHhcChhhhhCC-CCCcccccCCCCCceeeeEE
Confidence            87899999999999999999999999999999999999999999999999999999998 799999998 6689999999


Q ss_pred             EEEEEEEccCccccccccceee
Q psy5102         252 HKVDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~  273 (357)
                      ||+.|+|||+|++|+|+|++.+
T Consensus       363 Hka~ieVnEeGteAAAaT~~~~  384 (387)
T 4afx_A          363 QRTVIEVDERGTEAVAGILSEI  384 (387)
T ss_dssp             EEEEEEECSSEEEEEEEEEEEE
T ss_pred             EEEEEEECCCcccccccceeee
Confidence            9999999999999999998755

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A

Probab=100.00  E-value=4.7e-51  Score=394.35  Aligned_cols=260  Identities=24%  Similarity=0.330  Sum_probs=229.2

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc------h-----hhHHh
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT------G-----RSLSN   77 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~------~-----~~ll~   77 (357)
                      ...+..++++||++||+++... .+++|+||||+||+.+|+|++.||+|+|++||.++||++.      +     +.+++
T Consensus         4 ~~~l~~~~~~Fa~~l~~~l~~~-~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~   82 (341)
T 1as4_A            4 DLGLASANVDFAFSLYKQLVLK-APDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLR   82 (341)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHhcc-CCCCcEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCcCCCHHHHHHHHHHHHH
Confidence            3468889999999999999876 6789999999999999999999999999999999999964      1     34555


Q ss_pred             hc---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCcc
Q psy5102          78 KL---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGA  119 (357)
Q Consensus        78 ~l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~  119 (357)
                      .+   + ++.++++   |+++                     .+||   +.+   ||+||   |+|+ ++++++  ++++
T Consensus        83 ~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~~~T~gkI~~ll~~--l~~~  160 (341)
T 1as4_A           83 TLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKD--LDSQ  160 (341)
T ss_dssp             HHCEECSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHHHHHHHTTTSCCCSCCC--CCTT
T ss_pred             HHhccCCCcEEEeeehhHHhCCCchhHHHHHHHHHHhCCceEecCCCCHHHHHHHHHHHHHHhhcCchhhHhhc--cCCC
Confidence            55   2 5677776   7665                     6788   333   99999   9999 999975  9999


Q ss_pred             ceeEeecc-------cCCCCCCCceeeeeeec------------c----cccccCCCCeEEEe--ecCCeEEEEEEecCC
Q psy5102         120 LALVLLGS-------DGQTKDELTHFMGVATG------------R----SLSNNPEAYASFLE--KMRNEVYMYFILPKN  174 (357)
Q Consensus       120 t~lvLvna-------~~~F~~~~T~~~~F~~~------------~----~~~~~~~~~~~vve--y~~~~~sm~iiLP~~  174 (357)
                      |+++|+||       +.||++..|.+++||..            .    +|+++++++|++++  |+++. +|+||||+.
T Consensus       161 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~~-sm~iiLP~~  239 (341)
T 1as4_A          161 TMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNA-SALFILPDQ  239 (341)
T ss_dssp             EEEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSE-EEEEEEECT
T ss_pred             ceEEEEEhHhhcchhcCCCCccccccceeEeCCCeEEEEEEEEecCceEEEEEecCCCeEEEEecCCCCc-EEEEEeeCC
Confidence            99999999       89999999999999975            1    34566788999999  88874 999999933


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeE-EEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDV-IYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHK  253 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v-~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk  253 (357)
                      .+|.+++++|+.+.+..|.++++.+.| +|.||||++++++||+++|++||++++|+. .|||++|+++.+++|++|+||
T Consensus       240 ~~l~~le~~L~~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~~l~vs~v~hk  318 (341)
T 1as4_A          240 DKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITGARNLAVSQVVHK  318 (341)
T ss_dssp             TCHHHHHHTCCHHHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHSSSCEEEEEEEEE
T ss_pred             CCHHHHHHHhCHHHHHHHHHhccccccceEeeeEEEEeeecchHHHHHHcCchhhccC-CCCcccccCCCCEEEeeEEEE
Confidence            789999999999999999999999999 999999999999999999999999999986 799999998778999999999


Q ss_pred             EEEEEccCccccccccceee
Q psy5102         254 VDIEVTEQGTVAAASTGIII  273 (357)
Q Consensus       254 ~~iev~E~G~~aaa~t~~~~  273 (357)
                      +.|+|||+|++|+|+|++.+
T Consensus       319 a~ieVnE~GteAaAaT~~~~  338 (341)
T 1as4_A          319 AVLDVFEEGTEASRATAVKI  338 (341)
T ss_dssp             EEEEECSSEEEEEEEEEEEE
T ss_pred             EEEEECCCccccccccceec
Confidence            99999999999999998644

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1

Probab=100.00  E-value=8.9e-50  Score=382.65  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=227.3

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc--h--hhHHhhc-c-cce
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT--G--RSLSNKL-T-AHS   83 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~--~--~~ll~~l-~-~~~   83 (357)
                      ..+..++++||++||+++.+. ++++|+||||+||+.+|+|++.||+|+|++||.++|| ..  .  +.+ +.+ + ++.
T Consensus         4 ~~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~-~~~~~~~~~l-~~l~~~~~~   80 (323)
T 1mtp_A            4 GFLRDDHLEFALHLHRRLAEA-VPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG-TDPAPLLAAL-DRAVTDSPD   80 (323)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHH-STTCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHT-SCHHHHHHHH-HHHTCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHHhcc-CCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHHH-HHHHHHHHHH-HHHhCCCcE
Confidence            457789999999999999876 6789999999999999999999999999999999999 33  1  555 555 3 556


Q ss_pred             eeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc-
Q psy5102          84 LRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-  127 (357)
Q Consensus        84 l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-  127 (357)
                      ++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++++|+++|+|| 
T Consensus        81 l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~lvLvNai  160 (323)
T 1mtp_A           81 LASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNAL  160 (323)
T ss_dssp             EEEEEEEEECTTSCBCHHHHHHHHHSTTCEEEECCTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSCTTEEEEEEEEE
T ss_pred             EeeeeeeeeECCcEecHHHHHHHHHHhCCEEEEEcCCCCHHHHHHHHHHHHHHHhcCcccccCCcCCCCcccceeeeeee
Confidence            6665   6654                     6888    233   99999   9999 99999888999999999999 


Q ss_pred             ------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEeecCCeEEEEEEecCCCChhHHhhccCh
Q psy5102         128 ------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDY  186 (357)
Q Consensus       128 ------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vvey~~~~~sm~iiLP~~~~L~~l~~~L~~  186 (357)
                            +.||++..|.+++|| .              . +|++.+++++++|+. +++++|+||||+ .+|.++++  +.
T Consensus       161 yFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL-~~~~sm~iiLP~-~~l~~l~~--~~  235 (323)
T 1mtp_A          161 WAKARWTTPFEAHLTREGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPP-GTNAAAVP--TA  235 (323)
T ss_dssp             EEEEEBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB-STTEEEEEEECC-GGGTTCCC--CH
T ss_pred             eeeccccCCCCcccCeeeeee-cCCeEEEeeEEEeeeeEeeEEeCCCCEEEEEE-CCcEEEEEEecC-CCHHHHHh--CH
Confidence                  899999999999999 6              2 677788899999999 888999999998 88999988  88


Q ss_pred             hHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccc
Q psy5102         187 DKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAA  266 (357)
Q Consensus       187 ~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aa  266 (357)
                      +.+..|.+.++.+.|+|.||||++++++||+++|++||++++|+. .|||++|+++. ++|++|+||+.|+|||+|++|+
T Consensus       236 ~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~~-l~vs~v~hka~ieV~E~GteAa  313 (323)
T 1mtp_A          236 PLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGISTVP-LYVDTVIHQARLRVDERGAEGA  313 (323)
T ss_dssp             HHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBSSC-CEEEEEEEEEEEEEETTEEEEE
T ss_pred             HHHHHHHHhCcceeEEEEeeEEEEecccchHHHHHhCChhhhcCC-CCCcccCCCCC-ceeeeeEEEEEEEECCCccccc
Confidence            899999999999999999999999999999999999999999996 79999999876 9999999999999999999999


Q ss_pred             cccceee
Q psy5102         267 ASTGIII  273 (357)
Q Consensus       267 a~t~~~~  273 (357)
                      |+|++.+
T Consensus       314 AaT~~~~  320 (323)
T 1mtp_A          314 AATAAMM  320 (323)
T ss_dssp             EEEEEEE
T ss_pred             cccceee
Confidence            9998654

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A

Probab=100.00  E-value=8.1e-48  Score=366.28  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             HHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCchhhHHhhc----------c-cceeeeeec
Q psy5102          21 LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKL----------T-AHSLRRGIT   89 (357)
Q Consensus        21 ~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~~~ll~~l----------~-~~~l~~af~   89 (357)
                      ++||+++.+. ++++|+||||+||+.+|+|++.||+|+|++||.++||++...++ ..+          + ++.+...|.
T Consensus         1 ~~l~~~l~~~-~~~~N~~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~-~~l~l~~an~l~~~~~~~l~~~f~   78 (305)
T 1f0c_A            1 MDIFREIASS-MKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNK-DDISFKSMNKVYGRYSAVFKDSFL   78 (305)
T ss_dssp             CHHHHHHHHT-TTTSCEEECHHHHHHHHHHHHHHCCTHHHHHHHTTC----------CCSEEEEEEEEEETTSCBCHHHH
T ss_pred             ChHHHHHhcc-CCCCCEEEchHHHHHHHHHHHHhcCChHHHHHHHHhCCCCcccc-chhhhhheeeEEEeCCCcHHHHHH
Confidence            3789999876 67899999999999999999999999999999999998643111 111          1 222221121


Q ss_pred             c------ccCCH--H-HH--HHHHH---hCCC-cccC-CCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--
Q psy5102          90 Q------MTLDM--E-RA--IRSVM---TKNQ-NVVF-APLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--  144 (357)
Q Consensus        90 ~------~~~dF--~-~a--IN~wv---T~g~-~~~l-~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--  144 (357)
                      +      +.+||  . .+  ||+||   |+|+ ++++ ++  ++.+|+++|+||       +.||++..|.+++||..  
T Consensus        79 ~~~~~~y~~vdF~~~~a~~~IN~WV~~~T~g~I~~l~~~~--~~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~  156 (305)
T 1f0c_A           79 RKIGDNFQTVDFTDCRTVDAINKCVDIFTEGKINPLLDEP--LSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPT  156 (305)
T ss_dssp             HHHGGGEEEECSSSTHHHHHHHHHHHHHTTTSSCCSCCSC--CCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETT
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHhCCCccccccCC--CCCCceeeeeehHhhhhhhhccCCcccCeecEEEECCC
Confidence            1      25788  2 23  99999   9999 9999 54  566799999999       89999999999999975  


Q ss_pred             ---------c-----cccccCCC--CeEEEe--ecCCeEEEEEEec-CCCChhHHhhccChhHHHHHHHhcCceeEEEEe
Q psy5102         145 ---------R-----SLSNNPEA--YASFLE--KMRNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTI  205 (357)
Q Consensus       145 ---------~-----~~~~~~~~--~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~l  205 (357)
                               .     +|++++++  +|++|+  |.++ +||+|||| +..+|.+++++|+.+.+..|.++++.+.|+|.|
T Consensus       157 ~~~~V~mM~~~~~~~~y~~~~~~~~~~~vleLPy~~~-~sm~iiLP~~~~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~l  235 (305)
T 1f0c_A          157 EMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGD-TSMVVILPDNIDGLESIEQNLTDTNFKKWCDSMDAMFIDVHI  235 (305)
T ss_dssp             EEEEEEEEEEEEEEEEEEEECCTTCCEEEEEEEBSSS-EEEEEEEESSTTCHHHHHTTCCHHHHHHHHHTCEEEEEEEEE
T ss_pred             EEEEEEEEEecCcceeeEEcccccCCCEEEEEeCCCC-EEEEEEeCCCCCCHHHHHHHhCHHHHHHHHhhCceeEEEEec
Confidence                     1     23446788  999999  9888 99999999 888999999999999999999999999999999


Q ss_pred             ceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccccccceeee
Q psy5102         206 PKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIIT  274 (357)
Q Consensus       206 PkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~  274 (357)
                      |||++++++||+++|++||++++|+. .|||++|++ .+++|++|+||+.|+|||+|++|+|+|++.+.
T Consensus       236 PKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~-~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~  302 (305)
T 1f0c_A          236 PKFKVTGSYNLVDALVKLGLTEVFGS-TGDYSNMCN-SDVSVDAMIHKTYIDVNEEYTEAAAATCALVA  302 (305)
T ss_dssp             ECEEEEEEEECHHHHHHTTCCSSSST-TCCCTTTBS-SCCEEEEEEEEEEEEECSSEEEEEEEEEEEEE
T ss_pred             ceEEEEeeechHHHHHhcCCCcCCCC-ccccccCCC-CCcEeeeEEEEEEEEECCCceeccccceeeee
Confidence            99999999999999999999999998 799999994 58999999999999999999999999986543

>1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1

Probab=100.00  E-value=1.3e-37  Score=287.11  Aligned_cols=176  Identities=27%  Similarity=0.339  Sum_probs=162.8

Q ss_pred             cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec-----------
Q psy5102          92 TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG-----------  144 (357)
Q Consensus        92 ~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~-----------  144 (357)
                      .+||  +.|   ||+||   |+|+ +++++++ ++++|+++|+||       +.||++..|..++||..           
T Consensus        32 ~vdF~~~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~  110 (245)
T 1m93_B           32 TVDFTDSRTVDAINKSVDIFTEGKINPLLDEP-LSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMS  110 (245)
T ss_dssp             EECTTSTHHHHHHHHHHHHHTTTSSCCSCCSC-CCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEE
T ss_pred             hcCCCCHHHHHHHHHHHHHHhcCchhhhcCCC-CCCCceEEEEEeeeeechhcCCCCcccCceeeEEecCCcEEEEeeee
Confidence            5788  333   99999   9999 9999876 999999999999       89999999999999975           


Q ss_pred             ----c-cccccCCC--CeEEEe--ecCCeEEEEEEec-CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeecc
Q psy5102         145 ----R-SLSNNPEA--YASFLE--KMRNEVYMYFILP-KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSST  214 (357)
Q Consensus       145 ----~-~~~~~~~~--~~~vve--y~~~~~sm~iiLP-~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~  214 (357)
                          . +|++.+++  +|++++  |.++ ++|+|||| +..+|.+++++|+.+.+..|.+.++.+.|+|.||||++++++
T Consensus       111 ~~~~~~~~~~~~~l~~~~~vleLPy~~~-~sm~iiLP~~~~~l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPKF~i~~~~  189 (245)
T 1m93_B          111 MYGEAFNHASVKESFGNFSIIELPYVGD-TSMVVILPDNIDGLESIEQNLTDTNFKKWSDSMDAMFIDVHIPKFKVTGSY  189 (245)
T ss_dssp             ECSCEEEEEEECCTTCCEEEEEEEBSSS-EEEEEEEESSTTCHHHHHTTCCHHHHHHHHHTCEEEECEEEEECEEEEEEE
T ss_pred             eccCceeEEEecccccCCEEEEEecCCC-eEEEEEecCCCCCHHHHHHHhCHHHHHHHHHhCccceEEEECCeEEEeeee
Confidence                1 45667788  999999  9888 99999999 888999999999999999999999999999999999999999


Q ss_pred             chHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEEEccCccccccccce
Q psy5102         215 ELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGI  271 (357)
Q Consensus       215 dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~iev~E~G~~aaa~t~~  271 (357)
                      ||+++|++||++++|+. .||||+|+++ +++|++|+||+.|+|||+|++|+|+|++
T Consensus       190 ~L~~~L~~lGi~~~F~~-~Adfs~is~~-~l~vs~v~hka~ieV~E~GteAaAaT~~  244 (245)
T 1m93_B          190 NLVDALVKLGLTEVFGS-TGDYSNMSNS-DVSVDAMIHKTYIDVNEEYTEAAAATSA  244 (245)
T ss_dssp             EHHHHHHHTTCTTSSST-TCCCTTTBSS-CCCCCCEEEEEEEEECSSEEEEEEEEEE
T ss_pred             ccHHHHHhcCccccCCC-ccCcccccCC-CceEeeEEEEeEEEECCCcccccccccc
Confidence            99999999999999998 7999999988 8999999999999999999999999864

>1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1

Probab=99.35  E-value=5.2e-13  Score=93.73  Aligned_cols=50  Identities=30%  Similarity=0.559  Sum_probs=43.0

Q ss_pred             HHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc
Q psy5102          21 LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT   71 (357)
Q Consensus        21 ~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~   71 (357)
                      ++||+++.+. ++++|+||||+||..+|+|++.||+|+|++||.++|+++.
T Consensus         1 ~~L~~~l~~~-~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~   50 (55)
T 1m93_A            1 MDIFREIASS-MKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEA   50 (55)
T ss_dssp             CHHHHHHHHH-TTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHTTC----
T ss_pred             ChHHHHHHhc-CCCCCEEECHHHHHHHHHHHHhhccchHHHHHHHHhCCCc
Confidence            3789999876 6789999999999999999999999999999999999865

>3ndd_B Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 1ezx_B 3ndf_B 7api_B* 8api_B* 9api_B* 2d26_B

Probab=99.26  E-value=8.1e-12  Score=79.66  Aligned_cols=34  Identities=35%  Similarity=0.744  Sum_probs=31.4

Q ss_pred             CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       277 ~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      .+.+|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus         2 ~p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~   35 (36)
T 3ndd_B            2 IPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ   35 (36)
T ss_dssp             CCCEEECCSCEEEEEEETTTCCEEEEEEESSCCC
T ss_pred             CCCEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence            3678999999999999999999999999999973

>1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1

Probab=99.24  E-value=9e-12  Score=76.81  Aligned_cols=30  Identities=40%  Similarity=0.883  Sum_probs=28.5

Q ss_pred             CEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         279 PTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       279 ~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      .+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus         2 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P   31 (31)
T 1hle_B            2 ENFNADHPFIFFIRHNPSANILFLGRFSSP   31 (31)
T ss_dssp             EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             CEEEEeCCEEEEEEECCCCcEEEEEEecCC
Confidence            479999999999999999999999999998

>4afx_B Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_B

Probab=99.23  E-value=1.3e-11  Score=78.73  Aligned_cols=33  Identities=36%  Similarity=0.850  Sum_probs=30.8

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      +.+|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus         3 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~   35 (36)
T 4afx_B            3 PPVIKIDRPFHFMIYEETSGMLLFLGRVVNPTL   35 (36)
T ss_dssp             CCEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred             CCEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence            568999999999999999999999999999973

>2xn6_B Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn5_B* 2xn7_B*

Probab=99.23  E-value=1.4e-11  Score=78.11  Aligned_cols=32  Identities=34%  Similarity=0.812  Sum_probs=30.0

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      +.+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus         2 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~   33 (35)
T 2xn6_B            2 HPIIQIDRSFMLLILERSTRSILFLGKVVNPT   33 (35)
T ss_dssp             CCEEECCBCEEEEEEETTTTEEEEEEEESCTT
T ss_pred             CCEEEecCCEEEEEEECCCCcEEEEEEeCCcC
Confidence            35799999999999999999999999999996

>2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B

Probab=99.21  E-value=1.5e-11  Score=77.51  Aligned_cols=32  Identities=34%  Similarity=0.727  Sum_probs=29.9

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      +.+|.+||||+|+|+|+.|+.|||+|+|.+|.
T Consensus         2 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~   33 (34)
T 2h4p_B            2 VLKFKVDHPFHFFIRHNKSKTILFFGRFCCPV   33 (34)
T ss_dssp             CEEEECCSCEEEEEEETTTTEEEEEEEECSCC
T ss_pred             CCEEEecCCEEEEEEECCCCeEEEEEEeCCCC
Confidence            35799999999999999999999999999996

>2riv_B Thyroxine-binding globulin; TBG, serpin, cleaved, mutation, glycoprotein, secreted, signaling protein; 1.50A {Homo sapiens} PDB: 2riw_B* 2xn3_B*

Probab=99.20  E-value=1.9e-11  Score=79.79  Aligned_cols=33  Identities=33%  Similarity=0.767  Sum_probs=30.6

Q ss_pred             CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       277 ~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      .+.+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus         6 ~p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~   38 (40)
T 2riv_B            6 LHPIIQIDRSFMLLILERSTRSILFLGKVVNPT   38 (40)
T ss_dssp             -CCEEECCBCEEEEEEETTTTEEEEEEEESCTT
T ss_pred             CCCEEEecCCEEEEEEeCCCCcEEEEEEecCCC
Confidence            467899999999999999999999999999996

>1as4_B Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_B* 3caa_B 4caa_B

Probab=99.19  E-value=1.2e-11  Score=79.32  Aligned_cols=32  Identities=31%  Similarity=0.635  Sum_probs=30.3

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      +..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus         4 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~   35 (37)
T 1as4_B            4 GTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPK   35 (37)
T ss_dssp             CEEEECCSCEEEEEEETTSSCCSEEEEESCTT
T ss_pred             CCEEEecCCEEEEEEeCCCCcEEEEEEeCCCC
Confidence            56799999999999999999999999999996

>3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E

Probab=99.14  E-value=6.1e-11  Score=80.43  Aligned_cols=35  Identities=34%  Similarity=0.751  Sum_probs=31.2

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQR  312 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~~  312 (357)
                      +.+|++||||+|+|+++.|+.|||+|+|.+|+.++
T Consensus         5 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~~   39 (48)
T 3f02_C            5 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETMN   39 (48)
T ss_dssp             CCEEECCSCEEEEEEETTTCCEEEEEEESCCCC--
T ss_pred             CCEEEeeCCEEEEEEECCCCcEEEEEEeCCCCccc
Confidence            56899999999999999999999999999998544

>1m93_C Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_B 1f0c_B

Probab=99.07  E-value=1.6e-10  Score=75.71  Aligned_cols=33  Identities=27%  Similarity=0.524  Sum_probs=29.3

Q ss_pred             CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       277 ~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      .+.+|++||||+|+|+|+. +.|||+|+|.+|..
T Consensus         8 ~p~~f~~drPFlf~I~~~~-~~iLF~G~v~~P~~   40 (41)
T 1m93_C            8 VTNEFSADHPFIYVIRHVD-GKILFVGRYSSPTT   40 (41)
T ss_dssp             -CCEEECCSCEEEEEEETT-SCEEEEEEECSCC-
T ss_pred             CCCEEEeeCCEEEEEEECC-CCEEEEEEeCCcCC
Confidence            4578999999999999998 99999999999973

>1mtp_B Serine proteinase inhibitor (serpin), chain B; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1

Probab=99.02  E-value=3.4e-10  Score=74.90  Aligned_cols=35  Identities=29%  Similarity=0.605  Sum_probs=30.2

Q ss_pred             CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCCCCC
Q psy5102         277 SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQRP  313 (357)
Q Consensus       277 ~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~~~~  313 (357)
                      .+.+|++||||+|+|+|+  ++|||+|+|.+|....+
T Consensus         7 ~p~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~~~   41 (43)
T 1mtp_B            7 RTIRFSVDRPFHIVVRRR--GAILFLGSIADPHDPGP   41 (43)
T ss_dssp             -CEEEECCSCEEEEEEET--TEEEEEEEESSCCCCCC
T ss_pred             CCCEEEeeCCEEEEEEEC--CEEEEEEEeCCcccccc
Confidence            456899999999999998  89999999999975543

>3dy0_B C-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_B*

Probab=98.94  E-value=6.9e-10  Score=67.09  Aligned_cols=28  Identities=36%  Similarity=0.846  Sum_probs=25.9

Q ss_pred             CCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         278 KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       278 ~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +.+|++||||+|+|+++   ++||+|+|.+|
T Consensus         2 ~~~f~~drPFlf~I~~~---~iLF~G~v~~P   29 (29)
T 3dy0_B            2 SQRLVFNRPFLMFIVDN---NILFLGKVNRP   29 (29)
T ss_dssp             CEEEECCSCEEEEEESS---SEEEEEEESCC
T ss_pred             CCEEEecCCEEEEEEcC---ceEEEEEecCC
Confidence            46799999999999987   89999999998

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	357
g1jjo.1	334	e.1.1.1 (A:,C:,E:) Neuroserpin {Mouse (Mus musculu	3e-38
d2b5ti1	426	e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien	7e-34
d2b5ti1	426	e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien	5e-09
d2b5ti1	426	e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien	9e-09
d1qlpa_	372	e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap	3e-33
d1qlpa_	372	e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap	9e-09
d1qlpa_	372	e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap	5e-08
g1lq8.1	358	e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s	6e-33
g1lq8.1	358	e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s	2e-07
g1lq8.1	358	e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s	2e-07
d1xqga_	378	e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId:	1e-32
d1xqga_	378	e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId:	3e-08
d1xqga_	378	e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId:	2e-07
g1as4.1	369	e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human (	3e-32
g1as4.1	369	e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human (	3e-07
g1as4.1	369	e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human (	6e-07
g1hle.1	375	e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c	9e-32
g1hle.1	375	e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c	4e-08
g1hle.1	375	e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c	4e-08
d1lj5a_	379	e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu	1e-31
d1lj5a_	379	e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu	1e-07
d1lj5a_	379	e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu	2e-07
d1jmja_	420	e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin	1e-31
d1jmja_	420	e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin	2e-08
d1jmja_	420	e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin	3e-07
d1uhga_	385	e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId	6e-31
d1uhga_	385	e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId	9e-09
d1uhga_	385	e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId	7e-08
d1by7a_	381	e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu	3e-30
d1by7a_	381	e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu	7e-08
d1by7a_	381	e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu	9e-08
d1imva_	383	e.1.1.1 (A:) Pigment epithelium-derived factor, PE	3e-29
d1imva_	383	e.1.1.1 (A:) Pigment epithelium-derived factor, PE	4e-09
d1imva_	383	e.1.1.1 (A:) Pigment epithelium-derived factor, PE	6e-08
d1k9oi_	376	e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor	3e-27
d1k9oi_	376	e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor	5e-08
d1k9oi_	376	e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor	1e-07
g1m93.1	322	e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res	4e-26
g1m93.1	322	e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res	7e-08
g1mtp.1	355	e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax	2e-23
g1mtp.1	355	e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax	3e-09
g1mtp.1	355	e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax	3e-08

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 7e-34
 Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 7/189 (3%)

Query: 127 SDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPD-LSEFTKDLD 185
                    +        R            L    +++ M  ILPK    L++  K+L 
Sbjct: 236 KADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELT 295

Query: 186 YDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD--R 243
            +     ++   ++ +   +P+ ++     L+  L  M +  +F   KS L  ++ +   
Sbjct: 296 PEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRD 355

Query: 244 GVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP----TVKINRPFIFFIYHKPTDSI 299
            + V   FHK  +EV E+G+ AAAST ++I   S        K NRPF+ FI   P ++I
Sbjct: 356 DLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTI 415

Query: 300 VFWGSIYKP 308
           +F G +  P
Sbjct: 416 IFMGRVANP 424

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.9 bits (131), Expect = 5e-09
 Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 13/134 (9%)

Query: 33  KNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNKLTAHSLRRGITQMT 92
           K +++   P+ I  +        +G  +               +       L +  ++  
Sbjct: 6   KPRDIPMNPMCIYRSPEKKATEDEGSEQK-----------IPEATNRRVWELSKANSRFA 54

Query: 93  LDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLSNNPE 152
               + +      N N+  +PLSI  A A+  LG+   T  +L       T        +
Sbjct: 55  TTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTIS--EKTSD 112

Query: 153 AYASFLEKMRNEVY 166
               F  K+   +Y
Sbjct: 113 QIHFFFAKLNCRLY 126

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.5 bits (130), Expect = 9e-09
 Identities = 13/57 (22%), Positives = 23/57 (40%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
           L +  ++      + +      N N+  +PLSI  A A+  LG+   T  +L     
Sbjct: 46  LSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFK 102

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 2/155 (1%)

Query: 158 LEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELR 217
           L K        F LP    L     +L +D  ++ +E+ ++      +PK+ +T + +L+
Sbjct: 219 LMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLK 278

Query: 218 TVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRIS 277
           +VL  + +T +F  + +DLS + ++  + + +  HK  + + E+GT AA +  +    +S
Sbjct: 279 SVLGQLGITKVFS-NGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMS 337

Query: 278 KP-TVKINRPFIFFIYHKPTDSIVFWGSIYKPEPQ 311
            P  VK N+PF+F +  + T S +F G +  P  +
Sbjct: 338 IPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK 372

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.1 bits (129), Expect = 9e-09
 Identities = 16/83 (19%), Positives = 35/83 (42%), Gaps = 2/83 (2%)

Query: 82  HSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV 141
           + +   + +    + R +    + + N+ F+P+SI  A A++ LG+   T DE+   +  
Sbjct: 2   NKITPNLAEFAFSLYRQLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF 60

Query: 142 -ATGRSLSNNPEAYASFLEKMRN 163
             T    +   E +   L  +  
Sbjct: 61  NLTEIPEAQIHEGFQELLRTLNQ 83

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.8 bits (123), Expect = 5e-08
 Identities = 16/104 (15%), Positives = 41/104 (39%), Gaps = 3/104 (2%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           +   + +    + R +    + + N+ F+P+SI  A A++ LG+   T DE+   +    
Sbjct: 4   ITPNLAEFAFSLYRQLAH-QSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNL 62

Query: 72  GRSLSNKL--TAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAP 113
                 ++      L R + Q    ++    + +  ++ +    
Sbjct: 63  TEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVD 106

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-32
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 8/189 (4%)

Query: 127 SDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPD-----LSEFT 181
           +   TK      M         ++  +    L      + M+ +LPK+ +     L +  
Sbjct: 191 NKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVEDESTGLEKIE 250

Query: 182 KDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNM 239
           K L+ +  S+    +      V  +IPK KV    + +  L  + +  +F    SD S M
Sbjct: 251 KQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSDFSGM 310

Query: 240 LDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSI 299
            + +GVA+  V HKV +E+TE G  +    G  I +  K  +  + PFI+ I H  T +I
Sbjct: 311 SETKGVALSNVIHKVSLEITEDGGDSIEVPGARILQ-HKDELNADHPFIYIIRHNKTRNI 369

Query: 300 VFWGSIYKP 308
           +F+G    P
Sbjct: 370 IFFGKFSSP 378

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 3e-08
 Identities = 14/87 (16%), Positives = 40/87 (45%), Gaps = 1/87 (1%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVA 142
           +L+   +   +D+ + +        NV+F+P+++  +L+L  +G+ G T +E+   +   
Sbjct: 6   ALQLANSAFAVDLFKQLSE-KEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFE 64

Query: 143 TGRSLSNNPEAYASFLEKMRNEVYMYF 169
             + +    +   S + K+ +   +  
Sbjct: 65  NVKDVPFGFQTVTSDVNKLSSFYSLKL 91

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (118), Expect = 2e-07
 Identities = 12/102 (11%), Positives = 45/102 (44%), Gaps = 3/102 (2%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           L+   +   +D+ + +        NV+F+P+++  +L+L  +G+ G T +E+   +    
Sbjct: 7   LQLANSAFAVDLFKQLSE-KEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFEN 65

Query: 72  GRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAP 113
            + +       ++   + +++      +   +  ++++  + 
Sbjct: 66  VKDVPFGF--QTVTSDVNKLSSFYSLKLIKRLYVDKSLNLST 105

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 3/154 (1%)

Query: 158 LEKMRNEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTE 215
           L    + + M+   P   +  LS  T  L     S    +  ++  +  +PK  + +  +
Sbjct: 226 LPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVD 285

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
           LR  L  + +T MF   ++D +++ D   + V Q   KV IEV E GTVA++ST +I++ 
Sbjct: 286 LRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSA 345

Query: 276 ISKP-TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              P  + ++RPF+F + H PT +++F G + +P
Sbjct: 346 RMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (120), Expect = 1e-07
 Identities = 15/94 (15%), Positives = 37/94 (39%), Gaps = 3/94 (3%)

Query: 81  AHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
              +    +   + + + +    +K++NVVF+P  +   LA++ L + G+T+ ++   MG
Sbjct: 5   PSYVAHLASDFGVRVFQQVAQ-ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMG 63

Query: 141 VATGRSLSNNPEAYASFLEKMRNEVYMYFILPKN 174
                       A     +++        I   +
Sbjct: 64  FKI--DDKGMAPALRHLYKELMGPWNKDEISTTD 95

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (118), Expect = 2e-07
 Identities = 13/57 (22%), Positives = 31/57 (54%), Gaps = 1/57 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          +    +   + + + +    +K++NVVF+P  +   LA++ L + G+T+ ++   MG
Sbjct: 8  VAHLASDFGVRVFQQVAQ-ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMG 63

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-31
 Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 3/157 (1%)

Query: 153 AYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTS 212
                LE +     +  +  K   +      L      R  +S         +PK K+  
Sbjct: 263 CDILQLEYVGGISMLIVVPHKMSGMKTLEAQLTPRVVERWQKSMTNRTREVLLPKFKLEK 322

Query: 213 STELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGII 272
           +  L   L  M +  +FD    +++ + D R +A+D   H+  I V E+GT A   T + 
Sbjct: 323 NYNLVESLKLMGIRMLFD-KNGNMAGISDQR-IAIDLFKHQGTITVNEEGTQATTVTTVG 380

Query: 273 ITRISKP-TVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
              +S      ++RPF+F IY   T  ++F G +  P
Sbjct: 381 FMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANP 417

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (127), Expect = 2e-08
 Identities = 15/95 (15%), Positives = 42/95 (44%)

Query: 17  TQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLS 76
            +   ++ R ++  +    N+  AP+ I  A+ ++ LG  G+T +++   +      + S
Sbjct: 52  AKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNAS 111

Query: 77  NKLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVF 111
           +K    ++     ++T  + R       ++ N ++
Sbjct: 112 SKYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLY 146

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (117), Expect = 3e-07
 Identities = 12/65 (18%), Positives = 30/65 (46%)

Query: 89  TQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATGRSLS 148
            +   ++ R ++  +    N+  AP+ I  A+ ++ LG  G+T +++   +      + S
Sbjct: 52  AKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNAS 111

Query: 149 NNPEA 153
           +  E 
Sbjct: 112 SKYEI 116

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

 Score =  118 bits (297), Expect = 6e-31
 Identities = 34/186 (18%), Positives = 69/186 (37%), Gaps = 5/186 (2%)

Query: 127 SDGQTKDELTHFMGVATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPD---LSEFTKD 183
           ++ ++K     +       +   + +     L      + M  +LP         E   +
Sbjct: 201 TEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSMLVLLPDEVSGLEQLESIIN 260

Query: 184 LDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR 243
            +            +  +   +P+MK+     L +VL  M +T +F  S ++LS +    
Sbjct: 261 FEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFS-SSANLSGISSAE 319

Query: 244 GVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISKP-TVKINRPFIFFIYHKPTDSIVFW 302
            + + Q  H    E+ E G     S    +   S     + + PF+F I H  T++++F+
Sbjct: 320 SLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVSEEFRADHPFLFCIKHIATNAVLFF 379

Query: 303 GSIYKP 308
           G    P
Sbjct: 380 GRCVSP 385

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

 Score = 54.1 bits (129), Expect = 9e-09
 Identities = 15/81 (18%), Positives = 37/81 (45%), Gaps = 1/81 (1%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVA 142
           S+     +   D+ + ++     N+N+ + P++I+ ALA+V LG+   T+ ++   +   
Sbjct: 2   SIGAASMEFCFDVFKELKV-HHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFD 60

Query: 143 TGRSLSNNPEAYASFLEKMRN 163
                 ++ EA       + +
Sbjct: 61  KLPGFGDSIEAQCGTSVNVHS 81

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

 Score = 51.4 bits (122), Expect = 7e-08
 Identities = 13/74 (17%), Positives = 33/74 (44%), Gaps = 1/74 (1%)

Query: 12 LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
          +     +   D+ + ++     N+N+ + P++I+ ALA+V LG+   T+ ++   +    
Sbjct: 3  IGAASMEFCFDVFKELKV-HHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDK 61

Query: 72 GRSLSNKLTAHSLR 85
               + + A    
Sbjct: 62 LPGFGDSIEAQCGT 75

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 10/156 (6%)

Query: 163 NEVYMYFILPKNPD-----LSEFTKDLDYDKFSRIIESTN--KVDVIYTIPKMKVTSSTE 215
            +V M+ +LP         L     ++ YDK ++        + +V   IP+ K+    E
Sbjct: 226 GDVSMFLLLPDEIADVSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYE 285

Query: 216 LRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITR 275
           LR++L +M +   F+  +++ S M +   + + +VFH+  ++V E+GT AAA TG ++T 
Sbjct: 286 LRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTG 345

Query: 276 IS---KPTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
            +    P    + PF+F I HK T+ I+F+G    P
Sbjct: 346 RTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 381

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (122), Expect = 7e-08
 Identities = 21/113 (18%), Positives = 46/113 (40%), Gaps = 3/113 (2%)

Query: 83  SLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGV- 141
            L    T   L++ + +    +  QN+  +P SI   +A+V +GS G T+D++   +   
Sbjct: 2   DLCVANTLFALNLFKHLAK-ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFN 60

Query: 142 ATGRSLSNNPEAYASFLEKMRNEVYMYFILPKNPDLSEFTKDLDYDKFSRIIE 194
             G +      ++ S    +      Y +   N    E +     +++ R+ +
Sbjct: 61  EVGAAADKIHSSFRSLSSAINASTGNYLLESVNKLFGEKSASF-REEYIRLCQ 112

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (121), Expect = 9e-08
 Identities = 21/104 (20%), Positives = 45/104 (43%), Gaps = 3/104 (2%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           L    T   L++ + +    +  QN+  +P SI   +A+V +GS G T+D++   +    
Sbjct: 3   LCVANTLFALNLFKHLAK-ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNE 61

Query: 72  GRSLSNKL--TAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAP 113
             + ++K+  +  SL   I   T +      + +   ++  F  
Sbjct: 62  VGAAADKIHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFRE 105

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 6/152 (3%)

Query: 161 MRNEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRT 218
           +   + + F LP      L+   + L  +    I      V  + T+PK+K++   E+  
Sbjct: 233 LTGSMSIIFFLPLKVTQNLTLIEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTK 292

Query: 219 VLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK 278
            L  M + S+FD    D S +   + + + QV H+   E  E G     S G+    ++ 
Sbjct: 293 SLQEMKLQSLFD--SPDFSKI-TGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTF 349

Query: 279 P-TVKINRPFIFFIYHKPTDSIVFWGSIYKPE 309
           P    +N+PFIF +    T +++F G I  P 
Sbjct: 350 PLDYHLNQPFIFVLRDTDTGALLFIGKILDPR 381

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.3 bits (132), Expect = 4e-09
 Identities = 20/87 (22%), Positives = 39/87 (44%), Gaps = 2/87 (2%)

Query: 78  KLTAHSLRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTH 137
           K+  + L   ++    D+ R   S M+   NV+ +PLS+  AL+ + LG+D +T+  +  
Sbjct: 13  KVPVNKLAAAVSNFGYDLYRVRSS-MSPTTNVLLSPLSVATALSALSLGADERTESIIHR 71

Query: 138 FMGVATGRSLSNNPEAYASFLEKMRNE 164
            +      S  +    Y   L+ +   
Sbjct: 72  ALYY-DLISSPDIHGTYKELLDTVTAP 97

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (122), Expect = 6e-08
 Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 1/98 (1%)

Query: 12  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT 71
           L   ++    D+ R   S M+   NV+ +PLS+  AL+ + LG+D +T+  +   +    
Sbjct: 19  LAAAVSNFGYDLYRVRSS-MSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDL 77

Query: 72  GRSLSNKLTAHSLRRGITQMTLDMERAIRSVMTKNQNV 109
             S     T   L   +T    +++ A R V  K   +
Sbjct: 78  ISSPDIHGTYKELLDTVTAPQKNLKSASRIVFEKKLRI 115

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 163 NEVYMYFILPKNPD--LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVL 220
           ++  M  ILP   D   +   K  D    SR  E     +V  T+PK K+ ++T+L+ VL
Sbjct: 227 DQASMIIILPNQVDGITALEQKLKDPKALSRAEERLYNTEVEITLPKFKIETTTDLKEVL 286

Query: 221 NTMNVTSMFDVSKSDLSNMLD-DRGVAVDQVFHKVDIEVTEQGTVAAASTGIIITRISK- 278
           + MN+  +F    + L N+L     + VD    K  IEV E+G  AAA+    I   S  
Sbjct: 287 SNMNIKKLFTPGAARLENLLKTKESLTVDAAIQKAFIEVNEEGAEAAAANAFGIVPKSLI 346

Query: 279 --PTVKINRPFIFFIYHKPTDSIVFWGSIYKP 308
             P V I+RPF F +        +F G + +P
Sbjct: 347 LYPEVHIDRPFYFELKI--DGIPMFNGKVIEP 376

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

 Score = 51.8 bits (123), Expect = 5e-08
 Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 1/58 (1%)

Query: 11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 68
          ILR    Q T  M   +       QNVV +  S++  L  + L S G++ DEL   + 
Sbjct: 8  ILRESNDQFTAQMFSEVVK-ANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALA 64

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

 Score = 51.0 bits (121), Expect = 1e-07
 Identities = 17/57 (29%), Positives = 25/57 (43%), Gaps = 1/57 (1%)

Query: 84  LRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMG 140
           LR    Q T  M   +       QNVV +  S++  L  + L S G++ DEL   + 
Sbjct: 9   LRESNDQFTAQMFSEVVK-ANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALA 64

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	357
d2b5ti1	426	Antithrombin {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jmja_	420	Heparin cofactor II (Hc-II, leuserpin 2) {Human (H	100.0
d1uhga_	385	Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]}	100.0
d1lj5a_	379	Plasminogen activator inhibitor-1 {Human (Homo sap	100.0
g1hle.1	375	Elastase inhibitor {Horse (Equus caballus) [TaxId:	100.0
d1xqga_	378	Maspin {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1by7a_	381	Plasminogen activator inhibitor-2 {Human (Homo sap	100.0
d1imva_	383	Pigment epithelium-derived factor, PEDF {Human (Ho	100.0
d1k9oi_	376	Alaserpin (serpin 1) {Tobacco hornworm (Manduca se	100.0
d1qlpa_	372	Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId:	100.0
g1as4.1	369	Antichymotrypsin, alpha-1 {Human (Homo sapiens) [T	100.0
g1lq8.1	358	Protein C inhibitor {Human (Homo sapiens) [TaxId:	100.0
g1mtp.1	355	Thermopin {Thermobifida fusca [TaxId: 2021]}	100.0
g1jjo.1	334	Neuroserpin {Mouse (Mus musculus) [TaxId: 10090]}	100.0
g1m93.1	322	Viral serpin crmA (cytokine response modifier prot	100.0

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-60  Score=469.58  Aligned_cols=300  Identities=25%  Similarity=0.385  Sum_probs=263.6

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch------------hhHHh
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG------------RSLSN   77 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~------------~~ll~   77 (357)
                      ..+..++++||++||+++....++++|+||||+||+.+|+|+++||+|+|++||.++||++..            +.|..
T Consensus        44 ~~l~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aLa~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~  123 (426)
T d2b5ti1          44 WELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNC  123 (426)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTSCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGSCHHHHHTHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCCEEEECHHHHHHHHHHHHHhCchHHHHHHHHhcCCCCCCcchHHHHHHHHHHHHH
Confidence            358999999999999999743257899999999999999999999999999999999999751            23333


Q ss_pred             hc----c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-cccCCCCCCC
Q psy5102          78 KL----T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVVFAPLSIV  117 (357)
Q Consensus        78 ~l----~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~l~~~~l~  117 (357)
                      .+    + +..++++   |+++                     .+||    +.+   ||+||   |+|+ ++++++++++
T Consensus       124 ~l~~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~  203 (426)
T d2b5ti1         124 RLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAIN  203 (426)
T ss_dssp             HHTSCCCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSC
T ss_pred             HHhccCCCCcEEeeeehhhhcccccchHHHHHHHHHhcCCeEEEecccccHHHHHHHHHHHHHHhcCCCccCCCCccCCC
Confidence            33    2 4556555   6654                     6788    233   99999   9999 9999988999


Q ss_pred             ccceeEeecc-------cCCCCCCCceeeeeeec------------c---cccccCCCCeEEEe--ecCCeEEEEEEec-
Q psy5102         118 GALALVLLGS-------DGQTKDELTHFMGVATG------------R---SLSNNPEAYASFLE--KMRNEVYMYFILP-  172 (357)
Q Consensus       118 ~~t~lvLvna-------~~~F~~~~T~~~~F~~~------------~---~~~~~~~~~~~vve--y~~~~~sm~iiLP-  172 (357)
                      ++|.++|+||       +.||++..|..++||..            .   .|++. +.++++|+  |++++++|+|||| 
T Consensus       204 ~~t~l~Lvna~yFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~-~~~~~vveLPy~~~~~sm~iiLP~  282 (426)
T d2b5ti1         204 ELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRV-AEGTQVLELPFKGDDITMVLILPK  282 (426)
T ss_dssp             TTCCEEEEEEEEEEEEBSSCCCGGGCEEEEECCSSSCCEEEEEEEEEEEEEEEEC-GGGCEEEEEEBTTSSEEEEEEECC
T ss_pred             chhHHHHHhhhhhccccccCccccccccceeecCCCeEEEeecceeecceeeEEc-cCCeEEEEeecCCCceEEEEEecC
Confidence            9999999999       89999999999999976            1   33333 34899999  9999999999999 


Q ss_pred             CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC--CCceeeee
Q psy5102         173 KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD--RGVAVDQV  250 (357)
Q Consensus       173 ~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~--~~l~vs~v  250 (357)
                      +..++..+++.|+.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|++..|||++|+.+  ++++|++|
T Consensus       283 ~~~~l~~le~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~vs~v  362 (426)
T d2b5ti1         283 PEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDA  362 (426)
T ss_dssp             SSSCHHHHHHHCCHHHHHHHHHHCEEEEEEEEEECEEEECCSCHHHHHHTTTCCGGGCTTTCCCTTTSCSSSSCCCCCEE
T ss_pred             CCCCHHHHHHhhhHHHHHHHHHhhhhccceEeeeeEEEEEeecHHHHHHHcCChhhcCCccccCccccccCCCCcEEEeE
Confidence            8999999999999999999999999999999999999999999999999999999998757999999753  48999999


Q ss_pred             eEEEEEEEccCccccccccceeee-ec---CCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIIIT-RI---SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~~-~s---~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      +|++.|+|||+|++|+|+|.+.+. ++   .+.+|++||||+|+|+|+.||.|||+|+|.+|+.
T Consensus       363 ~hka~ieVdE~GteAaa~T~~~~~~~s~~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Pt~  426 (426)
T d2b5ti1         363 FHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCV  426 (426)
T ss_dssp             EEEEEEEECSSEESCCCCCCCCCSCCCCCTTCCCEECCSCEEEEEEETTTCCEEEEEEESCCCC
T ss_pred             EEEEEEEECCCceeccccceeeeccccCCCCCcEEEecCCEEEEEEECCCCCEEEEEEecCCCC
Confidence            999999999999999999987665 43   3568999999999999999999999999999973

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=462.60  Aligned_cols=296  Identities=22%  Similarity=0.349  Sum_probs=263.4

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc--------h--------h
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT--------G--------R   73 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~--------~--------~   73 (357)
                      ..+..++++||++||+++....++++|+|+||+||+.+|+|++.||+|+|++||.++||++.        .        +
T Consensus        45 ~~l~~~n~~F~~~ly~~l~~~~~~~~Niv~SP~si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~i~~~~~  124 (420)
T d1jmja_          45 QRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNLFR  124 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHHhhcchhHHHHHHHHcCCCCcCCcccchhHHHHHHHHH
Confidence            35677889999999999975424678999999999999999999999999999999999864        0        2


Q ss_pred             hHHhhc---c-cceeeee---eccc---------------------cCCH--H-HH--HHHHH---hCCC-cccCCCCCC
Q psy5102          74 SLSNKL---T-AHSLRRG---ITQM---------------------TLDM--E-RA--IRSVM---TKNQ-NVVFAPLSI  116 (357)
Q Consensus        74 ~ll~~l---~-~~~l~~a---f~~~---------------------~~dF--~-~a--IN~wv---T~g~-~~~l~~~~l  116 (357)
                      .+.+.+   + ++.++++   |+++                     .+||  . .+  ||+||   |+|+ ++++++  +
T Consensus       125 ~l~~~l~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~~df~~~~~~~~IN~wv~~~T~g~I~~~l~~--i  202 (420)
T d1jmja_         125 KLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISKTNNHIMKLTKGLIKDALEN--I  202 (420)
T ss_dssp             HHHHHHHSCCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHSSCCEEEECTTCHHHHHHHHHHHHHHTTTSCCCTTSS--C
T ss_pred             HHHHHHhcCCCCcEehhhHHHHhhCCccccHHHHHHHHHhhCceeeccccchHHHHHHHhHhHHhccCCcccchhcc--c
Confidence            334444   2 5567666   6665                     5688  2 33  99999   9999 999975  9


Q ss_pred             CccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec
Q psy5102         117 VGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP  172 (357)
Q Consensus       117 ~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP  172 (357)
                      +++|+++|+||       ++||++..|..++|+..              . +|++.++++|++++  |+++ ++|++|||
T Consensus       203 ~~~t~lvLvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vl~Lpy~~~-~sm~iiLP  281 (420)
T d1jmja_         203 DPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGG-ISMLIVVP  281 (420)
T ss_dssp             CTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-EEEEEEEE
T ss_pred             CCccHHHHHHHHHHHhhhhccCCcccccccceecCCCceeeeeeeeeeccEEEeeccCCCEEEEEEeecCC-eeEEEEec
Confidence            99999999999       89999999999999987              2 67788999999999  8765 99999999


Q ss_pred             -CCCChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeee
Q psy5102         173 -KNPDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVF  251 (357)
Q Consensus       173 -~~~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~  251 (357)
                       +..+|.++++.|+.+.+..|.++++.+.++|.||||++++++||+++|++||++++|++ .|||++|++. +++|++++
T Consensus       282 ~~~~~l~~l~~~l~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGi~~~F~~-~ad~s~is~~-~l~vs~v~  359 (420)
T d1jmja_         282 HKMSGMKTLEAQLTPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAGISDQ-RIAIDLFK  359 (420)
T ss_dssp             SSTTHHHHHHHHCCHHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TSCCTTTCSS-CCCCSEEE
T ss_pred             CCCCchhHHHHhhCHHHHHHHHhhCccceEEEEEEEEEEEeEechHHHHHHcCchhhcCC-CCcccccCCC-CceeeeEE
Confidence             88899999999999999999999999999999999999999999999999999999998 6999999875 89999999


Q ss_pred             EEEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         252 HKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       252 qk~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      |++.|+|||+|++|+|+|.+.+. ++.+++|++||||+|+|+|+.|+.|||+|+|.+|+.
T Consensus       360 hka~ieVdE~GteAaa~T~~~~~~~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Ptk  419 (420)
T d1jmja_         360 HQGTITVNEEGTQATTVTTVGFMPLSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR  419 (420)
T ss_dssp             EEEEEEECSSEESCCCCCCSCCCCSCCSEEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred             EEEEEEEcCCceeecccceeeeccCCCCcEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            99999999999999999987766 557789999999999999999999999999999985

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

Probab=100.00  E-value=4.5e-59  Score=454.85  Aligned_cols=296  Identities=21%  Similarity=0.393  Sum_probs=265.0

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----------------h--
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----------------G--   72 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----------------~--   72 (357)
                      .+..++++||++||+++... ++++|+|+||+||+.+|+|++.||+|+|++||.++||++.                +  
T Consensus         2 ~l~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~Laml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~   80 (385)
T d1uhga_           2 SIGAASMEFCFDVFKELKVH-HANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVH   80 (385)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTT
T ss_pred             cHHHHHHHHHHHHHHHHhcc-CcCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCCccccchhhhhcccHHHHH
Confidence            46789999999999999877 7899999999999999999999999999999999999864                0  


Q ss_pred             ---hhHHhhc---c-cceeeee---eccc---------------------cCCH----HHH---HHHHH---hCCC-ccc
Q psy5102          73 ---RSLSNKL---T-AHSLRRG---ITQM---------------------TLDM----ERA---IRSVM---TKNQ-NVV  110 (357)
Q Consensus        73 ---~~ll~~l---~-~~~l~~a---f~~~---------------------~~dF----~~a---IN~wv---T~g~-~~~  110 (357)
                         +.+.+.+   + +..++++   |+++                     .+||    +.|   ||+|+   |+|+ .++
T Consensus        81 ~~~~~~~~~~~~~~~~~~l~~~~~l~v~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~i~~~  160 (385)
T d1uhga_          81 SSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNV  160 (385)
T ss_dssp             HHHHHHHHHHTSCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSCCC
T ss_pred             HHHHHHHHHhhCCCCCceEEEEEEEEEecCccccHHHHHHHHHHhCCcccccccccHHHHHHHHHHHHHHHHccCCcccc
Confidence               2333444   2 4455655   6554                     5677    234   99999   9999 999


Q ss_pred             CCCCCCCccceeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEE
Q psy5102         111 FAPLSIVGALALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVY  166 (357)
Q Consensus       111 l~~~~l~~~t~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~s  166 (357)
                      +++++++++++++++||       +.||++..|..++||..              . +|++++++++++|+  |++++++
T Consensus       161 v~~~~l~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~~~~~~v~Lpy~~~~~s  240 (385)
T d1uhga_         161 LQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMS  240 (385)
T ss_dssp             SCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEE
T ss_pred             CCccCCCcccceeeeeeEEEecccccccccccccccccccCCCceeeehhheeccccccccccccCcEEEEccccCCCeE
Confidence            99999999999999999       89999999999999987              2 77888999999999  9999999


Q ss_pred             EEEEec-CCCChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCC
Q psy5102         167 MYFILP-KNPDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDR  243 (357)
Q Consensus       167 m~iiLP-~~~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~  243 (357)
                      |+|||| +..++.++++.|+...+..|..  +++++.|+|+||||++++++||+++|++||++++|++ .|||++|+.++
T Consensus       241 m~iilP~~~~~l~~~~~~l~~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~adfs~is~~~  319 (385)
T d1uhga_         241 MLVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SANLSGISSAE  319 (385)
T ss_dssp             EEEEEESSTTCHHHHHHHCCHHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTBCST
T ss_pred             EEEEECCccCchhhhhhhcchhhHHHHhhhhcccceEEEEEeeeEEeecceeHHHHHHhcCCchhhcC-CCCcccCCCCC
Confidence            999999 9999999999999999999964  5678899999999999999999999999999999998 69999999877


Q ss_pred             CceeeeeeEEEEEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         244 GVAVDQVFHKVDIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       244 ~l~vs~v~qk~~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +++|++++|++.|+|||+|++|+++|..... ++.+.+|++||||+|+|+|+.||.|||+|||.+|
T Consensus       320 ~l~vs~i~q~~~i~v~E~Gt~a~a~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P  385 (385)
T d1uhga_         320 SLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVSEEFRADHPFLFCIKHIATNAVLFFGRCVSP  385 (385)
T ss_dssp             TCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTCCCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred             CceeeeEEEEEEEEECCCCcccccccccccccCCCCCEEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence            9999999999999999999999999987655 5577899999999999999999999999999998

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=448.43  Aligned_cols=298  Identities=26%  Similarity=0.439  Sum_probs=265.3

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch--------hhHHhhc--
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG--------RSLSNKL--   79 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~--------~~ll~~l--   79 (357)
                      ..+.++.++||++||+++.+. .+++|+|+||+||+.+|+||+.||+|+|++||.++||++..        +.+...+  
T Consensus         6 ~~~~~~~~~F~~~l~~~l~~~-~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~   84 (379)
T d1lj5a_           6 SYVAHLASDFGVRVFQQVAQA-SKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMG   84 (379)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH-STTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhHHHHHHHHHHHhh-CcCCcEEECHHHHHHHHHHHHHhCCcHHHHHHHHHhCCCCChHHHHHHHHHHHHHhhC
Confidence            467899999999999999877 78899999999999999999999999999999999999751        4455555  


Q ss_pred             -c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeE
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALV  123 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lv  123 (357)
                       . +..++++   |+++                     .+||   +.+   ||.|+   |+|+ .++++++++++++.++
T Consensus        85 ~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~~~  164 (379)
T d1lj5a_          85 PWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLV  164 (379)
T ss_dssp             GGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTSHHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCCEE
T ss_pred             cccccchhhhhHHHHhccCcccHHHHHHHHHhhcceeccccccchHHHHHHHHHHHHhhcCCccccccCccCCCccceee
Confidence             2 5556655   6654                     5788   333   99999   9999 9999999999999999


Q ss_pred             eecc-------cCCCCCCCceeeeeeec--------------c-cccccC---CCCeEEEe--ecCCeEEEEEEec-CC-
Q psy5102         124 LLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNP---EAYASFLE--KMRNEVYMYFILP-KN-  174 (357)
Q Consensus       124 Lvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~---~~~~~vve--y~~~~~sm~iiLP-~~-  174 (357)
                      ++||       +.||++..|..++|+..              . +|++.+   ..++++|+  |+++++||+|||| +. 
T Consensus       165 lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~~M~~~~~~~~~~~~~~~~~~~~vv~Lp~~~~~~sm~iilP~~~~  244 (379)
T d1lj5a_         165 LVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKE  244 (379)
T ss_dssp             EEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESSTT
T ss_pred             eEeeEEEeeeecCcCCccccccccccccCCceEeecceeeccceeeEEeeccccceeEEEEeecCCCcEEEEEecCCccc
Confidence            9999       89999999999999986              1 344443   45689999  9999999999999 54 


Q ss_pred             CChhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEE
Q psy5102         175 PDLSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKV  254 (357)
Q Consensus       175 ~~L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~  254 (357)
                      .++..+++.|+...+..|...++++.|+|.||||++++++||+++|++||++++|++..|||++|+++++++|++++|++
T Consensus       245 ~~l~~l~~~l~~~~~~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~hk~  324 (379)
T d1lj5a_         245 VPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKV  324 (379)
T ss_dssp             SCTHHHHTTCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCEEEEEEEE
T ss_pred             cchHHHhhhccHHHHHHHHhhccccccEEEEEEEEEeeeecHHHHHHhCCChhhcCcccccccccCCCCCcEEeeeEEEE
Confidence            58999999999999999999999999999999999999999999999999999999767999999988799999999999


Q ss_pred             EEEEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         255 DIEVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       255 ~iev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      .|+|||+|++|+++|.+... ++.+.+|++||||+|+|+|+.+|.|||+|||.+|
T Consensus       325 ~iev~E~G~~a~a~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P  379 (379)
T d1lj5a_         325 KIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP  379 (379)
T ss_dssp             EEEECSSEEEEEEEEEEEESSCCCCCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred             EEEECCCceeecccceeeeccCCCCCEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence            99999999999999988776 6677899999999999999999999999999998

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-58  Score=446.95  Aligned_cols=299  Identities=23%  Similarity=0.400  Sum_probs=264.2

Q ss_pred             cchhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch-------hhHHhhc-
Q psy5102           8 SNLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG-------RSLSNKL-   79 (357)
Q Consensus         8 ~~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~-------~~ll~~l-   79 (357)
                      ++..+..++++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++||+++.       +.+...+ 
T Consensus         3 ~~~~l~~a~~~Fa~~L~~~l~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~   81 (378)
T d1xqga_           3 SMDALQLANSAFAVDLFKQLSEK-EPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVN   81 (378)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHHHH-STTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTGGGCSSHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHhh-CCCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCChHHHHHHHHHHHHHHh
Confidence            56678899999999999999877 78999999999999999999999999999999999999761       3444444 


Q ss_pred             --c-cceeeee---eccc---------------------cCCH-H---HH---HHHHH---hCCC-cccCCCCCCCccce
Q psy5102          80 --T-AHSLRRG---ITQM---------------------TLDM-E---RA---IRSVM---TKNQ-NVVFAPLSIVGALA  121 (357)
Q Consensus        80 --~-~~~l~~a---f~~~---------------------~~dF-~---~a---IN~wv---T~g~-~~~l~~~~l~~~t~  121 (357)
                        . ...++++   |+++                     .+|| +   .+   ||+|+   |+|+ ++++++.+++++++
T Consensus        82 ~~~~~~~l~~~~~l~~~~~~~~~~~f~~~~~~~y~~~v~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~~~~~~~~~~t~  161 (378)
T d1xqga_          82 KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTK  161 (378)
T ss_dssp             HHTTTSSEEEEEEEEEETTSCCCHHHHHHTTTTTTTCEEEECHHHHHHHHHHHHHHHHHHHTTTSCSCCSCTTSCCTTCC
T ss_pred             cccCCceEEEeechhhcccccccHHHHHHhhhhccceeEeccccchhhHHHHHHHHHHHHhccCCcccccCCCCCCCCce
Confidence              2 4555555   5554                     5788 2   23   99999   9999 99999989999999


Q ss_pred             eEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CC--
Q psy5102         122 LVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KN--  174 (357)
Q Consensus       122 lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~--  174 (357)
                      ++++|+       +.||++..|.+.+|+..              . +|++.+++++++|+  |++++++|+|||| +.  
T Consensus       162 ~~l~na~~f~~~W~~~F~~~~T~~~~F~~~~~~~~~v~mm~~~~~~~~~~~~~l~~~vv~Lp~~~~~~sm~iilP~~~~~  241 (378)
T d1xqga_         162 ILVVNAAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVED  241 (378)
T ss_dssp             EEEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSSEEEEEEESSCCS
T ss_pred             EEEEEEeEEeeeecCCCccccceecceecCCCceEecccccccceeeeeeccCCCeEEEEeecCCCcEEEEEEecCcccc
Confidence            999999       89999999999999975              2 68888999999999  9999999999999 43  


Q ss_pred             --CChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeee
Q psy5102         175 --PDLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQV  250 (357)
Q Consensus       175 --~~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v  250 (357)
                        .+|.++++.|+.+.+..|..  +++++.|+|+||||++++++||+++|++||++++|++..|||++|+++++++|++|
T Consensus       242 ~~~~L~~l~~~l~~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~i  321 (378)
T d1xqga_         242 ESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSDFSGMSETKGVALSNV  321 (378)
T ss_dssp             SSSSCHHHHHSCSHHHHHHHTCGGGCEEEEEEEEEECEEEEEEECTHHHHHHHTCCGGGCTTTCCCTTTCSCSSCCEEEE
T ss_pred             ccchHHHHHHhcCHHHHHHHhhhhhceeEEEEEEeeeEEEEEeechHHHHHhcCchhccCCCCCccccCCCCCCceEEEe
Confidence              57999999999999999974  56778899999999999999999999999999999986799999998878999999


Q ss_pred             eEEEEEEEccCccccccccceeeeecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         251 FHKVDIEVTEQGTVAAASTGIIITRISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       251 ~qk~~iev~E~G~~aaa~t~~~~~~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      +|++.|+|||+|++|+++|..... ..+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus       322 ~qk~~i~vdE~G~~a~~~t~~~~~-~~~~~f~~drPFlf~I~d~~t~~~Lf~G~v~~P  378 (378)
T d1xqga_         322 IHKVSLEITEDGGDSIEVPGARIL-QHKDELNADHPFIYIIRHNKTRNIIFFGKFSSP  378 (378)
T ss_dssp             EEEEEEEECSCBCCCCCCTTTTTS-SCCCCCBCCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             EEEEEEEEccCccccccccccccC-CCCCEEEccCCEEEEEEECCCCCEEEEEEecCC
Confidence            999999999999999888865332 245789999999999999999999999999998

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=444.53  Aligned_cols=296  Identities=28%  Similarity=0.478  Sum_probs=245.5

Q ss_pred             hHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-h----------hhHHhhc
Q psy5102          11 ILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-G----------RSLSNKL   79 (357)
Q Consensus        11 ~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-~----------~~ll~~l   79 (357)
                      ++..++++||++||+++.+. ++++|+|+||+||+.+|+||+.||+|+|++||.++||++. +          +.+.+.+
T Consensus         2 ~l~~~~~~Fa~~L~~~l~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l   80 (381)
T d1by7a_           2 DLCVANTLFALNLFKHLAKA-SPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAADKIHSSFRSLSSAI   80 (381)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH-SSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTTTTTCCG-GGHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHhc-CCCCcEEECHHHHHHHHHHHHHhcchHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHH
Confidence            57889999999999999877 7899999999999999999999999999999999999975 1          3344444


Q ss_pred             ---c-cceeeee---eccc---------------------cCCH-H---HH---HHHHH---hCCC-cccCCCCCCCccc
Q psy5102          80 ---T-AHSLRRG---ITQM---------------------TLDM-E---RA---IRSVM---TKNQ-NVVFAPLSIVGAL  120 (357)
Q Consensus        80 ---~-~~~l~~a---f~~~---------------------~~dF-~---~a---IN~wv---T~g~-~~~l~~~~l~~~t  120 (357)
                         . +..++.+   |+++                     .+|| +   .+   ||+|+   |+|+ .+++++.+++++|
T Consensus        81 ~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t  160 (381)
T d1by7a_          81 NASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDT  160 (381)
T ss_dssp             C------CEEEEEEEEEETTSCBCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSCTTSSCTTSCCTTC
T ss_pred             hcCCCCcEEeeccchhcccCCccCHHHHHHHHHhhCCceeccccccchHHHHHHHHHHHHHhhcCCccccCCcccCCCcc
Confidence               2 4445555   5554                     6788 2   33   99999   9999 9999998999999


Q ss_pred             eeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCC
Q psy5102         121 ALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNP  175 (357)
Q Consensus       121 ~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~  175 (357)
                      +++|+||       +.||++..|..++|+..              . +|++.++++|++|+  |+++ .+|++||| +..
T Consensus       161 ~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~~~~~~~~~~~~~~v~lp~~~~-~~m~iilp~~~~  239 (381)
T d1by7a_         161 RMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGD-VSMFLLLPDEIA  239 (381)
T ss_dssp             CEEEEEEEEECCCBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEEETTT-EEEEEEEESSCC
T ss_pred             HhhhhheeEEeecccCCCccccccccccccCCCeeEEEeeeeeccccccccccCcCeEEEEeccCCC-eEEEEEecCCcc
Confidence            9999999       89999999999999987              2 77888999999999  7665 89999999 543


Q ss_pred             ----ChhHHhhccChhHHHHHHH--hcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeee
Q psy5102         176 ----DLSEFTKDLDYDKFSRIIE--STNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQ  249 (357)
Q Consensus       176 ----~L~~l~~~L~~~~l~~~~~--~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~  249 (357)
                          .+..+++.++.+.+..|..  .++++.|+|+||||++++++||+++|++||++++|++..|||++|+++.+++|++
T Consensus       240 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~  319 (381)
T d1by7a_         240 DVSTGLELLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSE  319 (381)
T ss_dssp             SSSSSCHHHHHHCCHHHHHHHTSTTTEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBSCSCCCCCE
T ss_pred             chhhhhHHhhhhccHHHHHHHhhhhcccceeEEEecccEEEEeeechHHHHHhcCchhhhccccccccccCCCCCceEee
Confidence                4778888888888988864  4778899999999999999999999999999999997679999999887899999


Q ss_pred             eeEEEEEEEccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         250 VFHKVDIEVTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       250 v~qk~~iev~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |+|++.|+|||+|++|+++|...+. ++  .+++|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus       320 i~q~~~ieVdE~Gt~aaa~t~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P  381 (381)
T d1by7a_         320 VFHQAMVDVNEEGTEAAAGTGGVMTGRTGHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP  381 (381)
T ss_dssp             EEEEEEEEECSCBC-----------------CCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred             EEEEEEEEECCCccccccccceeeecccCCCCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence            9999999999999999999987665 44  46789999999999999999999999999998

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=441.46  Aligned_cols=294  Identities=21%  Similarity=0.339  Sum_probs=253.5

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc----h-----hhHHhhc
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT----G-----RSLSNKL   79 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~----~-----~~ll~~l   79 (357)
                      -..+..++++||++||++++.. ++++|+|+||+||+.+|+||+.||+|+|++||.++||++.    +     ++++..+
T Consensus        16 ~~~~~~~~~~F~~~L~~~l~~~-~~~~Niv~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~~   94 (383)
T d1imva_          16 VNKLAAAVSNFGYDLYRVRSSM-SPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTV   94 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH-CTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhcc-CcCCcEEECHHHHHHHHHHHHHhcChHHHHHHHHHhCCCCCChHHHHHHHHHHHHhh
Confidence            3568899999999999999887 7899999999999999999999999999999999999864    1     4445554


Q ss_pred             -c-cceeeee---eccc---------------------cCCH--HHH---HHHHH---hCCC-cccCCCCCCCccceeEe
Q psy5102          80 -T-AHSLRRG---ITQM---------------------TLDM--ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVL  124 (357)
Q Consensus        80 -~-~~~l~~a---f~~~---------------------~~dF--~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvL  124 (357)
                       . +..++.+   |+++                     .+||  +.+   ||+|+   |+|+ ++++.+  +++++.++|
T Consensus        95 ~~~~~~l~~~n~i~v~~~~~~~~~f~~~~~~~y~~~~~~~~~~~~~~~~~IN~wv~~~T~g~I~~~~~~--~~~~t~~~l  172 (383)
T d1imva_          95 TAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNPRLDLQEINNWVQAQMKGKLARSTKE--IPDEISILL  172 (383)
T ss_dssp             TSTTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCSCHHHHHHHHHHHHHHHTTTCSCCCCSC--CCSSCSEEE
T ss_pred             hcCCcchHHHHHHHhccCCccchHHHHHHHhhcCceeeeccccHHHHHHHHHHHHHhhCcccccccccc--cCccceeee
Confidence             2 4445544   6554                     4566  333   99999   9999 998865  899999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec---------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-C-CCCh
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG---------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-K-NPDL  177 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~---------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~-~~~L  177 (357)
                      +||       ..||++..|..++||..               . +|++++++++++++  |++ +++|++||| + ..++
T Consensus       173 vna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vv~lp~~~-~~sm~iiLP~~~~~~l  251 (383)
T d1imva_         173 LGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTG-SMSIIFFLPLKVTQNL  251 (383)
T ss_dssp             EEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEESSCCSCC
T ss_pred             ecceeeecccccccccccccccccccCCCeEEEeecccccccceeeeeccccceEEEEeecCC-CeEEEEEEecccCCCh
Confidence            999       89999999999999976               1 56778899999999  776 599999999 5 4689


Q ss_pred             hHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEEE
Q psy5102         178 SEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDIE  257 (357)
Q Consensus       178 ~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~ie  257 (357)
                      ..+++.++.+.+..|.++++.+.|+|.||||++++++||+++|++||++++|+.  |||++|+++ +++|++|+|++.|+
T Consensus       252 ~~l~~~l~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGl~~~F~~--adfs~is~~-~l~vs~v~hka~ie  328 (383)
T d1imva_         252 TLIEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFDS--PDFSKITGK-PIKLTQVEHRAGFE  328 (383)
T ss_dssp             HHHHTTCCHHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHHHS--CCCTTTCSS-CCCEEEEEEEEEEE
T ss_pred             HHHhhhccHHHHHHHHhhccceEEEEeeceEEEeeecchhHhhhhcchhhhccc--cCccccCCC-CcEeeeEEEEEEEE
Confidence            999999999999999999999999999999999999999999999999999974  999999875 89999999999999


Q ss_pred             EccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCC
Q psy5102         258 VTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPE  309 (357)
Q Consensus       258 v~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~  309 (357)
                      |||+|++|+++|.+... ++.+.+|++||||+|+|+|+.||.|||+|||.+|.
T Consensus       329 VdE~G~~a~a~t~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P~  381 (383)
T d1imva_         329 WNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPR  381 (383)
T ss_dssp             ECSCEEECC--------CCCCCCEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred             ECCCccccccccceecccCCCCcEEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence            99999999999877655 44678999999999999999999999999999997

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

Probab=100.00  E-value=2.4e-57  Score=441.44  Aligned_cols=297  Identities=27%  Similarity=0.390  Sum_probs=260.3

Q ss_pred             chhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCch---hhHHhhc-----c
Q psy5102           9 NLILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVATG---RSLSNKL-----T   80 (357)
Q Consensus         9 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~~---~~ll~~l-----~   80 (357)
                      +..+.+++++|+++||+++.+. ++++|+|+||+||+.+|+||+.||+|+|++||.++||++.+   +..++.+     .
T Consensus         6 ~~~l~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~La~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~~~~   84 (376)
T d1k9oi_           6 QKILRESNDQFTAQMFSEVVKA-NPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVRA   84 (376)
T ss_dssp             HTTHHHHHHHHHHHHHHHHHTT-STTSCEEECSGGGHHHHHHHTTTBCTHHHHHHHHHTTCSCTTHHHHHHHHHTSSCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHHhh-CCCCeEEECHHHHHHHHHHHHHhcChHHHHHHHHHcCCCCcchHHHHHHHHHHHHhh
Confidence            3468899999999999999987 78899999999999999999999999999999999999873   2233222     1


Q ss_pred             --cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccceeEe
Q psy5102          81 --AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGALALVL  124 (357)
Q Consensus        81 --~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t~lvL  124 (357)
                        +..++++   |+++                     .+||   .++   ||+|+   |+|+ ++++++++++++++++|
T Consensus        85 ~~~~~~~~~~~i~~~~~~~~~~~f~~~~~~~y~~~~~~vdf~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~~~~~l  164 (376)
T d1k9oi_          85 VKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVL  164 (376)
T ss_dssp             CSSBCCEEEEEEEEESSCCBCSGGGSTTTSSSCCCEEEECTTSHHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCCEEE
T ss_pred             cCCCcEEEeeehhhhcCCCcchHHHHHHHhhcCceeecccccccHHHHHHHHHHHHHhhCCceeeccCCCCCCcchhhhh
Confidence              4445544   5554                     5688   233   99999   9999 99999889999999999


Q ss_pred             ecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEec-CCCChhH
Q psy5102         125 LGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILP-KNPDLSE  179 (357)
Q Consensus       125 vna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP-~~~~L~~  179 (357)
                      +||       +.||++..|..++|+..              . +|++.++++|++|+  |++++++|++||| +..++..
T Consensus       165 vna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~l~~~vveLP~~~~~~sm~iilP~~~~~l~~  244 (376)
T d1k9oi_         165 VNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQVDGITA  244 (376)
T ss_dssp             EEEEEEEBCBSSCCCGGGCEEEEECSSSSCCEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSTTTHHH
T ss_pred             hhhhhhhhhhcCCCCccccccceeecCCCceEEEEeeeecccEEEEeeCCCCEEEEEeecCCCceEEEEEecCCCcchhH
Confidence            999       89999999999999987              2 77888999999999  9999999999999 8899999


Q ss_pred             HhhccCh-hHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCC-CCceeeeeeEEEEEE
Q psy5102         180 FTKDLDY-DKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDD-RGVAVDQVFHKVDIE  257 (357)
Q Consensus       180 l~~~L~~-~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~-~~l~vs~v~qk~~ie  257 (357)
                      ++++|.. +.+..|...+..+.|+|+||||++++++||+++|++||++++|++..|||++|+.. .+++|++++|++.|+
T Consensus       245 ~~~~l~~~~~~~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGl~~~F~~~~ad~s~~~~~~~~l~vs~v~q~~~ie  324 (376)
T d1k9oi_         245 LEQKLKDPKALSRAEERLYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLTVDAAIQKAFIE  324 (376)
T ss_dssp             HHHHTTSTTTTTTTTTSCEEEEEEEEEECEEEEEEEEHHHHHHTTTCCSTTSTTTSCBTTTBSSCCCCCCSEEEEEEEEE
T ss_pred             HHhhhcchhhHHHHHhhccceEEEEEeeeEEEeeeecHHHHhhhcCCccccCccccccccccCCCCCEEEEeeEEEEEEE
Confidence            9999875 45777777888899999999999999999999999999999999867999999764 479999999999999


Q ss_pred             EccCccccccccceeee-ec--CCCEEEEcCceEEEEEECCCCcEEEEEEEcCC
Q psy5102         258 VTEQGTVAAASTGIIIT-RI--SKPTVKINRPFIFFIYHKPTDSIVFWGSIYKP  308 (357)
Q Consensus       258 v~E~G~~aaa~t~~~~~-~s--~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P  308 (357)
                      |||+|++|+|+|...+. ++  .+.+|++||||+|+|++.  +.|||+|||.+|
T Consensus       325 vdE~G~~a~a~t~~~~~~~~~~~~~~f~~drPF~f~I~~~--~~~lf~G~v~~P  376 (376)
T d1k9oi_         325 VNEEGAEAAAANAFGIVPKSLILYPEVHIDRPFYFELKID--GIPMFNGKVIEP  376 (376)
T ss_dssp             ECSCBSSCSSSCCSSSEESCCCCCCEEECCSCEEEEEEES--SSEEEEEEESCC
T ss_pred             ECCCceeeecccceeeeccCCCCCCeEEeeCCEEEEEEEC--CeEEEEEEecCC
Confidence            99999999999987655 33  456899999999999984  899999999998

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=432.10  Aligned_cols=296  Identities=21%  Similarity=0.367  Sum_probs=260.2

Q ss_pred             hhHHHHhhHHHHHHHHHHHhccCCCCCEEEchhhHHHHHHHHHcCCCchhHHHHHHhhCCCc-h----------hhHHhh
Q psy5102          10 LILRRGITQMTLDMERAIRSVMTKNQNVVFAPLSIVGALALVLLGSDGQTKDELTHFMGVAT-G----------RSLSNK   78 (357)
Q Consensus        10 ~~~~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~eL~~~Lg~~~-~----------~~ll~~   78 (357)
                      +.++.+.++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++||++. +          +.+++.
T Consensus         2 ~~~~~~~~~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~   80 (372)
T d1qlpa_           2 NKITPNLAEFAFSLYRQLAHQ-SNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRT   80 (372)
T ss_dssp             CTTHHHHHHHHHHHHHHHHHH-CSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHH
T ss_pred             chhhHhHHHHHHHHHHHHhhh-CCCCcEEECHHHHHHHHHHHHHhccHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHH
Confidence            467889999999999999877 7889999999999999999999999999999999999975 1          233444


Q ss_pred             c---c-cceeeee---eccc---------------------cCCH---HHH---HHHHH---hCCC-cccCCCCCCCccc
Q psy5102          79 L---T-AHSLRRG---ITQM---------------------TLDM---ERA---IRSVM---TKNQ-NVVFAPLSIVGAL  120 (357)
Q Consensus        79 l---~-~~~l~~a---f~~~---------------------~~dF---~~a---IN~wv---T~g~-~~~l~~~~l~~~t  120 (357)
                      +   + +..+..+   |+++                     .+||   ..+   ||.|+   |+|+ ++++.+  +++++
T Consensus        81 ~~~~~~~~~l~~~n~i~~~~~~~l~~~f~~~~~~~f~~~~~~~df~~~~~~~~~iN~wv~~~T~g~i~~~~~~--~~~~t  158 (372)
T d1qlpa_          81 LNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKE--LDRDT  158 (372)
T ss_dssp             HSCSSCCCCEEEEEEEEEETTCCBCHHHHHHHHHTSCCEEEEECTTSHHHHHHHHHHHHHHHTTTSSCSCCCC--CCTTC
T ss_pred             hhccCcchhhhhheeeeeccCCccCHHHHHHHHHHhCceeecccccchHHHHHHHHHHHHHHhCCCCcccccC--CCCcc
Confidence            4   1 4445544   5554                     5788   233   99999   9999 999976  89999


Q ss_pred             eeEeecc-------cCCCCCCCceeeeeeec--------------c-cccccCCCCeEEEe--ecCCeEEEEEEecCCCC
Q psy5102         121 ALVLLGS-------DGQTKDELTHFMGVATG--------------R-SLSNNPEAYASFLE--KMRNEVYMYFILPKNPD  176 (357)
Q Consensus       121 ~lvLvna-------~~~F~~~~T~~~~F~~~--------------~-~~~~~~~~~~~vve--y~~~~~sm~iiLP~~~~  176 (357)
                      +++|+||       ..||++..|...+|+..              . +|++++++++++++  |.++.++|+++. +..+
T Consensus       159 ~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~f~~~~~~~l~~~~~~lp~~~~~~~~il~~-~~~~  237 (372)
T d1qlpa_         159 VFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLP-DEGK  237 (372)
T ss_dssp             CEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEE-CTTC
T ss_pred             hhhhhhhheeecccccccchhccccccccccCCceEEEeeeecccceeeeccccCCeEEEecccCCCceEEEEEC-CcCC
Confidence            9999999       88999999999999976              2 77889999999999  888766654443 4568


Q ss_pred             hhHHhhccChhHHHHHHHhcCceeEEEEeceeeEeeccchHHHhhhCCccccCCCCCCCCCCCCCCCCceeeeeeEEEEE
Q psy5102         177 LSEFTKDLDYDKFSRIIESTNKVDVIYTIPKMKVTSSTELRTVLNTMNVTSMFDVSKSDLSNMLDDRGVAVDQVFHKVDI  256 (357)
Q Consensus       177 L~~l~~~L~~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~qk~~i  256 (357)
                      |.++++.|+.+.+..|..+++++.|+|+||||++++++||+++|++||++++|++ .+||++|+++.+++|++++|++.|
T Consensus       238 l~~l~~~L~~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~ad~~~i~~~~~l~vs~v~q~~~i  316 (372)
T d1qlpa_         238 LQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTEEAPLKLSKAVHKAVL  316 (372)
T ss_dssp             HHHHHHHCCHHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHTGGGTCCGGGST-TCCCTTTBSSSCCCCCEEEEEEEE
T ss_pred             HHHHHHhhhHHHHHHHHHhccceEEEEEEEEEEEeeeccHHHHHHhcCchhhhcc-hhhhcCcCCCCCceeeeEEEEEEE
Confidence            9999999999999999999999999999999999999999999999999999998 699999998889999999999999


Q ss_pred             EEccCccccccccceeee-ecCCCEEEEcCceEEEEEECCCCcEEEEEEEcCCCC
Q psy5102         257 EVTEQGTVAAASTGIIIT-RISKPTVKINRPFIFFIYHKPTDSIVFWGSIYKPEP  310 (357)
Q Consensus       257 ev~E~G~~aaa~t~~~~~-~s~~~~f~~nrPFlf~I~d~~t~~iLF~G~v~~P~~  310 (357)
                      +|||+|++|+++|.+... ++.+.+|++||||+|+|+|+.+|.|||+|||.+|+.
T Consensus       317 ~v~E~Gteaaa~t~~~~~~~s~~~~f~~drPFlf~I~~~~t~~iLf~G~v~~Pt~  371 (372)
T d1qlpa_         317 TIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ  371 (372)
T ss_dssp             EECSCSSSSCCCCCCCCCCSSCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred             EECCCccchhhhheeecccCCCCCeEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence            999999999998987666 557789999999999999999999999999999984